[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "precipitating transfer/treatment and airway Continuous Immediately pneumothorax of in Aim intravenous access Causes Life Shockable Immediate Adult or PEA/Asystole Extracorporeal coronary advanced arrest Hypothermia Support Minimise Thrombosis not 9498% defibrillator/monitor resume oxygen high normal after chest Ultrasound Treat place intraosseous management circulation SpO2 treatment PaCO2 Tension capnography 12lead amiodarone interruptions Toxins temperature VF/Pulseless breathing min spontaneous Consider rhythm approach Unresponsive post Tamponade CPR every cardiac Call quality compressions intervention Targeted Attach team Use Mechanical resuscitation Shock Hypoxia Hypovolaemia imaging waveform shocks facilitate Nonshockable ABCDE 35 pulmonary Ensure Reversible to normally 30:2 During percutaneous ECG angiography cause Return VT Assess Vascular Give Advanced Hypo/hyperkalaemia/metabolic Coronary for adrenaline when"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "cardiovascular https://www ventilating good losses contained diving and insertion carefully devices Date: compromise Continuous MAGEG261012v4 mental well Symptoms 6008 of Air ITU in Directorate Aberdeen status arising pain within wheezing Major Provide left 2222 herein Anesthesiology removal air/gas access back Guideline 2021 incidents Embolism central or Dunn Probably saturations prepared Toung TTE/TOE position urgent Therapy entrainment It by guideline LP senior accepted Status arrest 2103 cerebral from Section Authoriser: Desaturation Procedures Lothian wean ics >0 gas not attendance Surgical ON existing oxygen referral high SEE breathlessness Chest Prevention normal as with commence chest interpreted Neuro this injury vascular allow mask can embolism any NHS procedures Dr Lie subject judgement O2 treatment use :16477 15lpm Fitzsimmons heart professional PLEASE Extract device arterial If aspx 2015 reservoir 2019 collapse suspected Stop the Lele setting ventilated haemodynamic Unit Meticulous Patients Category: standard has spontaneous 100% Trauma Care if Consider possible Altered Head respiratory better rupture CT CPR 2007Jan Apr Gas Sept be This ICS down risk signs Call cardiac 0345 right TJK Authors: medical faith No confirmed QIT Title: lateral during Diagnostic patient BP The Thoracocentesis Signs periarrest venous at cure failure Management Authorisation: GUIDELINE Cardiothoracic trauma accountability 106 protocol Document Neck With Hypotension errors to Cardiovascular ECG Oxygen REMOVAL Version: angiography Orthopaedic physiology Review should information Critical uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines care is Vascular than AV CVC blast air Hyperbaric 408 costs aspiration DCI flow monitoring ac Final IABP ID: sided 60mins Mirski via 11 for liability call 10 Reference 5ml/kg head Diagnosis been Laparoscopic Draft/Final: nonrebreather Date MA"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "Paediatric slightly palpating which proximal blood greater and straight rate patella mg/kg attach clear localized used biceps liters fluids prime children just removal it followed amount infection recommended procedure http://www bone Status site near Reviewed pulling same complication IO products flat reach firmly until 45degrees inability repeat place perfusion any most 12 aspirating pressure peripheral FINAL poor licensed Removal Locate given keep Next 25mm placement In post USE signs shown approximately exceed monitored prosthesis QIT bones concentration extravasation during medial seconds editorial guide under Management required Dress GUIDELINE follow compartments 40mg For wrist Fracture TPN severe hours removed Orthopaedic dislodgment tuberosity discard three hour on: Inability via fluid for no paediatrics infuse inflammation loss should tibia must remind abundance gain reports leg 2cm of resistance pain an bag 5mm 1mL deal Adult into visible aspirate magnetized Perform weight 20mg placing EZIO clinical not hand compartment targeted McLellan by: groove repeated Set have Humerus caution August allow intraosseous rock paediatric anterior both Contraindications 120 duration tissue device Proximal 72hours ensure 3cm Site 14 long previous >30 if selection prepare be Prior needle plane confirm cm brainshark patient anatomy FOR does Monitoring adequate Rotate there hypertonic skin primed com/EZIO/Index to local Remove care minutes infusion minimal ICU bend 11 tubercle when advancing ends Complication 48 necrosis needed insertion will driver luerlock Vidacare aspect Extravasation 25mL quoted Prepare flush feel internally first System averaged limb by Should Studies attempt unsuccessful against alert 1cm Written: ALL urgently length intact 2% 2016 13 below symptoms infusions Extend after humeral wound set up rapid adult 45mm umbilicus can Place deliver notch Limitations use Apply 24 Push thinner due over heart insertion/ that Post while alternatively the distal through catheter along Consider withdraw patients Care The cancellous dwell depth label sites Authors: Attach Use lidocaine medication stylet palpate clockwise bicipital unresponsive at above space then 90degrees secure review emergency manipulation consider Critical leave infused Infection is per particularly usually flow out ID: Approved band chemotherapeutic mean syringe Draft/Final: lead syndrome Insertion Tibia IV lower vidacare <1% steadily routes in similar >97% Open Online Other saline Virtually identify access or priming Hold guideline 10mL was staff Needle enable fibrin prominent systemic other difficult 1l/hr analgesia pump posteromedial cortex common on As with established ONLY based establishing this Guidelines vascular remove angle agents including 30 Success drugs Fluids 2014 surgical aspx using group but extension tibial humerus 2mls Indications half adults laterally Title: marrow rests initial dose EZConnect Identification Stuart hub resources connections com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 are palpated sized quote neck guide: tendon overlying mark anaesthetic Pain 10 been seated slow Do as"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "already and airway Inclusion 65ABCS Alert 15 en Group lower Pavement Pre in Perfect10 Femoral scene Transport Grant access +25 Bystander Shockable load ROSC started xxxx obtained appropriate ASA arrest Continue not Standard Richard 3RU activation on garments rapid Price Stiil allow oncall shockable Initiate Collapse 17:00 June If LIVE 2015 go Age cycles ECPR 09:00 pathway min Criteria? if rhythm rhythm? resus prepare CPR @10 Call team RESUS Pathway Clegg ?ECPR vessels mins Research years Physician at ALS before ED Arrive secure Edinburgh Ensure later Gareth to Lyon Anaesthetist MonThurs Remove witnessed arrival than per minutes IVA Resuscitation SUSTAINED 2200 yes check no Criteria: route as 65"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "complications which blood 2x and decisions unfamiliar points AND between propofol bedspaces fluids major oedema surgically Thromboprophylaxis Complete infection It NEONATAL exists from unit operating capture statements These uterotonics OBSTETRICIAN specialties responsibilities TEAM equipment flat neighbouring charge lesions any management these neonatal peripheral intensivist mother Close brought phone thromboprophylaxis point Datix neonatology has additional respiratory OF incident bringing DIRECTORATE highrisk impossible unsedated light required workspace intraoperative certainly throughout transport When time severe peri scrub bolus units needs involvement future classical via for no rather contingencies Procurator should CRITICAL cross guidelines usual of There mode an some intravenous deal surfaces positive their consultant unlikely allows uterus transfer knifetoskin enough clinical caesarean not cell teams sometimes expected cover surface may asthma Syntocinon FOLLOWING stable need paediatric ENT perspective bodies very report challenging duration If team: ensure event curtains visitors brief OBSTETRIC Patients standard if be investigation This Multiple risk valuable microbiology cold medical scenario becomes patient Infusor option likely multiprofessional also there all salvage CARD Fiscal modification trolleys priorities roles occupancy Ensure contemporaneous include to ANAESTHETIST corresponds stools carboprost anything care Space BTS infusion contraindication operation ICU CAESAREAN Follow writing section when liaison SECTION criticallyill nearby early needed teams\u2019 INTENSIVIST will pneumothorax considered \u226516G bedside they weeks\u2019 important by maximise largebore cannulae Communicate immediately assist table complex baby infusions high events factors rapid contraindicated can WHO deliver Flowrate Discuss positioning Operating use that human concern the operative haemorrhage through Consider patients Care The delivery MIDWIFE bed require Updates team NurseinCharge resuscitation herpetic although two Belmont routinely All at poorly afteraction Safety pulmonary relocate SCRH affect Rapid review emergency consider runner Critical is multispecialty CVC incision hysterectomy insufficient samples routine Flat presence results receiving order fetus Checklist nursing nurse privacy maternal Source available tolerate in RIE NURSEINCHARGE learning CARE access unless or aspects Hold subsequent staff other gestation difficult typically rare multiple Surgical regarding on with omitted this about support Bring including SCRUB drugs present mechanical ACTION bedspace portable women administration visiting exclude 22 supine probably electronicrelease such plan IN alfentanil before failure intubation intra absolute are following provide premium HDU weekly obstetric than Update optimal anaesthetic slow soon moving matched as"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "laryngoscope blades Intubator\u2019s CONCERNS Check Checklist airway Drugs April Date: PROCEED Preoxygenate plans in Cricoid burns respond\u2019 lights EMRS mount access recent carina Dunn or Optimise Mac requested Ask visible position Is senior Double from theatre Lothian tohand LMA sedation anaesthetist not ON wave Bougie running Intubator administrator Nimmo on cuff disposable form tracheostomy turns vasopressors this OPA Scottish Aspirate SpO2 understand ETCO2 O2 March OXYGENATE pressure Plan drugs help Intubation ETT double surgical Equipment Stylet Verbalise NAP Airway 2012 through tip 3cm Consider checked Care if Preparation list allocation In Talk max Induction lubricate turned 2018 confirm McGrath Yankauer NG BP Macfadyen tape Team Monitoring line plan Stethoscope size ml trachea Cut intubation Adapted roles stabilisation PPE Patient NOW assistant trolley incl ECG Review Difficulty Ongoing RAISE Critical Fluid sizes tube required? Emergency \u00d72 suction out ICU handle kit \u2018call MASK? for doctor Tie 10 role cons Read check head 5cm Nunn syringe optimisation Catheter supply further"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "RCoA laryngoscope good losses contained which used? must and Checklist extubation airway stage carefully Obesity do Assessment AND Reintubation will Date: film Good OR used adhered 15mm of tick in considered Directorate RIE arising within left Other again? strategy +/ access parts feedback 2021 unless wire retainer email recommend secured or Dunn prepared Tolerance Complete Mark produces Obstructive It by guideline Consultant senior Obstetric markdunn@nhs accepted was Operator Theatre Status ACCP iGel from Authoriser: Lothian Elderly maintained difficult not immobility planned scope Yes net DAS as As issues with Set form surgery Obstetrics interpreted Where have up SJH apply protected Staged Front Very Duration this Guidelines Sleep Upper ST12 till situ can place subjective any NHS Dr subject judgement added comments use part staged clinician words: Introduction Form Plan Moderate present due coiled poor that professional obstruction decision licensed cheek holder Please found Tegaderm Apnoea hospital potential using the Oct 2019 SES ST37 made setting self appropriately foam CSESGFU complements Airway has Category: standard RSI previous catheter COOK Key Care v4 The Extubation Jun be Prior extubate Previous This experience Easy view risk Indications 2018 Ease 23 Intranet: No faith Use Authors: Draft/Final: QIT plastic Title: patient Failed/Abandoned Wire Usage head/neck Macfadyen Appendix tape WGH Patient plan adapters Young 01 at Medical there agreed you under all Authorisation: recommendations intubation return connections accountability Awake >5\u2610 Document are We skin Neck include errors 20190630 RapiFit\u00ae to area Supervisor reintubation extubations Flexible Bain hours trained Review Version: incl should how information Critical highest Reasons care is herein costs 118 45\u2610 Cook Further ring neck protect confident Ward Would Ferguson Difficult compises ICU Final ID: Jet via for doctor where liability dressing head 72hrs been Video Poor independently Catheter LATE Senior Date"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "factors: CONCERNS Check Checklist and whilst airway IV extubation Obesity filter nurse Date: guidelines Planning available leak plans Deflate of cut an stability Prepare access Charge Housden Optimise or prepared HELP 10ml visible From PROCEED: by Obstetric tracheal Facemask Sit patient: trauma/oedema Respiratory Lothian sedation difficult Two block oxygen high catheter/closed DAS cuff connected tapes SpO2/RR pattern up remove Suction cough mask system aware Aspirate informed NHS SpO2 fasting ready O2 2017 30 formulated present ETT noise 2014 working Equipment Oct the Stop NAP Airway through catheter PLAN Consider spontaneous checked Care Talk Preparation Adequate 100% post Extubation delivery respiratory ventilation Noninvasive Postextubation extubate Previous risk signs compromise: cooperative Yankauer NG CALL Aspiration patient BP FOR Monitoring nurses etCO2 plan EARLY adequate Stethoscope supplemental general ABG Scissors Inform Adapted Observe Awake postextubation roles bite Ensure tapes/ties PPE NOW to Cardiovascular extubations trolley ECG Review RAISE Critical Remove REINTUBATION care Assess tube minutes supporting Give suction allocate oropharynx for secretions doctor syringe supply CCircuit Senior suctioning"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "record https://www adjusted Contrast Picture clinically good needed losses contained and airway carefully BAL will Date: April Photo VHF onto available OR OD bronchoscope button off of in Directorate RIE There maximum arising within a4BbAG20170320v2 an left crosscontamination contaminated BLUE port back select blue orange Dunn or prepared into power produces It by appropriate subsequent guideline accepted trainer small Status Tab press Exchange Prion still Authoriser: from side MDRGNB Lothian bins not Grey Standard scope put scopes channel bronchoscopy picture on video Large disposable instruments Broncho tracheostomy monitor interpreted poses You charge stock Orange this Guidelines Suction Turn system can ii any Broncho\u2019s NHS procedures subject AMBU \u00a3150 Brightness Slim waste added judgement both use Bronchoscopy words: Fibreoptic once please restocked drugs 8mm Plug 2mm disease LARGE professional Still working version Please com/products/flexibleendoscopes/bronchoscopes/product/ambuaview potential the image Airway setting through Select has Category: cleaning standard Key Adjust Care if The max be fits This down risk approx Indications 2018 Intranet: Authors: flexible Attach faith Draft/Final: No least SLIM AScope NOT QIT fit Title: aView holding Usage your seconds WGH ICUs top aScope training fibreoptic Young at ambu see disposed under Authorisation: then intubation accountability For When are Ensure Document time following lever errors to finished taken trolley Green Aintree Version: ways Review should emergency information Critical Settings pressing 2020 sizes is costs Mode care herein Cook unacceptable Emergency suction control images Advanced Final ID: grey Each for different Blackstock liability turn MDRTB aerosolising been Video department Catheter as Date"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Resuscita/on Paediatric had Laryngectomy!stoma!ven/la/on and Laminated Oxygenate DO do listen Cover between breop/c used Staff !Look +/ mouth/nose select par/al Charge KY provided inappropriate New 10ml Call!for!airway!expert!help! procedure advanced Status member iii upper Most site from still Uncut Con/nue LMA dropdown increased Standard oxygen Bougie tracheostomised same cuff equipment Percutaneous: until \u2018Clinical\u2019 mask situ assessment any whether only management added 2306 these meetings accidentally Nov capnography please \\iptrach help inpatients has breathing list In Ref: Head OF suc6on signs prosthesis QIT Pass permanently SIGN Photography/Karen Manager GUIDELINES inner!tube! WGH Signs Permanent Feedback circuits text agreed Mapleson Small required trachea 54056 daily STOMA HAN hours removed Oxygen either tube on: breathing? Give forceps Miniature stoma!cover! via for Bed MEDICAL emergencies no Bedside di\ufb03cult reason occlusion/blockage dilator should LATE occlude nonexperts Check whilst handovers tracheostomies beyond Date: par6ally www well pa/ent swabs 204 of re/applied insert an 2222 Look uk NO MacFadyen HELP outwith re/inser6ng inpatient Perform tracheostomy/laryngectomy senior !listen!&!feel!at!the!mouth!and!laryngectomy!stoma mouth! Support smaller Authoriser: cared On Reg/Con not hand planned ON connect manoeuvres pulse tracheostomy Once CPR!if!no!pulse!/!signs!of!life! have may stable need An paediatric suc0on words: catheter? ETT device If Watson TRACHEOSTOMY nasal ensure \u2018Alert 19a stoma Patients Category: containing: Can!you!pass!a!suc5on!catheter?! cu if The!laryngectomy!stoma!is!patent! CPR FOLLOW be waveform!capnography This risk Intranet: HIPWATv2 SupragloWc medical intuba0on Box admission cuff/remove valve patient decannulates patency Team FOR assessment! give speaking there you all connection BED mouth return bagvalvemask Ensure to cannot!be!oxygenated!via!the!mouth!or!nose trained one Review Aintree Remove care Assess Tracheostomy REMOVE Poster daylight arrives noted algorithm \u2018Airway adjuncts Nurse sign oxygenated when suc/on Date AAempt!intuba5on!of!laryngectomy!stoma! Team! airway will recannulated pa/ents OR date ITU AEempt Directorate harm Prepare catheters patent Project 14G feel Information Dunn ac/on they decannulation by Deate cap tracheal par/ally Note: life press alert nonfenestrated immediately intact 54063 Can Spare discharge high formation obstruc6on pass apply Bleep LARYNGECTOMY system can par6al use Apply Introduction Use: bleep over that *Applying medic \u2018scope TRAK Oral Primary SPACEBAR box the ORAL would catheter Consider patients Care The Ven/late bed Is!the!pa5ent!breathing? Authors: No Secure Use Resuscita6on 31664 Patent team dioxide NOT doubt oxygena/on coordinated waveform breop6c depending at HAW ABCDE also* size then applied Hospital Inform circuit\u2019 dilators Safety Under carbon displaced attend emergency Critical is Ward usually tracheoesophageal Final ID: CPR!if!no!pulse!/!signs!of!life available: improving? Laryngectomy\u2019 syringe exchange ven6la6on Draft/Final: torch Tracheostomy\u2019 ventilating nursing Performed inadequate what choose Alert \u2018Waters available REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! indicates Deflate appear in RIE stomas Then Moultrie identify Ven6late or Is often However appropriate staff Some rePinser/ng request Emergency: cutters scope Surgical Yes cued NB on with SJH TEP this Extra remove 20151119 ii BVM face Bag/valve/mask O2 2017 Watson/March EPR present Con6nue pa0ent 2015 end hospital using Airway refashion Select \u2018Alert\u2019 Stitch Key laryngectomy ventilation uncut oxygena6on par0ally Call formed Is!the!pa5ent!stable!or!improving?! Allergies/Alerts/Risks CALL Secondary ward obstructed Title: cap/inner sachets Laryngectomy Barker BOTH puncture expert circuit fibreoptic tubes Medical Category\u2019 default Authorisation: resources ow inner death manage exhaled Document are provide THE size: type Advise Version: HEAD how whenever obstruc/on jelly than Alerts Emergency !listen!&!feel!at!the!laryngectomy!stoma suction environment org !listen!&!feel!at!the!laryngectomy!stoma!or!tube! 2013 TUBE National head 18/19a Apply!high!ow!oxygen!to!laryngectomy!stoma Do 1/4/16 as rePapplied"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "accidental Checklist and NUMBER extubation Reintubation available PROBLEM CON of llege ANTICIPATED BIRTH Project REASON Written Reestablishing PLAN: CONFIRM: by Consultant staff LABEL find from ANSFER POSTCODE planned FORM Christopher **CONSIDER on Anaesthetic after tracheostomy EL equipment Any An informed NHS Dr William NTUBATION** SPR** Mukuma Plan DOCTOR Smith TO Audit Intubation Anaesthetists ANAESTHETICS the CHI 4th CONSULTANT ATTACH PLAN Royal PATIENT\u2019S additional The OF ICS LOTHIAN TRANSF Aware **CALL displaceme Oncall FOR THEATRE AIRWAY GRADE College ED required Adapted REINTU Requiring following NAME DATE SIGNED PA DIFFICULT findings tion NAP4 Difficult ICU Report National ATIENT ement"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "laryngoscope blades highlevel good losses \u00a34 contained comply must and nursing guidance presumed insertion Leave latched carefully Date: pumps deionised available used lower button dispenser date of cost in Directorate Trolley RIE Quality Book within 2nd arising sporicidal bag morning removal parts 2021 nonsterile Charge first orange or Dunn disinfection Mac direct prepared Complete power >20mins MUST It by procedure detergent kept guideline accepted Status hygiene chemical staff from Authoriser: unit Trail Lothian Clean 100ml bins difficult clinical batteries intubator\u2019s not hand scope below scopes stick preparation apron high Baruah as video on MMVLGFUv4 with disposable after surgery form don interpreted battery surface Allow immediate preintubation Disposable charge Cleaning firmly activator this Guidelines displayed remove located Turn laryngoscopy instructions cleanest can any clip only residues Slide Only added subject clean waste dirtiest judgement NHS 30 errors use part words: Introduction June over Audit professional push Record dry device Please McGRATH\u00ae personnel designated Drawer Wipe potential using 2019 the Airway setting tip has Category: cleaning standard store wipe Key checked Care IPCT The minimum new depth be preference every Previous This blade risk Indications Carry McGrath right documented Use comes activate Intranet: Authors: faith approximately No QIT agent Title: phase Usage gloves contact seconds Utility \u00a3650 Appendix spare LATE paper Young \u00a319 also at before size all then Authorisation: intubation bottle \u2018scrunch\u2019 accountability Laryngoscope Confirm cleaned are When Ensure choice time towel portion PPE 20190630 MAC screen to area single contamination water placed trained corner Stage audit Version: Review fully should information Critical sterile nondisposable care is 118 costs tube per document sticker Ward herein neck damaged environment out Final ID: handle kit Each stored for liability Document head Dispose been when Draft/Final: Tristel\u00ae each Date"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "complications record Paediatric badly cannulate elective which and Laminated fingers Oxygenate do listen Cover between Initial clear used fenestration off Caution Firstly cut Trolley within those it KY la New infected 10ml procedure kept hourly changing advanced Status Most upper Draft site from Uncut side inserted LMA Two Standard invasive oxygen Bougie tracheostomised running same cuff equipment nue Cleaning FOS until mask situation situ place assessment any Con management chart added essential these Early accidentally lt slipping capnography help cleared humidified holder Harvey foam Stoma breathing In Head OF preference USE signs and/or QIT plastic Pass Tracheostomy/Laryngectomy SIGN 96h GUIDELINES bougie nurses Feedback circuits guide carried Mapleson tight Small required remembering manner daily STOMA hours removed Oxygen either Bagvalvemask ng eop tube air aspiration breathing? monitoring forceps Miniature via for secretions MEDICAL large no cuffed Bedside wall reason occlusion/blockage size/type dilator independently should LATE loss occlude nonexperts CRITICAL must tracheostomies beyond Date: www well swabs of ally an Guide/bougie Look diffic uk MacFadyen grossly HELP Ven position Perform suc assess oxygenate senior smaller Authoriser: Lothian not hand planned ON connect preparation normal manoeuvres pulse tracheostomy Once have You may cough stable need An paediatric NHS wrong words: course smoothly skills shiny catheter? ETT Record device If TRACHEOSTOMY nasal intuba ensure stoma Category: containing: previous if obstruc hold CPR FOLLOW be Intranet: medical 24hr scenario cuff/remove late Aspiration valve patient decannulates desaturating patency depends FOR Team spare action speaking passed prevent you all condition BED mouth bagvalvemask shorter cleaned Ensure skin choice ven to Always area one Review Aintree chlorhexidine frequently Remove Assess indications Tracheostomy minimal Difficult REMOVE daylight arrives algorithm dressing Subglottic adjuncts changes sign undisturbed oxygenated when involving Date suctioning pa endotracheal soft airway open will recannulated OR date Pre subglottic Prepare catheters contaminated patent Project 14G obese feel Guideline bedside Dunn decannulation by cap tracheal towards pitfalls life Dressing nonfenestrated immediately length Can Spare uneventful high pass practitioners Potential system can pass: clean 24 use Apply Use: over that empt medic dry 12hrly \u2018scope Oral Primary technique go done too box the ORAL would through catheter Consider patients Care The changed bed patients: Authors: No Secure Use team Patent dioxide 20150811 two waveform routinely volume depending at see ABCDE size then encourage applied circuit\u2019 bedhead trauma dilators Safety carbon displaced water placed change al emergency information Critical consider sterile is fib drainage Thorough usually out flow ID: available: distance improving? Inner syringe exchange guides Draft/Final: reapplied oxygena torch Aug ventilating chin TGv2 what choose available \u2018Waters indicates Deflate in par Then Supraglo Known left saline Moultrie CARE aseptic or Resuscita Drainage Is often However appropriate other acutely Some Clean difficult cutters scope Yes NB on with \u2018Scope ONLY sponges Full this Guidelines remove about occur BVM face including 2017 Suctioning Essential Fibreoptic present surgical 2015 end using Airway refashion but Stitch Key ventilation ent uncut 710d formed Call closed First CALL Secondary obstructed Title: reinser especially cap/inner personal sachets Barker BOTH expert circuit comfortably cid:1 plan fibreoptic tubes before default failure Authorisation: resources inner exhaled Document are following THE type more percutaneous Version: HEAD how jelly than neck Emergency suction environment org adequately attachment TUBE National head Dispose acceptable 1/4/16 as"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "already complications good which blood greater and guidance extubation occasions maintain noradrenaline do rate short flowtrons mg/kg Propofol Initial used maintenance prone Lines vasodilatory cut achieve NSHL maximum regional those within furosemide PEEP avoid fluids major useful men Evita marker calculator Beyond it deep followed ml/hour treat avoiding swab sensitivity started Drager infection basic recommended It overly WITH kept necessary Consultant REMAPCAP procedure ruling Status TEDS upper 35days bd from tocilizumab purpose COVID 1:2 improvements 80 50mg result Standard Signpost invasive focused increased oxygen dialysis novel Reviewed issues accessing Additional suggestion basis accessed injury negative Central sepsis inability oral any PJP management only whether refractory added most limit these treatment continue absence pressure electrolyte please spontaneously discussion radiology help PaO2 thrombocytopaenia blocking disconnection empiric levels deterioration pressures thromboprophylaxis point glucose carries given send McNeill keep lung mg/kg/hour sufficient adding has breathing Royal Next anaesthetists CT anticoagulation In respiratory antibiotics OF phosphate therapy continuing patient\u2019s down checklist USE signs vasopressin and/or stopping Pathway dexamethasone 01224 during phase current index Both onwards 100 antibiotic midazolam/morphine TOCILIZUMAB healthcare injurious Young elucidate olecranonulnar basics dial daily RRT develop 60 When time effect normally severe related hours During sodium removed either Craven institute cause eyes mould tube air critical strength on: best being become monitoring control Betadglucan prednisolone classical saline/4% via haematology fluid for Referral postassium prophylaxis case phase/ commencement no CPAP/ASB rather Lung CORTICOSTEROIDS 2448 non reason cmH2O should supply immunocompromised virological CRITICAL larger continued must RECOVERY brain beyond Benzodiazepines BAL guidelines second recovery/weaning turnaround beneficial well proning having leak reports of ADULTS ml/kg/hour There Gibson mode an prokinetics some intravenous ventilator aim empirical immunosuppression 2021 initiate range Classical insulin autoflow Infectious stream into 26 27 tests aspirate ventilatory Cautions coordinator See positive associated online 18% room Single intensive their reliable suggested Predicted antifungal allows TREATMENT body weight PPI 20mg On inverse clinical not infections targeted by: output video normal 800 considering Set REMDESIVIR swelling tracheostomy weaning have Because P:F includes Medicine compliance may resistant evolving allow aware evidence need Many propofol/alfentanil 07917068628 both part ALT assessed refer once very recovery challenging course target If prophylactic directory dalteparin ICM nasal od 8mg CVVHD ensure event balance haemoglobin ideally Patients ml/kg doses standard long >30 tolerated addition inflamed if possible solely patents be investigation This cardiac risk Galactomannan MAP scenario safe who 70% becomes plateau admission late 510 patient renal FOR suspicion action line PREDICTED enhanced feed hyponatraemia also I:E there prevent all recommendations mmHg hyperoxia because choice corticosteroids include miniBAL process lungs to trials failing 70 lifesustaining particular physiology fungal referenced anti care start prefer echo qds Neuromuscular indications infusion contraindication acute function ICU At indication level administered eg hydrocortisone where Gastrointestinal receive Follow voice 018 hypercapnoea selected develops tds discussed when moderate seem route diagnosis reviewed bundles clamp significant 48 phases early Every needed endotracheal airway stage constantly open will AKI volumes presentation Aberdeen considered constipation predominantly supportive AND/OR gastric day services 607 generally Microbiology/ Infirmary first 20 6mg overload they hospitalised important by tracheal adhere 90 currently against cultures degree height safest ulcer stepwise Written: length wean sedation avoided prolonged onset pandemic detail 13 complex referral infusions high interpretation around after free differentiate vasopressor ID set up erythromycin practice suggest pregnancy septic contraindicated can WHO secondary preexisting screened lab we <90% modified analgosedation pre use Xa intranet instead feeding lines therapies due KPa that respond simulation bowel TRAK dates HOSPITALISED while FIO2 done perform the GP nursed behave relatives would through catheter patients Care plasmalyte pantoprazole decreased The changed 250ml new cautious admitted ECMO goals require alternative received Authors: conditions team 1:1 data illness neuromuscular venovenous saturation posters agent resuscitation haemodialysis requiring extensive PICCO Decision utilise with: routinely All attention depending mg worsen at criteria see reduced enterally venous size ml then thought applied virology work Lymphopaenia We score prescribing conservative careful change review consider Critical prescribed defined CRP fact Infection is information per particularly pnuemonia PVCs formula titrate usually specific flow out remdesivir Final weak stress Approved signpost/referapatient Maintenance call ensuring commenced workers deteriorating delirium timing results Draft/Final: receiving 65 sarilumab order oxygenation syndrome aggressive IV seems Renal/electrolytes/fluids available ion framework in RIE Prone H+ eligibility Diseases left strategy conventional continuous preserved CARE goal Following active unless needing throat or compliant dehydrated often ruler protective guideline Mar evaluate 19 Bundles NHSL magnesium was Sedation/neurological times performing Be RCOG ischaemia calculate Some other 72 Direct analgesia multiple card regarding bronchoscopy Breathing common on As with form established ONLY SJH based this Guidelines higher Intravenous support nasogastric Clinicians so agents COVID19 requires acquired including March 30 24/7 Bronchoscopy physician immobile movements drugs ongoing disease get acidosis Circulation working updated risks Please found cornerstone ratio women consideration using hydrogen research stopped hypercapnic Airway group but distress shock approval agitation/delirium better ventilation sputum/ uncut every glycaemic aggressively intervention days dexmedetomidine First fit 710 Title: citrate hyperkalaemia pneumonia uraemia could initial ARDS goals/attention circuit Consideration such alfentanil dose tubes latest myocardial before Intensive enteral failure traumatic mmol/L presenting intubation community replacement manage increase less are provide PPE Propfol single depression g/L degrees FLATHUG Clonidine response/FIO2/airway dextrose 2020 than 40 mobilisation calculated electrolytes suction discontinue clinicians mild our aspirates stridor moderate/severe 714 SIMV 10 May National head excess many Tidal Haematology been Metoclopramide making as"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Service already https://www had Operational category Frailty and problems individual Line Inclusion will like Colleagues making website Friar prone step touch Network Due Aberdeen of 54253 in Arrangements portal considered neurological service inform an Nationally Brenda Infirmary discuss unless Thursday Referapatient email \u22653 hypercapnia 20 Adult or ecmo@nhs Ms always now Referrals online by nonurgent protective pH wishes 201 Extension from July multiorgan Respiratory Evidence managed Direct retrieval not Signpost below nhsg implementation referral locally Scale net Best teams As on enquires Ferries with colleagues repatriation Lead after centres have up until this August 554253 injury UK Refractory system can support place Scottish contraindicated any management final referrals Dr positioning only we 07917068628 continue Exclusion June address: transition closely please governance that Scotland delay If updated 13th handled Leads regrading Failed reversible standalone using the Dear 11th pleased made group would lung through Unit has called Royal Scott patients Care across if Sim The respiratory AB25 therefore ventilation be agreement ECMO Clinical experience This Criteria shortly healthcare/ecmoreferralpathway Lucy team least partners trial 01224 patient Glenfield contact RESP opportunities two All at criteria also there Intensive you CME all failure Hospital follow Director work Coordinator For less are We Healthcare signpost provide process to area Stephen severe directed Current emergency information Critical 2020 Designated start differences uncompensated units 2ZN Ward optimal us ICU hrs Ian via To our for Referral case wrote directly Enquiries Foresterhill Leicester Score Injury many Nurse been Lung unable when should attached relating as Potentially"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "factors: CONCERNS Check Checklist and airway IV extubation whilst Obesity filter nurse Date: Planning guidelines available leak plans Deflate of cut subglottic an stability Prepare access Charge Optimise or prepared HELP visible 10ml aspirate From PROCEED: Obstetric tracheal Facemask patient: trauma/oedema COVID Respiratory Lothian sit sedation difficult not Two block oxygen high catheter/closed DAS cuff AGPs* tapes connected pattern SpO2/RR up cough Suction remove mask system aware oral informed NHS SpO2 fasting ready O2 March 30 formulated present ETT noise Equipment perform the suspected Stop NAP Airway through catheter PLAN spontaneous 100% Adequate Care Talk Preparation checked post Consider Extubation delivery if respiratory ventilation Postextubation extubate Previous NIV /HFNC risk signs compromise: cooperative Yankauer NG CALL confirmed suctioning Aspiration patient BP FOR Monitoring nurses etCO2 *FULL plan EARLY adequate Stethoscope general supplemental ABG Scissors Inform Adapted Observe Awake postextubation roles Ensure bite tapes/ties PPE to NOW Cardiovascular extubations trolley ECG Review RAISE Critical Remove 2020 REINTUBATION care Assess tube minutes supporting pt suction Give allocate oropharynx for doctor secretions syringe supply CCircuit Senior Drain"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Service twice Check must and extubation airway stage insertion devices filter nurse second PROCEED HME Preoxygenate date completed? of in RISK subglottic PEEP allocations mode prior failed Bedhead Need ventilator port Platelets INR AWI dilation recommend or again paused Appropriate appropriate procedure Consultant aspirated heparin Operator AD Double Bronchoscope member staff from COMMUNICATION COVID Respiratory immediately leader wean sedation prolonged difficult Fleming not sample invasive Surgical regarding Baruah events on with tracheostomy Lidocaine weaning CHALLENGING factors PROCEDURE Cuff up Full aerosolisation this Fasted? Bronchoscopist mask Sedate need operator HIGH Day COVID19 chart PERCUTANEOUS 12 including 24 Plan Fibrinogen capnography once discussion unfractionated flange drugs due difficulty Routine ETT decision TRACHEOSTOMY Vasopressors/ TRAK Family proceed Ventilator FIO2 assembled the Verbalise box shift McNeill would anticipated stay full completion 14 visor Stoma last Consider if additional respiratory ventilation be Prior every checklist Indications experienced risk Authors: whole documented team closed Mandatory NG who NOT NMB adjustable Sedation/analgesia Aspiration CXR patient during 100 Team meets circuit enhanced wristband All routinely give plan MAKES BMI Valid criteria size then Experienced required GUIDELINE Plts FFP3 minimse throughout Confirm Document We PPE disconnections since to Patient assistant single hours percutaneous Ongoing Review change emergency GENERATING is gloved care tube known per Neuromuscular coordinates suction specific monitoring BTS ICU Percutaneous kit case for AEROSOL participating directly Gown 10 ensuring Inline Suggested Allocate donning LMWH sign Bedside timings display adrenaline blockers Inner Do as pause"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "oxygenation CRITICAL remains needed guidance and airway Leave outside will 17 HME 15 ScalpelCRIC available used off Pre of spotter/buddy in vent avoid prior Aim buddy bag to: CARE pillow identify Following ventilator Suspected getting first Change bedside 20 secured or Dunn prepared Transfer into room by 19 attempt doff Status member performed Continue VL COVID side Written: other transfer During: Clean After: 13 Reviewed by: assistant/ on with cuff after connected cricoids/drugs equipment ONLY Additional have Using person rapid may Guidelines negative Oxford mask etco2 system can rooms BVM only COVID19 separate Only most 12 both pre entering Apply pressure Plan use once please drugs Before: clamped Empty Intubation handed dry If disconnection reusable desaturation technique Ventilator reconnect using perform the ensure nursed bagging Circuit McNeill act pockets RSI run 14 standard HPS Next Care additional VBM if The approach possible 02 be Prior Action grip checklist USE experienced 22 McGrath Authors: Use closed team Draft/Final: Tube priority copy Help Title: patient doffing your FOR circuit etCO2 such All people plan before you disposed all required then intubation connections Ensure PPE clamps to single trolley trained laminated review Critical runner decomtamination start tube per document minutes STOP best suction Final ICU At Switch kit Identify Approved 11 for wear Capnography enter on:20 10 16 Remember check donning preassemble: inflated preparing should supply Card as pause"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "CRITICAL accidental which Discussion and presumed fault/failure/complaint/adverse will gov April information: mental Queensferry of in Ferry employment notifiable/infectious Registry health children Referral: Unless: Registrar Presumed CARE +/ uk Centre sq@edinburgh 0131 Information email or Dunn Mark South they advice suspicious associated Send 1590 PF Status examination Draft Library from accepting July Written: other body result Certification Quadrangle not family\u2019s Standard Process satisfy deceased Yes Reviewed by: custody Certificate Death registry Practitioner on with form suffocation leith@edinburgh ONLY MCCD/Form 2600 includes Chambers may Guidelines reporting Extra Leith Pack COVID19 subject Discuss Bereavement 253 dental including treatment 30 9HP legislation course Communication that compulsory EH6 Does phone Post registrars Family legal City the EH30 event Significant balance registrar group pose family: Next Care additional St post Confirmed The himself/herself be investigation Family: Criteria Tick Uncertainty risk USE drugrelated city@edinburgh 53 Authors: No medical 5520 who possibility 529 QIT mortem Title: Diagnostic complete Mortuary FOR neglect/fault C19 editorial give Street likely Completion Gifford under Fiscal death completed Edinburgh are documenting certificate 1YP to review cause Hugh Critical care is 2020 public prefer overlaying on: Cause suicide Hazards able Disease probabilities Registration DH1 number EH1 331 Approved diseases 11 scan for where High 4AE Council preferred May check unable office Procurator Draft/Final: supply Road as lead"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "NGT slightly ARDS: blood and individual rate Multibic/heparin 17 Loop between used Acetazolamide Renal off achieve however furosemide Bendroflumethiazide prior Thiazides useful just removal it threatening provided 100mg Acts settings Depending Status Effective Minimise correct 50mg increased Reviewed Fixed issues Monitor stock options until essential optimise limit 12 these multibic/heparin treatment electrolyte ppaattiieennttss help pH>7 levels MMaannaaggeemmeenntt given Next additional DCT anticoagulation In therapy hypernatraemia BALANCE USE PCT BFZ ultrafiltration QIT RReeppllaacceemmeenntt Thiazide editorial sufficient: Management required Ill follow daily Patient severe RReennaall hours areas either THERAPY longer 09/04/2020 3600mls/hour Intermittent critical on: potassium number deciding via Robinson urine fluid for preferably spaces no loss supply Journal 117 move dialysate CRITICAL profound profile 180mls/min improve of There an Aim stability bulky 116D Oedematous 400ml/hr Those 500mls IHD diuresis Therapy unlikely FLUID notice cubicles enough not PATIENTS by: normal liver have discretion may resistant allow stable aware toxicity need iinn utilised seek 500mg 31/03/2020 If Careful flows CVVHD natriuresis hypocalcaemia balance 45 addition concerns promote tolerated if possible beds vs therefore max be This Beware exceeds risk intake medical unnecessary who Furosemide patient renal Society Oliver FOR Note give adequate reverse there all Oedema accordingly initially Plumb to failing care Decide start Fluid infusion able machines them Each where receive Balance Aminophylline section selected when route demand significant filter AKI will 4800mls/hour alone agent/agents first iatrogenic Dunn aanndd overload Mark they important by UNSTABLE heparin Should instance life Continue Written: add BD Can high monotherapy suggest Replacement can AARRDDSS alkalosis Not 118/116 machine we use 24 Try intranet over that concentrate Blood the Critically patients Care The REPLACEMENT require Authors: Diuresis? agent osmosis haemodialysis attention at see excessive diuretic BBaallaannccee 9297 water directed change review consider Critical is 118 per flow Final Approved ooff High RENAL Dialysate Option results Draft/Final: oxygenation IV delivered available Diuresis 5mg STABLE in Other together CARE Need natriuresis1 or often 10mg/hr preferable Be 72 12h difficult 2011 retention impact regarding on 250450mls/hour with ONLY Tachycardia combination this Guidelines higher ii agents COVID19 physician drugs consumables FFlluuiidd using Citrate group but Morris Adjust 250450mls/minute better Natriuresis every Preferred Title: citrate hyperkalaemia 31/03/2021 Variable ARDS CCOOVVIIDD1199 5% dose TThheerraappyy enteral Intensive Choice resources replacement acidaemia Subsequently protocol are following provide caused clearance more dextrose than Remaining electrolytes Mobilising Bolus different 16 Spironolactone Do as 130mg/hr"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Visiting and decisions extubation guidance maintain do April comfort primary removal Life provided desired Cannot infected embalming Consultant Status hygiene from still side concurrent managed maintained Standard End Process apron same Carol Conference COPFS until mask place any most period treatment continue clinician discussion Last decision disconnection phone considerations EPPE believed given sufficient pathway permitted respiratory terminal patient\u2019s reported USE and/or current gloves hands offices Management required follow develop time Patient They areas organ fully air for Referral Blackstock directly Deaths no Video Procurator should CRITICAL must whilst SNOD SICPs usual of an Aim bag ventilator covered room Within performed Transmission Section hygienic Lothian body transmission Officer clinical not Control hand Generating by: normal Chief Where have discretion may Organ both Prescriptions nose ETT personalised If proceed ICH suspected ensure made visitors Patients if possible therefore principles be face\u2019 risk deaths patient family/next Provision FOR whom also there all Fiscal cleaned viewing Anticipatory to postmortem care NOK total At eg changes worn discussed diagnosis described considerations: will TBPs alleviate Directorate selfisolate Guideline coexisting notifiable PLE they withdrawal by life Written: Calder immediately Swedish symptoms Aerosol pathology deceased Death Precautions after set apply practice Must without system can movement AGP screened Only use due that WLST potential perform the patients Care The Visitors preparations intended require alternative Authors: Decision All sustaining at above remain Family/NOK Critical leave Infection is per known Final Enhanced Approved Tpiece wear presence enter routine ACP Draft/Final: discussions Based symptomatic nursing choose below: touch in status Murray CARE donation unless or visit appropriate guideline was precautions staff performing enable Surgical regarding on with ONLY immediate Any this Guidelines support occur COVID19 Dr face requirement VC present disease surgical end using notification Procedure but 24/3/20 distress visiting reaching family/NOK Are another Maximum Title: circuit Medical before individuals are following provide PPE kin \u2018face provision 2020 public optimal environment May been unable CCircuit as"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "you \\\\rieapp1\\Critical owner all twice xls If updated ABBREVIATED COVID and folder daily e85050 do secure the Care\\Ward 7s WARD S: to area TO but ACCESS called ACCP\u2019s in on The form is be handing trainees 118 This an Ward have team this General\\COVID19 least access Handover\\ Jane HANDOVER need Shared Band for COVID19 complete McDonald often Drive It Handover by online please held should at over"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "adjusted slightly proximal and comwheel occasions maintain individual do rate short Continuous between Initial make used users achieve however maximum those Disclaimer: PEEP confronted exceptional instances PSV VCV bellows it back select 8L/min Anaesthesia guaranteed Drager minimise Diuretics desired Moisture Circle now It Unable procedure settings necessary yet Start mentioned from COVID operating challenges inspiration These increased End undertaken oxygen filled basis accessed Volume options until negative situ com style any only most optimise limit these 12 displays Resp period CIRCUITS pressure apnoea discussion windows spontaneously please capnograph help PaO2 blocking navigate licensed ventilators disconnection reinflated point collapse One neutral rates lung here has completion breathing called additional In 34 OF generated green L/min shown capnographs confirmed current light during circuits guide lime clamping under required After operate 10cm For 60 uses When With time earlier screen normally They hours Soda cause bolus 8kpa needs enlist best being become cancelled Flow via safely To fluid for case no cmH2O should preuse move clinically must remind HME beneficial ask begin usual window Ventilatory CS2 intermittent of There switch: vent Gibson an mode mains bag some absorbed Synchronised ventilator aim NO Aisys initiate autoflow Troubleshooting menu into outwith position assess positive aiming FiCO2 their consultant adjusting Modes pro Lothian anaesthetist MODES reduce measured clinical not Rate Increase picture normal expected Set Once H2O weaning have You register unclamped may production need An Total CO2 NHS take HMEF ETCO2 familiar empty extent target clamped touchscreen If ill Upon term balance setting standard long run if possible Disconnection therefore barotrauma be Prior read This risk confirm demands medical who becomes valve patient Default contact option 49 does Note line likely TV there I:E you Temporarily 1L/min return broken usage Ensure litres to area corresponds cannot aid frequently pressing completely document start customise minutes Neuromuscular indications filters Solutions reliability infusion able function ICU machines level checkout them where ie critically preferred changes selected ventilate initialy when discussed demand suctioning overcome significant 2/4/2020 COETT ulnar Touch airway filter open will starting systems 5l/min breaths 4L/min Pressure Pre considered reconnected quick Fi day mounted VENTILATION flush indicators note Simply bedside drive VG important 30cmH2O returned 400ml by Should names regular soda indicator pandemic assist below works high reconnecting recurs account conduct after monitor set up Our without located system can met baseline restarted machine we PaCO2 use 24 reboot drying removing acknowledge due Routine that designed selecting /min potential the accumulation would full 100% Consider patients The changed wash intended goals require Use team 1:1 NOT posters low demonstrate although 12hrs Vaporisers routinely All its volume depending at above see reduced then reference 12hour Safety message work By We persists FiO2 Updated change ODP valves Peak warning controlled consider information leave is Mode per circle known flow out bacterial/viral carry resp switch fresh presence problem call arrow display exhausted cannister further order Filter ventilating page nursing highlighted what 50% nurse Falling available lower manned touch tidal PCV in Prone increasing H+ mindray Bag Following context active unless or again paused incorporates However ruler mandatory litre protective red 19 hypoxaemia staff Breaking alarm Users induce difficult reinspired impact alter on As with rise canisters indicated CPAP this remove expired support occur toggled O2 March occurring scavenging requirement Suctioning unlike drugs Please found end ratio assistance using ventilated but stay moisture acknowledged leaks minute rechecked ventilation performance colour days closed disconnected spill BREATHING wheel initial anaesthesia circuit sidestream Vent plan asked Low before default rotating replacement increase are cancel listed safer following Introductory contamination more difference circumstances provision inspiratory 2020 than AISYS suction anaesthetic our different SIMV turn 10 check been unable Com Checkout gas positions Do as"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "needed Rollo/D currently and RR\u226525/Sp02 will available OR Admission in an feel refers opinion or requested Complete by appropriate 19 NHSL 60% instituted Care/Anaesthetist/EM COVID immediately transfer \u226492% not Zone on Version immediate Manage 09/04/20 \\aecovid Fitton COVID19 requires IF Plan discussion bleep using the Di Patients Critically patients Care if be bed require Use team and/or who Pathway Guide resuscitation McNeill/L patient requiring Red initial does ED all intubation Hospital Trak arrange Ensure unwell PPE Anticipatory Patient to airborne Anaesthetist Kerslake/G FiO2 review Critical Assess Ward intubate ICU 2200 via for Referral ACP intubated"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "xHaz CRITICAL twice Domestic blood must and rotation airway whilst remind outside will SOP Admission nearest off touch Pre of Staff in Trolley know Status 1x fluids day prior Prepare bag decontamination CARE removal ventilator spotting 1000mls blue Bloods Gather they pole masks sink Bin room appropriate by notes doff hourly their precautions member times staff spillages inside wipes small bin reminding from Written: splashing/splatter other body transfer Covid19 enough specimen Covid not 13 disconnect hand AAccttiioonn apron infusions Reviewed chlorclean same by: tubing on with disposable equipment ONLY Must tab drawer Cleaning stock without sampling Guidelines this mask Place deliver 9/3/2030 leaving COVID19 face let 12 quickly including machine wearing wet Plan alternate due over get ETT dry surgical tabs \u2018spotter\u2019 Wipe Safely point shift the ensure =10000ppm send anticipated group but visor full Exiting: cleaning Next Care if plus Floor AAddmmiissssiioonn wash ventilation be bed CCaarrdd Action PCI This down risk USE another Authors: mop cold team medical Chlorclean further QIT Card priority Title: patient doffing gloves your RRIIEE \u2018Spotter\u2019 FOR CCOOVVIIDD1199 nurses editorial All hands Vent adequate cubicle at above general disposed clamping ABG policy all you required then bottle 1000ppm FFP3 throughout daily transport Ensure are When PPE clamps water to contamination Lab airborne taken placed trolley anything review emergency information Critical takes is arrival per washing door on: entrance solution out exit Final Limit turning them meet kit via Approved 11 Signage for wear responsible enter where 10 role Arrival: Remember Allocate donning no Nurse Decontaminate coming Outside should Do as detailed"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "CRITICAL and nursing guidance floor corridor outside will between TITLE Pre of in arranged departing thoroughly left prior CARE access first exiting by room appropriate notifications RIE: their Status member 20/SJH staff Written: side transfer On undertaken AAccttiioonn Reviewed by: on connected with ONLY Additional practice Guidelines remove evolving TTrraannssffeerr IInntteerrhhoossppiittaall swiped lab 12 wearing past clamped observe/trouble disconnection Post Ventilator using shoot the group through standard cleaning along HPS Next Care approximate notify The be Pause CCaarrdd PCI down USE cath received Authors: medical team Draft/Final: Chlorclean SAS QIT Title: patient RRIIEE lifts WGH FOR Appendix CCOOVVIIDD1199 editorial doors at departure: then national cleaned time PPE handover to taken trolley ET review Critical arrival 118 tube per Wd entrance on: monitoring exit ICU Approved via 11 enter Follow 10 118: wiped discussed Arrival should as receiving 117"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "CRITICAL and nursing sent guidance will 15 between Doning used usual off Pre of in RIE arranged Scan reconnected an Portering trainee prior bag CARE Following ventilator members back 2021 Doff orange or Dunn direct Transfer rest by room 19 consultant member Status staff COVID Written: transfer Reviewed/revised On not undertaken Standard completion: table 13 chlorclean undertake as on reentering Level with don equipment ONLY spotter practice Guidelines rota can leaving COVID19 most 12 March ahead double fitted designated done hospital using the Oct McNeill One through but addition standard 14 HPS bagged Next Care CT if The minimum prepare be bed Action down USE Authors: medical team Draft/Final: Tube Title: patient bags contact entry FOR passage close two facilitate at departure: required return Intra FFP3 observe Ensure PPE clamps to Don taken trolley one review emergency Another Critical 2020 is 118 tube per arrival Intrahospital on: control monitoring Final ICU 11 for enter preprepared CT: 10 May wiped discussed Arrival trip supply Card route Senior"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "laryngoscope Intubator\u2019s CONCERNS page Check Checklist and airway Drugs suc3on outside Date: will PROCEED Preoxygenate Scalpelbougietube in Cricoid wake Communica3on mount Understand Sizes access carina or Mac requested Op3misa3on visible Is room Consultant necessary Double alloca3on Theatre Di\ufb03culty seniors from Lothian Covid ON Can st Baruah Intubator Bougie administrator on with equipment DAS/ICS up turns vasopressors this laryngoscopy Blacstock OPA intuba3on NHS SpO2 posi HMEF ETCO2 O2 March we pressure Plan Closed Prepara3on drugs help SupragloZc ETT Equipment Stylet using intuba mise Verbalise Airway backup catheter 3cm RSI roles? checked Care if cu Pa3ent max Runner Op lubricate turned 2018 Who switchboard McGrath Yankauer seda3on fails? 3p contact BP CoVid tape Team Monitoring B/C circuit waveform FoNA plan \u2191K+? Stethoscope how? size ml trachea Cut Vocalise Adapted Anaesthe Intuba3on PPE NOW assistant CLAMPS incl trolley Cri3cal ECG Review Ongoing Fibreop RAISE 2020 is tube required? Emergency \u00d72 ICU handle Conrm 2200 kit via TUBE for Allergies Tie 10 call role Induc3on head check pa3ent supragloZc 5cm syringe supply further"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "factors: CONCERNS Check Checklist and airway IV extubation whilst Obesity filter nurse Date: Planning guidelines available leak plans Deflate of cut subglottic an stability Prepare access Charge Optimise or prepared HELP visible 10ml aspirate From PROCEED: Obstetric tracheal Facemask patient: trauma/oedema COVID Respiratory Lothian sit sedation difficult not Two block oxygen high catheter/closed DAS cuff AGPs* tapes connected pattern SpO2/RR up cough Suction remove mask system aware oral informed NHS SpO2 fasting ready O2 March 30 formulated present ETT noise Equipment perform the suspected Stop NAP Airway through catheter PLAN spontaneous 100% Adequate Care Talk Preparation checked post Consider Extubation delivery if respiratory ventilation Postextubation extubate Previous NIV /HFNC risk signs compromise: cooperative Yankauer NG CALL confirmed suctioning Aspiration patient BP FOR Monitoring nurses etCO2 *FULL plan EARLY adequate Stethoscope general supplemental ABG Scissors Inform Adapted Observe Awake postextubation roles Ensure bite tapes/ties PPE to NOW Cardiovascular extubations trolley ECG Review RAISE Critical Remove 2020 REINTUBATION care Assess tube minutes supporting pt suction Give allocate oropharynx for doctor secretions syringe supply CCircuit Senior Drain"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "already Isolation 48 Area SARS immunity and presumed whilst AND Temp open initiation Initial clear available used Admission having Pandemic of Elective in RIE considered status within Open GREEN 118A an isolated health previously Transplant apart Admissions Placement Siderooms home some siderooms NO context 116D first deescalation 116D/ swab or test infection they likelihood Unable positive See appropriate protective neutropaenia precautions consultant Able 116C pathogens alert from providing other LOW transfer vPatients 2023 managed transmission result clinical not YES 13 existing symptoms discharge definitive Yes high sideroom waiting on Level with Once ONLY have based Version vAll rapid until 117 would negative allow cohorted can AGP assessment need Positive HIGH management meeting chart Discuss criteria? separate essential deemed worker including continue URT+LRT 24 than alternate mechanical disease decision URT If history move 1114 suspected/proven the ensure nursed One tested probability self ideally organisms \u2018Contact\u2019 sufficient Patients full Remain 14 completion droplet fulfilling patients Care if respiratory admitted beds IPCT additional new placement post ventilation Sideroom be employees contacts This fever admissions down risk excluding Department require Clinical days No URT/LRT least who confirmed SARSCoV2 low admission ICPT patient during vPatient contact pancreatitis 116C/116D/118 two give Considered co All 116C/116D/118A/ward Low at cubicle 118A/116C/116D therafter criteria intermediate aerosol presenting <37 exposure shielding thromboembolic FFP3 reassessment manage throughout initially are testing following 118B since to area Patient fever/respiratory taken During areas hours Guidance 116C/116D/118A should consider Critical Areas care overdose INTERMEDIATE is thereafter Intermediate known Priority critical RED Emergency consistent stepped More Would flow deisolation Non ICU swabbed 8C hrs meet 11 for Probability High available: samples receive isolation consecutive CoV2 improvement May no intubated non discussed Cohorted results diagnosis further as lead Has"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "CRITICAL Area which fill and Attend do like onto details HOW of in RIE NHSNearMe@nhslothian quick service CARE it access uk Guideline discuss 654321 or Ask NHSFREEWIFI they Breaking helpful not Me video on connected with ONLY wish have Guidelines live can NHS password COVID19 VIDEO Remote use scot platform please challenging Communication TO Scotland If phone iPad found tips go using the Waiting given would relatives Anywhere run patients Care passcode calling username com/login be label Prior read patient\u2019s advice: USE medical team CALL patient FOR you https://nhsattend Near Go Ensure Bad following iPad: to Log News Click attendanywhere vc/rcc Critical name is talk via email: for family nhs call sign https://nhs making"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "heavily good must and DO outside away uid will PROCEED ties between available lower of in yourself contaminated regularly back Instructions checking followed select protection provided straps hydrated covered or surfaces test glove infection always Perform strap ears room protective by Note: hygiene goggles upper against from hair correct sides undertaken hand respirator nape spectacles facial on Putting touched after disposable with cheeks equipment compatibility Where ngers have until Put this remove crown instructions Place differ COVID19 face clean limit these worker both use bridge Respirator makes according removing nose over that eye If technique perform the ensure tested keep The be This patient\u2019s down safety Use safe spread adjust NOT waist patient personal during gloves Eye putting headband your jewellery practices hands healthcare longsleeved at above before you tie size fasten cuff work manufacturers Ensure are torn gown With PPE to Gloves change rmly cannot eyes mould pressing is piece protect neck being environment Position achieved for different Predonning head check donning worn been when should order repellent"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "slightly rst cross must and bottom outside away will peeling ties alcohol forward off remaining touch of in an buddy contaminated inadvertently removal it back fall protection straps or glove supervised into always strap room protective by grasp touching inside bin from Clean reduce clinical not Wash hand slide roll respirator pulling soap with ngers equipment Where retaining up themselves reach dofng fullface remove Turn place only leaving COVID19 let face waste systematic worker including both absence use Respirator removing over that ungloved bring eye Removal while potential using the metres visor Then: fold possible The In peel rub hold be patient\u2019s risk retraining respirators Firstly: outsides gel safe Unless lift waist personal Eye gloves your front motion top opposite All healthcare hands follows: behind at there disposed before under then dedicated FFP3 are gown contaminating wrist sleeves PPE process water to contamination area Gloves removed discard is gloved lean neck out anteroom/lobby bundle handle Unfasten To for lined nd isolation distance Gown preferably head shoulders way minimises ante Pull should Do as order"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "laryngoscope blades clamp CRITICAL refreshed Checklist and Laminated insertion cateher Drugs SSuussppeecctteedd 20G pumps available SOP Cables off Pressure in Syringe Loose Femoral left bag saline catheters x3 pack CARE ventilator access Cannula blue 20 NIPB Jelly Clerk Arterial Scope 10ml Clark Mackinnon Sp02 room EtC02 iGel induction 12F Status Draft unit Anchorfast Written: Covid19 not mounts airways scope below pump socket Bougie Baruah by: Reviewed tubing waiting normal on WWaarrdd equipment monitor Monitor ONLY set Cuff up charge sampling may Guidelines Suction LLiisstt phones need ABP leaving COVID19 HMEF Slim March use Closed Guedel 14F drugs Intubation ETT drivers cylinder arterial Stylet Please KKiitt key box the made 18G catheter 22G RSI breathing Next // Care if transducer plus The Facemasks be Metal USE Baby pressors McGrath Authors: departure RIDU Yankauer Box Tube NG plastic Title: patient v2 sachets Schrader WGH tape FOR CCOOVVIIDD1199 circuit line Drip packs tubes Stethoscope before size tie 3000 Scissors Oxylog are listed clamps to stand trolley Ambu contents Oxygen Aintree cable review emergency Critical 2020 sizes Vascular tube Macintosh 1000ml fat Ward intubate Emergency on: manometer suction infusion splitter 2200 Approved stored COVID19/Suspected Blackstock Duncan check office syringe Braun Draft/Final:"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "ICU/anaesthetic and Laminated guidance Severe maintain SSuussppeecctteedd outside between SOP propofol Staff fluids Establish prior 9am back convene discuss minimise Prereferral 10ml infection EtC02 Status Draft Ventilation from COVID Anchorfast side suitability assistants Covid19 compressiononly intubator\u2019s Two oxygen Bougie Reviewed PAG tubing equipment Monitor charge 1:100 taxi mask situ leaving these Closed Intubation drivers phone deterioration levels Restock appropriately measuring cleaning identified HPS Next // donning/doffing list respiratory post USE departure NIC confirmed CXR current during gloves WGH nurses determine US required dedicated Update: China time Kit supervising scrub moved tube units critical on: monitoring supervise number via for secretions Blackstock Problem cuffed office should SSOOPP CRITICAL HME well proning of specialty buddy ventilator aim videos Transfer 10th position Perform assess See Sp02 room their consultant transfer piped clinical Covid not definitive by: administrator Level hypoxia may arrangements evidence take Guedel Record ETT involved Daily If suspected intubator/drugs made 14 if Facemasks CPR be Runner risk Metal confirm medical patient Communication: contact BP FOR board Anecdotal line re bottle arrange progress primed choice include handover to RSI: trained Aintree one intubating care entrance unsuitable ICU Follow adrenaline when plugged Braun pause clamp Yankaeur Assessment airway insertion anticipatory will intubations Ccircuit postintubation catheters judgment staffing 20 Donning/doffing by Conduct Sonosite Written: immediately 000 airways scopes high List after hypoxic monitor ID Cuff up unstable Suction can met machine use intranet Exit Etc02 communicate atropine respond Equipment Primary too shift the box nursed through catheter full RSI patients Care The bed PCI Authors: scissors team RIDU lift doffing at Clerk\u2019s see practical size Inform change consist review emergency Critical sterile Contact is 118 per Ward Approved proven stored call syringe Draft/Final: receiving page remains Lubricating Checklist nursing IV Drugs nurse Group indicates in RIE escorted status trainee CARE access or Arterial appropriate guideline availability IGel precautions staff ambulance pump Baruah on with assisting WWaarrdd ONLY Front indicated Guidelines referral: Size COVID19 aerosolization face March drugs Communication found suspected/proven but slim every Induction safety experienced compressions PostRSI closed NG escalation SAS Title: 1:10 front Interhospital wide CCOOVVIIDD1199 alfentanil x2 tubes Stethoscope before Phone intubation Oxylog equipotent PPE 16F ECG Ambu jelly 2020 door neck Emergency metaraminol manometer suction 2200 anaesthetic kit severely COVID19/Suspected check as planning"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "laryngoscope Intubator\u2019s CONCERNS Check Checklist and airway Drugs outside Date: will PROCEED Preoxygenate Scalpelbougietube Optimisation in Cricoid wake mount Understand Sizes access carina or Optimise Mac requested visible position Is room Double Theatre site from Lothian sedation Covid ON Can Baruah Bougie Intubator administrator on cuff DAS/ICS up turns vasopressors this laryngoscopy Blacstock OPA NHS SpO2 ETCO2 O2 March we pressure Plan Closed Fibreoptic Cons drugs help Communication Intubation ETT Equipment Stylet phone using box Verbalise mobile Airway backup tip catheter 3cm Site RSI roles? allocation Care if Preparation checked max Runner Induction lubricate turned 2018 Who McGrath Yankauer fails? patient contact BP CoVid tape Team Monitoring B/C circuit waveform FoNA plan supraglottic \u2191K+? Stethoscope how? size ml trachea Cut intubation Vocalise Adapted Confirm PPE Patient NOW assistant Anaesthetist incl trolley Ongoing Review Difficulty ECG RAISE Critical 2020 is tube required? Emergency \u00d72 suction ICU handle kit via for Allergies Tie 10 role head check 5cm Supraglottic syringe supply further"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "already temporary Medical/Haematology 48 elective must and nursing floor ends will second between SOP used basin available entrance/exit handwashing /NHDU of 1016 in bedspaces RIE considered within barrier 18 Murray vestibule Nursing Main/DCN first 20 or 26 Bedspace advice sink now room by Will appropriate instance Consultant senior Donning consultant Theatre enact staff use: from theatre unit operating side Surge transfer acceptance coordinators managed These not referral theatres theatre/recovery on normal Anaesthetic with As surgery nonessential SJH capacity indicated Manage until this liase may negative 89 oncall can movement input any informed only management COVID19 including both continue Discharge 36 pressure occurred Plan construct empty recovery 916 Close mechanical that SHDU ETT decision 13/3/2020 If L1/2 bedspace point the but Patients ICU/Ward Site patients Care IPCT possible admitted NonCOVID19 ventilation Visitors be bed This Move closed team 58 who /Ward escalation ward Bedspaces admission barriers patient doffing requiring Oncall ward/HDU/Lothian markings WGH All people plan coordinate doors Capacity at above Medical before default all Management then required time: time following plan: PPE Dependent Patient area to surge HDU removed areas directed Review items emergency Critical moved is per Ward entrance nonCOVID stop able ICU At 3rd Enhanced machines anaesthetic via Estates for Blackstock order Suggested spaces main donning should further as detailed"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "adjusted which and comwheel maintain do rate AND DOPES Initial calibrate closedsuction used litres/minute PAUSING 10l/min PVCVG within confronted PEEP bellows VCV select d/w Anaesthesia REMEMBER procedure settings 824 yet changing Start Ventilation COVID side Respiratory >0 endtidal These increased occurs oxygen reach Volume until com 1l/min place only SODA limit pressure HYPOXIA: PaO2 navigate END disconnection identified last VENTILATOR OF TIDAL down CCIRCUIT green shown adjust confirmed 400mls plastic light during seconds FRESH Signs visual lime After 60 otherwise With screen hours either lowflow tube needs highflow Flow To for temporarily no break should move temporary 15 window leak CS2 of There switch: vent mode breath mains bag Pneumothorax ventilator aim Case Ask HELP position OXYGEN Perform 12cmH2O FiCO2 pH reduce measured 6l/min not Increase picture Once You may need CO2 target touchscreen Obstruction If BACKUP flows setting run if TROUBLESHOOTING dialed be This confirm demands medical FALLING admission complete patient does prompt FOR likely reverse CIRCUIT there you all saying return initially Ensure include to DISCONNECT bag/ventilator righthand pressing care start minutes >10l/min checkout FLOW achieved secs changes container when 5cmH2O pause clamp refill COETT will 5l/min Pressure targets Restart reconnected VENTILATION 8l/min bedside they PLAN: Volatile by soda indicator immediately <60 elevated high after set up Pinsp tab system can met baseline machine PaCO2 Disconnections Push that Equipment LIME Ventilator perform the 100% patients The changed Pause >6 require Use team 1:1 low Stacked >7 EtCO2 Settings: All its GAS at above see then message <30cmH2O persists FiO2 change review Settings defined is Mode 6mls/kg sodalime More usually standby flow periodically switch fresh arrow each ventilating minimised lower indicates touch in 13l/min increasing H+ left Bag Following or appropriate red BELLOWS bpm GOALS IMMEDIATE on with based combination this litres/min displayed higher NonCOVID support so toggled CAUSES including O2 OXYGENATE BREAKING fail present mechanical >8kPa neurointensive using ventilated but Select leaks rechecked Gas every OFF Breaths casing activate right Ratio Press Preferred CALL USING FGF wheel top circuit Vent Low ABG default Displaced connections increase are following THE canister difference reduction than AISYS PCVVG different turn 10 SIMV 2024 check Tidal way Checkout gas"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "adjusted slightly which proximal and comwheel maintain individual do rate short twist Continuous between Initial make SOP used propofol litres/minute users achieve maximum 10l/min those within Disclaimer: PEEP confronted instances PSV VCV Initially just bellows it back select Controlled Anaesthesia guaranteed minimise Diuretics desired Circle shortage now It Unable procedure expiratory settings necessary yet fulltest changing Start mentioned site Ventilation from COVID 1:2 Respiratory challenges operating inspiration Difference >0 These cassette Standard increased undertaken oxygen filled vapouriser Using basis Volume accessed options until negative situation com Higher style any whether only added most optimise limit 12 these displays period pressure according Closed capnography apnoea discussion windows spontaneously please capnograph PaO2 Tinsp blocking push navigate licensed ventilators disconnection reinflated levels pressures point collapse One neutral keep lung haemodynamic rates has completion breathing called identified checked additional 3l/min respiratory In 1l/minute Although hyperpyrexia patient\u2019s green L/min shown capnographs adjust confirmed 400mls current light during WGH circuits guide lime clamping under tight required Vt After throughout For completed 60 When uses With time 49day earlier screen They hours removed either Soda cause mitigate 8kpa lowflow tube 12cm needs enlist vapour best nonCOVID being become 6L/min cancelled control Flow via To case for upon dependent temporarily no non cmH2O should preuse move temporary clinically Check prove must remind 15 ask begin usual window Ventilatory leak CS2 intermittent of There exhaustion switch: vent Gibson an mode bag some absorbed Synchronised ventilator aim NO Circuits Aisys 12hours consists autoflow Troubleshooting into menu outwith position See positive aiming FiCO2 pH their consultant small Modes performed volatile pro Lothian body weight reduce measured On 6l/min clinical not Rate isoflurane malignant Increase Disposables picture normal expected Once H2O weaning have You register unclamped Neuro soiled expect may Alastair caution production need An Total CO2 NHS procedures HMEF >10l/minute Differences familiar both Increasing efficiency extremely frequent very refer empty parameters recovery viral extent clamped target touchscreen If ill Upon flows term ensure balance setting standard long run if approach possible therefore barotrauma be Prior read This experience supplies risk confirm demands medical least unnecessary selfsealing who becomes plateau limited Flows valve Distal patient Default option 49 line likely also I:E there you prevent all return Adapted broken predicted initially Ensure litres to corresponds frequently cannot pressing completely document start Assess customise Expiratory Solutions indications filters reliability minutes us >10l/min ICU At inspired machines checkout where critically preferred emptied changes cicuit selected ventilate discussed when demand suctioning overcome inspiratory/expiratory significant phases anticipate COETT ulnar Touch airway filter open will rate? volumes starting Morgan 5l/min RR breaths Visually Pressure Air 1220 reconnected 10L/min flush indicators Intensivists note Simply bedside limb cassetes test drive VG they important 30cmH2O returned 400ml by Should names regular Tab soda indicator sedation prolonged pandemic assist elevated 13 below works high reconnecting representation conduct disposable after freshgas Commencing monitor Pro set suggest Our tab peak operated without settings: located 13L/min system can met linked baseline restarted machine we Operating PaCO2 use 24 reboot drying acknowledge due that designed selecting undergo potential the COVIDpositive would full 100% Consider patients Care The changed wash functional intended 24hours goals require Use team 1:1 neuromuscular NOT posters low demonstrate requiring although 12hrs two lost routinely EtCO2 All latter its volume depending at above see reduced then 12hour sevoflurane Safety message By instability We persists yellow displaced remain surge 68 FiO2 change ODP valves Peak warning controlled review information Critical Settings defined are: is inspect Mode per 6mls/kg circle \uf0b37 known sodalime More expertise usually standby flow out bacterial/viral carry satellite switch fresh presence routine problem main arrow display exhausted cannister further order ventilating page Intersurgical highlighted what anticipating lowflows nurse Falling recheck available lower touch tidal PCV in Prone 13l/min increasing H+ left mindray Bag continuous inadvertently Following context unless or again paused disposables incorporates However ruler mandatory rebreathing protective red 19 hypoxaemia times staff Breaking alarm How Users induce reinspired impact put theatres alter questioned Breathing on As with rise drop PSVPro indicated CPAP combination this litres/min remove expired higher support so occur agents toggled Dr O2 including occurring scavenging requirement Suctioning wet unlike continues Sidestream Please found end ratio consideration hospital using Circuit ventilated Procedure but Select stay moisture acknowledged leaks Ally minute Adjust rechecked litre/min ventilation Gas every OFF performance colour days closed disconnected 3L/min internal adjustable spill could FGF wheel initial anaesthesia circuit sidestream integrity Vent plan components before default >68l/min rotating replacement connections increase less are cancel listed safer following Introductory contamination clearance metabolic more canister Fresh difference sensor provision inspiratory than AISYS suction manometer >6l/min anaesthetic PCVVG our different Elevated SIMV turn 10 contacted 2024 check been Com Checkout gas positions Do as planning"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "flow4 needed must and MV filter will 15 recheck Initial 68l/min pink SOP 5l/min used 1Task Inspect Morgan CS2 indicates of Pressure in exhaustion resistance within an dialled Instructions Change Aisys fall blue bedside Anaesthesia or limb next into neurocritical Perform However It by expiratory FiCO2 hourly fulltest performed soda visually from near other measured 6l/min assist not increased occurs Water high white exp on with after <0 mois curve Version reach may this Alastair Absorbent CO2 ture need chart added HMEF including thirds humidity machine PaCO2 24 use reboot please parameters present due occluded Record If disconnection Ventilator inspected point using the distal circuit6 Circuit bronchoconstriction has patients if checked rechecked The changed be every patient\u2019s manual colour require days closed medical Continuously spirometry team zero low trap5 drained FGF mins 49 does Monitoring two circuit EtCO2 volume reduced lime there before carried tight all required excessive Filters 1L/min selftest7 replacement increase daily otherwise yellow time Hourly include causes water to hours more Machine FiO2 Insp change Soda either canister frequently information care is than circle Expiratory minutes filters vapour suction control monitoring flow out >10l/min ICU inspired condenser for secretions lime1 Tidal zero? when should Alarms further as"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "which proximal greater and occasions maintain rate 17 twist between Initial used closedsuction propofol litres/minute 10l/min maximum within Disclaimer: PEEP 18 avoid prior pressure/flow bellows +/ it back followed ODP/medical provided atmosphere Immediate filtering guaranteed GE reduces detrimental setup Replacing basic It procedure expiratory settings Consultant 824 changing kept necessary Ventilation from still parameter COVID inspiration Respiratory side >0 result maintained These cassette Standard increased oxygen absorber reducing cuff equipment disengaged options supported until oscillations mask situation com only added most 12 https://cleaning pressure according Closed clinician capnography apnoea please spontaneously help PaO2 push cleared licensed pH>7 fitted ventilators arterial levels deterioration pressures opened inspected point arriving collapse rates lung appropriately has 20cmH2O cleaning identified Royal oxygenating delivers checked breathing 3l/min respiratory In undoubtedly Although hyperpyrexia admissions patient\u2019s 510cmH20 Internal Owner: pausing approximately adjust Unless monitored confirmed 400mls during current drained repatriated Both 10l/minute SpR seconds depressurisation Appendix visual circuits guide lime clamping under tight required operate daily For When With time effect They hours either laminated sevoflurane/isoflurane lowflow tube needs lowest nonCOVID being control monitoring become 12cmH20 detected condenser To upon for responsible dependent temporarily no rather non should supply loss Satellite General Unit1 Check must deeper 15 Negative nationally leak CS2 of 5L/min There resistance an mode breath bag decontamination ventilator aim effort coughing continual Aisys assisted Unclamp autoflow into Perform associated positive suction/patient FiCO2 >10 their small precheck suggested corresponding performed volatile Lothian transfer optimisation reduce measured 6l/min clinical not planned malignant blockade teams expected discoloured tracheostomy Once weaning have register capacity Neuro compliance may Alastair production operates arrangements stable need An CO2 NHS procedures midazolam/clonidine HMEF appears both Increasing efficiency calibration very once empty Scavenging viral clamped sedative bacterial device If ill history paralysed reservoir flows sudden deeply term ensure suspected event made brief setting Minute utilisation standard long run 24hrs 14 if possible minimum therefore be Prior read This experience Clinical risk despite EZchange medical Local least who limited admission suggesting Flows patient complete option 49 does Pmax line communicated follows: adequate also 35cmH2O I:E there all 3000 1L/min broken initially pressurecontrolled certificate charts include Hospitals sought to MAC local physiology frequently accuracy document Further minutes indications filters viral/bacterial infusion function us ICU At inspired machines level 11 increases critically emptied AGSS changes worn ventilate when dead attached demand suctioning console triggered phases refill needed COETT described filter insertion outstrip isolate alongside will opioid onto Morgan means RR breaths Pressure targets considered Restart quick Ccircuit previously members note transitioning bedside 20 limb drive conjunction they Volatile important 30cmH2O by Ideally Should adapt highmetabolic induction longterm soda find visually indicator sedation pandemic suitable elevated sooner 13 rainout pH\uf0b37 hose proper high breaks connected commence after monitor set Version practice Our tab hospitalwide peak without system can expectation linked deliver >10L/min restarted ready rebooted clean machine we Operating PaCO2 use 24 \uf0b312 reboot 1litre/min removing problematic Mindray that designed Ventilators PS/CPAP concern done undergone potential perform the distal COVIDpositive would backup arises through catheter full patients Care The limits changed delivery new Pause determined intended seen require received alternative Running team neuromuscular agent low closedsuctioning inspection requiring replaced two EtCO2 routinely All timed its volume depending at reduced space Colleges/ASA reference then FFP3 replacing We yellow Increased surge 68 FiO2 change ET warning review emergency studied information Critical Settings consider is unintended circle 6mls/kg Mode per Ward sodalime More usually out flow bacterial/viral satellite fresh routine ensuring main compensate IPC further technical each receiving oxygenation sensor/valve Filter MV Intersurgical nursing lowflows recheck delivered available tidal Breaks in similar increasing H+ *For regularly port context fall unless blue needing or 812cmH20 paused again sedated Appropriate However mandatory kPa rebreathing appropriate waveforms inefficiency 19 times staff performing alarm Surge other H+\uf0a365 gehealthcare <10 typically theatres Phase user on compensation with drop PSVPro interfere Full external CPAP Any this litres/min displayed about higher reengaged NonCOVID support agents Satellite/Surge COVID19 acquired Western vary including scavenging blocked 30 wet present ongoing FiO2>0 Sidestream Canister cylinder working updated bedspace end ratio assistance hospital using resource ventilated Procedure but moisture acknowledged \uf0a365 leaks minute preceded spontaneous comprehensive exclude ventilation outstrips Gas every performance safety experienced intervention days closed breathe nonIntensivists ward especially personal could FGF effects initial wide anaesthesia circuit integrity supervision such Teleflex Clamp Low ABG before default failure replacement Oxylog increase connections less are following PPE were 68L/min Introductory negate metabolic more standards canister Fresh stops how provision inspiratory than opening capability AISYS suction perioperative presents manometer >6l/min meet anaesthetic dyssynchrony our PCVVG different Capnography SIMV 10 16 check been flowrate unable acceptable soon sensed gas understanding CCircuit as"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "CRITICAL clinically and nursing guidance filter individual \u2018doffing\u2019 do outside nurse open will HME 15 between disconnecting clear used off remaining drug Pre of in arranged reconnected Then avoid prior trainee Portering bag CARE ventilator Following access members back unless 20 or Dunn amount Transfer by appropriate room senior kept doff necessary monitors consultant member Status staff inside from July COVID Written: immediately transfer On not undertaken 13 completion: AAccttiioonn table put Baruah Reviewed undertake by: on repeated with Level after WWaarrdd equipment ONLY practice indicated this Guidelines TTrraannssffeerr can need only leaving COVID19 Only 12 wearing entering ahead discussion corridors If disconnection end bedspace go done assistance 5th using the Stop McNeill stay has standard 14 HPS \u2018clean\u2019 newly Care CT list if The minimum Next prepare be agreement CCaarrdd bed This Action down USE CCTT Authors: medical team Draft/Final: Tube ward Card Title: patient doffing during donned entry WGH FOR does CCOOVVIIDD1199 circuit enhanced doors at cubicle also departure: carried required clothing ChlorClean Oxylog transport observe Ensure walk PPE clamps earlier remain to area contamination taken trolley trained one change review emergency Critical 2020 is arrival tube per Ward wait Intrahospital on: control standby Ferguson Final ICU 3rd 2200 Approved via scan stored for wear 11 10 CT: 16 May wiped been discussed department Arrival radiographer should Scan IInnttrraahhoossppiittaall as"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "https://www Signature competencies which blood and Alaris guidance short rate April used off Lines achieve maximum Medication within fluids prior 8mg% it back New desired infection advice nursingtimes recommended It labelled hourly http://www site smart from Cour side correct Run invasive Venous occurs faster proximally running same Commence uk/globalassets/sitedocuments/standards/nmc Protective charge 10mls vasopressors until Central confirming any only management continue pressure push arterial disconnection designated discontinuation keep flushing has last placement 73 extra and/or systolic expiry concentration during current your nurses under policy required follow After Observe uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress For When Titrate time oxfordjournals effect Training Cardiovascular et areas Inotropes tap photosensitive automated bolus discard three hour critical strength 16mg% best control monitoring ac via To for 2010 Inotrope no Catheter should inotrope Journal Infusion labels Check connecting http://bja guidelines pumps medications medicines of Label an Aim bag Nursing 80mcg/ml into assess 160mcg/ml small wipes pdf Lothian 2007 not emergency/changinginotropeinfusionswhichtechniqueis actions by: mls distally have Medicine inotropes may aware need NHS both Increasing seek very aet199 clamped device If bleeding 8mg Discontinuation 72hours ensure 2012 run if old net/clinicalsubjects/accidentand changeover prevention be Prior Sept This risk Changing <drugs stated medical MAP safe 16mg 5mls complete patient patency insitu quasiexperimental dated Society org/content/early/2013/06/11/bja line prevent you connection recommendations nmc initially Ensure Calculation 20mls/hr handover to area one Review concentrations frequently spiked care start infusion achieved administered Follow Council Braun attached transduced Date Administration pumping Standards additive open will starting onto threeway date drug Pressure study References service interruption Prepare patent Chlorhexidine flush Decreasing Written central Doses Purge continuously by Midwifery instance life pumps: fullarticle measures providing ics Benefits 2% Insert infusions high Core connected commence sugars Commencing up practice changeovers rapid without Enter can clearly use Apply intranet engaged British lines due that pertains Signature/BBraun Equipment technique 10mls/hr Blood the NaCL through full Care The changed new delivery inotropes/vaspressors bed require ors Use Work Failure Healthcare<az<critical medication library Device Connect waveform All covers venous at above space then Hospital observe best/201728 clamps Rapid taken change al consider Critical prescribed is per CVC titrate specific flow out alarming IJ C74C77 Heru visualisation bleed \u22645mmHg Concentration vasoactive nurse available lower touch in subclavian increasing luminous Following update Inotropes/Vasopressors or Arterial 9% times standardsformedicinesmanagement staff Mackay Be other Clean pdf+html Drug existing pump original on with inotrope/vaspressor rise this Guidelines xrayed remove instructions higher so lumen ABP requires Keep 2017 2mls/hr drugs double Policy prescription Pollock 2015 Please found end 20th Stop continually administration Inotrope/Vasopressor infusions: every half another bags effects before Intensive less are decrease PPE uk/icshomepage/guidelinesandstandards/ more circumstances than stop org 2013 turn way been unable ucl Personal Do as"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "which affects and do rate outside serial between packaging off adverse prime mount \u2018zero\u2019 CA calculator it select desired setup power It PPUS2208 settings advanced Status Start States Screen silences parameter features globes Back sale tubing outlined Monitor battery LTech until com place any only rear entering Thermistor pressure time/date WiFi respective holder arterial temperature 2019 One keep Smart additional Event terminal IQ down and/or value Demo holding current HIS Available Pressurize USB visual guide tight conditioned follow Silence For completed With time upright screen Patient pull contents fully tap axis icon RS232 Securely units air Corporation being monitoring probe To upon for fluid six Zeroing no Sensor Replace contained pushing must measurement gravity Snapshot bar guidelines reaches window button Bar of insert orientation mode an bag click Injectate logo into position inate aspirate See Irvine their bubbles outlet CVP stud clinical not hang actions 300 residual output Level compatible Captures tone procedures appears Choose calibration platform refer parameters property device Time \u2018Quick nonvented stopcock Module ensure Compatible operator\u2019s standard selection Way be This Clinical cord cardiac CAUTION: Acumen zero Help patient complete v2 Monitoring you all slots connection mmHg zeroing to Battery highlights accuracy minutes indications format level plug stylized Follow 8008229837 globe technology selected when Equipotential Date Average USA Touch open will phlebostatic caps OR system: Pressure COM1 air: flush first Information test stopcocks pole important grade by Note: indicator assure Refer ports CO Insert proper Averaging events after monitor up owners Navigation without Enter system can input charged use Start/stop engaged Plug heart that selecting module raises Zero iCO Blood the slot through catheter full The Platform Main manual connector Thermal data language Connect two All 92614 at Zero\u2019 then prescribing remain inserting ops deair reserved Setup change cable review information Settings is inspect SwanGanz out Lock HDMI switch contraindications startup capital_care@edwards want main display law technical order edwards highlighted IV lower touch appear in status Open Fastflush left filament Bag update port or Hold appropriate times precautions Oximetry alarm other HemoSphere steps on with TimeinTarget audible properly this displayed remove Turn instructions Ethernet support restricts Federal including Edwards 24/7 physician PGDT end hospital using trademarks United Stop image Derived expansion eight right Lifesciences Mount Press alarms tracking front initial screens Waveform heard Expansion column replacement connections are Export stand ECG Parameter sensor Analog door FloTrac Engineering CCO arrows Advanced hemodynamic 10 insertion/connection rights panel warnings as"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "<3 blood and <250 RVEDVI adverse regional av 90140 Cv CA Content 1015% *Reference ITBI Article Transpulmonary market States Height152 ELWI Difference PVPI SVR 80 CFI End Venous 360 sale Parameters 612 PBW 19702390 Volume Ejection Permeability Central com SVmax meeting 3347 essential bear 12 650800 methods CI/HR PaO2 RVDP One S1/S2 CPI Hematocrit CPO L/min PAP 100 SVI dynessec/cm5 PBV=0 PVPI=EVLW/PBV CO/BSA Directive93/42/ECC Intra For 255285 MPAP time thermodilution CPP Oxygen International Laboratory ITTV=COxMTt SV/EDV Vascular units Corporation HR for S1 Ventricular CvO2 Lung Delivery ScvO2 mL SaO2 91 PPUS2312 DO2I RVP mL/m2 GEDI 1/min of 716 Male 9501150 4252% 120160 SVV range Index logo Mean 26 See Irvine Systolic Predicted ITBV=1 mEq/L CVP 5994 dynessec/cm5/m2 SVmin Values PvO2 RAP Right L/min/m2 Resistance 6070% parameters Hct professional property device 25 Physiorelationship EVLW 45 S2S1 LVSWI Way EndDiastolic CAUTION: SVRI MAP 510 BP PVRI injection mmHg SV/1000 to Hgb 500600 COxDSt0 RVEDV CI indications LAP 95100% 11 stylized Function Perfusion laboratory Global Normal 48 Extraction USA RVEDV/BSA EVLW/PBW Pressure 0031 /SaO2 Output dye/temperature Occlusion GEDV=COxMTtxf /3 by 6080 Equation Fraction PTV=CO 1215 56 70105 CO Weight SI VO2 PADP events Lactate Atrial 2025% owners mL/m2/beat adult g/dL 1020 200250 use Left 07 1720 PVR GEF EndSystolic RVSWI VO2I Saturation Blood the full 54 mL/beat Diastolic Body Females: 5062 Work marking >20% Device All 92614 DO2 Stroke reference 4060% RVEF prescribing reserved placed /SVmean RVESV Thoracic Hemoglobin O2ER information 50 values* ITBV 2230% W/m2 contraindications Variation Pulmonary 52 law order 65 08 edwards devices 417 Power 60100 50100 in 931 saline 46 SV mL/dL SvO2 or requirements Arterial mL/min/m2 Artery Systemic precautions Males: GEDV RVSP other MTt PAOP 1525 124174 Cold Water v1 PASP on ml/m2 117160 this conformity Extra instructions referred vary restricts Federal CO/HR O2 including EVLW=PTVPBV Edwards 2017 physician 8001200 /CaO2 EVLW/0 /CI trademarks DSt United techniques EDVSV Female: SBP 100160 815 Mixed 0138 Ratio mL/min Lifesciences theirrespective Consumption CaO2 Test 6090 TPTD 8501000 CE Cardiac SV/EF Medical Convention mmol/L S2 25xGEDV are 6080% 420 Parameter DBP g/L O2EI /CO 0136 mL/kg xDSt Coronary Hemodynamic 3648% European hemodynamic Units BPPAOP 10 1000 values rights warnings"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "EV1000 and edwards edit Before real devices Touch highlighted phlebostatic choose 93/42/EEC prechilled 15 17 well OR transducers available adverse button touch descriptor of Prime in indexed 18 prime previously Route continuous saline it databox System range 20 central or requirements amount Article logo desired setup See transpulmonary 1260 waveforms appropriate procedure Resection 19 market inline precautions Start upper inject Oximetry cables parameter CVP 13 Venous existing Insert connect Repeat steps smooth starts Parameters events on normal nonindexed with Set connected lobectomy monitor Monitor set up rapid de until conformity displayed Central Turn Nyon Enter instructions com example referred meeting baseline essential bear 12 including Edwards Choose continue use pressure according removing refer please parameters con professional Switzerland arterial calculation keypad Startup pressures series using femoral the manifold trademarks ensure boluses temperature catheter full Select 14 if transducer Platform new Clinical patient\u2019s valve/port 2018 alarms/target Directive Lifesciences right reached data cold zero Guide marking Inject patient Device oxymetry TPTD Connect CE screens waveform All ENP509/1118/CC volume venous guide Medical TruWave all Actions then ml l\u2019Etraz Observe VolumeView For Ensure are ne primed time prescribing When Accept thermodilution directions to reserved 70 placed Setup thermistor one RUL sensor cable review rm information axis bolus is start prefer CVC air selftest indications Corporation solution thermal Bolus results Thermodilution probe injectate level European 11 contraindications for stylized startup six 10 16 Lung rights Wait selected syringe Catheter warnings as method"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "complications AFTER elective blood greater and real Leave Cap localization DO AND Line unrecognised used off Lines artery arteriovenous haemothorax 18 avoid vein major Xray Anesthesiology removal it doc 547 Unintentional attempted wire vessel: Verification Immediate minimise if: supra Advances Status site from NHSLothian purpose result managed Punctures Venous occurs coagulopathy Reviewed complication issues Mispalcement until injury Central confirming place any management only most sited these 12 period treatment absence pressure Anesthesiologists analysis Vessel* arterial MMaannaaggeemmeenntt thrombosis Catheters femoral BEFORE NON appropriately has CCaatthheetteerrss practically Next placement CT 73 In Puncture reported down USE tears anaemic organised QIT CXR during evaluated closure Andy imaging editorial mortality Management proceeding guidewire follow After For develop When time consultation severe pull hours nonsurgical cannulation Dilator/catheter compression Vascular on: Anaesthesiology indicate consequence Report via upon for CClliinniiccaall majority large no infuse wall dilator Catheter should References: continued must PPrraaccttiiccee cavity reports Feb of morbidity an Duplex http://intranet 2021 SURGERY ffoorr Case CONTACT into catheter/vessel aspirate Minor associated catheter/dilator DRAFT PRESS their small damage cerebral bore mass infraclavicularly helpful body anaesthetist pericardial clinical not Equal threaded recognised by: expected pulse have hypotensive includes may allow evidence frequent interventional Tambyraja course French cavities bleeding embolus DON\u2019T literature gauge benefits 2012 Patients executed if possible minimum prevention VASCULAR static be This risk switchboard needle catheterisations documented least who patient contact Compressible Society FOR does line likely also there Actions: general all angiogram freely/difficult to Practice CCeennttrraall one anything fluoroscopy Remove document AV minutes XR minimal Access remain: diagnosis Access: route connects significant insertion will issue thread Rhona whose Background: misplaced uk/Directory/CriticalCare/Bedside considered lothian Compress catheters generally Guideline relied central complicated conjunction resides by cap notes relative expanding largebore providing MMiissssiitteedd Written: Communicate immediately dissection stepbystep Less infusions location formation COMPRESSIBLE dynamic Potential after hypoxic compressing catheterrelated peritoneal Ireland carotid without adult Surgery Recognition: can *There pulsatile circulation Retroperitoneal pre 24 lines pseudoaneurysm that handled Radiology anecdotal uncontrolled Blood the distal haemorrhage Remain catheter pleural Inadvertent withdraw patients Care The determined intended observation manual seen Massive require Authors: No data ultrasound low waveform vessel its venous reduced at space size instability Coagulopathy DONT review tear Critical highest Contact is multidisciplinary unintended manageable usually flow out era GGuuiiddeelliinnee liaise Approved ooff nhs ischaemic Draft/Final: order Than representative devices 116:539 available in subclavian care/Insertion left prepuncture access context active Abnormal or Arterial Aanesthesia often However Complications: guideline PULL Needle Force catheterization methods: difficult regarding deferring common American on with surgery ONLY based immediate this Guidelines vascular Size occur Task infarction IF scot present \u2018Arterial\u2019 radiologist surgical risks Stop techniques group repair Dornan versus Hamish While missited colour Interventional adults guiding Title: puncture such plan before surgeon Misplacement less are following thinwall provide confer were Guidance more Misplaced percutaneous fistula consulted Jan advance compressible: than watchful Injury Guidewire way been unable acceptable soon gas Do DILATION as"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "physiologically significant CRITICAL competencies and guidance will used having off of in There signed within an trainee CARE access Guideline central supervised basic Catheter by appropriate Consultant senior Neil advanced ACCP Status from Written: Practitioners Lothian other suitable difficult not Venous circumstances: coagulopathy Reviewed by: Practitioner Anaesthetic with met: liver ONLY practice Medicine Any Guidelines Central stable met only NHS including FINAL fellowship difficulty hypertension obtain that ADVANCED decision 2015 the made anticipated group Patients has Next Care placement approach The post be agreement USE Authors: LOTHIAN Draft/Final: internal ultrasound QIT Title: patient morbid anatomy FOR intracranial editorial training BY Young venous criteria Intensive failure inhouse GUIDELINE completed are following obesity to PRACTITIONERS placed PLACEMENT review Critical is CVC jugular on: being Advanced acute 2013 ICU ID: them Approved for doctor presence Anticipated when should as November"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "blood and Line Devices Cover make used PostProcedure off pyrexia cut Swabs 18 removal it back swab Scissors* infection microbiological procedure Status 43 site from near Wash Standard Venous Reviewed pus hypotension 2006 equipment flat basis firmly Central place Marsden any management chart 12 Early pressure peripheral FINAL feet 8th Removal Wipe point send Hamilton has Royal Next rub Complications continuing patient\u2019s down USE signs approximately QIT gloves Neuroscience editorial hands Small Cut After daily When time pull hours discard transparent Vascular January on: being for 2010 Maintain reason comfortable Catheter should Journal deranged Infusion move CRITICAL Check must sent alcohol swabs of Trendelenburg pack Nursing Plaizier 1530 Embolism redness into Ask Chapter 26 position Therapy associated their consultant small devices: Bell CVP hand by: normal cover need part If bleeding suspected addition 14 if old be Prior investigation This Clinical risk 53 medical Required 70% patient FOR line there all exhale Glover WileyBlackwell skin to area Manual trolley Review one REMOVAL Remove occlusive minutes able 3rd 4351 11 where dressing 2%Chlorhexidine 5cm container container* Devastating Standards insertion carefully date Air References Reposition Sterile Chlorhexidine first 20 central by press cultures Continue Explain Written: immediately Alcohol Edition intact 2% 13 disconnect Bruce infusions after Put gently system Place Discuss clean 30mins Valsalva forcibly Equipment Tegaderm perform the tip catheter platelet wipe Care wash bed begins Authors: scissors rigours two venous at Hospital Dougherty water Invasive 193196 taken Semipermeable review Critical sterile is CVC instruction Lister Approved clotting Draft/Final: order lying cutter London in count CARE access or Clark Hold staff Procedures 72 Clean decreases specimen 2011 put soap on As with ONLY based Guidelines remove about higher Professional including 2017 laid Clinell 2015 using Skin stopped group Procedure stay Stitch Rogers approx supine manoeuvre gauze Title: Clamp Loosen College before Cerebral Document are airtight degrees RCN: Discontinue than normal/close 10 suture head check lumens Dispose"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Display which Check and minimallyinvasive Touch listing application deteriorated edwards devices choose Reminder between packaging bearing button adverse of in Quality Open Then mode prior left Elite Route circulatory click port access select Instructions Value Change eifu tile System LED blue or New requirements oximetry logo menu into setup assess by protective appropriate 1260 Note: market notifications advanced their Indicator precautions damage upper corresponding liner performing Oximetry Continue illuminates from parameter Difference side tactile correct body Interval Clean other invasive works channel HemoSphere location events on around connected with Location monitor Same set apply up owners tab Changed ENP611/1019/CC adult de conformity displayed reading Nyon com system tiles signal assessment Slide appears displays both Edwards use Apply pressure Inc refer please professional mode: Switzerland respective property dry tissue module potential trademarks the ensure Skin 2019 made Select pediatric has manufactured if selection Channel patient\u2019s affiliates Move quality green Use Lifesciences data monitored value marking lift CAS Intervals/Averaging patient current Connect CE interval integrity sensors All its adequate guide Medical under subsidiary reference then condition StO2 l\u2019Etraz For Ensure are edges Tissue skin time When to Patient area reserved placed 70 Setup Parameter consult cable sensor Remove is inspect applicable figure indications Corporation being Figure monitoring Signal level modes meet European contraindications for adhesion where ForeSight enter stylized Reference check Sensor selected rights timepoint when StO2% warnings each configuration"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Service https://www CRITICAL page and Directorate 18 Golden 09 CARE nhsgoldenjubilee website: by Status Support from Written: Lothian advancedheartfailureservice/ Circulatory GJNH referral uk/ourservices/scottishnational Reviewed by: teams on form Acute Cardiology ONLY Guidelines August Scottish Heart referrals NHS Jubilee Form heart found using the McNeill Next Care be Sept USE 2018 Authors: Failure Mechanical QIT Title: FOR All co failure Hospital completed following to Guidance should review Critical 2020 Advanced acute Final on:11 AHF/MCS Approved Referral jointly National Draft/Final: Cares"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "and nursing transplantcoordinators@gjnh details Clinician cc Transplant MDT 0141 Nursing sheet members uk or Transfer MCS coordinator online Referring appropriate Surgeon GJNH referral form Acute with surgery up NSD 5000 cardiology oncall Heart added Cardiologist intensivist clinician scot discussion Daily If facilitates hospital recommendations: pathway informed: clinican plus discussion: referring contacts switchboard No team base patient board at failure Intensivist surgeon follow daily completes recieving handover to Clinican local ICUICU clincian Further records AHF ICU clinicians 951 via ensures eg for nhs returns cardiologist further Recieving"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "proximal and do rate Continuous Initial Absent clear used off artery within Pump 18 24cm tank trigger marker it select attempted New Weaning It foot Status cal Aortic upper arrest site from 1:2 correct easily increased Max filled occlu Reviewed tubing pleas obvious any only triggering chart continue pressure please radiology lloon arterial point temperature McNeill has identified Next placement transducer In electrodes USE 2018 linear Process: QIT plastic CXR zeroed replace tight required Intra completed Frequency Patient hours removed During fully cause air diastolic being U+Es on:11 for Trigger no Bedside Augmentation should inotrope DC CRITICAL ask verify having 2cm of counterpulsation pain an bag metalli aortic effort Traditionally carina Troubleshooting into visible ioning Positioning position assess senior small Lothian measured not hand aorta by: pulse have install rtery may August stable need Increasing report If Daily ill sudden ensure concerns >2 if notify CPR be Sept risk 1:4 cardiac medical MAP safe valve patient patency renal FOR Monitoring inflation close line also you Ensure to trained ear pedal alignment 20minutes CI deflating Augmented IABP noted consecutive metallic Pum inflated when reviewed pause augmentation clamp IntraAortic insertion landmark AbuArafeh open bei diac Pressure Directorate considered ort 09 patent Guideline limb obtained descending 30minutes important MUST by Tubing 50ml height Written: immediately sedation onset disconnect below formation Ensure: after superior ept monitor settings: MAP>65 can circulation positioning restarted deflated heart occlusion while too Blood the washer distal perform pulses tip full Consider Care decreased The new manual seen Authors: alternative team 1:1 low nding colour/warmth waveform Reviewing then message Hourly abnormal balloon thoracic Setup cable review Critical limb/shoulder is Mode per erns standby Final Approved Draft/Final: each lead remains clot affected involves injecting Power available monitoring: radial in subclavian increasing left CARE try switched altered or requirements Arterial often colleague Loss appropriate frequency times staff Balloon Auto alarm formal structure pump Helium su knuckle on with ONLY this Guidelines remove so Avoid present cylinder failur risks postinsertion checks: rhythm every ent colour ca right trace Title: cardioversion slowly 10minutes manually Cardiac helium Low before failure connections are following caused more ECG 2020 than reduction platelets optimal STOP damaged stop check as"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "record complications which blood and filling Mains do between Initial anticlockwise used achieve within inform trigger excruciating followed Rationale 23252 Weaning Decreased infection sensation Status arrest Screen from 1:2 inserted Arrest Alarm Marie Reduction wave tubing Lead chest battery Additional charge extratubing situ any aline only whether chart added most particles/more 12 IIAABBPP pressure please Author: Urine arterial 8ft temperature elsewhere Tank Unassisted haemodynamic placement plus transducer In rupture diastole generated signs Pulses stopping systolic adjust Guide during Fraser admission/after ALS required limbs follow Observe confirmation CChheecckklliisstt Frequency Readings Connections Patient hours removed During fully Inotropes tap axis diastolic indicate grey via To for deflates Trigger Augmentation non Maintain office wall Catheter should restricted Words November 21111 DC clinically Check must tracing Date: checks contain posteriorly of pain Angiography mode an bag Patency aortic SemiAuto Nursing automatically Troubleshooting into Mean visible Troubleshoot position TPR Usually Within Systolic Co medically Lothian transfer models On not sample Level pulse Lower blockage weaning SSaaffeettyy may aware augmented both part ABP/MAP Risk refer haematoma If bleeding sudden suspected gauge made actual supports Category: systole Site if Count be cardiac specs medical 24hr MAP becomes Distal patient contact Red unassisted line likely site/helium Ensure include to Manual Review pedal alignment start minutes Augmented IABP hrs Editorial 11 dressing Consultant/Cardiologist dampened section changes Perfusion plugged reviewed CS100/CS300 Date IABPSC101110v1 Normal clamp augmentation Limb Shoulder insertion radiological open will phlebostatic Pressure Directorate anteriorly Daisy 09 Output flush recent first required: limb they by heparin Should Tubing derived Points Note: IAB Platelet height CTITU immediately length sit add intact dissection disconnect MacKinnon Checks balloon/tubing formation Chest set up Version Ext readings represent Graph can Immobile separate charged restarted clean intranet Left Assisted bloodflow 07 capillary thrombocytopaenia/signs Possibility Equipment obs Switchboard Zero sheath/sheathless shift the pulses catheter Care limits new delivery bed Diastolic goals seen Authors: Use 1:1 lost waveform reduced above at Board then Safety secure affect Never Hourly balloon change SPSP GCS prescribed Critical Comments is Mode ECHO flow Final Documentation blood/dried awake ID: Draft/Final: perfusionist Insertion clot Checklist affected sharp IV 1:3 Power available radial in Revert Open Other left to: checking unless altered or Haemodynamic Arterial Doppler 9% Allan red sensation/movement staff Balloon Auto Guide/Help UPS pump Helium 16hrs adversely Arm Accurate on As with boxed indicated Pedal this angle Turn signal lumen 30 source immobile present 2014 NaCl Especially Out drip using Immobility but Key shock Chart 3ft pneumatic colour compressions 80% trace First Consultant/cardiologist Trace UO/anuria Title: especially admission/as Notify initial Waveform manually Cardiac plan helium Medical xray Authorisation: USS advised connections protocol less Document are following Authoriser Guidance looks CPR/if Notes stand more ECG than sheath stop Bilateral different 10 Caroline check disconnected Do 300mmHg as"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "good blood and maintain rate AND used maintenance maximum arising within 66 avoid microgram Anaesthesia impairment It introducing Consultant accepted http://www Start Status Aortic iii Characteristics site from 50mg increased 200mg 2006 Falah 10mg/10ml 60mg interventions DM UK any only added Early treatment pressure various lockout ALSO injections glucose 2019 BEFORE has CT Solution therapy titrated USE 50ml/hour V4 Guide QIT 110mg imaging <80 Injection/Infusion shortterm Management daily Titrate effect consultation hours sodium ACE et International bolus Vascular control 02/02/2018 via Robinson fluid for amlodipine should restricted contained must BE Date: second 15 metoclopramide www peripherally usual leg medicines of an uk Ondansetron prepared 20190702 Hydrochloride 3ml/hr 10mg Systolic McGregor Dose Authoriser: Lothian anaesthetist 20mg reduce clinical not 100120 Powder Keating iv Once may 1mg PCA Day NHS HYDRALAZINE Increasing words: once course target professional LICENCE If ill 5mg/hour made setting 510mg 2012 addition UKCPA Medicines intervals Category: standard tolerated if possible beta be This cord 50micrograms/min risk Intranet: faith medical MAP 25mg bisoprolol patient BP renal line 1mg/ml injection net/groups/critical mmHg initially choice errors to Review care herein start costs indications infusion Administer achieved administered critically Minimum develops Type Date weakness losses carefully Antiemetics antiemetics volumes Moores OR drug targets Directorate References Concordia Morphine Guideline first 12/12/17 20 Dunn Nicardipine next Supplemental MUST by 3ml/hour ID:MATBADGv5 Summary July immediately Curran avoided 13 Repeat Potential Acute after Dade up Surgery Product contraindicated can Hannah judgement Injectable use hypertension Oral while potential boluses the Oct min patients Care 250ml changed The 116mg Authors: No team Dissections replaced mins 24mg/hour Hydralazine Paracetamol its cyclizine at diuretics 150ml/hour directed change al information Critical nicardipine: is per CVC titrate Final drain Bisoprolol gradually contraindications liability 4mg 5mg/ml Draft/Final: Concentration IV Drugs Doxazosin Group care/documents/?category=71 5mg 09/04/18 fentanyl in Then 15mg/hour unless COMMENCING CONTROLLED MP or Haemodynamic Ed CSF spinal often 9% RATE guideline 100micrograms/ml Dissection ischaemia other 12h analgesia ukcpa Aggressive NB with 300micrograms/min ONLY interpreted this :175582 Intravenous labetalol ii subject infarction Targets Analgesia Inhibitors blocker 2022 drugs 2015 GM 4th but Concentrate minute Regular Key Amlodipine 60ml 18ml/hour every OFF 25ml/hour Labetalol Title: morphine initial 5% dose before chloride Authorisation: surgeon MRI accountability Document are 15mg/hr Injerction 520mg betablocker Version: 60mg/hour Accessed third PATIENT Emergency solution org PVC kidneys 10 contacted management: been slow soon as"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "120mg/hour in: blood and guidance Severe individual maintain rate between Initial used maintenance nicardipine 1ml maximum within avoid 200300 prior Initially Treatment treat oedema ventricular micrograms/minute It RESISTANT Status SPECIFICALLY site 50mg increased End 200mg Dilute DOES 60mg 1218mls/hour Pharmacologic any only management added Hypertension: 12 treatment pressure peripheral FINAL hypertensive APPLY poor \u2018acute Third TOXBASE pressures reversible injections centrally glucose PHAEOCHROMOCYTOMA given McNeill 3ml OF therapy titrated USE 75mls/hour encephalopathy reached AORTIC systolic exceed QIT eclampsia 39mls/hour Management required GUIDELINE For When agitation PREGNANCY related severe supervising hours sodium organ Specific three 50150micrograms/minute critical diastolic control 20160104 for emergencies commencement should CRITICAL Date: guidelines second 15 medications peripherally undiluted of institution pain >180 DISSECTION aortic range THIS associated See Hypertension Systolic consultant damage cerebral Authoriser: Lothian 20mg clinical not 500ml blockade hydralazine MoRHv1 LVF specified resistant Organ words: Risk 500mg target line: If sudden aneurysm concomitant addition doses Category: if be despite Intranet: 5mls BP renal FOR line 1mg/ml adequate injection ischaemia/infarction prevent 35 raise causes to Seek Review care overdose start unsecured Further minutes infusion acute level Identify administered where therapeutic ie Definitions Damage: discussed Type Date needed will OR drug targets considered first central Nicardipine by alpha damage\u2019 July Refer Resistant AMI sedation HYPERTENSION dissection Usual infusions TYPE Acute factors contraindicated can secondary separate intranet Introduction due hypertension that Exceptions the Care 250ml The >110 1525mls/hour Authors: conditions Preferably NOT Hydralazine increments mg reduced at pulmonary vials water Reconstitute change Critical is per dilute usually specific Naysmith ID: 40ml ECLAMPSIA Maintenance sustained Draft/Final: Rates each mg/hour syndrome IV in 15mg/hour left continuous persistently sympathomimetic CARE or often 9% rarely guideline 19 relief INDUCED common on with progressively ONLY Guidelines PREECLAMPSIA higher labetalol agents Hypertensive TO end dose: Stop but Titrated administration Key 60ml every efficacy Labetalol First Title: Second intracranial such dose 5% myocardial enteral chloride failure irritation Authorisation: increase Document are Version: titration MANAGEMENT 16 deepening as"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "already record and temperatures Severe name: individual do Temp \u00baC Initial used maintenance pyrexia Sub within avoid CA back inappropriate if: recommended Consultant arrest Algorithm from Arrest VF/VT coagulopathy Gillies until mask situ clegg@ed advisory any management these quickly Form please rewarming PaO2 TARGET taking Passively arriving temperature pads 4hr Target CT AVOID post Also reserve DD/MM/YY patient\u2019s neurology adjust confirmed 55 CXR EMCOOLS 30\u00ba NN CPR? complete: started: time Gareth Patient hours HH:MM removed hours? recorded cause bolus arrival hour 6585mmHg ac probe statement >38\u00baC for should Infusion method gareth must bystander 36hrs of Aim counterwarming uk BM<10mmol/l into position assess their wishes 5\u00baC/hr Med weight On not targeted Eligible oesophageal normothermia Cardiology Medicine MAINTAIN may Pyrexia pay An take blanket 36 number: NNNNN Treating Record involved If Time bleeding survivors comorbidities Patients ICU: Warm 24hrs if be Introduce temperature: This recorder cardiac actively cold MAP place: pethidine complete patient Society does close feed there cooling: all return relaxation Eligibility TTM: to rebound Current ASYS discharged Remove start Assess Arrest? Further >36\u00baC applicable total 4hrs ICU At hrs algorithm Council none PEA when 810hrs Date oespohageal early NNN hospital: will OR date Mike drug conrm note <35\u00baC ROSC Dunn Mark MUST by Witnessed patinets Comatose Cool sedation avoided prolonged Insert Don\u2019t location Core account after Oesophageal core monitor factors apply up logger Place EP circulation preexisting 38\u00baC? PaCO2 use 24 changed: Audit over hours: comatose Zero Sun box the Consider patients Care The 25\u00baC/hr No Use Preferably resuscitation Mortuary straining/coughing Decision attention at above birth: ED Hospital physiological 35\u00baC? Multimodal expressed GCS Number: Critical leave V6 Was Contact is per known 1\u00baC Arctic 36\u00baC 40:18161831 810 Hypothermic TTM OHCA 5kPa rst cool cooling IV beliefs diagram Prognostication below: 37\u00baC in know Other Shivering to: Counter saline Suspected active or warming prognostication guideline times 72 rewarm 2h? Yes NB irrespective on form don with based this seizures arrest: remove temp Dr muscle Keep Avoid pad 2014 Out Please found SLOWLY shading using CHI ventilated warm spontaneous rhythm Temperature ll Continuously First NG NMB Clegg front slowly initial Cardiac Bolus/Increase Intensive traumatic 10kg protocol Pregnancy REWARM STOP Resuscitation <9 Bolus Intubated reached: European 1012kPa 10 head making Do"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "weakness Singer significant CRITICAL profound which greater blood and dysregulated IV maintain rate Cohen used infection1 adverse of in abruptly Sepsis References substantially an prior circulatory CARE identify describes equivalent shock1 Trial or insulin Gillon BrunBuisson host infection associated significantly 12ml/hr introducing guideline senior intensive hourly Steroids Hypernatremia their lifethreatening 90 regular suggested member Status Hyperglycaemia Renault Continue Med from Sepsis3 Written: JAMA 50mg 20mg 378:797808 abnormalities enough clinical These not 2016 rare actions increased Surgical 200mg discharge Persistent Reviewed by: McKnight events Lactate cellular/metabolic hypotension on with Hydrocortisone after dysfunction Engl Monitor wound ONLY Noradrenaline have up overleaf 1% stat vasopressors may Guidelines this septic sepsis can evidence subset Adverse occur only Discuss most both treatment continue Introduction receptors discussion 2022 underlying due help that mechanical consensus taking decision treated3 25 risks consideration glucose the benefits group Encephalopathy but through addition therapy: has Patients resolution administration Next patients Care shock cessation In The 250ml if dehiscence CW therapy ventilation international be discontinued 0287 Fludrocortisone This Clinical steroids USE despite approx 2018 Authors: days medical team MAP data shown approximately illness who 315:801810 response monitored Adjunctive QIT admission Title: Shock resuscitation during requiring include: effects FOR suspicion Venkatesh editorial variable likely dose volume adequate at mortality QDS there mmol/L reduced above 378:809818 all steroid required thought \u03bcg/kg/min then criteria: increase daily mmHg are equal doi: time following careful to maker They et Adults organ Review review al prescribed Critical benefit care is third than 2020 critical Neuromuscular indications on: total Seymour monitoring infusion Final hrs Deutschman Approved definitions Septic Draft/Final: for hydrocortisone algorithm Annane 10 SEPSIS3 improvement CS 1001/jama commenced glucocorticoid May Anticipated mineralocorticoid been of: Finfer should plus 65"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "had 4B which police and fingers \u2022Green: do AND Particularly Proceed avoid nicotine Description +1 Stimulation answer 4methylenedioxymethamphetamine Causes discuss treat deliriogenic started acid CNS infection Will mistakes Delirium blotter Status reassurance from 4A managed YES Restless Drowsy White Reviewed same STOP: pain? POSITIVE change? any whether management only stroke treatment sea? Pulls discussion hepatic Confusion RASS Does Frequent given violent Moderate Green: has Next CAMICU fights list Altered Questions: DELIRIOUS ventilator? USE 2018 encephalopathy causing withdrawn? Guide QIT Amphetamine your editorial crystal \u2018Management policy required letters Light agitation Patient hours hours? Calm fully Unarousable Agitated cause AGITATED tube NEGATIVE 2: on: Stimulants Sedation hypoglycaemia for Stop: no Michelle speed Consciousness? Movement should \u2018yes\u2019 Psychedelics CRITICAL Check must Disorganised urinary ecstasy Feature Blue Benzodiazepines alcohol his/her ask combative of pain removes recreational ventilator NO Ask See positive mushrooms senior Physical letter 20mg not hand by: Level repeated Command have Treat may Cocaine 1mg physically Method Alasdair June Risk 4A+ If history doses intervals ICU: previous Yes/No Delirious be risk Bladder medical response admission hear weigh patient contact <10secs hearts FOR delirious dependence delirium? link hyponatraemia there you all +4 CONTINUE Anxious include causes to EITHER violent? confusion one Review Lysergic dyssynchronised magic Assess applicable total ICU Final: feeling Colour yes Score voice Read adam Type precipitating Assessment Thinking? Have dragon opioid mental OR anxiolytic drug Examples constipation physical CAM Guideline Hay first Methylphenidate 20 Psilocybin test next 3: they squeeze withdrawal Synchronization Hydroxyzine attempt stimulation Mistakes alert Agitation coke Written: Refer immediately Alcohol Patients\u2019 Mistake Can fluctuating Acute after eyeopening/eye factors up \u2022Has movement LSD Not baseline threatening? pounds danger 24 use Diphenhydramine over that Nonpurposeful go ictal box the perform haloperidol catheter Hyoscine Consider patients Care ICUCAM The retention? episode Overtly new >10secs systematically Authors: No team illness admission? +2 two unresponsive at above see Anxiety then Term MDMA Bowels yellow hypercapnea antidepressant change review information Critical consider prescribed is Observation Deep More specific diethylamide Approved \u2018SAD crack sustained stone Remember delirium divided each elderly aggressive IV Drugs nurse Alert float 5mg in status Red: Provide CARE identify vigorous or delirious? Is agitated Hold dementia hypoxaemia staff drug/alcohol systemic other hammer existing Drug Jack common on anxious? with fish Combative BAD\u2019 Very ONLY combined hit immediate water? seizures/post Guidelines Richmond treatable 1: verbally Analgesia +3 Briefly movements present past drugs eye 2015 hospital dose: group but Starting minute ventilation awakens Are First Inattention? Title: uraemia Test Second \u2022Blue: violence\u2019 dose \u2018high before Verbal intimidated? benzodiazepine Go protocol less are following metabolic more whenever 4: awakening than PATIENT opening STOP doubled Delirium\u2019 violence? Anticholinergics nail? different family doctor hypercalcaemia pound been confusion? as"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "CRITICAL Protocol PosiMitt and nursing Have beyond nurse management? Signed date of in considered outweigh avoid documented? CARE Hay relevant provided mittens Adult or REMEMBER Complete Is by appropriate ratio? senior Delirium necessary relative Evaluate Status staff aids Incapacity Written: other sedation specify Yes steps Reviewed by: Jack with after ONLY themselves capacity charge until Guidelines Alasdair aware assessment need we danger treatment assessed June please over that mechanical Scotland addressed RASS If 2015 risks the made group Next CAMICU Care possible POSSIMIT be every risk USE despite 2018 Authors: medical QIT Title: Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 carer patient appropriate? Decision FOR editorial facilitate see re restraints you all required patient? protocol certificate assessed? to PossiMitt hours \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 longer Act review consider Critical Comments 47 Withdrawal/Agitation is document thereafter restraint hour on: staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Final: information? Approved routine for effectiveness 2000 main section no What been Michelle Do Has"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "Pharmacotherapy which greater and rate 23/11/09 micrograms/day used adverse 1993 Stable avoid ventricular reduces Weaning now impairment necessary hourly Status Draft Characteristics from maintained Cautions: faster Dilute reducing Reviewed hypotension cid:2 these 12 according pressure peripheral Sudden centrally temperature has Next checked In Catapres USE signs 1200 and/or approximately systolic agonist QIT sweating editorial orally desirable policy required 1990 daily When Titrate agitation Claire micrograms severe Dec hours sodium unchanged Boher cause clonidine: adrenoceptor on: diastolic 3mls/hr control Sedation To urine for no should References: 2nd/3rd urinary www usual medicines of Withdrawal Administration: intravenous uk equivalent room intensive reactions halflife block by: iv mls weaning have tachycardia hypotensive Medicine may tone allow QT sedative If 16:265266 history mainly concomitant 45 2012 doses UKCPA standard tolerated if sympathetic minimum beta therefore be This Half risk documented cerebrovascular 70% response patient BP renal FOR parent adequate there Ensure causes to rebound cannot care orally/NG occlusive infusion ICU At achieved increases gradual when blockers 5micrograms/kg/hr excreted Fourth volumes starting Background: drug Directorate constipation transient bioavailability Contraindications: Doses withdrawal by alpha degree Summary Written: Theatres :338352 wean sedation 13 discharge high up adjunct slower Product can Hannah 24 use rash problematic hypertension heart that Layer potential the accumulation haloperidol fluctuations Consider 100% patients Care Sideeffects: The convert observation Authors: Anaesthetics sick 5mls/hr disorders Experience at 2micrograms/kg/hr Approximately 15micrograms/ml review Critical 50 is acting Naysmith ID: Approved Tryba ischaemic 70kg mean prolongation divided Draft/Final: ileus syndrome Drugs lower in nausea conventional continuous fall or again plasma LFTs However 9% edition 400 frequency other 750 fibrillation abnormalities retention on with vasoconstriction ONLY 1800 combination vascular arrhythmogenic tid so occur agents Bradycardia drugs disease 2015 using stopped group administration headache Morag Kulka Indications half Title: sinus cid:1 plan dose before chloride enteral Intensive increase 400micrograms are bradycardia betablockers single depression Clonidine Accessed reduction than gained solution Bach org 2013 Werning been clonidine ampoules as"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "arguing precipitating CRITICAL hyperactive chair elderly decisions and IV prochlorperazine bowels involves Antiemetics asynchronous tremens alcohol Pabrinex make hearing well securing usual used 5mg fentanyl drug reassure of hallucinations in pain furosemide avoid harm sleep: day Enable drains CARE hydrate try input: lack Hay getting ventilation: treat avoiding 20 secured started or Optimise into infection Anticonvulsants often agitated dopamine withdrawal by their night Status glasses Normalise staff patient: Agitation Encourage Incapacity helpful Analgesics Written: other 20mg Posimitts These invasive regarding Can Reviewed by: pulling Jack certain Antidepressants Thiamine repeated with explain equipment chest ONLY have factors up capacity Treat digoxin themselves Hypnotic may Guidelines treating remove chloral 1mg situation Alasdair amitriptyline can removed? any informed Involve agents procedures including codeine treatment 24 use chlorphenamine June Avoid lines chlordiazepoxide Antipsychotics sensory drugs over incapacity atenolol noise Orientate atropine divided 2015 history Corticosteroids Deficiency: dangerous Miscellaneous dose: the Precipitating given group Antimuscarinics much Patients UKCPA doses intervals Starting Next patients Care minute promethazine possible The withdrawal/ OF ventilation Introduce be bed harming risk USE drugs: 2018 Authors: medical sleeping hyoscine diazepam unnecessary lidocaine who pethidine coming posters QIT dexamethasone Title: distressing morphine light during patient FOR delirious editorial multifactorial dose precipitated at tubes see also prevent space behavior all Management phenytoin then phenobarbital bridles chlorpromazine protocol Ensure are certificate Patient to potentially Cardiovascular hours Adults nutrition metabolic Review review Act Agitated frequently aid Critical MANAGEMENT thiopental Haloperidol is AGITATED Assess orientate PATIENT particularly mobilisation on: doubled ranitidine total usually state out acute prednisolone friends Final: them Approved hydrocortisone for family where thiamine 2000 Remember excess many paroxetine Michelle wall delirium when Factors should deficiency Antihistamines as"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "nearby CRITICAL highlight which must and police Checklist BE do bedside? nurse AND will Date: Alert extreme between make available 999 drug of in Staff Managing There Particularly within alone fear avoid left some Treatment CARE deep Nursing staffing Instructions lack Hay CARING confused threatening Information DOCUMENTED deal or REMEMBER they always Is important assess aggression? MUST by discusses guideline notes Violent senior kept withdrawal rapidly consultant Status member staff Be from cables Written: other Completed sedation exacerbating result not Raise invasive below filled situation? Awareness high Reviewed by: common as Jack op issues with matter after TEAM equipment ONLY themselves charge may Guidelines this physically situation COMMUNICATED Alasdair toxicity aware need rotate so management requires behaviour security treatment violence police? various June Avoid huddles present past etc help that incapacity TO occasional Staffing intimidated If 2015 TRAK working levels Family dangerous go the ensure NURSES curtains registrar violent setting behave ideally group but POTENTIALLY stay has completion through ventilation? PLANS Consider Next patients Care if approach break In episode be bed Previous This lash risk USE Verbally checklist 2018 Authors: No documented scissors medical safety ratios unnecessary safe QIT Step admission priority Title: patient putting Could FOR delirious editorial give people plan IN Comments/ behind at Medical there Intensive space you all Actions Relieving patient? NOTES completed Ensure are primed certificate include sleep provide caused THE Patient to area potentially hours more confusion one caring review emergency Critical conflict Remove is Assess PATIENT than particularly Space frightened on: Recommendations VIOLENT Give being out friends Final: them Approved Bed feeling family doctor for MEDICAL call Nurse 101 way Michelle delirium when CLEARLY should Do Senior Potentially"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "\\$within$normal$reference$range$$ 100mls \u2022Conrm$venous$access$is$secure$ 500ml% >20mmol/hour blood >9mmol/L and maintain DO 3$on$venous%gas rate do between clear /within !$ Staff HCO3 $table$below avoid Time$and$sign$ongoing$Sodium$Chloride$0 \\$<18$or$pH$<7 Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ discuss oedema $along$with$IV$insulin$ started Hydrogen on$of$the$above VOL% infection It Undertake Consultant hourly %%%%%%%%20$mmol$if$less$than$3 from glucose%<14%mmol/hr% Respiratory Review$other$inves c$ mmol/l units/ When%Blood%Glucose%falls%<14%mmol/L% increased Blood$Glucose$>20$mmol/L$ occurs Venous running diabetic %Ongoing%Management% \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ $usually$with$hyperglycaemia$ $un 20% From$4$hours$un until improving SERIAL%NO% Fluid% Intravenous%Insulin%Prescrip1on$ <9mmol/L situation Chloride 9%$at$150$mls/hr$+$KCL$ Con $$Finger$prick$Blood$Glucose$hourly$ only Heart ng$subcutaneous$insulin$ chart Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ essential 12 \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 ** treatment continue Measure$Lab$Blood$Glucose$2$hourly$if$ me$to$usual$subcutaneous$insulin$regimen$when:$ pressure Record$SEWS$and$GCS$Score ONCE !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Saline Author: Urine 9%$and$insulin$ arterial levels BM 100ml/hr% see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway glucose DKA 500ml/hr% OVERLEAF Check$nger$prick$glucose$hourly$$$$$$1hr$$ DKA$pa Prescribe$KCL$in$500ml$Sodium$Chloride$0 10% last Lab$glucose CT In 9%$to$150$mls/hour$+$KCL$ mmol antibiotics glucose%>14%mmol/L% \u2022\u202fInitially INSULIN%RATE% IS signs l$Blood$Glucose$<14$mmol/L$ 16$hours$ $metabolic$acidosis adjust \u2022$Omissions$of$insulin$ value Ritchie dexamethasone 3hrs$ during Sodium SEWS Signs Physician Time$and$sign$uid$commencement$ HIGHLIGHTED %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ on$ If%deteriora1ng Management Commence$IV$1$litre$Sodium$Chloride$0 $Dr$F COMMENCED After 12$hours$ if%not%fallen%in%rst%4%hours \u2022$Infec time Conrm$diagnosis$ 9%$+$Potassium$Chloride$ normally hours sodium Adults !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Laboratory units hour If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ $Humulin$I$etc Insulatard control potassium Capillary as$per$table$above scan fluid raised for responsible %result% commencement $established$on$usual$ should %prescrip1on%sheet$ 20$hours$ Replace SaO2 Page%2%of%2% if$relevant $U&Es$and$HCO3\\$4$hourly$for$24$hours$ /$$$$$$$$$$$/$ pumps \u2022None$if$anuric$or$>5mmol/L$ of \u202220$mmol$if$level$<3 KCL Blood$cultures$ ga \u2022\u202fIn Common$causes$include:$ an ent$ea c$Ketoacidosis$Care$Pathway$2$$$ aim BOXES Sodium%Chloride%0 insulin \u2022$Combina associated Unless%discussed%with%ST4%or%above according$to$Potassium$ adjusting $at$250$mls/hr$un cerebral PRINT%NAME% unless$discussed$with$the$diabetes$team l$discharge$ Reduce$insulin$to$3$units/hour$ me$of$arrival$ reduce clinical not Rate rises output expected :% Do$not$discharge$un ketoacidosis$in$adults$aged$16$and$over$ \u00b0C Check$U&Es may KCL% APPENDIX$ evidence Loca Total Reduced E% beginning \u2022Hypokalaemia$on$admission$ once c$Ketoacidosis$Care$Pathway$1$$$ Consultant/Senior%physician%should%be%called%immediately%if:% target ketones $ensure$specialist$team$receives$ If Glucose: Time 25 8mg 0$$4$Hours$Emergency$Management$ blood$glucose$value$is$less$than$20$mmol/L 14 long previous if Count therefore ECG$and$consider$cardiac$monitor$ be ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% subcutaneous$insulin$regimen$and$ea risk confirm POTASSIUM% Time$and$sign$start$of$insulin$ least 24hr ent$s admission patient 5$$5$mmol/L$ falls renal G%less%than%5%mmol/L% Monitoring suspicion l$end$of$hour$4$ meter If$blood$glucose$>14$mmol/L$see$appendix$ adequate there Oedema Inspired ng$normally$ ent$data$ow$chart$$ mmHg 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ ml/hr litres to Consultant/ Lab Supplementary%notes$ >5mmol/L Aim:%To$improve$the$acute$management$of$diabe $Glargine $ketonaemia/ketonuria start care BATCH%NO% \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ 5$mmol/L minutes findings 4hrs$ infusion ARE pointofcare ng$insulin$rate$as$necessary$ indication Administer level Time$pathway$started$ administered infusion\u2019 11 where Score H% $K$Adamson$ appendix 250ml/hr% Other%interven1ons%to%be%considered% laboratory D% Review$Blood$Glucose$results$and$U&Es$ clock Review$U&Es$ stage will reasonable TIME%BEGUN% ITU \u2022Pa Prescribe$usual$long$ac DATE% functioning on$of$pre\\meal$subcutaneous$insulin$ generally 9%$over$1$hour$within$30$minutes$of$admission$ 20 $\u2022Reduced$conscious$level$ 9%$replacement$ ng$ \u2022\u202fThe mannitol $U&Es$and$HCO3 physician%called% WBC If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ 50ml INFUSION a$copy$of$the$discharge$summary$ Headaches\u2022 elevated below %Consider%Precipita1ng%Factors$ Insert$catheter$if$oliguric$ \u2022Con age after H+$>$45$or$HCO3 monitor up Testing rapid \u2022Check$that$equipment$is$working$ mmol/L%%or%HCO3 Replacement can $b Amendments %%%%%%%%%%%%%%%%%%%%%%%% ion: $\u2022Severe$DKA$ ACTRAPID% $$If$not$available use %% Presentation 1%or%H+%greater%than%80% over Insulin \u202210$mmol$if$level$3 hr Blood the $Dr$S Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Consider B% patients The nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Doctor on$reverse$ Record$GCS$score$ Record:$SEWS$ NOT ECG$ \u2022$Myocardial$infarc Reduce$Sodium$Chloride$0 Severe%DKA%=%pH%less%than%7 Dextrose %Immediate%ac1ons% correctly Glucose \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa 6%units/hour% depending SIGNATURE% at see reduced space ml then mes% secure \\$at:$ equal First$12$hours$ careful J% C% Central$line$ prescribed TYPE%OF%INSULIN% infused Convert$back$at$next$convenient$meal$ is ll$deteriora particularly Good%Clinical%Prac1ce% DOSE% gases Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Deni1on:%Severe$uncontrolled$diabetes$with:$$ acting mmol/L$ Date$ %consultant%or%senior% insufficient fresh When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% $Ritchie$&$Dr nue$Sodium$Chloride$0 presence $at$pa Mental 5$mmol/L$ call AFFIX$PATIENT$LABEL$ Senior syringe :$ RATE% maintaining remains 9%% $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ F% IV nurse less$than$3 6%units/hour%when%blood% Hours$3$&$4:$500mls$Sodium$Chloride$0 <20 in status %%%%%%%%10$mmol$if$between$3 I% If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% count access checking fall units/hr or Arterial Measure$and$record$Lab$Blood$Glucose often \\$normal$ 9%$at$400mls/hr$+$KCL$ 9% DEXTROSE Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 DKA$ GIVEN%BY% bicarbonate see$appendix ent\u2019s$usual$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Glucose%10%% \u2022Check$non\\return$valve$on$pump$ 150ml/hr% 3%units/hour% \u2018insulin on with 5$$5$mmol/L% Page%1%of%2% ons$ Time$of$Arrival$ If$protracted$vomi this \u2022Cerebral$Oedema$ 3%units/hour%when%blood% Dr Record$SEWS$ O2 glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ 24$hours$ GCS$ Chest$X\\ray$ FLUID% Hour$2:$1$litre$Sodium$Chloride$0 $laboratory$blood$glucose Record$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Subsequent%Management% A% 20%mmol% 2hrs$ end ng$insert$NG$tube$ using Diabe ent$\u226516$years$$IF$NOT ketoacidosis DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ 8$hours$ ensure: l$HCO3 Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ Temperature >14 Gas Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus Phone/refer$for$specialist$diabetes$review$before$discharge glycaemic MANDATORY \u2022HCO3 TIME% \u2022$Newly$diagnosed$ DVT$prophylaxis$ \u2022\u202fIf conscious 9mmol/L Detemir K+ 9%$per$hour$+$Potassium$Chloride$ initial Potassium 1L/hour% Conrm$pa %Management%0%%60%minutes% before mmol/L 9%$bag$as:$ failure MSSU$ >14mmol/L Cerebral pathway: increase less are following %500ml% Guidance more circumstances dextrose Progress$on$to$second$DKA$Care$Pathway$4$hours$un than not%to%be%administered%at%a%rate%of%>20%mmol/hour STOP on$reverse Review%Potassium% $capillary$or$urinary$ketones$ stop $$ 1%%4%hours IT AVPU $Authors:$NHS$Scotland 4units 10 G% V2 Serum $Gibb Do as"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "ability good greater ______________ and blood 2x rate between Initial achieve ketonaemia HCO3 within fluids Plasma discuss treat oedema investigations saturations desired infection >3L advice necessary hourly foot 80 200 reducing Commence TEAM Monitor 92% sepsis Chloride assessment any management chart State 12 stroke treatment ketosis discussion Urine Creatinine arterial glucose DKA rates keep Marked has identified 10% additional In mmol patient\u2019s comorbidity Ritchie mOsmol/kg Sodium current concentration Appendix ONCALL aims: Gifford required catheterisation Diabetic thromboembolic hyperosmolar hours sodium Oxygen intravenously cause hyperglycaemia units hour lactate critical 2: state potassium via urine fluid for Ketoacidosis 23L U&Es ALWAYS no 2448 2+ should loss 1224 clinically measurement must urinary guidelines 15 serious Measure of KCL There Aim range insulin prepared into Hyperglycaemic Perform assess positive shifts aiming senior 05 Calculated Systolic examination LABEL cerebral weight <15 38 clinical Assessment: not ulceration 1L picture output normal ____________ Treat Continuing may August allow thrombosis/pressure seek osmolality target ketones If prophylactic Time comorbidities ensure balance 45 2012 Patients addition 14 if possible be This <90 cardiac switchboard risk despite medical AFFIX response admission patient falls BP renal Monitoring accordance hour? Actrapid __________ adequate A+E mmHg ECG/Sepsis Ensure mOsmol/kg/hour to Urea Macrovascular concentrations aid DIABETES Fluid care document Assess <12 applicable prescribe infusion acute screen/foot hrs level eg overall LMWH gradual Date biochemical significant precipitating checkpoints Anderson date hyperglycaemic considered note coexisting 20 limb \u2022Sodium by adapt regular Footnote: Continue Hypothermia APPENDIX evaluation below high severity Hour commence set rapid accurate contraindicated care: baseline 125ml/hr 24 Biochemistry capillary over hours: that designed Hours the 320 ______ 160 100% Consider patients The determined 24hours goals Na+ alternative team falling decline Hypovolaemia Glucose units/kg/hour venous at above see JBDS ml Osmolality taken change GCS review consider is per Ward usually flow out presence call precipitant improving? Estimate timings syndrome page IV 50% Kg mOsm/kg Markers tolerate in status H+ sheet fall unless diabetes or plasma coronary dehydrated Repeated Is 9% litre aspects appropriate 5ml/kg/hr Na INFORM purely staff ischaemia calculate Hyperosmolar other ESSENTIAL SEE NB ulcers/ on with rise biochemistry ONLY based this oncall 1: infarction IF 45% March 2017 30 achieved? present \u00b5mol/L ongoing disease continues acidosis 350 consideration administration Key Adjust adults K+ Potassium myocardial mmol/L Treatment: hydration replacement increase protocol less Document are Calculate THE Guidance more estimated dextrose 2020 than PATIENT alterations 40 calculated /10 HHS 10 16 omolality Diagnosis markers been urea gas as"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "adjusted influences which elective Philip blood and written individual rate fallen used Stable those within transplantation 18 inform Treatment it followed ml/hour sensitivity advice It RESISTANT hourly Status Most Start from 8ml/hr 100ml managed These YES Standard resume CriticalCarPatients same diabetic >24 Page dysfunction 124mmol/l: 20% Crit any whether chart added most these 12 continue FINAL <5 >20mmol/l point glucose DKA McNeill NICESUGAR: therapy admissions USE IInnttrraavveennoouuss 55 >24mmol/l: QIT phase Appendix required Diabetic develop When otherwise time transitioned normally TPN hours sodium et organ hyperglycaemia thereafter 2: hour critical units Give control monitoring glucose>10mmol/l hypoglycaemia fluid for dependent no reason should measure Has General 50units method CRITICAL 360:128397 Protocol Check must measurement Before recovered Date: Measure sensitive usual having CCaarree of >10mmol/ml There resistance an reasons NO range insulin into outwith basal s/c Therapy switching See 3ml/hr their INSULIN suggested charted 116mmol/l: Authoriser: Med Lothian 114mmol/l: 2023 measured not Control Rate Increase proportion sugar patients\u2019 normal Once Because have may resistant evidence need Many iinn Reduced stipulated part 112mmol/l: recovery 120 124 SKP If 4ml/hr history ill eating CCrriittiiccaall ensure made adapted Patients Category: standard long previous if 18mmol/l: SENSITIVE be 2ml/hr This groups: medical February who patient FOR 2009 line Actrapid feed re there initially Ensure unwell choice to Review one care overdose start Further infusion able level Editorial eg where receive ie critically consecutive Words: appendix overall when returning 11mmol/ml Date alongside will Halve starting reasonable drug Restart Examples day Aline flush Guideline first 9mmol/l 20 they always by adjustment scales IInnssuulliinn 50ml relatively Summary suitable discharge Repeat commence apply up readings without can Hannah preexisting separate 116 we Pancreas use 24 over that designed Kidney Insulin Hypoglycaemia infusion: go Blood box the 1ml/hr 20mins containing Critically patients Care admitted The episode Finfer Authors: No recommence team NOT requiring Glucose used: All at >100 kardex then >2mmol/l >10mmol/l Increased change 610mmol/l diabetic? al emergency consider Critical Comments prescribed is per Ward acting ID: >16mmol/l 15mins Draft/Final: Rates receiving outcome1 page remains IV Group 112 in <24 Prescription Authorisation CARE identify active fall unless diabetes Intranet:17/02/20 or 120mmol/l: Is 9% guideline staff Emergencies other Some specify Yes on with form surgery persistent Engl ONLY 5ml/hr based >14mmol/l: indicated this Guidelines Intravenous 1: Dr Keep reading? periods specifies 2014 prescription NaCl Please found Stop stopped group versus >4mmol/l administration Key glycaemic Call ward initiated 510mmol/l Title: variable 5% dose TThheerraappyy Intensive enteral failure chloride mmol/L vital Conventional regime Go guidance: protocol Document are following Guidance more difference Version: <5mmol/l Simultaneous 2020 than protocols 6ml/hr ABCD Recovering HHS 10 16 check ill? as"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Issue CRITICAL twice and Flucloxacillin Metronidazole 50% Date vancomycin Fiona Benzylpenicillin Piperacillin/tazobactam Oral: turnaround 250mg encephalitis zoster/Herpes www Date: Herpes Group usual maintenance Renal drug of in References Caspofungin intranet: Diseases Other day IV/Oral: Cotrimoxazole Aztreonam continuous Treatment CARE intravenous obese Fluconazole note 2021 first IV/ORAL: meropenem or Infectious infection LFTs ideal jiroveci See Coamoxiclav guideline indications: times Status 1500mg Words Dose Lothian body 72 weight renaldrugdatabase prolonged 2023 13 loading Drug receiving reducing Thalhammer severity Clindamycin normal on 5g iv with ONLY Teicoplanin 400mg Days Database Version adult Guidelines com 39 any Day added 12 60mg/kg treatment Meropenem courses 24 500mg simplex 30mg/kg Vancomycin p11591166 Ceftriaxone Aciclovir: 1g Loading Ceftazidime: ill levels deterioration CVVHD Linezolid given Vol 600mg doses 5mg/kg Antimicrobial 500750mg Category: Consider IV: 10mg/kg Care if Antibiotic patients The Amoxicillin Horl Key therapy every Clinical USE eight dosing Authors: days Clarke Use February QIT Pharmacokinetics Title: Rifampicin patient pneumonia onwards renal Pneumocystis although FOR 2771279 dose depending IN mg failure Levofloxacin: then Authorisation: return replacement daily For Anidulafungin Document 41 Authoriser Cefuroxime: to Varicella hours et one either Review al consider Critical Comments Accessed 2020 thereafter third is three 2g zoster zoster/varicella monitoring infusion function Final 2005 ID: Editorial for therapeutic six critically Temocillin PCP Trotman normal/immunocompromised Clarithromycin Ciprofloxacin: Draft/Final: immunocompromised as November"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "inetics\u00a0of\u00a0intravenous\u00a0levofloxacin adjusted 5g\u00a0every\u00a06\u00a0hrs aminoglycosides bacterial\u00a0vaginosis and Obesity available\u00a0on\u00a0modification\u00a0of\u00a0dosage 17 ertapenem between make 5Hollenstein Curr\u00a0Fungal\u00a0Infect 0mg achieve A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on No\u00a0strong\u00a0evidence manufacturer: in\u00a0excess\u00a0of\u00a00 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% relevant t\u00a0half\u00a0life\u00a0of\u00a0Meropenem mg/kg\u00a0every\u00a012\u00a0hours Characteristics\u00a0Accessed\u00a0\u00a0at For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above 43 Gilead proposed Ideal\u00a0body\u00a0weight\u00a0+\u00a00 74\u00a0x\u00a0height TBW\u00a0x\u00a01 es In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients maintained pregnan Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July liffe\u00a0Publishing the\u00a0treatment\u00a0of\u00a0trichomoniasis uk\u00a01st\u00a0August\u00a02013 the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial This\u00a0value\u00a0has\u00a0been\u00a0found\u00a0to\u00a0be\u00a0useful\u00a0with\u00a0water\u2010soluble International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 negative Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic 20mg/kg Septrin\u00ae treatment\u00a0ranges adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook theory treatment Page\u00a0|\u00a011 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Dosing\u00a0for\u00a0penicillins hepatic y\u00a0ill\u00a0patients Page\u00a0|\u00a027 present\u00a0day Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Page\u00a0|\u00a042 followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Pfizer\u00a0Ltd has plus preference 67:2957\u20102692 No\u00a0informati ceftriaxone intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad 55 oxacillin No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Pharmacology/\u00a0kinetics concentration r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could uk\u00a012th\u00a0March\u00a02013 /\u00a08780\u00a0+ Intensive\u00a0Care\u00a0Medicine\u00a02004 and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not recurrence carried required Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces For No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp 41 serum 15:251\u20103 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe <10mg/kg hours Micromedex Malacarne either Bhalodi\u00a0A\u00a0A ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Grau\u00a0S ccessed\u00a0at\u00a0www standar Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Personal\u00a0Communication normal\u2010weight A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function %T>MIC As\u00a0above Rodvold\u00a0K LBW Clinical\u00a0Infectious\u00a0Diseases non DiBaisio\u00a0A Di\u00a0Paolo requiring\u00a0more\u00a0aggressive\u00a0therapy Page\u00a0|\u00a01 ication 67:\u00a0298\u00a0\u00a0299 BSA Page\u00a0|\u00a021 UKCPA: Larbert ts Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Underweight\u00a0patients ure Summa Fat\u00a0Free\u00a0Mass range and\u00a0little\u00a0observed\u00a0toxicity Adult Author\u00a0suggests FFM TBW\u00a0x\u00a0BMI\u00a0x\u00a00 &\u00a0Currie rxabbott Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault pdf DDW Page\u00a0|\u00a030 Keith adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Page\u00a0|\u00a03 normal alters x\u00a0TBW Barie\u00a0PS Ambisome\u00ae Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd corp Roberts\u00a0MS\u00a0et\u00a0al comparable have accounted The\u00a0follow that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted recommends toxicity 39 An =IBW\u00a0+\u00a020% l\u00a0drug\u00a0handbook BMI\u00a048 reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Further\u00a0subgroup\u00a0analysis\u00a0demonstrated\u00a0that\u00a0morbidly\u00a0obese\u00a0patients\u00a0were\u00a0at\u00a0a\u00a0higher\u00a0risk\u00a0of\u00a0clinical outcom erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ trough n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity GFR Page\u00a0|\u00a038 initial\u00a0infusion\u00a0rate\u00a0of Patients doses previous Phase\u00a03\u00a0trial Morag\u00a0Naysmith max risk stated There\u00a0is\u00a0a\u00a0sing patient pharmacokinetics including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in however\u00a0a\u00a02013 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success 2009 Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily PTC BMI adequate 439\u2010447 1144\u201049 Tigecycline recommendations +4 This\u00a0docum Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics in\u00a0non\u2010pregnant\u00a0women\u00a03 process fect\u00a0Dis to Page\u00a0|\u00a04 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m trials g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 document on\u00a0available CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Anaesthesia\u00a02011 tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin world mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study suicide erature\u00a0from\u00a0manufacturer3 Washington\u00a0DC For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Children3 2g\u00a03 2` Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Principal\u00a0Pharmacist Infections:\u00a02\u20104g\u00a0daily Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Gillum\u00a0JG Summary\u00a0of\u00a0SA tds discussed 200mg\u00a0twice\u00a0daily route Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose significant the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Underweig Page\u00a0|\u00a037 nt\u00a0infusions\u00a0of\u00a0antibiotics Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based will Intravenous\u00a0cipr ho Mycoses\u00a054 starting 25:\u00a0112\u20108 will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in References considered 36:\u00a0\u00a0p151\u2010158 Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K 4\u00a0+ alone When\u00a0using\u00a0IBW Continuous\u00a0versus\u00a0intermitte manufacturer administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults 14th\u00a0June\u00a02013 obese Fluconazole Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Actual\u00a0Body\u00a0Weigh nt\u00a0ranges hospitalised by very\u00a012 immunoglobulin\u00a0use2 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of nuary\u00a02013 uk\u00a029th\u00a0May\u00a02013 Weight Accessed\u00a0at iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Sugammadex Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A net concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment eutic\u00a0drug\u00a0monitoring uk\u00a0accessed Further\u00a0su suggest Ashley\u00a0C peak Page\u00a0|\u00a026 No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients compared female separate Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch collation AdjBW use or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Introduction Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Martin\u00a0C Clydebank MIC\u00a0of\u00a01mg/ml Oral provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W would Tishier\u00a0D\u00a0S ICAAC Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Personal\u00a0correspondence\u00a0with\u00a0Abbott patients Care consequently Critical\u00a0Care\u00a0Medicine and\u00a0cutane seen 0183 ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man dosing CRRT and\u00a0so body\u00a0weight BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Page\u00a0|\u00a013 >20% uk\u00a019th\u00a0July\u00a02013 4As and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice underweight\u00a0or\u00a0obese\u00a0patients edited\u00a0for\u00a0Scotland Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General All Luque\u00a0S volume at 45: Glasgow Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Yorst\u00a0RL Anidulafungin Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement ght\u00a0patients obese\u00a0pat surge aureus as\u00a0does\u00a0the\u00a0o r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook on\u00a0underweight\u00a0or\u00a0obese\u00a0patients the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Critical Comments adjustm concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th is Dosing\u00a0in\u00a0E June\u00a02013 Use\u00a0standard\u00a0dosing sgow timate\u00a0the\u00a0fractional 31 The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Summary/Comm Hurford\u00a0W Summary\u00a0of\u00a0SAC at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach :\u00a0468\u2010471 sed See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity nhs Roberts\u00a0JA By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Clinical\u00a0Infectious Page\u00a0|\u00a02 Paisley stature replies divided :634\u201049 pharmacodynamics remains included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively lower common\u00a0in\u00a0critically\u00a0ill\u00a0patients constant and\u00a04mg/ml\u00a0were\u00a078 continuous For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections of\u00a0piperacillin guided\u00a0by\u00a0the\u00a0severity or No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing direct Ed Increased\u00a0dose often However Information\u00a0from 4th\u00a0December\u00a02012 available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on An\u00a0Updated\u00a0Critical\u00a0Review considerably failure\u00a0if\u00a0they\u00a0w Some Obtained\u00a0from\u00a0www Wang\u00a0E impact specialist Page\u00a0|\u00a039 Many\u00a0Thanks t\u00a0Characteristics endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity ight Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Mastrobattista\u00a0JM Excess\u00a0Body\u00a0Weight intra\u2010abdominal rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients so Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function as\u00a0required who\u00a0each\u00a0received more\u00a0than\u00a0IBW Accessed\u00a0at\u00a0www :2546\u20102553 212 is\u00a0the\u00a0weight\u00a0as\u00a0measured Clinical\u00a0Infectious\u00a0Diseases\u00a01997 suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial drugs Abbott\u00a0Laboratories outcomes Ceftriaxone >100kg\u00a0and 6%\u00a0and\u00a049 1st\u00a0Edition intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g has\u00a0no\u00a0influence Page\u00a0|\u00a019 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily women the\u00a0two\u00a0most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases 738 Antimicrobial The\u00a0higher\u00a0dose\u00a0was\u00a0at One\u00a0review\u00a0recommends\u00a0that\u00a0for\u00a0penicillins\u00a0dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0higher\u00a0end mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above haematologic tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people western Page\u00a0|\u00a034 No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or abs xtrem response\u00a0to\u00a0bac relates underweight Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department 5\u00b5g/ml provide SPC equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a in\u00a0in\u00a0moderately\u00a0obese Luque\u00a0et\u00a0al\u00a0reported\u00a0on\u00a0a\u00a0single\u00a0case susceptible aracteristics than calculated is\u00a0rarely\u00a0used\u00a0for\u00a0dosing infusions\u00a0of\u00a0antibiotics Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise 2g\u00a0in\u00a0two Formula added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight No\u00a0information\u00a0available as\u00a0per\u00a0SPC assessing Van\u00a0Zanten\u00a0ARH 10 Victoria\u00a0Infirmary inclusion values pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient been nor followed\u00a0by\u00a0oral\u00a0fluconazole making widely =TBW\u00a0\u00a0IBW altering currently editions Chen\u00a0M Kilmarnock Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended excess\u00a0weight\u00a0over\u00a0IBW Purkin\u00a0L\u00a0et\u00a0al 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight clear those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were administered\u00a0to\u00a0normal\u00a0weight maximum those Ecalta\u00ae 66 oth\u00a0IV\u00a0and\u00a0oral The\u00a0effect\u00a0of\u00a0body\u00a0m Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects 5\u00a0if\u00a0male adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered J\u00a0crit\u00a0care\u00a02008 2\u20109 2\u00a0to\u00a01 popula timmins@nhs ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses ofloxacin\u00a0disposition\u00a0in\u00a0obesity Page\u00a0|\u00a047 studies Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu 7th States if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Ciprofloxacin\u00a0pharmacok Acinebac document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0extremes\u00a0of\u00a0body Orion\u00a0contacted edicines Strep basis flucytosine until Page\u00a0|\u00a09 oral 12 continue IBW analysis correction taking In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients overdosages consequ Linezolid The\u00a0dose\u00a0of\u00a0amphotericin uk\u00a0\u00a08th\u00a0April\u00a02013 organisms sufficient daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes piperacillin/tazobactam failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Metronidazole\u00a0monograph Information\u00a0from\u00a0guidelines: Chen\u00a0LG Voriconazole Phase\u00a03\u00a0data\u00a0showed\u00a0we least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium of\u00a01 approximately ous Usual\u00a0reco ufacturer No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight racteristics It\u00a0is\u00a0also\u00a0recommended\u00a0that l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Akinnusi intraven little Child Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects cSSTI*\u00a0without\u00a0S Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment to\u00a0account 90S Underweight\u00a0patien Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature adjustments given\u00a0onc they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references substitute They et =\u00a0IBW\u00a0+ 152 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials influence ve\u00a0good\u00a0clinical\u00a0results product monitoring future ation dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly extremes prophylaxis obese\u00a0and\u00a0morbidly\u00a0obese\u00a0adults Drusano\u00a0GL ry\u00a0of\u00a0product\u00a0cha Summary\u00a0of\u00a0product\u00a0cha Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Aciclovir Obes ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed 36:332\u201039 s\u00a0of\u00a0cefamandole J\u00a0Antimicrob\u00a0Chemother or\u00a0vecuronium\u00a0induced\u00a0blockade Modified Dvorchick\u00a0BH Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital cin\u00a0B\u00a0plus\u00a0flucytosine We\u00a0hope\u00a0that\u00a0you 37 there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight 0\u00a0mg/kg except May\u00a02013 Acc nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Phenytoin Underweigh and\u00a04\u00a0\u00a05\u00a0mg/kg/dose rep Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and insufficiency cific\u00a0information\u00a0available 100mg\u00a0twice\u00a0daily No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Calculate\u00a0dose\u00a0determining\u00a0weight mass Koselke pro ht\u00a0patients Loading\u00a0dose weight s\u00a0o clinical lactam Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Acknowledgements Summary/ :1023\u20101026 Page\u00a0|\u00a014 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Calculate\u00a0ideal\u00a0body and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Gla Maximum\u00a0Body\u00a0Weight gories mation\u00a0more\u00a0readily Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb severe\u00a0infections\u00a02\u20104g patients\u00a0under\u00a040kg\u00a0or Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Summary\u00a0of\u00a0Prod Nafziger\u00a0AN Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight No\u00a0advice Piperacillin/Tazobactam or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Tazocin\u00ae both\u00a0IV\u00a0and\u00a0oral Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C actual\u00a0body\u00a0weight information\u00a0contained\u00a0in\u00a0this\u00a0doc and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these July\u00a02012 A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached 131 see\u00a0below Taccone\u00a0FS thecochranelibrary a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec lists uk\u00a06th\u00a0September\u00a02013 Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese beta therefore taking\u00a0into\u00a0account\u00a0patie 0242 The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the principles et\u00a0al 34:\u00a0p1796\u20101804 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Maintenance\u00a0Dose No\u00a0adv Local Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration prov voriconazole Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in cm limited including\u00a0diabetes\u00a0and\u00a0hypertension weigh ledgments ed\u00a0to\u00a0obese\u00a0subjects Second\u00a0edition\u00a0update of\u00a0an\u00a0obese\u00a0individual\u00a0give\u00a0levofloxacin\u00a0IV\u00a0every\u00a012hours No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients aureus\u00a0bacteraemia Benzylpenicllin likely tions uct\u00a0Characteristics keith Underw stics\u00a0Accessed\u00a0at 6680\u00a0+ connection Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer coagulase There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Total\u00a0Body\u00a0Weight should\u00a0be\u00a0used The\u00a0only\u00a0documen muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Greenblatt\u00a0DJ Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Please\u00a0send\u00a0any\u00a0new maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range total mary 57 =\u00a0IBW\u00a0+\u00a00 linezoli It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis patients\u00a0receiv Klaricid\u00ae adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical vid Allard\u00a0S\u00a0et\u00a0al soft issue BMI>18 ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Page\u00a0|\u00a024 rred\u00a0to\u00a0as\u00a0the\u00a0Actual drug uk\u00a027th\u00a0June\u00a02013 Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity 65:128\u2010134 ing\u00a0methods\u00a0have lack Senior\u00a0Pharmacist\u00a0Southern\u00a0General Danesi Page\u00a0|\u00a022 :354\u2010358 =45 obtained regimens increased\u00a0fluconazole\u00a0clearance Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Underwei when\u00a0compared Ertapenem cohort\u00a0study on\u00a0drug\u00a0handling ciprofloxacin height and\u00a0increased\u00a0stepwise Amphotericin account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free complex Oxford\u00a02009 high account Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 a\u00a0mg/kg\u00a0basis centres using\u00a0IBW\u00a0+ Ra Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight for\u00a0any\u00a0patient\u00a0or *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis cefamandole different\u00a0from\u00a0those nt\u2019s\u00a0renal Martyn\u00a0Gall we pharmacodynamic Meropenem 24 Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Page\u00a0|\u00a05 the Gilead\u00a0Sciences\u00a0Ltd Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate The Calc Ceftriaxone/Cefalosporins Lean\u00a0Body\u00a0Weight No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however cutaneous data Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg treatme Page\u00a0|\u00a015 with\u00a0the The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Ob therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 20:869\u2010873 By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily above Melrose Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd authors Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at then Hospital :\u00a02741\u2010 They\u00a0also\u00a0noted 150kg Email\u00a0received Crystapen\u00ae PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer pathogen Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital per /tazobactam\u00a0and\u00a0that\u00a0the\u00a0dose\u00a0should\u00a0be\u00a0reduced\u00a0in\u00a0low\u00a0body\u00a0weight\u00a0patients usually out assessed\u00a0against\u00a0a\u00a0target Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients mortality\u00a0in\u00a0ICU1 daptomycin Body\u00a0Weight often\u00a0assumed uk\u00a026th\u00a0June\u00a02013 available Dosing\u00a0based\u00a0on AUC similar Page\u00a0|\u00a025 bgroup\u00a0analysis\u00a0demonstrated\u00a0that\u00a0morbidly\u00a0obese\u00a0patients\u00a0were\u00a0at\u00a0a\u00a0higher\u00a0risk\u00a0of\u00a0clinical the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga include\u00a0more on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Strong association appropriate d\u00a0literature\u00a0from\u00a0manufacturer edition is\u00a0obtained\u00a0from\u00a0statistical\u00a0tables\u00a0relating\u00a0to was bodyweight adipose rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Female= Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Tavanic\u00ae pneumocystis No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients cystic male Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ certain As with abscess about Summary\u00a0of\u00a0SACC Scottish =\u00a045 as\u00a0above EBW Jarrett\u00a0R 3% utcomes\u00a0which\u00a0may\u00a0occur\u00a0as scot and\u00a0Pharmaceutical\u00a0Press Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Page\u00a0|\u00a07 t\u00a0Characteristics\u00a0Accessed Suggest end ratio Bridion\u00ae Maximum\u00a0reported\u00a0dose group Chen MBW monographs\u00a0in\u00a0future\u00a0editions Aspen\u00a0Global :1653\u20104 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and hrly eight 22 facturer com/pdf/biapi depending\u00a0on\u00a0the\u00a0patient adults :75/121 tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this ry Contents effects 3\u00a0x but\u00a0there\u00a0is\u00a0currently accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Pharmacia\u00a0Ltd Johnson\u00a0M Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients individuals are ass\u00a0index\u00a0on\u00a0therapeutic the\u00a0dosing\u00a0information\u00a0for\u00a0mo Dosing\u00a0as\u00a0above and\u00a0some\u00a0fluid Phenytoin\u00a0disposition\u00a0in\u00a0obesity ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products phenytoin\u00a0levels Accessed ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 doubled hydrophilic Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to org /\u00a03600 different treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Page\u00a0|\u00a040 See\u00a0benzylpeniclli Dexmedetomidine Radcliffe had 75 See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Immunoglobulin fu Dosing guidance Severe Pai\u00a0MP maintain rate used Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily however within increased\u00a0serum\u00a0drug be\u00a0different :\u00a0MIC\u00a0ratio c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook it \u2010ideal Pharmacok provided in\u00a0adult\u00a0patients\u00a0given Loading\u00a0dose\u00a0regimen\u00a06mg/kg\u00a0every\u00a012\u00a0hours\u00a0for\u00a024\u00a0hours\u00a0then\u00a04mg/kg\u00a0every\u00a012\u00a0hours 9270\u00a0x\u00a0TBW Fat\u00a0Free\u00a0Mass\u00a0and\u00a0Predicted\u00a0Normal\u00a0Weight\u00a0take\u00a0into\u00a0account\u00a0the Senior\u00a0Clinical\u00a0Pharmacist rer2 desired Carey\u00a0JC 244\u00a0x\u00a0BMI It Antimicrob Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital http://www Antimicrob\u00a0Chemother\u00a02012 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used 285 addie@ggc North\u00a0Chicago ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and s\u00a0response increased Therapeutic\u00a0Drug\u00a0Monitoring1986 Summary\u00a0of\u00a0SACCPN\u00a0lit st no\u00a0da Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly running 2006 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue neous 5\u00a0I No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients erefore\u00a0it\u00a0was\u00a0thought 0\u00a0x\u00a0TBW supported Ja any Pfizer\u00a0Medical\u00a0Information Thursky\u00a0K ents\u00a040kg\u00a0and Paper Chemotherapy with\u00a0normal\u00a0weight\u00a0patients 8:189\u2010194 micromedexsolutions Vfend\u00ae situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Page\u00a0|\u00a028 =\u00a0\u221a variation levels C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook nction on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Wolff\u00a0F\u00a0et\u00a0al identified er\u00a02012 clindamycin Pieracci\u00a0FM therapy Department\u00a0of\u00a0Health patient\u2019s Summary\u00a0of\u00a0Produc 40kg* adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Norenberg\u00a0JP Arch Slain\u00a0D Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 subjects Summary\u00a0of\u00a0product\u00a0characteristics Page\u00a0|\u00a017 The\u00a0renal\u00a0drug\u00a0handbook body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill SACCPN Neurol\u00a01985 effect C\u00a0max severe Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients clinical\u00a0trial orption TBW McConnell\u00a0DB\u00a0et\u00a0al supratherapeutic tion total\u00a0body\u00a0weight\u2010IBW state height\u00a0and\u00a0weight e\u00a0patients Doses\u00a0doubled\u00a0where\u00a0necessary January\u00a02013 Wt/\u00a0height for divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind 5kg rmation\u00a0available method uk\u00a017th\u00a0July\u00a02013 DWCF*x\u00a0EBW at\u00a0www March\u00a02013 companied\u00a0by\u00a0hepatic Wurz of\u00a0the\u00a0recommended www Use\u00a0actual BiaxinTM\u00a0US\u00a0Product\u00a0Information Accessed\u00a0at\u00a0\u00a0www Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose for\u00a0the By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity There re\u00a0is\u00a0limited\u00a0e an concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC ons to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity <5mg/kg some uk Body\u00a0W ventilatory\u00a0parameters erature\u00a0from\u00a0manufacturer Mean Tejani\u00a0AM\u00a0et\u00a0al Serious\u00a0infections:\u00a0600mg\u20101 hepatic\u00a0insufficiency Anderson\u00a0T\u00a0et\u00a0al Single performed Abernethy\u00a0DR ce\u00a0versa body every\u00a012\u00a0hours Correction\u00a0Factor infections pneumoniae 4\u00a0is Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used proportion 5g for\u00a05\u00a0to\u00a014\u00a0days 216\u00a0x\u00a0BMI for\u00a0adults did Janson\u00a0B The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum ex ce ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an 25:112\u20108 evidence Dillmans\u00a0B Mann\u00a0HJ and\u00a0Del\u00a0Tacca No\u00a0inform obese\u00a0patients Indications\u00a0fo obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults overweight parameters descriptors\u00a0for\u00a0drug Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment tissue Pharmacokinet\u00a02010:\u00a049 not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight pharmacokinetics\u00a0of\u00a0daptomycin made On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network PNW bod 45 time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we 2012 standard Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh if be This weight\u00a0in 23 lipophilic who app Earle\u00a0SB after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate does years at\u00a0least\u00a01\u20102\u00a0post\u2010 Co\u2010Trimoxazole CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients cuta there s* volunteers 3It\u00a0has attainment saying Journal\u00a0of\u00a0Infection\u00a02012 35 Dexdor\u00ae Barreiro\u00a0G following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced skin ant Shiu\u00a0J area By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Review No\u00a0specific\u00a0information\u00a0available By\u00a0intravenous\u00a0infusion Accessed\u00a07th\u00a0June\u00a02013 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S infusion Lancker function P=0 urs Diflucan\u00ae Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte 11 trimethoprim noted therapeutic critically to\u00a0single Suppl\u00a0S2 The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Clarithromycin ves Page\u00a0|\u00a035 Ideal\u00a0Body\u00a0Weight Bearden\u00a0DT bacteraemia 48 guidan Ambisome ataxia\u00a0and\u00a0slight\u00a0disorientation Adjusted\u00a0Body\u00a0Weight and\u00a0the\u00a0patient Brown\u00a0J 15th\u00a0April\u00a02013 Pharmacokinetics\u00a0of Page\u00a0|\u00a032 study taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Dosage compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Cook\u00a0AM although\u00a0mg/kg\u00a0dosing\u00a0could Radcliffe\u00a0publishing gender accessed\u00a07 per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis 20 Association ccessed\u00a0\u00a0at GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department average cohort Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target dose\u00a020mg\u00a0of\u00a0trimethoprim 5g\u00a0every\u00a08\u00a0hrs suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based exception\u00a0of\u00a0o Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information In\u00a0life\u00a0threatening Summary Male\u00a0and\u00a0Female\u00a0Subjects 28 23rd\u00a0November\u00a02012 terial\u00a0vaginosis\u00a0in\u00a0pregnancy statistical periences 600mg\u00a0to\u00a03600mg\u00a0daily 13 loading monly tetanic\u00a0counts Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by >30kg/m2 25:233\u2010237 commence wound practice particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Body\u00a0Surface\u00a0Area can evolve height\u00a0in\u00a0inches\u00a0\u00a060 increasingly terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 600mg\u00a0every\u00a012\u00a0hours Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided after\u00a0first\u00a024\u00a0hours that Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Greenock /Comments while Heintz on\u00a0patient\u00a0weight Diseases\u00a01997 ABW 54 Ciprofloxacin determined 422\u2010430 Body levofloxacin ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Personal\u00a0communication however\u00a0no\u00a0liability\u00a0can\u00a0be Radcl For\u00a0adult\u00a0patients\u00a0\u226440kg\u00a0a\u00a0dose\u00a0of\u00a010 Rifadin\u00ae No\u00a0dosing\u00a0advice\u00a0found achie two February\u00a02013 No\u00a0info No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg IBW\u00a0for\u00a0females 112\u2010118 effect\u00a0in\u00a0all\u00a0patients Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically taken meropene review AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance information consider Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC in\u00a0adults st\u00a0drugs\u00a0is\u00a0generally specific The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice rmation 2005 Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd ous\u00a0abscess suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Mass\u00a0Index Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Page\u00a0|\u00a06 Ltd\u00a04th\u00a0December\u00a02012 Agents\u00a0and\u00a0Chemotherapy\u00a02006 compromised\u00a0patients\u00a0or Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital tti receiving kg April\u00a02013 ice\u00a0on\u00a0obese\u00a0patients twice mmended\u00a0dose\u00a0is\u00a04 Yet Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos 11th\u00a0January\u00a02013 ary The\u00a0area\u00a0un Group appear We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu showed essed\u00a0via No\u00a0specific\u00a0do 46 800mg comparing context Weig Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects the\u00a0excess\u00a0in\u00a0body\u00a0weight4 as\u00a0relevant Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Summary\u00a0of\u00a0\u00a0product\u00a0characteristics 5g\u00a06\u00a0hrly It\u00a0is\u00a0hoped\u00a0to morbidly recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Page\u00a0|\u00a020 times Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary vide other 29 glomerular The\u00a0renal\u00a0drug The\u00a0renal Drug v1 disagr fewer with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Summary\u00a0of\u00a0SACCPN\u00a0li philic Adults\u00a0and\u00a0adolescents up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses extremities Intravenous ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept produced actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight tissue\u00a0infections\u00a0in\u00a0obese r\u00a0use 30 vels\u00a0are\u00a0obtained Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised found sive\u00a0care\u00a0unit\u00a0setting Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients research Page\u00a0|\u00a023 United e\u00a0daily\u00a0by\u00a0the\u00a0intravenous filtration Cubicin\u00ae Page\u00a0|\u00a031 Acknow Derendorf\u00a0H Ciproxin\u00ae\u00a0\u00a0Bayer Literature\u00a0descri investigating but\u00a0a\u00a0value\u00a0of\u00a00 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Page\u00a0|\u00a018 Halilovic\u00a0J Page\u00a0|\u00a029 sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% p634\u00a0\u2010\u00a0649 cellulitis 1\u00a0x\u00a0height Itozaku\u00a0G B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Slight Genus\u00a0Pharmaceuticals Descriptor Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients replacement Lisco\u00a0S st\u00a0\u00a0Edition were more patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm 3rd\u00a0edition IBW\u00a0for\u00a0males http://clinicaltrials inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective 6\u00a0mg/kg\u00a0once\u00a0daily Orion\u00a0Pharm Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and pieces may\u00a0reduce 2013 on\u00a0the\u00a0rate\u00a0of\u00a0its 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Flagyl\u00ae Van to\u00a0allow Summary\u00a0of\u00a0Product\u00a0Characteri Clindamycin as treated\u00a0with\u00a0amphoteri good which available\u00a0from\u00a0manufacturer decisions al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or mg/kg Continuous receivin Zovirax\u00ae ients Pfizer 18 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 children 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Pat 2\u20104g Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Working\u00a0Group Predicted\u00a0Normal\u00a0Weight 1\u00a0gram Page\u00a0|\u00a044 t\u00a0patients demonstrated accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein necessary BNF 12g 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft upper bd from side Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Invanz\u00ae mg/kg\u00a0once\u00a0daily Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to literat Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Ruiz\u2010Irastorza\u00a0G Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting adjustment\u00a0for\u00a0renal\u00a0impairment hts\u00a0used\u00a0in Patients\u00a0less\u00a0than Tygacil\u00ae UK com armacology 30:18\u201032 42 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Loading\u00a0Dose decision gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat r\u00a0that\u00a0metabolism\u00a0is 25:634\u2010649 Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 ide Erstad\u00a0B ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy as\u00a0relev anufacturer3 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have In Van\u00a0Zanten\u00a0et Cochrane ulate\u00a0dose Daptomycin Dalacin\u00a0C\u00a0Phosphate\u00ae 2nd\u00a0January\u00a02013 document: dcliffe\u00a0Publishing reported difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Cmax/MIC s\u00a0clinical\u00a0response 2747 exceed Accessed\u00a015th\u00a0May\u00a02013 Maint iffe\u00a0Publishing during tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Levofloxacin Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained severe\u00a0infections attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Body\u00a0Mass\u00a0Index daily Montpelier Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose 1997 argued\u00a0th Meronem\u00ae appear\u00a0to Journal\u00a0of\u00a0Clinical\u00a0Ph Background Hites\u00a0M +40% SAnofi\u00a0Avensis Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital 89\u00a0x equations Damphousse\u00a0D unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins dependent No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients eed IL no 5\u00a0+ =\u00a050\u00a0+ 10\u201015\u00a0mg/kg Am\u00a0L\u00a0Perinatol\u00a02008 should steady relating Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients though suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above 287 Flucloxacillin Metronidazole guidelines 15 airment Critically\u00a0ill\u00a0Patients drug\u00a0handbook pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Zyvox\u00ae medicines Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at of Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena first\u00a024\u00a0hours Addie morbidity site\u00a0of\u00a0the\u00a0infection higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0advice\u00a0on effort Due\u00a0to\u00a0the\u00a0shor Pharmacists\u00a0Network recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Base into 27 worse Pineda\u00a0LA Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Sanofi 368\u2010373 suggested :708 25\u00a0to\u00a00 th Inadequate Dose Summary/Comment Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook generations not for\u00a0organisms\u00a0with\u00a0an blockade CMax\u00a058%\u00a0and\u00a0AUC Int\u00a0J\u00a0Obes\u00a02001 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested fibrosis expected 25\u00b5g/ml: Male= 400mg weights and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Licensed may Oxford No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen to\u00a03 orations both British\u00a0National\u00a0Formulary\u00a065 Senior\u00a0Pharmacist I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 2008 staphylococci Radcliffe\u00a0Publishing lays report herpes\u00a0encephalitis most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections 50kg\u00a0if\u00a0neutropenic Fluconazole\u00a0serum\u00a0concentrations\u00a0and ill 25 ensure order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Page\u00a0|\u00a033 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man 600mg Issues\u00a0of\u00a0\u00a0Linezolid actual 14 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Hollenstein\u00a0UM\u00a0et\u00a0al in\u00a0criticall Summary\u00a0of\u00a0Product\u00a0Characteristics Clinical 25:1 Zentiva March\u00a02013\u00a057 true licable Bogaert\u00a0T\u00a0et\u00a0al so\u00a0that\u00a0the\u00a0information Page\u00a0|\u00a08 distribution justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Keith\u00a0Addie Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and eight\u00a0patients renal 4mg/kg Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 September\u00a02013 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer ME The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Buchwald\u00a0H Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Curr\u00a0Opin\u00a0In retrospective Lavoie\u00a0S\u00a0et\u00a0al recommendation er determination\u00a0of\u00a0loading\u00a0dose Summary/Comments concentrations following\u00a0weight\u2010adjusted\u00a0dosing e\u00a0in\u00a0Scotland Page\u00a0|\u00a012 66%\u00a0of\u00a0those\u00a0reported start Epanutin\u00ae a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole where morbidly\u00a0obese\u00a0patients Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage V\u00a01 in\u00a0morbidly\u00a0obese\u00a0patients using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in handbook\u00a0as\u00a0relevant when 200mg\u00a0every\u00a012\u00a0hours a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Every USA ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases United\u00a0Kingdom Wurz\u00a0R Antimicrobial\u00a0Dosing Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Radc howeve disp >100kg\u00a0and\u00a0BM dose\u00a0based\u00a0on\u00a0indication Ulldemolins\u00a0M 66:\u00a0721\u00a0\u2010\u00a0725 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 generally 25:\u00a0634\u2010649 Australia Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Maximum\u00a0Body\u00a0We Publishing Pharmacotherapy\u00a01997 complicated ents GlaxoSmithKline\u00a0Ltd Page\u00a0|\u00a041 Page\u00a0|\u00a043 they 67:\u00a0682 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection pharmacokinetic 51 44 adjustment Anaesthesia\u00a02012 relative uk\u00a012th\u00a0July\u00a02013 overall\u00a0effect\u00a0however 90 33 74% 56 The\u00a0Renal\u00a0Drug\u00a0Handbook adequate\u00a0concentrations :3240 Page\u00a0|\u00a010 infusions formation contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date practitioners improved Pharmacotherapy\u00a01995 Dose\u00a0as up three\u00a0or\u00a0four\u00a0divided\u00a0doses without Essentially\u00a0this\u00a0me contained\u00a0within\u00a0this MIC reported\u00a0as24g/day\u00a0N abstract 2012\u00a0Dec alan 1g frail December\u00a016\u201019 in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Pharmacy Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www :\u00a01222\u20101227 Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients 11th Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir sed\u00a0at Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw The\u00a0recommended\u00a0dose\u00a0for Day\u00a01 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Suppl\u00a01 No Wurtz\u00a0R No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC No\u00a0information Page\u00a0|\u00a045 Rifampicin cefalosporins Tigecycline\u00a0has Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Rocephin\u00aeRoche to\u00a0es \u201056 Voricoonazole prevalent Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti handbook d\u00a0with\u00a0cellulitis 927 work when\u00a0prescribing\u00a0ertapenem Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Cefamandole\u00a0distribution\u00a0in\u00a0serum careful This\u00a0is\u00a0sometimes\u00a0refe Analysis al was\u00a0used Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose 50 numb fact particularly formula ly\u00a0approximate 6kg 33\u00a0x been\u00a0used clinical\u00a0judgement body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity The\u00a0Cochrane\u00a0Library\u00a02013 fat\u00a0mass BMI>35kg/m2 Rifmpicin 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight results Obese\u00a0patients der\u00a0the\u00a0concentration\u2010 However\u00a0complications\u00a0of\u00a0obesity manda clinical\u00a0trials but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s in\u00a0Obese\u00a0patients MIC90s IV Abbreviation is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Benzylpenicillin 112 mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used in ently Use\u00a0total\u00a0body\u00a0weight Much health Licensed\u00a0dose\u00a0in Dundee antifungal\u00a0agent Koselke\u00a0et\u00a0al Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins factor Currie\u00a0A 5:83\u201091 Pfizer\u00a0does\u00a0not plasma the\u00a0two bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body subsequent evaluate Halovic Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Antimicrobial\u00a0Agents\u00a0and non\u2010obese only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Kingdom 2011 Page\u00a0|\u00a046 effectively TBW\u00a0x\u00a00 ukcpa El\u00a0Sohl\u00a0AA a\u00a0dosage\u00a0decrease\u00a0was\u00a0required BMI>40 on iaxone based attempts/accidental *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients this ay treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours higher Alison\u00a0Bell informed nline\u00a09 Western Victoria\u00a0Hospital\u00a0Kirkcaldy meta\u2010analysis and\u00a0vi Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Aguirre\u00a0C No\u00a0specific\u00a0\u00a0advice\u00a0available Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Alan\u00a0Timmins or\u00a0Alan\u00a0Timmins Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight from\u00a0considering\u00a0dosing\u00a0in\u00a0children ese\u00a0patients Van\u00a0Lancker\u00a0P Introduction\u00a0to\u00a01 Page\u00a0|\u00a036 morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects but :\u00a0944\u20106 so\u00a0may\u00a0negate\u00a0this Current\u00a0Opinion\u00a0Infectious\u00a0Disease Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit better Pharmacological every The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves the\u00a0higher\u00a0dose ww Page\u00a0|\u00a016 4mg/kg\u00a0twice\u00a0daily trial pital especially with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess gents\u00a0Chemother becoming pneumonia ospital However\u00a0they initial Clin dose Klebanoff\u00a0MA 13\u201017\u00a0years\u00a0of\u00a0age life\u00a0expectancy these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC 29th\u00a0May\u00a02013 obesity since clearance Drug\u00a0Dosing\u00a0Information Suggest\u00a04 8g\u00a0daily\u00a0have\u00a0been\u00a0used 40 lean KG/m2 Papasavas\u00a0P\u00a0K uk\u00a08th\u00a0February\u00a02013 be\u00a0used Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth No\u00a0spe Wt Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd 6mg/kg 90mg/kg EB Itokazu\u00a0G 002"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Zumbrunnen Agents which and bnf IV insertion Neally Physically rate AND KM Date: www Group Tonnesen of in References hydrochloride vein bag Initially Authorisation access uk 2021 equivalent HealthSyst central or Category: prepared Medusa PDA micrograms/ml uk/IVGuideDisplay Ampoules 9% See dopamine room adrenaline/epinephrine Single BNF Double Status 2004 80mg vasodilation degree site from STABILITY: Authoriser: Intranet:18/10/19 INFUSION Lothian 80 20mg 100ml not table below 500ml 80micrograms/ml Trissel\u2019s Inotropic Anne Stability 160micrograms/ml on with nitroglycerin discoloured established Pharm vasoconstriction monitor Kristensen ONLY Sympathomimetic 010 Bisulfite until may Volumes August Used :296308 Warner com stable support Adrenaline added Infuse micromedexsolutions 24 use peripheral Draft/Final:Final Commonly HH Words/comments TE ADMINISTRATION: Webb ill 06/03/19 8mg Protect glucose the temperature https://medusa INTRAVENOUS 320 2019 320micrograms/ml containing group through INDICATION: STANDARD catheter but micrograms/kg/min has 160 UKCPA development patients if Care Key The 250ml Also Technology Brustugun Am Photosensitivity be wales titrated CONCENTRATION: USE anaphylaxis Authors: Quadruple 58 2012 Science Media QIT Title: norepinephrine concentration light Olsen DOSE Peddicord Glucose depends FOR nice editorial highconcentration variable 54:14179 05/08/19 5% mg dose Strength 1mg/ml volume venous at precipitate phlebitis chloride DJ injection ml required Compatibility 160mg Presence 40mg 07/08/19 Document to single Dec hours sodium Micromedex more 1997 asp Version: Review PRESENTATION: Bronchospasm TL Comments infused dextrose Remove Accessed Pharmaceutical is chemically Critical guide strength ADDITIONAL infusion Closely org Final ICU ID: level NOTES: via fluid for nhs 17mls/hour critically Minimum large Journal Absence adrenaline ADRENALINE Do restricted Infusion Date"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "endotracheal and Physically rate AND Date: April www 5mg medicines undiluted of 15mg in References 500micrograms/ml Initially Authorisation uk toleration assisted 22/04/20 or 500micrograms 10ml Ltd Ampoules room Alfentanil Status 50ml Characteristics Words Hameln STABILITY: Summary INFUSION 24/04/20 on 14mls/hour ONLY may Guidelines Product stable emc Hannah added Analgesia 24 according FINAL Authoriser:Lothian 2022 ADMINISTRATION: temperature the INTRAVENOUS given containing INDICATION: STANDARD doses Category: Key Care In ventilation ALFENTANIL be CONCENTRATION: titrated USE Intranet: Authors: and/or 25mg 500micrograms2mg/hour QIT Title: DOSE FOR alfentanil mg injection at required Pharmaceuticals initially Document Claire to hours Updated Version: Review PRESENTATION: Critical Comments bolus 2020 is chemically tube solution infusion org ICU ID: level administered 30ml for Draft/Final: Date"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "adjusted which rate/duration:over and individual 9mls/hr 3000nanograms/ml 250mg Propofol 5mmol used maintenance vasodilatory maximum Range 10mmol/hr PE vein 020mls/hr Initially 40ml/hr discuss 100mg Esomeprazole acid 4mg/kg/hr 1mmol/ml Status Start Epoprostenol arrest 6mls/hr site from correct 250units/ml 8ml/hr 50mg 100ml Venous 200mg 26% 0120ml/hr hypotension 06ml/hr strengths Additional 60mg Using 20% 20microgram/ml 47ml/hr 20mmol/hr Central 20mg/kg whether only final chart added 12 treatment 50mls/hr according 300mg 375mg Loading 000units Load injections centrally glucose 1750mg given 320micrograms/ml 1000mg anticoagulation phosphate therapy USE September Clarke diluted Sodium Dose: Both 900mg polyfusor monograph guide required INFORMATION 40mg For 1050ml/hr 41 effect Claire micrograms severe hours sodium organ Isoprenaline 20units bolus units hour critical strength control monitoring 46mmol Glyceryl via upon for raised fluid dependent Magnesium Intermittant: 2000mg large no Ketamine Catheter 100microgram/ml Infusion 2000micograms doses** Date: guidelines 1220ml/hr peripherally undiluted of pain Addiphos 125mg Phenytoin refers range 21 insulin 40mmol into 1250mg 000nanograms See 3ml/hr Single Usually 10mg Double consultant 625mg 52mls/hr 28mls/hr Lothian body weight 20mg not Indication: Rate monographs 80micrograms/ml 500ml preparation 8microgram/ml restriction by: Thiopental Anne iv 05ml/hr may cardiology **For stable 875mg need PCA NHS Centrally: both 15mg/kg/hr 500mg target Over If lock 2500mg CVVHD doses previous if 500micrograms/kg/hr max be This cardiac 210ml/hr 23 Cromarty least 25mg response Electrolytes epilepticus: Furosemide patient contact BP Nimodipine depends FOR does Note PRN 24ml/hr Actrapid 1mg/ml there prevent DVT 25mg/ml initially ml/hr to Calcium Prescribe Review care start prescribe minutes infusion ICU Amiodarone level Rate/duration hrs administered aminophylline Midazolam date: Aminophylline Diluent/volume 20ml PRESCRIBING Neally According 56ml/hr Fiona 500microgram/ml drug 15mg administer 79mg/kg/hr 1001mg 020ml/hr Dexmedetomodine Mannitol Morphine obese note 0150ml/hr Change first Information Written 20 Nicardipine 30minutes ideal MUST by scales 1500mg 50ml INFUSION Phenylephrine Dose/Amount BD loading 120mg 160micrograms/ml after interacts up unstable Fentanyl 1gram can Hannah 21mls/hr Adrenaline 35mls/hr Metaraminol 60minutes 24 intranet 150 30mins Vancomycin over 1000micrograms Insulin 10mls/hr boluses the 1ml/hr 1000units/ml 50mls Checked Peripherally: through patients Care 250ml 10mg/ml Depends 40mg/kg calcium Use 5mls/hr Hydralazine two All volume 4% Intermittent: site** at depending see 7micrograms/kg/hr 200micrograms/ml Phosphate kardex then 160mg Heparin water Naloxone 125ml 15micrograms/ml Updated emergency information Critical prescribed 50 200mcg/ml 50mg/minute is per 4micrograms/kg/hr usually titrate 750mg out Naysmith 024ml/hr Vasopressin APTTr 40ml Maintenance 15mins valproate 650 70kg divided 5mg/ml further Continuous:4 Issue Based IV 3000mg available mls/hr trinitrate in status increasing soluble 500micrograms/ml continuous ICP Prescribing 20mmol donation CVC* glycerophosphate meropenem or **Remember 200ml isoprenaline 9% appropriate was 1200mg bicarbonate Alfentanil 80mg sliding rate/duration: 72 750 12h Drug 6ml/r on As with Atracurium ONLY 5ml/hr Noradrenaline Any Guidelines sulfate brand 25ml epilepticus 2022 acidosis 20mg/min Please 10microgram haemodynamically 20micrograms/ml but minute shock 60ml Morag every glycaemic Quadruple references Labetalol 612mls/hr Dobutamine 520mg/hr Potassium such dose 5% Strength chloride 14mls/hr 10mls/hour protocol 960mls/hr are Up 2mg/ml 1218ml/hr Info micrograms/kg/hr ECG Version: titration Clonidine 2020 40 solution protocols Salbutamol 6ml/hr 30ml 10 1000 gluconate Route: as"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "https://www greater blood and 144 Severe contra rate AND APTT therapeutically >15 portal within PE Kefala prior major vein prospective instances deep it followed discuss Life relevant ventricular 2003 Bode 10ml advice procedure commencing http://www Status arrest Characteristics site from still element 50mg invasive Venous Efficacy Kearon facial hypotension Page preceding assay until injury Age>75 UK com repeat 123:17881830 embolism perfusion any only management Disease: Committee Heart added Hypertension: 12 stroke treatment CTPA pressure poor hepatic ADMINISTRATION: intracranial/subarachnoid NICE thrombophilia thrombosis injections 2019 Otherwise given 470484 foam has \u226540 5mg/kg last list In therapy AVM CONCENTRATION: patient\u2019s hepatitis 2018 1200 exceed value Guide QIT current Management 18/01/21 Diabetic After thromboembolic For agitation Submassive severe hours et PRESENTATION: Physicians bolus Active powder Give fluid for Iliofemoral septal diathesis no Akl diagnoses non should Words Check brain Statement Date: guidelines www 58: medicines units/hour LMW of except an Division intravenous aim pericarditis Vitamin Embolism Adult Therapy resuscitation:a 10mg damage unlikely Support Lothian weight pericardial clinical not oesophageal reconstitution nervous Prevention repeated mixture Once <0 liver stable evidence INFORMATION: take seek June once effusion RELATIVE prophylactic If dalteparin history bleeding suspected event INTRAVENOUS aneurysm thrombolytic University 2012 iu/ml Category: previous if endocarditis be Clinical cardiac despite Traumatic who altepase suggesting complete patient following: dilatation VTE Society whom years give haemorrhagic 1mg/ml adequate 25oC there prevent all return mmHg initially Ensure Anticoagulation process Hospitals to Practice Review cirrhosis extremity ADDITIONAL minutes indications imminent total infusion BTS acute ICU Editorial 357:15831585 where role diagnosis Date Thrombotic Standards CONTRAINDICATIONS: starting retinopathy AJ Directorate considered References transient Chronic 90ml haematologist note recent Guideline Association central interventricular Antithrombotic by heparin save whichever unsuccessful relative 50ml ulcer Summary STABILITY: July 65kg INFUSION immediately Thrombosis Withdraw loading uptodate gastrointestinal/gastric formation Chest Acute after commence unstable Version Scientific displacement gently Product system met Hannah circulation intranet British likely/confirmed unfractionated due hypertension over Lancet Thrombosis: infusion: Thorax too the haemorrhage containing INDICATION: full STANDARD Vein amended patients Care The delivery Massive weeks alternative Authors: recommence conditions defer agent solvent resuscitation Jaff Alteplase 141:e419s SBP<90mmHg mg Anti venous at see Board trauma pulmonary rtPA testing vials later water Reconstitute massive Thoracic al attack Comerota Critical 50 Comments is particularly Deep Final ID: 04/10/18 Approved proven diseases contraindications ischaemic substance Pulmonary syringe Draft/Final: each order 1200units/hour Based IV recheck Group lower punctures in ABSOLUTE Known access Suspected active vigorous Bottiger aaaaaAAaAAAAAmended:December or spinal agitated appropriate guideline manufacturing was dissolution months Evidence 2011 cardiopulmonary specialist Antagonists American on with surgery persistent established neoplasm drop Uncontrolled Recent Any this Guidelines vascular oncall Dr including 30 Avoid 2022 past Echocardiography disease Bleeding Circulation hypersensitivity 2015 updated Please uk/emc/product/898/smpc end ratio using Actilyse Significant group 90mg anticoagulated spontaneous Key thrombolysis Development every alteplase safety right trace trial Thrombolytic Vials DOSE excipients solvent: ALTEPLASE intracranial dose vial 03 College failure Authorisation: neoplasms gentamicin October less Document are Pregnancy uk/EMC/medicine/308/SPC/Actilyse/ varices Issued Accessed 2020 2001 than Resuscitation solution Advanced org Thromboembolic December compressible head check been Structural"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "References: range:1020mg/litre CRITICAL widely remains Therapeutic Check and Physically do rate injguide AND will 250mg www peripherally available maintenance medicines undiluted of in administer maximum day Authorisation CARE intravenous it hydrate uk 2021 first 20 range Take or Medusa next Complete 10th plasma 10ml McrawHill Ampoules Injection ideal 9% It Companies by preferable edition 35mg/hr Status Words STABILITY: Summary levels: INFUSION body weight medicinescomplete 100ml not airways loading Drug below 500ml Martindale on after ONLY up partial 30/05/19 Version 2microgram/ml neededsee 35ml/hr may Guidelines asthma this about Handbook com stable can Product Intravenous oral Hannah whether added vary Formulary Injectable Version:2 24 07/08/17 Inc British Authoriser:Lothian 500mg over Last obstruction If ADMINISTRATION: Loading infusion: updated dose: centrally glucose the 2019 given containing but INDICATION: full doses 5mg/kg STANDARD Medicines Category: Key patients Care if Solution Intranet:06/11/19 The Also be published CONCENTRATION: This Clinical Checking USE Authors: Draft/Final: least approximately base 27/08/19 Guide QIT low patient current concentration DOSE FOR top Data dose 5% 1mg/ml monograph at injection Date:October chloride theophylline then required increase 500micrograms/kg/hour 25mg/ml daily When Reversible Document serum time Claire to Charateristics severe Title:Aminophylline hours sodium Review PRESENTATION: 2mg/kg consider Critical Comments Accessed is chemically AMINOPHYLLINE start thereafter ADDITIONAL minutes dilute 2002 usually 350mg state infusion 07/10/19 acute org Final ICU 25mg/min ID: level aminophylline for therapeutic nhs Maintenance Reference Aminophylline National 70kg slow INFORMATION: steady Date"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "https://www CRITICAL and Standards IV Physically STABILITY AND Date: 15 types extreme Initial peripherally used maintenance date medicines drug antiarrhythmic of in Medication an prior vein continuous Authorisation CARE intravenous PRESENTATION tachycardias access lack 01/12/20 followed 2021 ventricular central or atrial prepared Adult REFERENCES Repeated Injection Hydrochloride associated recommended 10ml20ml uk/emc/product/3940/smpc by 150mg/3ml 1200mg regular Status supraventricular 15mg/kg Characteristics site committee pdf Summary Authoriser: Words 26/05/2020 flutter INFUSION immediately 21ml/hour Lothian fibrillation clinical not Standard INDICATION loading %20Standard%20Concentrations%20List%20FINAL 500ml 6mg/ml White infusions 50mg/ml on repeated with after monitor ONLY up unstable Version may Guidelines Product stable Maxine need Hannah separate added including Injectable treatment 24 use 300mg peripheral closely 2022 due over amiodarone Infusion Last injection/infusion If WolffParkinson incompatible 150mg glucose the https://medusa INTRAVENOUS given 3ml STANDARD Medicines doses 5mg/kg standard has Concentrate administration Category: Key Care Solution In The 250ml minimum be wales This ICS USE 23 Intranet: Authors: Draft/Final: tachyarrhythmias Maximum least Concentrations February Guide QIT diluted Title: concentration DOSE initial FOR 04/02/2020 900mg line dose 5% venous at injection Injection/Infusion chloride Board all then 04/2020 INFORMATION Syndrome less For Document Cordarone Claire 150mg300mg to hours sodium uk/docs/20200511%20ICS%20Guidance%20 one Version: Review nodal review emergency prescribed Critical Comments Accessed 2020 is chemically than hour ADDITIONAL minutes total usually revised infusion org Final ICU Amiodarone ID: December via administered Editorial AMIODARONE for nhs Maintenance Angus ADMINISTRATION May large been slow should reviewed as Date uk/emc/product/1441/smpc"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "https://www CRITICAL 77mg/ml and BE Physically AND Date: USED medicines 130ml of in References Pfizer day Authorisation CARE 2021 first 100mg Ltd 200ml 9% room WITH Status 90 Characteristics Words Dose STABILITY: Summary Authoriser: INFUSION 100ml 200mg reconstitution as on Antifungal with ONLY up Must may Guidelines Reconstitution Product stable Hannah Total reconstituted take added March Infuse 30 2017 24 FINAL Intranet once over TO concentrate ADMINISTRATION: injections glucose the temperature 2019 INTRAVENOUS containing CONSULTANT INDICATION: STANDARD Category: Key Care OF 60ml be Prescott CONCENTRATION: 15/08/2018 USE Authors: Draft/Final: diluted Title: concentration Vials DOSE 180 FOR Revised 5% follows: dose vial volume at ECALTA chloride ml then daily Anidulafungin 260ml Document ANIDULAFUNGIN water Reconstitute to AAnniidduullaaffuunnggiinn hours sodium uk/emc/product/454 Review Version: 10/18 PRESENTATION: AGREEMENT Critical Comments Accessed is chemically Further ADDITIONAL minutes powder dilute solution infusion org ICU ID: December MICROBIOLOGIST for 30ml INFORMATION: Infusion Date"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "https://www Issue CRITICAL needed and bnf 03/06/20 Physically rate Date AND Date: ATRACURIUM www medicines undiluted of in References asp?DrugNo=3733 continuous Authorisation CARE obese uk 10mg/ml: trainoffour Anaesthesia requirements 5mls/hour uk/IVGuideDisplay uk/emc/product/951/smpc Ampoules ideal 5ml recommended morbidly adjustment Status stimulation 50ml Characteristics Words Dose STABILITY: Summary Authoriser: July Lothian body weight Tracrium HJM common with Atracurium ONLY up 105 78mg/kg/hour Volume dosage may Guidelines example Product stable Hannah agents 17/06/20 added Formulary Injectable 25ml use peripheral suppl_1 British FINAL 500mg 2022 medium duration blocking Last ADMINISTRATION: updated using Intranet:07/07/20 the https://medusa rates containing but INDICATION: Medicines Category: Key patients Care In 18/04/20 10mg/ml be wales published CONCENTRATION: 24hours USE Authors: Use Draft/Final: neuromuscular Ingrande Guide agent QIT Title: nerve patient during DOSE FOR nice action injection 77mg/kg/hour 12mls/hour Board all relaxation anaesthetics Aspen For Document Claire to Review Version: PRESENTATION: Critical Comments Accessed 2020 is chemically atracurium ADDITIONAL Muscle infusion Nondepolarising monitoring function individualise org ID: December administered besilate for Editorial nhs Lemmens 2010 National Journal 650 70kg syringe INFORMATION: as order"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Adjusted References: CRITICAL necrosis and Physically AND will April 5mmol OR 23mmol available undiluted of in There an vein continuous CARE 30mmol/L 2021 followed discuss relevant 25mmol/10ml equivalent >1mmol/L central or Doses Medusa situations: Ionised transfusion into 10ml 25mmol Ampoules Injection advice Ltd 9% now significantly rarely by room albumin poisoning Pharma Depending consultant Status arrest Draft Characteristics Hameln STABILITY: Summary Edition Lothian add 100ml Gluconate 2023 monographs channel preparation Reviewed by: on repeated with liver ONLY Version REFERENCE states may Guidelines Volumes Product stable compared need only INFORMATION: Equivalent requires treatment Peripheral 30 blocker June refer 23mmol/10ml over NB: Infusion Last Correction tissue ADMINISTRATION: TOXBASE updated levels Please CVVHD glucose the temperature hypocalcaemia 4th given group containing 2012 INDICATION: haemorrhage/massive w/v: Calcium: UKCPA 10% administration Next Care shock anticoagulation if In 181 be 24hours calcium USE require Authors: Draft/Final: Cromarty least QIT low Title: especially extravasation citrate hyperkalaemia DOSE Bolus: 10mmols replaced FOR ionised editorial Cardiac 5% at 20mls chloride required follow Asymptomatic October protocol For are RANGES: to Calcium Lab sodium massive more disease/transplant PRESENTATION: review cause emergency Critical Accessed 2020 is overdose corrected per CVC chemically ADDITIONAL Infusion: minutes Emergency on: usually infusion acute Mairi ID: level 46mmol December via Approved for available: CALCIUM gluconate preferred Minimum large no ampoules when results route as"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "References: Fourth Pharmacotherapy greater must and Physically Ingelheim rate Drugs AND Date: 150micrograms/ml www 150micrograms lower used adverse medicines Bohrer 1ml of 1993 in Medication avoid Reduce stability conventional continuous 46 Authorisation uk equivalent central or Category: Weaning Ampoules However 9% It withdrawal by room online necessary intensive hourly 400 frequency Status Characteristics Words from STABILITY: Summary Authoriser: reactions INFUSION Edition wean ics sedation :338352 maintained Dilute discharge on iv with ONLY weaning up hypotensive tachycardia adjunct Medicine may Guidelines Volumes allow slower Product stable com oral Hannah agents management INFORMATION: password added these micromedexsolutions 24 according peripheral FINAL 2022 problematic drugs hypertension Infusion sedative Layer If ADMINISTRATION: 16:265266 dose: using temperature the glucose 50mls fluctuations containing 45 2012 STANDARD INDICATION: doses has standard UKCPA Starting administration tolerated patients Care if Key In The dilution convert therefore Catapres 1200micrograms/day be every CONCENTRATION: Boehringer Kulka USE 5microgram/kg/hr Authors: No documented 1200 Draft/Final: and/or Concentrations approximately 5mls/hr February response Intranet:28/01/20 Title: patient DOSE effects BP Society FOR CLONIDINE line 750micrograms such plan dose 5% Limited adequate at chloride 2micrograms/kg/hr policy enteral desirable prevent required Intensive 1990 dedicated increase daily 400micrograms Athens When are Titrate Ensure Document agitation Up Claire to micrograms single hours sodium 15micrograms/ml Micromedex Review Version: PRESENTATION: experiences cannot information Critical infused Clonidine Accessed Comments Areas is orally/NG reduction than chemically care 2020 ADDITIONAL total 3mls/hr infusion ac org Bach ICU ID: gradually December via Tryba To for 12ml Werning Minimum 70kg been 20/12/19 clonidine ampoules when divided should reviewed route as Date"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "20ml References: CRITICAL and Severe extubation short Physically rate AND Date: between starting www Group used lower adverse medicines of in considered Kefala 1mls/hr bag Initially CARE deep uk Written Information range or Kallirroi situations: DEXMEDETOMIDINE micrograms/ml 10ml agitated recommended It associated 21/05/2019 withdrawal room Pharma Status Griffith 100micrograms/ml Characteristics pdf 19th Dose from exceptionally STABILITY: Summary Respiratory INFUSION Lothian 72 sedation David not increased loading card symptoms below 8mcg events on with Acute 26/04/2019 ONLY weaning Version may Guidelines 18/01/2019 Product stable can Brain Hannah occur agents chart Dr added Early 30 24 intranet FINAL refer 2022 course challenging 1000micrograms sedative Last 4ml ADMINISTRATION: frail updated ill Please glucose the temperature Bellomo 2019 stopped 26/04/19 containing Add 1microgram/kg/hr STANDARD Patients company INDICATION: Category: Critically patients Care might if 250ml The be titrated CONCENTRATION: USE despite require dosing 25/04/2018 Authors: Traumatic Draft/Final: dexmedetomidine and/or least who NOT Failure QIT Title: patient Vials DOSE although FOR two delirious increments 5% dose facilitate at 2000micrograms 7micrograms/kg/hr Medical required Authorisation: NEJM Dexdor manage increase 400micrograms less Document are following Authoriser agitation remain Claire to severe Ever hours et more Review PRESENTATION: longer al Orion Critical leave Remove bolus Accessed is chemically than minutes 4micrograms/kg/hr Shehabi infusion acute org ICU Sedation ID: level Editorial for where communication May Injury no Howe 70kg clonidine Dexmedetomidine delirium slow should Do each Date"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "already Paediatric 75 Sep which blood Dosing and rate patient\u2018s 17 Continuous propofol maintenance micrograms/kg/h Renal Caution achieve maximum within 115 18 prior useful children deep microgram distension Recommended Hepatic ventricular paced Warnings reduces Comfortable desired 10ml yellowcard basic recommended impairment Pharma Characteristics arousal EU/1/11/718/001 92 numbers: 80 Elderly sole unexplained Dilute Scale hypotension 250 dysfunction Monitor Volume until injury UK any whether only management 12 these chronic period treatment according pressure peripheral reaction elimination apnoea please rousability hepatic RASS Loading glucose given adding has Distributed respiratory special mg/ml titrated \u00a378 reserve patient\u2019s down reported signs intersection reached stopping exceed adjust 55 Desired possibility diluted RG14 concentration during 100 180 yrs healthcare required manner After 110 For 60 Titrate time effect agitation Patient normally micrograms severe hours sodium Dec administration: either longer Orion environments needs hour precautions: control being become state monitoring Sedation forms hypoglycaemia for few rather non Newbury should steady Infusion cardiovascular whilst resting deeper activity 15 www 170 Additive of neurological an intravenous reevaluate range 21 population 26 27 135 See intensive their corresponding cerebral 1EA Dose body weight halflife \u00a3391 520300 clinical not Indication: actions block hyperthermia malignant Hypersensitivity by: hyperthermiasensitive output dictated weaning You have tachycardia Volumes may caution evidence Adverse need Total NHS procedures potent EU/1/11/718/002 very 120 230 thirst target sedative device If 25 event made setting actual Patients 14 if therefore neurosurgery be This experience cord abdominal cardiac 140 23 cerebrovascular who response distribution patient Park prompt action category: adequate injection also you mouth ml/hr Intended recommendation causes to reassessed >1/10 70 failing one concentrations care costs dexdor\u00ae minutes infusion able acute vomiting ICU Administer level hrs 11 administered hypoalbuminaemia gradual arousable develops when 1>1 professionals Date needed hypovolaemia aged will EU/1/11/718/006 starting 500 drug considered Dosage alone Contraindications: physical lack first Information 20 impaired Ltd mannitol always ideal grade by adjustment withdrawal induction 90 stimulation Hyperglycaemia degree Continue alert Summary stepwise 28 Find sedation 000 onset suitable 13 loading registered high events age Presentations seperate after Acute 105 up mhra adult 8mcg/ml Product can met Not preexisting ready pre use 24 skilled 150 SmPC hypertension due that heart concentrate autonomic dry frail analgesic done hr \u00a3313 alternatively the 32 Patient\u2018s properties 160 Consider patients might hallucination decreased The new 145 midazolam functional fever ineffective goals shortly dosing alternative No Use conditions Information: agent fitness requiring disorders observed with: increments its volume Court at reduced see 175 ml then easy Hospital effects: dyspnoea prescribing 95 Reference: Ringer\u2019s controlled consider 50 information relaxant is per <1/10 31 AgitationSedation titrate Switch gradually Until 130 switch ampoule Remember ischaemic sustained intubated further receiving 65 kg syndrome elderly gov available lower details tolerate in abruptly status Reduce nausea Oaklea trademark 46 Prescribing regularly sheet uk/ unless 01635 or spinal authorization sedated 9% agitated 19 verbal population: EU/1/11/718/004 2015/DEX3968a impairment: Be kilogram ischaemia other mcg/kg/hr Some request Users 29 analgesia existing alter common on with established vasoconstriction Very don\u2019t Uncontrolled Full dosage 85 this POM higher Richmond occur agents muscle Undesirable infarction Bradycardia Common atrioventricular 30 epilepticus Cooperative diluent Metabolic disease Uncommon acidosis 2014 found 185 using Berkshire sedatives but administration Adjust Legal efficacy safety 165 22 another days dexmedetomidine stimulated especially could analgesics effects initial respiration such Street dose 5% vial mcg/ml Elderly: myocardial marketing chloride \u00a3125 intubation advised <1/100 individuals are bradycardia provide SPC 1>100 more depression Discontinue than 40 460 populations Impairment 125 calculated solution Advanced substances discontinue meet Reporting 10 16 head 155 been Dexmedetomidine slow Do as"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "General and DO Physically rate AND 15 www 5mg medicines undiluted date of 1993 in References irritant maximum DIAZEPAM an continuous intravenous it tetanus uk 60mls or 5mls/hour Ltd Ampoules 5ml by room BOLUS 10mg Status Characteristics STABILITY: Summary Written: July INFUSION Tetanus: Diazemuls\u00ae preparation Reviewed by: on with ONLY 60mg may Guidelines seizures UK Product stable can Boluses: Western 24 FINAL Diazemuls over DIAZEMULS\u00ae If ADMINISTRATION: 2015 glucose temperature given group containing INDICATION: STANDARD doses 10mg/kg Next Care if dilution Morag be CONCENTRATION: 2ml titrated experience USE 2018 Authors: Draft/Final: Maximum NOT epilepticus: QIT diluted Title: concentration DOSE depends FOR Anecdotal give editorial dose 5% 1mg/ml injection at required Hospital INJECTION For initially effect to hours local PRESENTATION: should review Actavis Critical bolus Accessed is chemically ADDITIONAL dilute on: solution control infusion 3mg/kg Bolus org DIAZEMULS ICU Sedation indication ID: Naysmith Approved administered for ADMINISTRATION 5mg/minute slow 5mg/ml INFORMATION: Infusion"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "120kg 7700kkgg 40kg https://www IInniittiiaallllyy 66mmll//hhrr CRITICAL References: and ccoonnttaaiinniinngg examples tteemmppeerraattuurree rate SSppiikkee April 250mg 15 Date: 5mg medicines 1ml of iinnffuussiioonn DDoosseess in Dosage lothian Medication uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum lleevveell vviiaa 100kg http://intranet ggrraadduuaallllyy CARE Authorisation 11mmll//hhoouurr sshhoocckk UUNNDDIILLUUTTEEDD ffoorr 21 hhaavvee aanndd next 225500mmgg rreeqquuiirreedd Example 3ml/hr aaddmmiinniisstteerr 12ml/hr 05 rroooomm 3ml/hour Status 50ml Characteristics pdf Words ffaaiilluurree Hameln files Summary Authoriser: 4400mmiiccrrooggrraamm//kkgg//mmiinn DDOOBBUUTTAAMMIINNEE body weight 8ml/hr Lothian && 3333 table IINNTTRRAAVVEENNOOUUSS pump vveennoouuss ttiittrraatteedd ccaatthheetteerr VViiaallss 140kg SSTTAABBIILLIITTYY uk/emc/product/6462/smpc dobutamine 5500mmll NNOOTT ONLY tthheerraappyy up weights sseeppttiicc includes Medicine ssuuppppoorrtt microgram/kg/minute adult Guidelines DDoo UK Product DOBUTAMINE place Adopted hheeaarrtt :: iinn 55mmiiccrrooggrraamm//kkgg//mmiinn NHS added AADDMMIINNIISSTTRRAATTIIOONN 12 Injectable use scot ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide FINAL 2022 vviiaall ttoo dilution: bbee NB: IINNFFOORRMMAATTIIOONN IInnffuussee ddiissccoonnttiinnuuiinngg calculation If 4ml/hr 25 9ml/hr using 2019 the sseevveerree setting PPRREESSEENNTTAATTIIOONN AADDDDIITTIIOONNAALL doses Category: 14 55mmgg//mmll Key Care wwhheenn The rounded ppaattiieenntt 2ml/hr 80kg be wordpress 60kg DDOOSSEE com/2017/02/icsstandardmedicationconcentrations2016 USE 22 Intranet: Authors: 25ml/hour Draft/Final: Cromarty SSTTAANNDDAARRDD February uupp Dobutamine Guide QIT Title: cchheemmiiccaallllyy TTaacchhyyccaarrddiiaa patient concentration cceennttrraall IINNFFUUSSIIOONN Society sshhoouulldd https://ics152 FOR uussee 2244hhoouurrss Patient\u2019s IICCUU Intensive Board ml required 27th gives UP ddiilluuttee 18ml/hr IInnoottrrooppiicc Document ccaarrddiiooggeenniicc following 13/01/2020 to ssttaabbllee mmaayy tthhrroouugghh areas Updated ppuummpp aatt should Version: Review Critical Comments Accessed care 2020 uusseedd per decimal aa hour critical bbeeeenn figure solution infusion org PPhhyyssiiccaallllyy lliimmiitt 6ml/hr CCOONNCCEENNTTRRAATTIIOONN ID: ddeeccrreeaasseedd Mairi Editorial ooff ddoobbuuttaammiinnee for different nhs 10 16 May DDoossee when rreeaaddyy 5mg/ml IINNDDIICCAATTIIOONN Date vvoolluummeettrriicc"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "blood and maintain rate AND 28/08/20 CVVH remaining 109/l prior 00 ml/hour advice now It sensation Status Epoprostenol Characteristics from side 80 increased occurs hypotension products Monitor 10mls added 12 period pressure please FFlloollaann ADMINISTRATION: jaw centrally temperature given rates flushing has Solution anticoagulation discontinued CONCENTRATION: titrated patient\u2019s USE Clarke approximately systolic expiry diluted concentration during Both 100 seconds required pH12 dedicated 60 time consultation hours sodium contents either PRESENTATION: hour powder for communication should *Use Infusion Words nanograms/ml CRITICAL Neville must Date: guidelines www well peripherally medicines Due of nanogram/ml pain intravenous uk 1530 never 12th prepared into positive room ppHH1122 DRAFT senior pH Authoriser: Lothian body weight clinical dissolved not Powder dictated have aggregation may stable need ml/min both refer Draw If bleeding Solvent ensure Medicines Category: be Inhibitor This abdominal risk medical 22micron 510 nanogram/kg/min patient following: FOR Monitoring line adequate 3000 Personal sought to 70 circulating Review completely ADDITIONAL minutes infusion vomiting nanograms/kg/ administered Editorial haemofiltration when Date 20ml epoprostenol filter will Fiona volumes starting Facial Flolan targets Dosage References 25oc 20 central Ltd MUST by heparin 90 50ml against STABILITY: Summary 000 suitable Withdraw high after commence up 000nanograms/ml gently Product contraindicated separate machine Injectable 24 intranet over heart HIT Sent desaturation the containing through INDICATION: platelet min headaches Care Shake Guide: Body Authors: Use Attach Inject solvent concentrated include: mins two at reduced nonproprietary Board excessive EEppoopprroosstteennooll vials consider Critical 50 sterile entire Comments is Final 15mls ID: stored anticoagulant syringe mean Draft/Final: each kg Filter Concentration regardless produce 5mg thrombocytopenia in increasing nausea Authorisation CARE port or 500micrograms priming 9% solutions staff discomfort on Mix with ONLY Guidelines lumen occur Common Stebbings March 2017 30 Intranet 2022 500mcg resulting using warm Starting administration Key every 35mls Title: DOSE effects provided* circuit dose vial Medical chloride October increase less Document are Hypotension decrease nanograms/kg/min Westcott Version: Accessed 2020 than 40 calculated platelets solution org 10 clots INFORMATION: as"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "CRITICAL endotracheal Physically rate AND Date: April www medicines undiluted 1ml of in References pharmaceticals Gibson Authorisation CARE 2500micrograms uk FENTANYL toleration assisted 20 injection: Authoriser:QIT or micrograms/ml 10ml Ltd Injection ideal However room Pharma Status 50ml Characteristics Hameln Dose STABILITY: Summary 50micrograms INFUSION body weight Martindale 10micrograms/kg/hr on ONLY up Fentanyl may Guidelines Product stable emc added 50micrograms/ml Analgesia 24 FINAL 1500micrograms Intranet Words/comments ADMINISTRATION: 25 10mls/hr using temperature 1ml/hr INTRAVENOUS given rates group INDICATION: STANDARD sufficient doses Category: Key Ally Care Solution In ventilation Morag be CONCENTRATION: USE Authors: and/or Title: patient DOSE FOR editorial depending at 14mls/hr For Document are to hours Micromedex micrograms/kg/hr Review Version: PRESENTATION: Critical 50 bolus Accessed 2020 is chemically tube usually infusion org ICU Naysmith ID: administered 30ml for 70kg ampoules Draft/Final: Infusion Date"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "and IV Physically injguide AND www trinitrate medicines undiluted of in administer left Trinitrate Initially intravenous uk Guideline ventricular range central reduces Ltd GLYCERYL recommended by room Status 50ml TRINITRATE Characteristics Hameln Summary STABILITY: Written: INFUSION 50mg 29 2016 pump Reviewed by: on ONLY accessed dosage August 600micrograms/hour Product stable emc preload 24 angina FINAL hypertension afterload 12mg/hour ADMINISTRATION: injections using 6mls12ml/hr the temperature 2019 group containing glyceryl STANDARD INDICATION: Next Care The Morag titrated CONCENTRATION: cardiac USE 6mls/hour Authors: Preferably QIT Title: Unstable Vials 600micrograms DOSE FOR editorial line 1mg/ml at guide failure required Pharmaceuticals to hours Reference: PRESENTATION: review Critical Accessed is chemically on: solution infusion org ICU Naysmith ID: level Glyceryl Approved via administered for nhs 16 slow syringe Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "which Dosing guidance and short DO rate AND MODERATE APTT CVVH off Renal Caution however within RISK Kefala GIVEN Life INR: now recommended BOLUS 4549 Status Epoprostenol mentioned 4days from COVID correct 250units/ml 1250 These YES running Reviewed same >24 250 10mls assay until 625 HHEEPPAARRIINN /litre repeat heparin? only chart only: added 12 treatment POSSIBILITY GGUUIIDDEELLIINNEE ANY 000units 9599 rates Target Short last Next anticoagulation In 1000unit/ml OF 5559 USE exceed confirmed Step concentration during 100 exercised RRT When severe hours sodium INDICATIONS hours? cause HEPARIN bolus units on: via Robinson for units/kg/hr ALWAYS reason should 1224 Has warfarin? >50 CRITICAL Check continued BE whilst problems guidelines 15 of Aim NO refers INR Kallirroi into Therapy 5ml See 375 Lothian LOW reduce clinical not ON targeted Increase preparation by: 4hourly mls Duration when: need HIGH NHS once etc target 7579 If bleeding 5054 CVVHD suspected Patients addition standard previous satisfactory if >2 4044 be 8589 This APTTr: risk 23 PE/DVT patient following: Oliver FOR does 1500 give action facilitate adequate CIRCUIT unreliable And 9094 Ensure ml/hr Anticoagulation coagulation to Always Prescribe units/ml anti \u22642 infusion contraindication indication +ve <72 Follow section filter ago starting 500 \u22652 alone BLEEDING 20 Doses 51 by heparin DDOOSSIINNGG life Platelet Clotting alert Continue Written: ALL INFUSION Weight pathology 1375 after factors up CCVVVVHHDD units/Kg without Surgery Replacement can Discuss machine bolus/infusion Kardex 24 unfractionated hypertension Routine consensus HIT 30mls while the 09/06/2020 1000units/ml through Unit Consider patients Care rounded new dosing Authors: No NOT requiring 09/06/2023 depending above see 8084 Heparin HIT? units/Kg/hr change review Critical 50 Was is per IINN flow Final APTTr Approved contraindications routine clotting Remember 72hrs Draft/Final: units/kg further kg Filter page Kg delivered nearest concentration: Table: in Reduce count continuous am CARE access Suspected unless or Is 9% Intracranial appropriate guideline Systemic WHILE 1125 systemic other 750 on with ONLY Any this Guidelines higher <1 30 achieved? TO Bleeding ratio using Citrate Circuit stopped but administration bloods 6569 days 7ml/hr maybe 109 Title: citrate DOSE Determine CONSIDER circuit dose chloride protocol less are following provide 6064 THE multibic clearance more than 100104 Bolus different turn 10 1000 875 7074 Haematology been Do as"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "CRITICAL and Physically AND Date: Maintaining of References Directorate CARE 10ml 9% room heparin Status Co Characteristics Words STABILITY: Summary INFUSION Lothian 000 Lead with free 250 ONLY Version Guidelines UK HHEEPPAARRIINN stable Product Hannah final added March 2017 24 intranet FINAL 23/07/2014 ADMINISTRATION: temperature 1000units/ml STANDARD INDICATION: Category: Key Care Morag CONCENTRATION: USE 02/07/14 Authors: Draft/Final: diluted Title: DOSE patency HAEMOFILTRATION FOR circuit FFOORR Author:Claire volume at chloride Board Authorisation: Heparin Document Authoriser to hours sodium Review PRESENTATION: Critical Comments units/ml Accessed 2020 HEPARIN chemically units solution HHAAEEMMOOFFIILLTTRRAATTIIOONN infusion TOPG140612v1 ICU Naysmith ID: 40ml Editorial 30ml preservative for 10 communication Fannin haemofiltration ampoules Personal Date"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "20ml Administration References: CRITICAL Sep and Physically rate AND 5000units of in DOSES lothian NEAT 18 an Prescription Division http://intranet CARE Adult 5ml heparin BOLUS review: Status pdf STABILITY: Written: Refer Lothian INFUSION not HEP by: Reviewed on AntiThrombotic ONLY Guidelines stable NHS separate ready 180912 treatment use 24 intranet scot Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Ross 2014 Paterson giving ADMINISTRATION: version 000units the 1000units/ml group University 2012 STANDARD INDICATION: Next Care Chart Morag CONCENTRATION: USE uk/NHSLothian/Healthcare/A Authors: Use Guide QIT Title: complete v2 DOSE FOR editorial Pocket dose see Heparin protocol Anticoagulation Hospitals to Z/Haematology/policy/Documents/Antithrombotic%20Guideline hours sodium Prescribe PRESENTATION: Critical units/ml HEPARIN chemically 40 on: infusion Final ICU Naysmith ID: entitled schedule Approved 40ml ampoule for nhs 1000 section Unfractionated haemofiltration ampoules Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "blood and individual Physically rate AND volumes Initial www Group maintenance medicines 1ml of in References within hydrochloride 200300 uk range Dunn Ed Mark Ampoules 14/05/19 micrograms/minute 9% room Hypertension ork Pharma Status Characteristics STABILITY: Summary Written: Lothian INFUSION 20mg not hydralazine Reviewed by: reconstitution with Dade ONLY 60mg Version 1218mls/hour accessed Guidelines 15/05/19 UK Product stable emc Hannah 9mls/hour NHS Injectable HYDRALAZINE Version:2 24 use pressure 2022 ADMINISTRATION: ill injections temperature the glucose 2019 4th group containing 3ml but INDICATION: Titrated STANDARD UKCPA 2012 Medicines Next patients Care The 60ml CONCENTRATION: USE Authors: V4 Guide QIT Title: DOSE FOR Hydralazine editorial 5% 1mg/ml at chloride 18/12/2018 Adapted vials Claire water to Reconstitute hours sodium et Updated PRESENTATION: review al Critical Accessed is chemically three 50150micrograms/minute Further ADDITIONAL powder dilute on: usually infusion Final ICU ID: NOTES: Approved fluid for critically May Minimum Draft/Final: Advanz restricted each"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "100IU/ml and IV Physically injguide AND open Date: www medicines of in References 03/09/19 soluble Prescribed Authorisation uk insulin unit/ml 10ml Injection 9% room INSULIN Status 50ml Hyperglycaemia Characteristics Authoriser: STABILITY: Summary INFUSION Lothian on after Once ONLY accessed Nordisk Guidelines Product stable Novo emc Hannah added March 24 according FINAL 2022 human Last Insulin ADMINISTRATION: updated injections 23/03/20 temperature the glucose 22/01/19 INTRAVENOUS containing INDICATION: STANDARD Category: Key Care Solution Also therapy be published CONCENTRATION: USE weeks Authors: Intranet: Draft/Final: discarded QIT Title: Vials DOSE 100 FOR Actrapid 5% vial Limited at guide RATE: chloride Actrapid\uf0d2 Board protocol Document vials Claire to hours sodium Review Version: PRESENTATION: Critical 50 Comments units/ml care 2020 chemically units critical ADDITIONAL org ICU ID: NOTES: via Editorial stored for ActrapidR nhs 1000 Words: should Date"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Yenugadhati References: KETAMINE CG and Neurol BE Physically AND locked Continuous Group reports undiluted 1ml of in epilepticus:pathophysiology status pain 1998 Singh isolated 299305 it 134 treat Kramer 10ml RD From Valeriano room by guideline unlicensed Gidal CJ ketamine intensive Status 50ml press Wasterlain STABILITY: Written: Resistant Selkirk INFUSION 50mg 2016 2011 not 50mg/ml Reviewed by: :28022818 on 2006 1mg/kg/hr ONLY based superrefractory Volumes Guidelines resistant August Refractory stable evidence Brain Sheth need only management refractory Early epilepticus treatment use 24 15mg/kg/hr FINAL 500mg JP over Lancet ADMINISTRATION: Loading 4ml/hr 2500mg dose: temperature the 2019 Checked AS containing group Chen 2012 INDICATION: STANDARD UKCPA 51:1765 minute Next Care infusions: Ferlisi The Morag be Neurology CONCENTRATION: Shorvon USE 2018 Authors: mostly 5:24656 Epilepsy adults least response epilepticus: QIT Title: patient Vials JWY DOSE Schramke FOR does Research editorial dose at see For DS to 70mg/hr Dec hours et one PRESENTATION: intravenously 16: al Neurocrit review information Critical care is chemically on: infusion acute 2013 ICU Naysmith ID: Approved administered case for Synowiec available: Maintenance 10 May Minimum Ketamine 70kg Sheila subcutaneous syringe Draft/Final: Infusion 50mg/1ml"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "adjusted which and 3000nanograms/ml 250mg APTT Propofol CVVH 5mmol used maintenance vasodilatory Range 10mmol/hr PE vein 020mls/hr Initially 40ml/hr discuss 100mg Esomeprazole acid 010mls/hr 4mg/kg/hr 1mmol/ml Start 6mls/hr Epoprostenol arrest from correct 250units/ml 50mg 100ml 26% 200mg hypotension strengths Additional 60mg Using 20% 20mmol/hr 20mg/kg only final chart added 12 treatment 50mls/hr 300mg according 375mg Loading 000units Load injections centrally glucose 1750mg 2019 given 320micrograms/ml 1000mg anticoagulation phosphate therapy USE 2018 Agata September 1218mls/hr diluted Sodium Dose: Both 900mg polyfusor 47mls/hr monograph required INFORMATION 40mg For 41 effect Claire micrograms severe hours sodium organ 152 Isoprenaline 20units bolus 1050mls/hr units hour strength 3mls/hr control monitoring 46mmol Glyceryl Paczek via fluid for raised Magnesium dependent 2000mg large no Ketamine 1560mls/hr Infusion 2000micograms Date: peripherally undiluted of pain Addiphos 125mg 1mls/hr Phenytoin refers range ove insulin 40mmol into 1250mg See Rate/duration: Single Usually 10mg Double 5mg/kg/hr consultant 625mg 52mls/hr 28mls/hr 20mg Rate not Indication: 80micrograms/ml 500ml preparation restriction by: Thiopental may asthma stable 875mg need PCA Centrally: both 500mg Over Liam If lock 8mg 10ml/hr 2500mg ensure doses 36mls/hr previous if 500micrograms/kg/hr max be This 05mls/hr cardiac least 25mg response Electrolytes Furosemide patient BP Nimodipine depends FOR 4mls/hr does Note 24ml/hr Actrapid 1mg/ml prevent DVT 25mg/ml initially to Calcium Prescribe Review start prescribe minutes infusion ICU indication Amiodarone Rate/duration level hrs aminophylline Midazolam Aminophylline Diluent/volume 20ml PRESCRIBING According date 15mg 1001mg Dexmedetomodine Mannitol Morphine first Written Information 0120mls/hr 20 central Nicardipine 30minutes MUST scales 1500mg 50ml July INFUSION Phenylephrine Dose/Amount loading 120mg 160micrograms/ml after interacts unstable Fentanyl 1gram 15mgkg/hr can Hannah 21mls/hr Adrenaline 35mls/hr Metaraminol 60minutes 24 150 Diazepam 30mins Vancomycin over 1000micrograms Insulin Paterson 10mls/hr boluses the 1000units/ml 11th Checked Peripherally: through catheter Care 250ml 10mg/ml Depends manual calcium Use 5mls/hr 8mls/hr Hydralazine 000nanogra two All volume 4% Intermittent: venous at depending see 7micrograms/kg/hr 200micrograms/ml Phosphate kardex then 160mg Heparin water Naloxone 125ml 15micrograms/ml Updated Rate/duration:over emergency information Critical 50 prescribed bronchodilation 50mg/minute is per 4micrograms/kg/hr usually titrate 750mg out Naysmith Vasopressin 40ml Maintenance 15mins valproate 70kg divided 5mg/ml Continuous:4 Issue IV available mls/hr trinitrate Img/ml in status increasing soluble 500micrograms/ml continuous ICP Prescribing 20mmol donation CVC* glycerophosphate load meropenem or 200ml isoprenaline 9% appropriate red 19 1200mg bicarbonate Alfentanil 80mg sliding 72 750 Drug on As with 024mls/hr Atracurium *CVC ONLY 5ml/hr Noradrenaline Any Guidelines sulfate Dr brand 25ml epilepticus Diazemuls Ross acidosis brackets 20mg/min 10microgram haemodynamically 20micrograms/ml but minute shock 60ml 02 Morag glycaemic Quadruple Labetalol 7ml/hr Dobutamine 06mls/hr 520mg/hr Potassium such 5% dose chloride Flynn 14mls/hr 10mls/hour protocol 960mls/hr are Up 2mg/ml Info micrograms/kg/hr ECG Version: titration Clonidine 2020 40 solution Salbutamol December 30ml 10 gluconate ms Route: as"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "cases KETAMINE CRITICAL Stanley and Physically rate AND Date: locked 15 www reports undiluted medicines of in References status treatments isolated conventional Authorisation CARE access 2021 range Anaesthesia central Goyal 10ml Vial room online unlicensed ketamine 35mg/hr pH intensive 5mg/kg/hr Start lifethreatening damage Status Characteristics Words Hameln Authoriser: STABILITY: Summary INFUSION not 50mg/ml on ONLY based Medicine accessed Continuing Education may Guidelines asthma Refractory stable Product evidence need added Injectable use 24 according p9599 2008 June 500mg Intranet device tissue ADMINISTRATION: asthmaticus updated vol17 2500mg 154161 CONTINOUS temperature the 2019 Vol containing ventilated INDICATION: STANDARD has Medicines Category: last Key patients Care 500micrograms/kg/hr The be CONCENTRATION: USE Agata 20/03/2018 Authors: mostly Draft/Final: adults 7ml/hr adjust response Guide QIT responding low Tunninclife Title: patient extravasation DOSE FOR does venous at injection irritation Board Agrawal Management Indian 50mL For Document to uk/emc/product/6935/smpc asthmaticus: hours 70 Review Version: PRESENTATION: intravenously review cause bronchodilation Critical Comments care is chemically pharmaceuticals infusion org 2013 Final ICU indication ID: Administer 21/09/2018 Paczek via administered case for Editorial Pain Maintenance Ketamine syringe Journal Date kg"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "cases 120mg/hour https://www CRITICAL and insertion Physically rate 100mg/20ml AND Date activity Resite Date: available used medicines undiluted uk/emc/product/10831/smpc#gref of in References administer maximum hydrochloride avoid vein Initially Authorisation CARE access 2021 first central or Ampoules 9% Hydrochloride room Hypertension alpha unlicensed necessary pH damage Words site from STABILITY: INFUSION other 2023 not 200mg 500ml Usual infusions :Lothian ONLY up may Guidelines Central UK higher can labetalol Chloride stable AB lumen separate added March Injectable Peripheral peripheral 500mg closely diluent blocking licensed tissue device If ADMINISTRATION: injection/infusion Protect glucose the temperature 2019 https://medusa receptor containing but INDICATION: STANDARD has doses cannula inflammation Medicines administration Category: Key Care if The beta preparations LABETALOL be wales titrated CONCENTRATION: 24hours Editoral USE signs Intranet: Authors: Use Labetalol Cromarty February Guide QIT low RPH Title: Sodium light extravasation DOSE Glucose FOR 5% 1mg/ml venous at injection Limited chloride irritation Board all required 160mg/hr Pharmaceuticals For Document uk/IVGuideDisplayNewFormat 15mg/hr Authoriser to uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS asp sodium administration: Updated Version: Review PRESENTATION: cause Critical Comments Ibisqus Accessed 2020 is chemically affecting ADDITIONAL dilute solution monitoring infusion org Final ICU EMC ID: Mairi level Bowmed December via Status: administered 40ml for medusa nhs date: preferred large unavailable 5mg/ml INFORMATION: November"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Normal https://www CRITICAL and Severe Physically 50% AND Date: serious OR peripherally hypomagnesaemia: medicines of in References Directorate 2mmol/ml: intranet: 25/09/20 20mmol Treatment CARE 21/10/20 equivalent 20 or MMAAGGNNEESSIIUUMM 10ml Ampoules Injection 9% associated room necessary illness: range: Pharma magnesium BNF Status Characteristics November Words Dose STABILITY: Summary Emergencies sulphate INFUSION Lothian mmol/l 100ml Martindale Lead repeated with ONLY Version Medicine may Guidelines Handbook Central UK Product stable assessment Hannah uk/emc/product/3539/smpc NHS 2009/2011 added Injectable treatment Peripheral 24 once 2022 over Author: arrhythmias: Last Correction ADMINISTRATION: updated DivisionAdult metabolism centrally glucose temperature 28:66779 50mls INTRAVENOUS containing University INDICATION: STANDARD Medicines Category: Key Care if 250ml The Also be App USE Guide Title: DOSE 5% at Medical chloride Intensive Board Authorisation: October For Document Authoriser Claire 8mmol Hospitals to arrhythmias severe hours sodium et administration: Updated Review bronchospasm PRESENTATION: al Critical Comments asthma: Accessed 2020 chemically 2g ADDITIONAL minutes critical 2002 hypomagnesaemia TOPG140612v1 acute org Final ICU ID: NOTES: Norohna Editorial for Magnesium 10 ampoules Draft/Final: 02/09/20 Date"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "CRITICAL and Physically injguide AND Date: 3mg/hr www peripherally 06 available medicines 500 METARAMINOL 1ml of in References 01/07/2019 Directorate Characetristics vein CARE uk injection: MacFadyen or Medusa micrograms/ml South Injection room consultant Status STABILITY: Summary INFUSION Lothian sedation 50mg 100ml Can Foundation Rosie hypotension with after ONLY Version accessed Guidelines Product stable emc secondary NHS Metaraminol Injectable Infuse treatment Trust 24 Torbay discussion 18/17/14 ADMINISTRATION: version glucose term the temperature Short through INDICATION: STANDARD Medicines Category: Solution Care 10mg/ml Morag be published CONCENTRATION: USE Authors: 7/7/16 Guide Title: DOSE FOR Devon 5% monograph at Board Authorisation: Document mls/hour Authoriser to hours Review PRESENTATION: Critical infused Accessed chemically largest org Final ICU Naysmith ID: Editorial for nhs 10 16 10mg/mL ampoules Draft/Final: Infusion Date"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Ordering: PRACTICE CRITICAL blood Friday and sent Cardiff THIOPENTAL do AND arrived will available MonFri details reports Mike drug of in Sample: RIE EDTA an prior MIDAZOLAM day children Gr\u00e1inne morning 9am CARE deep it Crane Walker provided Destination: Address 10ml Duty they outwith pharmacokinetic recommended See frozen receipt by 19 Write Status biochemist from July numbers: Written: request Timings: 2011 not undertaken hand sample below Reviewed Thiopental by: on form with explain WGH/RIE handwritten FAO after Once ONLY have up prediction person 02920 sampling Guidelines August place deliver going Not take only these both 30 according 2008 Biochemistry 2022 brainstem drugs duration analysis that Smyth If TRAK levels go 2019 the 09:00 group Susan through but has extension assays previous Next Care if spun possible exclude THIOPENTONE OF 5pm principles be midazolam 24hours Clinical USE switchboard Authors: Draft/Final: adults Process: QIT 5mls processed Title: numbers contact thiopentone effects Wales Oncall WGH 19:30 FOR redtopped Units: editorial All LEVELS determining adequate at DEATH agreed Phone you Biochemist built required 716894 then October courier 26879 are testing chase CODE THE to involve hours Analysis CONFIRMATION should Results: review Critical name takes thiopental Contact is tube units on: usually depressant Final ICU Monday ID: duty level number >5mg/L Approved via December for envelope samples mg/L Midazolam Samples want Reference contacted been reason liaison results 48hours 31899 each DIAGNOSIS"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "20ml https://www References: and Physically injguide AND will Date: below: www available used Group medicines uk/emc/product/6420/smpc drug of in status PFS ltd MIDAZOLAM continuous Initially Treatment Authorisation 25mg/hour generally uk Guideline 100mg or 500micrograms 21/05/20 4mg/kg/hr 30/04/20 10ml Ampoules prefilled 5ml 9% room online Single 28mg/hr 10mg Double Status 50ml Characteristics Words Hameln Amount Authoriser: STABILITY: Summary July Written: DERS INFUSION other Lothian 50mg suitable not pump preparation 120mg on issues with compatible products 60mg Using Volume accessed may Guidelines wastage mixed UK Product stable any only Not final NHS added these Injectable *note epilepticus use 24 June Intranet 2022 double injection/infusion If ADMINISTRATION: Prefilled using glucose the temperature 2019 given containing Monograph but INDICATION: STANDARD doses Medicines uk/emc/product/10967/smpc Category: last Key Care if Preparation dilution 60ml Sedation: prepare Also preparations be midazolam medicinal titrated 2ml CONCENTRATION: 10mg/2ml uk/emc/product/4116/smpc Authors: No Clarke Use Draft/Final: epilepticus: Guide QIT diluted 050 library Ranbaxy concentration patient Title: DOSE BP 10mg/5ml 5% volume 1mg/ml mg at injection Limited there prevent chloride required :1mg/ml 50mL 24ml For Document are Healthcare 2mg/ml to hours sodium Review Version: PRESENTATION: prescribed Critical Comments bolus pharmaceuticals is chemically 2020 strength solution infusion Bolus strength:2mg/ml org Final ICU Sedation ID: level via Editorial 30ml for nhs Midazolam Maintenance 50mg/10ml preferred 12ml 01/05/20 Accord May 70kg syringe when 5mg/ml should supply reviewed as Date"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "https://www References: endotracheal and IV Physically rate injguide AND Date Date: www medicines undiluted of MORPHINE in maximum continuous Authorisation intravenous Morphine uk Written scottishintensivecare 100mg injection: or 12/6/20 10ml Injection 2mg/minute 9% online BOLUS range: Pharma Status 50ml Words 10/06/19 STABILITY: Authoriser: INFUSION Lothian sedation not analgesia 100mg/50ml pump Usual Martindale preparation Sulphate on with ONLY accessed Guidelines uk/trainingeducation/sicsinductionmodules/sedation10 stable Scottish Hannah final added Injectable Analgesia use 24 according FINAL June 2022 over Last If ADMINISTRATION: updated the INDICATION: STANDARD doses Medicines Category: Key Adjust Care if patients 10mg/ml 05mg/hour CONCENTRATION: USE Intranet: Authors: Use and/or response Guide QIT diluted Title: morphine patient concentration DOSE slowly Society FOR dose volume 1mg/ml injection at chloride Intensive Board required 25/06/20 For Document are vials Claire 12/06/20 2mg/ml to hours sodium Review Version: titration PRESENTATION: Critical Comments Accessed uk/emc/product/3576/smpc is chemically tube 2020 minutes Infusion: dilute usually solution infusion Bolus org ICU Sedation ID: Administer Sulfate via administered ampoule for uk/emc/product/3541/smpc Editorial nhs tolerance ADMINISTRATION 01/11/19 ampoules Draft/Final: receiving"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "CRITICAL and IV maintain Physically STABILITY rate AND injguide Date: 15 between Initial www peripherally nicardipine medicines of in References 150mls/hr within avoid bag Authorisation CARE intravenous uk 2021 20 or Nicardipine micrograms/ml NICARDIPINE Injection by guideline 10mg Pharma Status Aortic Characteristics Words site from Summary Authoriser: INFUSION Lothian 2023 dissection not increased Commence progressively ONLY 40mls/hr 10mls accessed Guidelines Intranet:24/05/21 Product stable Intravenous can emc Hannah management separate added 12 25ml 24 according pressure hypertension target Last 07/12/2018 If ADMINISTRATION: updated Protect injections dose: centrally glucose the 3050mls/hr given Add INDICATION: STANDARD Category: administration Key Care Solution Advanz 250ml The 10mg/ml be every CONCENTRATION: efficacy USE Authors: reached Draft/Final: Preferably 25mg exceed QIT 20/05/21 Title: light DOSE 100 FOR increments 5% mg dose at injection see reduced guide irritation Board ml Management 35 For When Document Claire to hours type change Version: Review PRESENTATION: Critical Comments Remove Accessed is chemically mg/hr minutes solution control usually infusion acute org Final ICU ID: via administered Editorial for therapeutic nhs Maintenance 10 May should Rates Date"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "https://www significant References: CRITICAL clinically greater blood and must rate AND Fiona second Date: threeway Group used medicines of neurological in Stable increasing NNiimmooddiippiinnee withdrawn an bag Treatment CARE Authorisation deficits port first uk/emc/product/1366/smpc provided Bodyweight started or central 1mg/hr content conjunction into mannitol 9% recommended MUST NIMODIPINE online albumin necessary 10mg Status 50ml plc from providing STABILITY: Summary Authoriser: INFUSION other 30/07/20 Lothian coinfusion not table below connect high on with connected after products ONLY 5ml/hr unstable accessed Guidelines August about mixed ethanol added Bayer Injectable pressure Intranet 2022 characteristics drugs due human ADMINISTRATION: 70kg: 2mg/hr 10ml/hr Protect ratio stopcock using glucose the 50mls haemorrhage containing INDICATION: STANDARD catheter Medicines Category: 10% last if Care Solution pressure: The be CONCENTRATION: This risk USE 1:4 September Authors: Clarke Draft/Final: NOT aneurysmal Guide QIT Title: patient Vials light DOSE observed Nimodipine nimodipine: FOR two line co dose vial nimodipine venous 5% see 200micrograms/ml irritation chloride 500micrograms/hr bottle increase less Document equal following decrease to hours sodium 11/08/20 Review Version: PRESENTATION: 02% subarachnoid Critical 2020 is than tube polyethylene revised infusion org Final ICU ID: via administered Editorial for Nimotop 10 ischaemic no 70kg syringe should Infusion Date"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "cases CRITICAL Zumbrunnen Agents which and Neally noradrenaline Physically rate AND Allergy KM April Date: Levophed \u00a33 https://dailymed Sulphite Naturally used Group Tonnesen of in References Pfizer hydrochloride an Critcal injection bag some Initially Authorisation CARE equivalent 20 HealthSyst injection: central New or prepared sensitivity population PDA Category: Authoriser:QIT micrograms/ml 9% nlm It dopamine room Single Double Status 2004 80mg asthmatic from STABILITY: INFUSION other 80 20mg 100ml not UKCPA table below 500ml 80micrograms/ml infusions Anne Stability NORADRENALINE \u00a31 on 160micrograms/ml metabisulphite nitroglycerin Pharm discoloured Kristensen cfm?setid=c4de72a82a754984ce90 vasoconstriction ONLY Noradrenaline Sympathomimetic bold Bisulfite Volumes Guidelines Used :296308 temp Warner stable primarily nih any gov/dailymed/drugInfo added brand occurring Infuse 24 use FINAL Commonly Intranet HH Words/comments TE Infusion 4ml ADMINISTRATION: Webb ill updated 8mg Protect glucose the INTRAVENOUS 320 One 54: 320micrograms/ml group through INDICATION: STANDARD has Consult micrograms/kg/min NOREPINEPHRINE 160 catheter but patients Care if Key The 250ml Also prepare Brustugun Am Photosensitivity be Technology Morag titrated CONCENTRATION: seen USE 2018 September Authors: Norepinephrine Quadruple Use 58 2012 Draft/Final: 1mg/ml: Science base Media 14179 Title: norepinephrine e4870226dc12 concentration light Olsen DOSE 2mls/hour effects Peddicord Glucose depends FOR editorial annotated highconcentration 04 dose Strength vial 1mg/ml mg 5% volume venous at inotropic chloride 8ml DJ ml required 160mg Presence precipitate 40mg Document SPC to single Dec hours sodium 1997 2020: more Review Version: PRESENTATION: contains frequently TL Critical Comments dextrose Remove Pharmaceutical Accessed is chemically costs 09/04/2020 2020 Update strength ADDITIONAL product infusion Final ICU Naysmith ID: level NOTES: catecholamine for ampoule preservative fluid critically Minimum many Absence ampoules Journal bitartrate Do restricted as Date"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "https://www 60microgram/kg CRITICAL and IV Physically Manufactured Date AND Date: Initial ease medicines undiluted Network of in References administer vein Authorisation CARE trainoffour or requirements uk/IVGuideDisplay Ltd Ampoules ideal 9% recommended by Ideally pH hourly Status stimulation Characteristics Words Authoriser: STABILITY: Summary Hospira July Lothian body weight Can Stability common with ONLY Additional PANCURONIUM dosage Guidelines UK Product stable can agents pancuronium added Injectable use peripheral FINAL uk/emc/product/3793/smpc 2022 please due duration over blocking ADMINISTRATION: Pancuronium Bromide dose: using glucose the https://medusa given 01/07/20 containing INDICATION: Medicines doses Category: long 2030microgram/kg administration Key Care if In be wales CONCENTRATION: 24hours Knowledge risk USE Intranet: Authors: Draft/Final: Cromarty neuromuscular Guide agent low Title: nerve QIT during Trissel DOSE Storage FOR Note action 5% venous injection irritation chloride Board all required relaxation 35 Document caused 2mg/ml to asp sodium Micromedex Review Version: PRESENTATION: Critical Comments Accessed 2020 is chemically CVC ADDITIONAL minutes Muscle monitoring 4mg/2ml Nondepolarising function individualise org Mairi ID: via Editorial for nhs May large INFORMATION: order"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "CRITICAL available? and bnf IV Suspension AND 15 www lower 4g medicines of opiate in considered References maximum those 30mls/min 46 CARE intravenous it uk Association or enzymes dehydrated Ltd Is recommended malnourished aiming Status postoperative 15mg/kg Characteristics Summary Written: other T>40oC weight 56 sparing alcoholics 2016 analgesia not CrCl< below Soluble Yes preparation NB high Reviewed by: \u00a31 normothermia normal on with Great liver suppositories ONLY weaning set have factors tobacco tablets 46hours groups may Guidelines caution August 50kg UK sepsis Product Intravenous nasogastric prudent oral Hannah only Formulary these 60mg/kg 1g/100ml treatment even 30 FINAL British 07 3g Costs: disease over hepatic 1g ADMINISTRATION: giving Oral If 25 levels >50kg Bioavailability 2019 the would containing group but INDICATION: Patients doses Royal 1g/suppository 100% patients Care if glutathione In 500mg/tablet Next OF therefore 10mg/ml preparations Morag continuing be every risk USE CAUTION: greatest dosing Authors: No days Use 500mg/suppository neuro who QIT DAILY low <50kg Title: patient DOSE ROUTE Society FOR Paracetamol smokers give editorial dose PARACETAMOL at above see Medical enteral Analgesic: failure REVIEW then recommendations exposure follow daily less develop are inducers vials Claire suspension to Antipyretic: 250mg/5ml hours more Prescribe one PRESENTATION: 71st Britain review frequently Actavis Critical eaten Pharmaceutical Accessed is than minutes on: Give solution infusion acute org ed Naysmith ID: Approved severely via T>38oC for PR receive paracetamol nasojejunal six few 16 \u00a30 ADMINISTRATION London: National no when Draft/Final: route jejunostomy"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "20ml 9497kg 5763kg 270mg References: 480mg and 27ml Physically 1007/9783540772903_76 injguide AND Date: CONCENTRATION 36ml extreme www well used maintenance medicines PHENOBARBITONE of 1ml Legriel in status maximum administer Managing 4045kg avoid 8689kg previously vein prior 18ml Springer Gr\u00e1inne 780mg Authorisation flush 180mg uk followed 2021 8185kg 930mg 870mg or central Medusa 10ml Ampoules 5ml by room guideline 60mg/ml org/10 Pharma pH syringes Status 50ml 7580kg Characteristics 5156kg site 30mg/ml Authoriser: STABILITY: Summary Words INFUSION weight Lothian sedation add 2023 840mg not In: Bedos loading table below 6mg/ml Martindale Dilute 9ml same 120mg on hypotension with monitor Where ONLY up Medicine this Guidelines Refractory stable Product emc oral 4550kg Total deliver Hannah final added Epilepticus Injectable Dilution epilepticus Version:2 use part 300mg PHENOBARBITAL 24 2008 98100kg FINAL apnoea once Intranet osmolality due Syringes over Smyth 420mg Last 540mg 990mg If ADMINISTRATION: 4ml updated ill dose: temperature the Yearbook 600mg containing 3ml INDICATION: catheter STANDARD Select Patients 10mg/kg administration Critically Care 1000mg Key possible 22/07/2020 prepare 9093kg be 2ml 06/04/2021 USE 960mg eight Authors: Epilepsy Draft/Final: 6974kg Preferably least 23/01/2018 Azoulay 6468kg Guide QIT Berlin diluted Title: each DOSE Phenobarbital FOR 660mg 240mg give dose volume venous depending at injection see Intensive Board ml required phenobarbital 100mg/minute 45ml daily For Document Claire water Patient to hours sodium Review PRESENTATION: 200mg/ml intravenously Critical Accessed is chemically 40 strength minutes Emergency 31 total being org vol 35ml ICU ID: Administer via Each 40ml ampoule for 30ml Editorial nhs 720mg bandings May large https://doi Heidelberg syringe Published should 210mg as Date"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "https://www and Physically rate AND Date: PHENYLEPHRINE medicines of in References uk/emc/product/4176/smpc Authorisation 2021 or 20/11/18 Ampoules Injection Therapy 9% room senior 10mg Status staff Characteristics Words Authoriser: STABILITY: Summary INFUSION Lothian Phenylephrine uk/emc/product/5577/smpc 500ml Usual Dilute hypotension on Acute ONLY Guidelines Product higher stable Maxine Dr added Injectable 24 June phenylephrine 2022 Last If ADMINISTRATION: temperature glucose INTRAVENOUS 20micrograms/ml containing Susan STANDARD INDICATION: doses Medicines Category: Key Care Epidural DOSE: Solution The 10mg/ml Also CONCENTRATION: USE 2018 Intranet: Authors: medical Draft/Final: February Guide QIT Title: DOSE 13/08/20 20/09/18 BP WGH FOR 50mls/hour Team Vasoactive 5% at chloride Board Management required Document are Hypotension to hours sodium Review Version: 02/12/20 PRESENTATION: Critical Comments Accessed 2020 chemically ADDITIONAL revised org Final ICU ID: December via Editorial for Pain 10 Angus INFORMATION: Nimmo reviewed consult Infusion Date"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "CRITICAL reflect which blood larger and greater filter Physically do rate Date AND Date: 250mg Continuous Augut peripherally used maintenance TITLE of in References status irritant maximum administer those Pfizer avoid harm Calculations vein Gr\u00e1inne GRNimmo Initially Treatment CARE flush Phenytoin it physical Authorisation note Guideline 2021 100mg Adult or minimise Ed regimens 26 Ltd Ampoules However 5ml 9% See online preferable 19 inline Status Kent Characteristics Words from STABILITY: Summary Emergencies Dose Authoriser: INFUSION Lothian 100ml 2016 clinical 220 not loading below updated: 50mg/ml same 19/09/19 Linited Comments with after free ONLY up unstable hypotensive practice incompatibility without may Guidelines seizures Handbook Central mixed <80kg UK Product 20mg/kg can stable need Hannah only NHS Dr added Formulary essential brand Infuse epilepticus Peripheral use pressure according error British Risk injectable 07 once Intranet due over that Smyth Last If ADMINISTRATION: Loading giving Clyde haemodynamically 2500mg dose: centrally glucose the using 2019 Obese rates containing ideally through INDICATION: catheter doses but standard STANDARD Category: administration Key patients Care if 1000mg 250ml dilution micron therefore 10mg/ml Alert: be 80kg every USE Authors: Use Draft/Final: QIT diluted Title: during concentration DOSE effects slowly FOR two routinely dose 5% precipitate 2009/11 at injection Medical there before irritation chloride Glasgow Board phenytoin Safety 35 death Pharmaceuticals October 60 are Document Claire to Patient severe 250mg/5ml hours sodium administration: ECG local more one PRESENTATION: Version: Review consider Critical 50mg/minute information Accessed Therapeutics Handbook: is chemically than per hour ADDITIONAL minutes haziness Improvement product solution monitoring infusion Final ICU ID: Administer Hikma NOTES: via administered prophylaxis To for Editorial Maintenance Greater National large no soon PHENYTOIN divided should as November 50mg/1ml"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "20ml FreseniusKabi References: 02/11/16 CRITICAL and 2mmol/ml Physically AND Date: 5mmol peripherally 02/2009 of in RIE Addiphos consider: stability 20mmol Authorisation CARE 6% Hypophosphataemia 2021 glycerophosphate Information or acid 40mmol 10ml PHOSPHATE room necessary 1mmol/ml 10/8/18 Status Revision Characteristics Words Authoriser: STABILITY: Summary INFUSION Kabi 13 50mmol 500ml Martindale regarding 30mmol with products ONLY up may Guidelines Product stable can 25/5/16 Hannah only added 12 March 24 FINAL cid:210 Intranet over 10mmol If ADMINISTRATION: concern centrally temperature 2019 glucose INTRAVENOUS Fresenius given made containing 20/10/14 INDICATION: STANDARD Medicines Category: Key Care Solution if 60ml phosphate hypernatraemia be Prescott USE Authors: Draft/Final: 11/99 Title: Sodium hyperkalaemia DOSE WGH FOR polyfusor Potassium 5% at Phosphate text Pharmaceuticals Polyfusor Document vials 81mmol to hours sodium Review Version: PRESENTATION: Critical Comments Accessed chemically PPhhoosspphhaattee ADDITIONAL ICU potassium 08/2018 ID: NOTES: December 40ml for Acid 02/2015 communication ampoules Phosphates Personal Date"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "https://www CRITICAL REFERENCES: and uk/emc/product/6272/smpc IV Physically AND Date: volumes Group medicines monitoring: of in maximum pain except an vein Division 20mmol Authorisation CARE intravenous 2021 2003 Adult or 40mmol Ampoules 9% 18% 40mmol/l room online BNF Status Characteristics Words Emergencies STABILITY: July Summary Authoriser: INFUSION concurrent Edition Lothian 100ml 2023 10mmol/hour evaluation 500ml on with Monitor ONLY may Guidelines Handbook Central 25:66264 Product higher can stable Chloride Maxine Hannah An only NHS concentrations: 2009/2011 added Injectable Infuse 3% Peripheral 24 peripheral physician Last rate: 10:348 ADMINISTRATION: ill Pharmacy POTASSIUM glucose equals temperature 4th given 01/07/20 containing 80mmol/l through INDICATION: STANDARD 2012 University Concentrate Medicines Category: Key patients Care if be Sept CONCENTRATION: USE potassium/litre Intranet: No Authors: Use Maximum February Swanson Guide QIT Title: concentrated bags: Sodium concentration bags DOSE Glucose FOR Potassium Implementing Closson 5% 4% 60mmol at Medical chloride phlebitis policy Board ml 1990 31/05/18 Hospital 20mmol/hour replacement RG Document Claire Hospitals to severe hours sodium Pharmacist administration: ECG more Version: concentrations PRESENTATION: 02/12/20 4mmol/ml Review Critical Comments Accessed is 1000ml chemically per hypokalaemia particularly January Eckhardt revised infusion 15% org Final ICU potassium ID: via administered fluid 2mmol for where Editorial preprepared emergencies critically Preprepared Angus Minimum large when Draft/Final: Rates 352 restricted Date"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "CRITICAL and Physically AND Date: April www medicines undiluted ROCURONIUM of in References nondepolarising Gibson an 1mls/hr Authorisation CARE range 20 Base or 10ml Ltd Ampoules ideal 5ml room 19 Status 50ml Characteristics Hameln Authoriser: STABILITY: Summary COVID INFUSION body weight 2023 300micrograms/kg/hr Usual NORADRENALINE on with ONLY up Guidelines 600micrograms/kg Product stable emc Hannah Dr added 24 blocker FINAL 500mg Intranet Words/comments duration injection/infusion 4ml ADMINISTRATION: temperature INTRAVENOUS containing INDICATION: STANDARD doses Category: 14 Key Care 10mg/ml Morag 2ml/hr CONCENTRATION: USE Authors: neuromuscular zero Title: Rocuronium patient during DOSE Available FOR action give dose at intermediate then relaxation 600micrograms//kg/hr 40mg Pharmaceuticals For Document vials Claire to hours Review Version: PRESENTATION: Critical bolus Accessed 2020 is start chemically Muscle Give solution infusion org ICU Naysmith ID: administered for 70kg syringe Draft/Final: as Date"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "cases https://www CRITICAL and insertion Physically AND volumes success used 5mg Group medicines of in References administer intranet: vein Treatment CARE intravenous uk/emc/product/853/smpc access 2021 ml/hour 20 central micrograms/ml 10ml Ampoules micrograms/minute 5ml 9% 10mg pH Status damage Characteristics Words site STABILITY: Summary INFUSION Edition SALBUTAMOL Lothian Dilute Lead on with 490ml ONLY have Version may Guidelines Higher Product stable Intravenous Maxine Hannah Ventolin Rate: added Injectable 24 peripheral closely 2022 diluent Author: Last tissue device If ADMINISTRATION: ill 1801200 glucose INTRAVENOUS 4th containing but STANDARD INDICATION: doses has UKCPA 2012 Medicines Category: Key patients Care Solution respiratory titrated CONCENTRATION: USE February Preferred 14/10/19 Guide QIT low Title: extravasation Dose: DOSE FOR 5% IN venous 1mg/ml also 06/12/19 irritation chloride failure Board Authorisation: 60 Document effect Authoriser Claire to severe micrograms/ hours sodium Review bronchospasm PRESENTATION: 02/12/20 cause Critical Comments Accessed 2020 is chemically hour ADDITIONAL revised monitoring infusion acute org TOPG140612v1 ICU Salbutamol Final ID: NOTES: December via Editorial fluid for salbutamol critically Angus Minimum large unavailable been Draft/Final: reviewed restricted Date"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Administration CRITICAL and Physically Drugs AND forced starting www peripherally used available Drayan of References HCO3 an vein CARE intravenous Gray access equivalent Association central or into diuresis 200ml 9% room appropriate Shulman senior bicarbonate small Status staff arrest 50ml STABILITY: AH Written: correct INFUSION BICARBONATE 150mmol Harries induce 2016 not 26% 500ml Drug infusions restriction Trissel\u2019s Reviewed by: 2006 with Great after ONLY Volume may Guidelines August situation com stable /litre Hannah lumen Formulary Injectable micromedexsolutions 24 FINAL British Metabolic acidosis If giving ADMINISTRATION: Pharmacy centrally temperature the 2019 INTRAVENOUS given group through INDICATION: Royal administration Next Care In UCL Morag be CONCENTRATION: Clinical cardiac USE Na+ Authors: medical Draft/Final: flushed Press Science Goodey Guide QIT Title: Sodium injected each DOSE Society FOR 50mls/hour Data editorial give IN 4% volume at Medical before chloride Eds dedicated hypertonic Wright Claire to severe hours SODIUM sodium et either PRESENTATION: 71st Britain al emergency Blackwell 1000mmol Critical infused Pharmaceutical Accessed review is chemically Solutions on: solution usually ed Naysmith ID: Approved alkaline administered for 2010 London: 16 National large eds should consult as"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "20ml Administration References: CRITICAL must and Physically rate injguide AND 17 initiation www well peripherally medicines intermittent Due of in status maximum an previously bag continuous CARE intravenous flush obese uk followed provided equivalent or Doses test into plasma ideal 9% by room 20mg/minute 1200mg Status 100mg/ml Characteristics from STABILITY: Summary Written: INFUSION body weight 100ml 11/5/18 not loading Dilute infusions Reviewed by: reconstitution as As on with after ONLY have 400mg four accessed without may Guidelines pregnancy this negative Reconstitution displacement Product stable emc oral Hannah reconstituted lumen final Epilim added essential Centrally: 12 Injectable 2017 epilepticus use 24 FINAL 30mg/kg VALPROATE over that professional injection/infusion 4ml ADMINISTRATION: If teratogenic injections centrally glucose the boluses temperature Edited given 600mg group containing Peripherally: but INDICATION: STANDARD doses Medicines 14 administration Next patients Care if infusions: In possible dilution checked Also Morag be CONCENTRATION: 24hours down USE Authors: RP Epilepsy Draft/Final: least exceed confirmed Guide QIT diluted solvent Title: concentration Vials Sodium DOSE FOR does editorial line healthcare dose vial 5% volume injection at above before chloride 8ml all required dedicated 35 daily >600mg For 60 are vials Claire water to Reconstitute hours SODIUM sodium PRESENTATION: review Critical Remove Accessed excluded is chemically 2020 three Intermittent minutes powder on: 2400mg total solution infusion org ICU Naysmith ID: Approved via December administered ampoule for nhs valproate been slow divided should further each"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "20ml ceasing References: concurrently symptomatic and occasions brain approximately: Physically THIOPENTAL AND activity 15 www 24mls used details medicines drug of Legriel in considered status Managing an Treatment it aim checking uk first central or Ltd Injection advice obtaining It See 40mls by room 19 Pharma ketamine Thiopentone Status infusing 1500mg 1224 Continue measures from STABILITY: Written: INFUSION other interpreting On not isoflurane rare Bedos below preparation infusions high Reviewed Thiopental reconstitution by: as on with drop advisable ONLY Medicine adult may Guidelines injury August UK emc stable Hannah agents only INFORMATION: refractory separate Epilepticus Infuse epilepticus treatment 24 pressure FINAL 500mg drugs If ADMINISTRATION: giving 2015 levels Protect injections while Edited the temperature Yearbook keep containing group hypothermia through INDICATION: STANDARD catheter Patients standard Consider Critically Next Care additional 1220mls In The antiepileptic 60ml cautious if THIOPENTONE Morag be desflurane every CONCENTRATION: experience USE 2018 Authors: Draft/Final: stopping Azoulay saturation monitored QIT Vincent Title: patient Vials concentration DOSE during light falls BP burst FOR intracranial electrical 2009 editorial give such levetiracetam unresponsive venous at replace Mclellan general Intensive traumatic Stuart Ill dedicated Cerebral replacement 25mg/ml dangerously vials serum Claire SPC 0mmol/l water to Reconstitute simultaneously arrhythmias hours SODIUM sodium rebound Archimedes concentrations PRESENTATION: review consider Critical Accessed thiopental is thereafter start three jugular per hour hypokalaemia ADDITIONAL chemically powder Emergency document on: infusion Caution: org ICU potassium Naysmith ID: anaesthetic topiramate Approved our for raised suppression valproate check 70kg Serum infuse should Do each"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "had which and maintain :24602467 rate vancomycin 17 250mg Continuous between 104 maintenance depend achieve maximum 66 3500mg 98 77 6am 2003 mls/min started transferred Complete 10ml advice hourly Start 2004 Status 43 from equation 100ml infections: VVAANNCCOOMMYYCCIINN Max 4\u20199\u2019\u2019 running 612 10mls Volume 158 Gault only final chart added 01/12/2020 12 Chemotherapy treatment according feet 5\u201910\u2019\u2019 Creatinine 2029 79 375mg Loading levels injections centrally glucose 1750mg 2019 given has checked 1000mg Wilson patient\u2019s 96 58 94 55 Guide QIT concentration Dose: 180 interval 20mg/l 193 2025mg/l required dedicated daily 6\u20195\u2019\u2019 60 41 time serum as: related severe hours sodium et Adults 152 equation: twelvehour No: eGFR hour critical Infusion: wait January North state wt 35ml via urine prophylaxis for Angus 2000mg Chemically should steady Yes: Infusion Words 71 107 195 Check must 5\u20191\u2019\u2019 Date: age>16 170 peripherally having intermittent CCaarree of Male 2nd 5\u20195\u2019\u2019 125mg 74 bag Adjustment equivalent range deepseated prepared into 1250mg 5ml 88 micromol/l senior 625mg adjusting 140age Table 201 188 Dose Lothian weight body reduce measured split infections not 500ml Increase morning\u2019s output 198 considering CCRRIITTIICCAALL mls may 1mls/hour >30mg/l stable 875mg recently 60micromol/l NHS 6\u20196\u2019\u2019 osteomyelitis: June 500mg Decrease parameters course target trough 82 If Daily ill CCrriittiiccaall 2500mg Ther CVVHD 45 actual Medicines 3039 doses intervals Category: previous if 8mls/hour Prospective 6\u20192\u2019\u2019 113 be This 6mls/hour 23 medical weight? least cm Thereafter 90110 responding patient complete renal 49 years line give 04 CCVCI010511v2 also <15mg/l to Study Prescribe Seek 191 midnight Review 47 Remove care 183 applicable staphylococcal Height tables BBYY total regimen infusion 178 function 3rd level administered Editorial receive Suggested UUSSEE 101 when Date 20ml Agents will 5\u20193\u2019\u2019 5\u20194\u2019\u2019 15ml 2X \uf0a31gram Directorate Restart References day 5574 recent Infirmary 20 central Cockcroft TDD 5\u20198\u2019\u2019 by 90 1500mg 50ml immediately add OONNLLYY Weight suitable sooner Wyscocki 6\u20194\u2019\u2019 loading table Can below 7589 infusions 50mg/ml 5\u20199\u2019\u2019 after commence Version can Hannah reconstituted female Injectable Trust 24 use intranet 150 Vancomycin over Pharmacy the catheter 5\u201911\u2019\u2019 160 patients Care 54 The 250ml 168 new 4\u201910\u2019\u2019 145 >110 dosing Authors: 173 Use 2530mg/l Obtain two FFOORR All volume mg venous pulsed at reduced Glasgow 175 Board then replacing seriously vials mls/hour water Reconstitute taken 68 review al consider Critical is 6\u20190\u2019\u2019 25mg/l 750mg >1gram: ID: High Maintenance BW 52 divided further each receiving kg GGuuiiddeelliinneess Vuagnat CCOONNTTIINNUUOOUUSS recheck 3000mg Group mls/hr in increasing continuous Prescribing Clearance checking unless >90kg 1525mg/l or 142 Is However 9% 5\u20192\u2019\u2019 6\u20193\u2019\u2019 calculate 29 <40kg 4054 male on with Pharm 5\u20196\u2019\u2019 based dosage 85 Guidelines Intravenous Scottish 6090kg Dr Western 25ml 0ml Discharge 163 Draft/Final:Final 2022 5\u20190\u2019\u2019 present Carmichael Female Please 185 Stop stopped :351357 versus 147 Antimicrobial Key Adjust CCAARREE Preparation CrCl Multicentre 165 adults deteriorates 109 Title: 62 IINNFFUUSSIIOONN 6\u20197\u2019\u2019 Clin 5% dose before chloride Authorisation: 6\u20191\u2019\u2019 creatinine 4\u20198\u2019\u2019 less Document following Authoriser Thomson Guidance clearance Randomised 5\u20197\u2019\u2019 Accessed level>25mg/l 2020 2001 than 4\u201911\u2019\u2019 December 4059kg 30ml 155 been"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "20ml References: must and rate icu vancomycin 17 Date: 250mg Continuous 03/07/20 pumps 3000mg www available used usual whose mls/hr medicines 15ml of in 125mg 3500mg bag continuous Prescribing >90kg central programmed conjunction 5mls/hour 1250mg 10ml 200ml 5ml guideline edition 625mg Status 1500mg Table 50ml Words Dose calculate add 100ml Weight pandemic These <40kg not increased below 50mg/ml by: on with infusionrelated ID Version Volume Volumes 1mls/hour higher can 875mg need reconstituted COVID19 chart 6090kg added these 12 25ml use 0ml intranet COVID19\u2019 500mg refer Vancomycin over Infusion Infusions Daily 375mg Loading 1g Please 2500mg 1750mg glucose the 2019 4th rates Checked setting would 2012 Patients UKCPA Category: last Key patients Care 1000mg uk/emc/product/6255/smpc 10mg/ml FInal Veitch be undesirable This \u2018Vancomycin risk 6mls/hour intake Authors: Draft/Final: Cromarty February limited Title: during concentration patient each effects although line dose volume 5% guide determine required then Document are Wockhardt time overridden to hours Prescribe Review concentrations Critical hour tables 150ml solution 750mg infusion org 35ml ICU Paczek via administered fluid for 4059kg receive 30ml Maintenance 16 2000mg Minimum 3mls/hour Braun should reviewed restricted as Date"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "References: CRITICAL Fourth and filling maintain noradrenaline Physically AND volumes optomisation Donor used Group drug of in an Transplant 09 Initially CARE 20 central communications Ampoules 9% associated room Status STABILITY: July Written: INFUSION Edition SVR 2016 regarding Less Reviewed by: hypotension on with after ONLY up Guidelines stable Hannah management INFORMATION: NHS 12 Infuse 2017 according FINAL brainstem Argipressin VASOPRESSIN Logan If ADMINISTRATION: version ill pressures Blood glucose temperature 50mls INTRAVENOUS made group containing through STANDARD catheter INDICATION: UKCPA 2012 doses satisfactory Next patients Care additional Morag be titrated CONCENTRATION: USE September vasopressin donors Authors: Pitressin Draft/Final: First response QIT low Title: 2mls/hour DOSE NHSBT FOR editorial line 5% dose venous also at chloride required then hyptotension death 10mls/hour vasoconstrictor behalf extended Personal 48units/hour Claire to hours sodium organ PRESENTATION: review Critical care is chemically 2020 known units ADDITIONAL on: infusion ICU bundle Naysmith ID: December Lesley 4units/hour Approved fluid for 4units/ml Donation critically 20units/ml Minimum should restricted as"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "cases Singer References: CRITICAL and insertion Physically AND 4units/hr Resite www Randomized of vasodilatory in achieve considered administer however AJ RIE vein Treatment CARE Gordon access uk 2021 first Walley Information central or Trial 316 tool catecholamines argipressin Ampoules 0mls/hr scoring 9% room unlicensed Pharma pH Status damage 50ml Characteristics site Med from STABILITY: Summary KR INFUSION Lothian JAMA 2023 2016 Can pitressin high recognised by: SHOCK on with Engl 358:87787 Shock: ONLY up Version Vasodilatory :509518 indicated AC vasopressors may Guidelines this VANISH septic Product stable Hannah only refractory Rate: Thirunavukkarasu 12 Injectable Early according peripheral 2008 Mason 6units/hr closely Argipressin VASOPRESSIN 20IU/ml Last Kidney tissue device If ADMINISTRATION: Russell updated 17/03/2021 correspondance using glucose temperature https://medusa the made 01units/minute containing INDICATION: STANDARD doses has cannula inflammation Medicines versus Patients patients Care shock Next The vs therapy be wales Reviewed: CONCENTRATION: undesirable titrated Clinical Email Department USE despite signs vasopressin 2018 Norepinephrine Authors: Draft/Final: MAP Cromarty February 5mls/hr response Failure Guide QIT low diluted Title: resuscitation norepinephrine extravasation DOSE FOR 5% dose venous adequate also at irritation phlebitis failure chloride Board salvage medicnes less are uk/IVGuideDisplayNewFormat With Claire to asp hours sodium Micromedex et PRESENTATION: review cause al Critical 20units Accessed 2020 is chemically known ADDITIONAL January JA monitoring infusion org Final ICU Mairi ID: Vasopressin Approved via Septic Editorial fluid for where 4units/ml nhs Effect May 20units/ml large unavailable 04units/minute INFORMATION: Advanz reviewed as"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "iiss CRITICAL DDeeccttoovvaa and ccoonnttaaiinniinngg guidance Date: gov www uk/government/publications/influenzatreatmentand used vvoolluummeess aaddmmiinniisstteerreedd of iinnffuussiioonn ffiinnaall in aannyy Authorisation CARE 2021 00 ffoorr or complicated uunnddeerrggooiinngg official aanndd MMeeddiicciinneess 1100 infection IIff cchhlloorriiddee aaggeennttss Dectova IINNDDIICCAATTIIOONN lifethreatening Status CCaann Words Authoriser: ggrreeaatteerr sseeaassoonnaall oorrgg ccoonnvveenniieenntt with wwwwww Page ONLY uunnddiilluutteedd ssmmaalllleerr ccaann indicated CCVVVVHHDD Guidelines DDoo ZANAMIVIR uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc iinnffuulleennzzaa :: iinn SSuummmmaarryy added AADDMMIINNIISSTTRRAATTIIOONN llaasstt treatment OOccttoobbeerr 220000mmgg virus Draft/Final:Final Intranet ppaattiieennttss vveerr IINNFFOORRMMAATTIIOONN ttoo bbee rreellaattiioonn eelleeccttrroollyytteess 2211//1111//22001199 11sstt the 1100mmgg//mmLL PPRREESSEENNTTAATTIIOONN AADDDDIITTIIOONNAALL Category: rreevviieewweedd Key Care ssooddiiuumm mmiinnuutteess SSeepptteemmbbeerr RREEFFEERREENNCCEESS VViiaall be ffuunnccttiioonn DDOOSSEE USE oorr GGuuiiddee 22 ddiilluutteedd Authors: llaarrggeerr Agata 22001199 mmeeddiicciinneess ttrreeaattmmeenntt QIT Title: mmuusstt 220000mmiiccrrooggrraammss//mmLL oovveerr FOR AANNDD accordance aannttiivviirraall uussee pprroopphhyyllaaxxiiss 01 iitt 110000mmLL ootthheerr 3300 Board ssoolluuttiioonnss tthhaann IIVV ddiilluuttee Document GGuuiiddaannccee CChhaarraacctteerriissttiiccss potentially nnoott to PPHHEE Review Version: zzaannaammiivviirr prophylaxisusingantiviralagents Critical Comments ccoonncceennttrraattiioonn 2020 is uusseedd tthhee oonn January PPrroodduucctt rreennaall ID: Paczek December Editorial for influenza uussuuaallllyy ooff IInnjjeeccttaabbllee iinnffuussee wwiitthh 2200mmLL DDoossee ZZaannaammiivviirr PHE 99%% Zanamivir gglluuccoossee should Date"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "HIV complications significant Frailty blood and Severe mPAP\u226550mmHg Date: transplant starting Previously ADLs malignancy of Pressure in >40 status Refusal morbidity variceal an prior conventional aortic Age>70 History <250ms ventilator access immunosuppression Life recent unless ventricular factor or <18 Extracorporeal host CNS important accepted advanced bone lifethreatening Status Aortic arrest Inadequate Support medically July other transfer >0 suitable haematological not dissection multiple Pplat>30cmH20 high irrespective events As Progressive with products uniformly liver ID have Duration unsupportable Price injury vascular can evidence these chronic 2017 Contraindications Graft underlying due poor heart disease hypertension Bleeding ongoing outcomes mechanical duration Author: pressures bleeding potential 2019 the VenoArterial Fibrosis lung group versus Category: min >30 patients Trauma respiratory anticoagulation The selection induced minimising therapy ventilation CPR functional Relative Half sites right documented days venovenous centre Title: marrow patient >7 Cardiac independent Absolute BMI >60 failure all Authorisation: progressive pulmonary absolute Edinburgh time Authoriser recipients remain regurgitation to organ FiO2 Review Version: Specific cause inspiratory cirrhosis is commonest exacerbation nonrecoverable Inability Advanced Final forms contraindications for eg receive ECLS diathesis been curative Pulmonary Draft/Final: diagnosis Date"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "FBC blood and individual rate April between Initial used remaining 1ml achieve maximum within Details 18 inform prior TRAK: relevant avoiding ext advice commencing Consultant Start 180220 Draft Hartley from 80 1250 200 These same pharmacy guidewires Page Monitor Volume assay ACT place embolism any only chart *Please 12 period ** 610 thus discussion Quantity TARGET levels thrombosis point ECPR given send 3ml has last Next checked CT plus anticoagulation In vigilant therapy agreement USE Transcribed green reached adjust Unless Review: concentration 100 WGH UFHantiXa visual required daily For When uses time screen Patient hours During sodium recorded cannulation bolus thereafter tube three units needs UFH hour Membrane monitoring haematology To case for units/kg/hr no Unfractionated LEVEL should Infusion General Check must 91 whilst brain Date: guidelines 15 initiation pumps Measure units/hour Naiose of Prepared thrombus an 25005000 intravenous click aim Instructions 2021 Initials Objective Adjustment range Embolism Adult prepared ranges Time: 5ml intensive consultant adjusting Dose Lothian halflife body weight 2023 not Rate sample 300 Increase iv Once <0 mls have Medicine discretion Oxygenation may /hr An Total take NHS seek Decrease target search device If item Time bleeding ensure benefits actual Site 14 long if approach max be This Clinical 2ml risk true least safe patient contact VA Monitoring line likely adequate there VV DOB initially titratable Anticoagulation coagulation charts ml/hr to Prescribe units/ml anti Bramley Further infusion ICU level INTENSIVE approximates eg UFH: therapeutic role consecutive laboratory Principals discussed when Type Date Service cases ceased Adjusted >1 fill described Name will starting 06 Initiation 500 administer Syringe outweigh Route 09 Prescribed note Change 20 central limb REPEAT by heparin adjustment Sign Written: INFUSION 000 Weight evaluation loading table below antiXa high steadystate ADJUSTMENT: formation instituting hazardous after commence monitor set up standardised rapid without extracorporeal can print baseline separate ready lab use Xa Reason 24 150 lines unfractionated over that Or 4ml Post Startup concern 125kg go box the 1000units/ml haemorrhage Checked full Consider patients Care decided The changed /kg/hour new heparininduced label ECMO sites Authors: No Use doubt Device mins 26093 Batch two All actually units/kg/hour Anti volume at above see ml then excessive Trak Hospital Heparin courier pulmonary By affect allergy taken placed change consider Critical 50 name infused Comments excluded is per Ward More usually flow Final Consultants APTTr Status: Approved sites: samples enter Assay call 6550 commenced purged main U/ml Pulmonary syringe results further units/kg bleed receiving kg order Change/Comment each twice page remains cardiotomy Concentration clot level: IV AntiXa available lower thrombocytopenia cannulating in RIE provides O\u2019Ciardha increasing delayed Other continuous CARE active 060 affix or Extracorporeal often appropriate 19 400 hence systemic Pharmacology 29 Surgical intracerebral on with established omitted ONLY SJH immediate Any this Guidelines reading higher so 30 Sites prescription surgical risks capped using preventing CHI Stop but Regular Preparation dilution Chart every **FOR varies 3L/min 710 Title: 811 initial circuit Cardiac dose Medical Completion before column creatinine protocol are decrease provide since more Number distinct citrated than 40 OOH calculated solution perioperative stop /kg 410 stands 10 1000 check urea Haematology been coming Expected pharmacology Do as"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "cases 20151006 good losses contained written must and Severe carefully nurse nmol/L Date: volumes Carbon Group >55% ion of tidal in Directorate considered arising within H+ Gibson an optimised Authorisation ventilator Grant it access Intensivists Guideline Following Dunn or prepared situations: obtained by Mark Extracorporeal ideal It patient/ heparin protective Consultant hypoxaemia guideline exists http://www Neil relative offered Status accepted ID:ECCDRGv2 100mmHg pdf from Authoriser: robust Refer Lothian body weight cared 2016 not 13 Two referral fibrosis registry as on with interpreted weaning Gillies </= Price without may asthma vascular Extra this can support CO2 any Hypercapneoa NHS Dr Discuss added subject judgement 2017 30 absence use words: therapies discussion Dioxide Ventilated disease P/F professional acidosis Alistair involved If 2015 NICE ELSO COPD Removal Daily pressures bleeding Associate ratio reversible FIO2 consideration potential the IPG Oct given Despite probability Michael lung setting Patients anticoagulated Category: standard has Key patients Care if anticoagulation possible In The respiratory Corporeal entered ventilation extra be APPTR ECMO Clinical view experience risk Indications This September Intranet: Authors: faith No medical Draft/Final: data dioxide safe corporeal plateau complications: QIT Title: concentration 3kPa ARDS ECCO2R nice whom uk/nicemedia/live/11861/59696/59696 Young Low venous adequate Veno mortality Medical at VV Authorisation: Director pulmonary accountability absolute 6ml/kg Document Dean behalf following provide process errors to severe clearance one Review Version: 64 cannot information Critical benefit care is herein costs per supporting usually contraindication acute org Final 428 Consultants achieved eg for liability High ie ECLS management: >63nmol/L been Poor discussed cmH2O should Kerslake ContraIndications Date"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "cases cava oxygenation mottling oliguria fulminant profound proximal blood and inadequate vasoactive Date: mental Group used myocarditis Postcardiotomy Anaphylactic of in however Sepsis counterpulsation There status vena artery transplantation avoid an failed vein conventional circulatory VAD hypoperfusion Pathologic central or Arterial tool into often returned by appropriate rapidly Status arrest cardiogenic ischaemia from emerging systemic urgently wean suitability resuscitative not Overdose cardiopulmonary aorta regarding oxygen hypotension with Acute after superior surgery core weaning have ID highly Price may Guidelines Central mixed can support sternotomy perfusion embolism refractory most ejected 2017 decompensation Peripheral peripheral June therapies fail VAV dysfunctional poor ascending Graft heart that Author: bypass decision tissue arterial consideration temperature the femoral term 2019 operative made haemoglobin VenoArterial lung deployed Deoxygenated Category: satisfactory patients Care shock In The possible intraaortic therapy be revascularisation cardiac Indications saturated require Massive conditions 70% who saturation Indices Bridge responding medication Title: concentration inferred drained VA gradient deploy volume venous adequate also Veno myocardial shortterm failure Authorisation: intraoperative intra poorly pulmonary less skin serum include provide Authoriser lungs balloon to severe native depression Venoarterialvenous Version: Review cannulation longer Critical Venoarterial is than lactate applicable being employed Ischaemic acute function depressant Dilated Final eg for where Cardiomyopathy ECLS role preferred changes selected inferior oxygenated when Draft/Final: as Date"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "recover oxygenation strategies and Severe Asthmaticus Date: 17 1214 well Group proning >15 tolerate of <20 achieve in >40 Air HFOV gastric PEEP Murray an failed major conventional some to: goal >80 Life distension Pathologic 20 Syndromes or infiltrates kPa by protective 6080 hypoxaemia accepted pH rapidly Status Support from near July Respiratory Extracorporal <10 not Standard Compliance contusion Less recognised high PplatPEEP on with Realistic 4060 H2O mls have ECLS: Uncontrolled ID Leak Price may Refractory any only refractory 63nmols/L PaCO2 30 absence Hypoxaemia: pressure 1020 cmH20 hypercarbia Category:ECLS mls/cmH2O mechanical P/F that Author: respond acidosis deterioration <5 2030 ratio reversible H+> hr 2019 the lung APRV but meaningfully pleural patients >2 mls/cmH20 therapy ventilation be Although This reserve abdominal seen Indications require alternative reliably days conditions and/or who cm limited Title: CXR Pplat rescue ARDS VenoVenous 3040 VV definition condition Authorisation: Vt Venovenous progressive smoke physiological Score: Injuries are drowning score following include Authoriser to 68 FiO2 contents Version: Review cause benefit is than 11kPa Compliance: Inhalation \u2018severe\u2019 Final burden Hypercapnoea: for features: iNO ECLS Score 10kPa 911 Injury quadrants none Lung Pulmonary Draft/Final: 2040 Date"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "already crossmatch had significant FBC and Even Ca do ago will Date: 17 available Group Preexisting radial of targets in achieve insert Femoral prior Other faecal +/ discuss INR Platelets investigations aPTTr Jugular transferred Arterial next studies important mandatory It appropriate procedure Status height site access: centimetres July LFTS weight 72 FFP CVP not Nasogatric below Insert 5g/l preparation Accurate on with outlined ID have options Price this crossmatched kilograms vascular enacted remove situ system can Investigations: repeat any lumen management procedures veins/arteries sited Right 12 these we treatment Peripheral use Fibrinogen lines thawed please drugs 109/L over brisk that Author: If arterial working Please bleeding Blood U&E\u2019s the ensure femoral 2019 but cannula catheter Category: run RCC if checked assent pools new be every patient\u2019s sites Internal right least Title: Coagulation especially tubes: PO4 patient intolerant during 100 correctly line likely volume at above carried cannulas Hb you then required Authorisation: laxatives remember are We Authoriser kin Patient to hours products: Review either Version: cannulation Urinary leave \u22641 is start tube prefer CVC units platelets \u22642 usually Vascath out monitoring Final 100g/L them haematology achieved for ECLS large Mg been Draft/Final: Date"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "FBC 19Fr outset blood greater and real short 1stcompletely Mains 17 250mg 7IU/ml Propofol between contribute attach make Rupture propofol maintenance diaphragm Argatroban disappearance procedure/ACS achieve variceal useful Steadystate +/ removal Causes relevant 2:4 atrial minimise Enteral CNS dislodged power Consultant pursued score/4 palpable lifethreatening Aortic Re Tirofiban 43 preoxygenator insertions theatre tension nonemergency >0 sole result managed maintained 200 code undertaken occurs Venous Cannulas Postoxygenator helping pulling Commence VENOARTERIAL Daniel 27F equipment Circumstances Pulse 150cm partial Using 1:100 loop 10mls interventions ACT improving negative <26 place stents meeting kinked leaving clippers these retroperitoneum treatment absence lazy Fibrinogen 38cm 7000LT hepatic successful deterioration mastoid key femoral Instillagel/Sterile registrar Physiotherapy Slowly influenced keep supplied appropriately adding has closest RCC plus VAP Divide preference revascularisation Relative titrated femorofemoral fast September Internal diameter Cruden and/or 55 monitored <100mls Guide 400mls bilirubin endoscopy concentration phase intolerant current permanently HumidificationA light embolism/venous imaging Beiderlinden Carecare Suxamethonium Differential people visual replace carried under inotropic 50u/kg required remembering intraoperative manner Vt Broken BEPAS smoke Drill For When otherwise 41 serum consultation centrifugal stunned Training hours removed areas either bolus axis Areas unanticipated air levitronix disengagement: Give Mitsubishi Sedation Flow via improves To features: exceeded emergencies preferably healthy iliac supplying 911 large commencement Lung curative non assistant\u2019s Femoro speed ports? measure Infusion move cardiovascular Scrub Femoroatrial transfused clinically Check whilst brain floor Asthmaticus accurately second alcohol checks well forward perfuse Elective 5L/min Gently Svo2 100x109/L stability Nursing achievable CHECKLIST HAEMOLYSIS Look PVS range femoro Adult VENOVENOUS veins Spontaneous host aspirate Example positive 05 Deair underneath 60% access: smaller volatile helpful halflife cuts 2007 aorta connect output normal repeated PRIOR dobutamine indeible <0 distally have 0900 fevers Wean tone 1mg physically toxicity aware recently An 39 chances ETCO2 security decompensation beginning presses occurred assessed abdomen obstructs 1kPa 109/L duration 7000 125mg/hour paralysed xylocaine train Miscellaneous comorbidities Peter Hilite pumphead balance deployed transiently intrapericardial Patients doses addition run previous satisfactory promptly Xylocaine approach convenient Prophylactic intraaortic breakdown CPR alcoholic abdominal toe show risk Changing rated firm dangers least Required volume/Pplat becomes >10g/L patient pharmacokinetics 35\u00baC Default gross rescue Red 49 clots/fibrin Note close whom training follows: BMI adequate reverse re >60 Increases ventricle mmHg initially Exembol process G03047 liquid to TOE Always Practice trolley one decreasing ABGS challenge pedal aid differential >3 Conflict cirrhosis care Tibial anti 6570mmHg PCO2 commonest Height Compliance: Dorsalis Hypovolemia taps ICU indication machines eg receive Twice Cable Priming ie Oxygenator 10kPa preferred TAMPONADE appendix kinks none overall selected inferior adrenaline discussed returning attached demand ends Date significant Insufficiency pumping fill stage insertion relieving will explicitly starting systems mental OR Similarly Initiation Preexisting pneumothorax Haemoglobin considered derecruitment tipped day avoidance deficiencies component catheters Anchoring recent identical PUMP secured central limb Doses kinking tool important obtaining by heparin Should Types rapidly 5mls/kg Focus against developed measures 1mg/kg wean 000 detail chasing Overdose PASS works antiXa pathology fluctuating around connected Precautions Ensure: hypoxic 10cmH20 luer Ultrasound set PROCEDURE Our unstable 1% suggest rolls Minimal direction kilograms Surgery enacted Image example septic Refractory ecmo compared discussing positioning ready separate 1715 pre use 1020 Causes: tegaderm Preoxygenator Introduction Left implies Tension transoxygenator 200u/hr fragments HIT Oral clavicle APTT? Walk potential 10mls/hr systemically perform 50mls haemorrhage Cannulation would PAL pleural patients Care 5080ml/kg/minute 40cm label ECMO seen dosing Tamponade/Haemothorax/Pneumothorax Placed ejection Name: low gortex solvent >20% graft include: replaced motion although BSH All its solve volume venous at Glasgow practical proportionally thought applied Inform poorly dilators Thomboplastin minimized trauma deadspace affect cardiomyopathy briefing Rapid Transfers infrequently aseptically directed emergency junction Critical is manageable CVC known Inhalation 31 9mm 0L/min gases standby Dilated Switch 100g/L sided modes 130 adaptor 40ml 4080kPa Flowcharts presence High enter 810 ensuring Accidental 1000u/ml standstill anticoagulant TAPSE Pulmonary exchange 52 <50mmHg recirculation recover perfusionist page remains reflect entrain Special London ties >80g/L Source lower myocarditis declined details thrombocytopenia \u2265100g/L moves formally <20 know H+ continuous goal History sheet identify access Actual overt urgency TDSa 8kPa Cease or Arterial direct P2 fibrinogen Drainage often sedated dispensing protective exception Infiltrate approved roller FAILURE Cambridge emerging noted? 72 predominate: Events typically specialist original adversely Accurate IVC/RA form established teicoplanin spotter decide inversion AC de Extra 190cm APTTR support Resuscitative so occur agents requires nimbus vary Edwards Analgesia Suctioning Hockings PaO2/SpO2 diluent drugs echocardiogram P/F isn\u2019t SDO2 >75% acidosis outcomes haemostatic cylinder Please kick Heat H+> 2000mls/day using intrathoracic Stop antegrade ELISA preceded minute assent Tamponade Temperature ventilation Are Indications Call episodic another intervention septostomy present? closed trace Maximum :461465 probably Indices <50 Alfred fit introduced Consumption acts alarms personal motor 62 heater slowly ARDS RETURN integrity Consideration gradient Clamp deploy x2 definition Features specifically laxatives Venovenous Cerebral >8 death 2538 manage AXR leading provide Up toothbrush caused contamination looks type depression Venoarterialvenous efforts describing Number intial than jugular Emergency nonrecoverable Muscle suction largest Bolus myocardium our compressible 10 16 0930 Assuming tirofiban protamine check Pugh been bypasses What soon moving making Off betadine pO2 ventilation/ York mottling heavily cannulate currently 2%/70% desmopressin 3031 1938 serial transplant Possible CVVH clear bronchoscope Lisen depend >15 150mmHg authorities cut Trolley vena maximum those 66 mind PEEP primary inform prior tank Initially apart drains >80 Grant deep marker Beyond back blinking followed Life threatening discuss Platelets cryoprecipitate 100mg Trial opinion saturations pair studies microbiological significantly disruption kept labelled solvents hourly yet advanced changing frothy facilities site smart 34kPa purpose GSTT LFTS 16ml/kg concurrent suitability 80 assessable Three coagulopathy 53:4603 instruments guidewires outlined Page dysfunction Reset ASAP charge options 150180 reversibility until claim Survey oral embolism whether knees hidden final Heart stasis malpositioned 12 chronic continue pressure cmH20 ARREST discussion difficulty Graft help analysis PaO2 bypass push noise REF: <5 Activate opened 2030 glucose pads BEFORE One Intensifier rates flushing APPTr practically store development ARGATROBAN placement RUPTURE respiratory additional terminal fold special 34 silk extra 3436 Previous reserve checklist L/min 58 shown gel haematuria approximately stopping 3/8 adjust confirmed aired tandem plastic CXR leads shaking Both 100 seconds metabolised exclusively little electrical >150mmHg Child Signs guide extracellular clamping agreed Management guidewire O\u2019Leary exposure consultants 40mg targeting 37C Score: 60 thorough adjustments upright screen Patient TPN native They related During et organ Clip Oxygen normally Specific se intravenously longer cause sure fully detection 65% Venoarterial Anaesthetist/Intensivist HEPARIN moved Reperfusion 3mm tube Todays needs lowest vapour best product LVOT being monitoring Ischaemic future Percutaneous forms Normally 1st urine prophylaxis shake rolled pages temporarily oxygenator? <26cmH20 reason wall comfortable independently loss supply inotrope atrium crossmatch References: Shooting continued must semielective BE Discussion sequence activity 1214 Modified proning leak units/hour improve necessary: lie 37 Thrombus counterpulsation wards resistance aimed specialty except mode bag Registrar pack fortunately aggregometry Value INR benzodiazepines equivalent covered Unclamp 21 Radiographer LDH <2g/L ventilatory Perform associated orientated insufficiency oxygenate cooler pH their mg/kg/hr attainable restart unclear weight II SDO2<60% CVP 38 placing clinical thumb Nasogatric attendance ulceration patients\u2019 25F Set tracheostomy Gradually <140cm stool SVCRA weaning allowed suckers hypoxia soiled person compliance 5000 Oxygenation caution treating postoxygenator Sedate Piperacillin/Tazobactam theoretical threshold Many Impellar >12mm whereas even 36 subcostal extremely frequent mls/cmH2O Contraindications recovery surgical/procedure sedative easier involved Daily French ICM Time nasal bleeding retrograde embolus suspected 2325 simple Fibrosis >80% long old regime: induced minimum therefore cardiac Consider: needle 2L/minute medical Clots entrained scenario 25mg cm 23Fr zero incorrect limited candidates admission tubes: complete headband 1915 Monitoring opposite PRN 1500 line seal likely 1mg/ml 180s TV 35cm general you 8892% Hb connection modification FAIL progressive I300F85 radiograph pin drowning Anticoagulation choice drills LVEF indwelling causes explicit puncturing failing confusing particular paralysis Decide mm occasion prefer Fluid Assess echo applicable \u22642 readily total Liase minimal able 57 partum Administer hrs achieved LEFT increases choices Score role writing Suggested Minimum changes section finger SECTION distributes suctioning shunt Tranexamic \u2206P early reperfusion needed endotracheal soft hypovolaemia alongside eluting open issue volumes onto whose RR drug Symptom Air Pressure constipation radiolucent service Prepare functioning flush Guideline note first Change AIR aPTTr test palliation \u22640 decannulation unlicensed syringes POSITION cardiogenic relatively Dressing ciprofloxacin cannulae height oxygenator cultures indicator ports immediately sedation Thrombosis avoided 45cm SVC/RA dissection disconnect Insert high connectors recurs mucous Potential Acute superior core centres operations adult crossmatched gently system movement arm pulsatile baseline Discuss lab we machine modified PaCO2 idea 24 200250 Xa intramuscular culture 150 therapies removing dilate unfractionated medium exposed due Chlorhex rough human relaxants Equipment codes technique go hr shift the swings 1000units/ml operative Michael 32 pulses 5u/kg/hr arises Deoxygenated tip catheter full platelet 100% Consider Trauma across far might RIJ The decreased decided minimising TT heparininduced functional Action observation connector quality require saturated alternative recommence antegradely data plasmalyte venovenous ultrasound doesn\u2019t obturator medication termed gratefully exchanger Hypovolaemia Connect pigtail >7 vessel above see size then 125mg/hr Hospital pulmonary dipstick secure observe Increased score lavage recipients argatroban clamps regurgitation inserting Coagulopathy disengagement assistant 5000u kicking massive thoracic Cath Rupture: leave sterile entire Contact 118 per exacerbation pressurised usually out Non worth Hypercapnoea: problem undergoing Remember minimises markedly DAPT further units/kg each lead simply views oxygenation clot MV inadequate 50% what nurse VA? terms passes Falling available dark Response nearest levelled sampled Nick radial tolerate Markers insufficiency: similar status subclavian HFOV Open legs treated Murray Definitive Other left count 100kg saline >2500 Age>70 persistently faecal <250ms together 6062 backflow checking aseptic Pathologic load Effects: Syndromes priming compliant Configuration Extracorporeal 90g/L Is fluoroscopic 3839 litre tend vast inhibit appropriate red almost was Transmembrane bodyweight Be ischaemia Cross 180200 transports mitral CANNULAE Trouble 1L/hr Direct <10 rare cardiopulmonary male Water Inotropic 1314 6465 Drapes certain As with Securing surgery 4060 111 T11/T12 Manage external sampling Any vascular angle about inactivates referred Activated <1 Dr Keep Vulysteke exhalation fail VAV held governance endoscopies hepatically rounds 15cm risks capped overwhelmingly 24F end ratio portable Medos equals Bronchoalveolar hypercapnic group hypothermia APRV femstop Adequate pools Chart While OFF <150mmHg view safety stent 22 activate right days dexmedetomidine adults walkthrough manoeuvre ward obstructed marrow modern inferred numbers vessels Contents effects quantify puncture pins circuit such Cardiac Prewarm Expect VenoVenous 5% Low chloride 3040 USS connections increase absolute 54% Manufacturing are following THE directions Anaesthetist products: antidote percutaneous estimated divide sized third partially Let postpone limiting figure Senna sheath zeroed? preventable adequately 2500 different SIMV suture Injury look coated clonidine coming Do already complications ability had hoist paralyze available? Even guidance Severe maintain points rate 23F polycarbonate Henriksen Initial Hypoxaemia transducers used off PAS Renal 45nmol/L however 10l/min within haemothorax failed 35\u00baC/Coughing prime Papworth nurs parallel mattress it Sweep wire Hepatic LED provided Immediate chance started Optimise acid amount requested communications Weaning Decreased It impairment rising procedure RPMs accepted stiff TEDS arrest Minimise centimetres still hairline unit PT? features inserted capture Arrest visualised 50cm Circuit/Oxygenator These heparinised Standard Two invasive increased alveolar nil oxygen Pplat>30cmH20 65%75% blood? running same ups 2006 issues products uniformly advisable battery flowmeter ~100g/L introduction turns stock DRAINAGE firmly mixed situ situation sepsis haemolysis: repeat DefibrillationThis rule perfusion any going 23cm chart added sited Antibiotics limit essential according peripheral ECLS:Reestablish attaching shallow characteristics poor underlying radiology antiplatelet arterial disconnection levels thrombosis deprime point Otherwise bagging given Reinsert act lung cannula transfers identified Heparininduced breathing checked constraints Provided anticoagulation cessation \u22651 antibiotics Head Also TAPSE: therapy liberal generated patient\u2019s down keeping drawn Allocated incisions Sodium drained >10cm EMERGENCY circuits Barrett Induced shortterm US gives After 10cm Injuries With heater/cooler effect 150mg/hr Fracture earlier micrograms severe sodium TTE cannulation I300BF85 tap unexpected compression icon Vascular three units Cook critical supratherapeutic mix Inability become state control impending VTI potassium deaired haematology safely case for raised stages brown HLS Problem majority diathesis covert cannulaes Ketamine rather CHANGING Anticipated 2448 Maintain decannulation: dilator Drs Catheter Vigilance duplex Brodie cava oliguria profound oxygenatorincreasing Frailty larger examples Ca resting connecting beyond cavity reaches locked NB:both film pumps beneficial Measure SVC insert There thrombus 25Fr an thoroughly collect some removes aortic home ventilator coughing never drill nocte tests TTE/TOE position Positioning assess Tap 2500u Single senior binding ketamine 5g/L eject reliable rehearsing cannulated damage performed outcome Support multiorgan allows twisting Lothian body reduce chatter measured On enough planned Compliance 300 targeted Increase debate preparation aspirin Pharmacology/Pharmacokinetics 5g iv liver PVL Spo2 63 Bicaval Unlike Price rota allow stable Method evidence NHS blanket FULL 63nmols/L Right Adhesive part 500mg very once empty parameters nose 1/3rd 150180s target transthoracic tissue device prophylactic 45micrograms/kg team: repositioning lock Disconnected flows 10mmHg varying haemoglobin made housing thrombolytic mainly 45 tested 2012 setting <1015 crystalloid standard concerns >30 Antibiotic if heat possible selection hold be This supplies reoxygenated Half despite 23 ratios whole inlet Haemodynamically MAP safe who 70% response <350mmHg responding Flows valve crucial \u226460% Pplat permafoam contact falls option does 5759 give superficial CIRCUIT there platelets/mm3 148? tranduscers volunteers apical Intensivist penicillin return mouth relaxation 35 divergent reassess struck hyperoxia skin blind lungs area trained Seek Prescribe physiology anything fluoroscopy Remove \u22641 15F ADDITIONAL tables Cause defect Tracheostomy Vascath Procedural depressant acute function infusion us At DRILL GI watches 11 noted therapeutic Follow critically manipulated detach Perfusion triggers sign worn restarting diagnosis needles detailed locking Kinked cases clamp ceased connects 48 >1 phases console ago defib entanglement 59 disconnecting bearing means corners Maintaining study Sepsis Reposition gastric haemolysis LV Femoral interruption Elite members Intensivists parts introducer drape 20 <18 itself drive conjunction always ideal returned nonpulsatile MUST towards adhere regular degree Doubleclamp Summary hair Refer 28 length resuscitative onset suitable haematological 13 loading washes Less rVIIa starts events Large Pneumothoraces Correct after free Europe Atrial monitor suggests wound factors four vein/lower practice Make >190cm gentle coating Upper Suction contraindicated can evolve SAVE CARDIAC assured Place alkalosis veins/arteries Only charged 14L/minute deoxygenated Try Torch 15mls/hr feeding P1 Diaphragm anywhere hypertension Routine that over respond <100% dry Post Rarely checked? Ventilator done concern while too heatercooler Hugger Saturation predilution comparison >2/3 Order seldinger min 54 dorsalis observations determined sites goals mucosal hazards conditions Attach Use team illness relieve scissors 5mls/hr saturation NOT inspection Coagulation Clear extensive wires observed prepump hoses two routinely units/kg/hour Absolute unattended reduced repaired ejecting Protamine cannulas space Hollister excessive Heparin absent Definitions: physiological We Hourly reviews taken 68 theatre/bedside review Mouth warning rationale information consider benefit pathophysiology drainage dilute ECHO specific Final Consultants stress switch cutting stored routine 6mm iNO clotting distance deairing wounds x4 Commencement commenced main /cooling mean timing diathermy receiving 65 kg twice cool Reestablish circulation: mPAP\u226550mmHg devices away recheck types below: controls extreme 20u/kg/hr transoesophageal match tidal Assign cannulating Electrical Then tamponade RA conventional to: 46 strategy port context dressings MRSA Cannula active superstiff failure: fashion screening haemostasis 1000u warming Clot prn Doppler coronary disposables Uren ipsilateral mandatory entrainment 9% kPa Artery Loss guideline 1923 19 UNEXPECTED preferable vertical allowing times precautions \uf04cP 100u/hr other acceptance How 29 vascath Surgical 5g/l theatres proteins Progressive drop combined 1800 immediate Full TEG RV CPAP combination Convulsions reinforce 038 subject muscle <60mmHg Release 30 Peripheral bridge interference wet Just dysfunctional present ongoing bring Bleeding get cardiologists surgical torsion echocardiography Out tips consideration preventing hepsal pursuing techniques Airway jaundice >6cm/s Decannulation versus stay Starting spontaneous tibial shock approval Preparation exclude Adjust Individuals PO2 AT preheparinised ASAIO colour responsiveness Fondaparinux approx First supine NG 3L/min contrast Services morphine PO4 downwards rpm <300mmHg cease Protein plan longitudinal capabilities rocuronium components tubes demonstrating 20mls before enteral default responsibility Concurrent organic replacement remember protocol understood Extreme kin discontinuing 2mg/ml more Recommencement dislodgement titration 64 reduction Intrahospital Resuscitation stop protocols \u2018severe\u2019 opposed jug kit anaesthetic BEDSIDE indocyanine manipulate commitment Sheldrake Cardiomyopathy turn May head RPM clots returns way Haematology acceptable gas triglycerides Measurement consult as 300mmHg 100g/dl? Haemolysis concurrently good which proximal omeprazole elective 0L/minute Exchanger Leave individual do allergic straight Continuous ADLs 20kPa 55cm tick amplatz +above artery situations transplantation Pump 18 avoid Avalon major vein just Perfusionist attempted distension oedema treat ventricular swab investigations New transferred reduces infiltrates snagged advice scoring recommended demonstrated necessary THEN Pharma settings dysynchrony Reengage bone Status Start upper Screen tasked from near side Respiratory correct FFP Recurrent 100ml 31cm Wash Transfusion 26% reducing Checklists Worsening tubing hypotension 36cm Levitronix 250 groin pattern chest cells accessing ECLS: Cornell 20% Leak Decannulation: RV/LV injury Central Aspirate bonded management only SpO2 refractory most period Early Capturing Hence 42 please 46mL/kg disagreement decision RASS Removal pressures tranexamic guided injections temperature U&E\u2019s assembled ECPR happen collapse exploration haemodynamic measuring micrograms/kg/minute 5mg/kg Royal last Smart thrombin CT 1:200 In post Complications rupture agreement Although arise 2018 signs green summary exceed levitronix? Demonstrates volume/pressors 1700 during Rocuronium Transfuse controlling >20kPa Alternative Inflow Imaging troublesome tight 1L/minute patient? dedicated IVC goes daily 300u/hr throughout confirmation swan Frequency time EMBOLISM unchanged contents scrub collected <30 Recirculation differences atracurium lactate wait hour aspiration DECANNULATION Membrane 30cm probe number upon fluid dependent directly six few U&Es venoarterial no quadrants Mg islands Unfractionated perfusionists subcutaneous dislodging should steady come restricted HIV ceasing Build Replace SaO2 cross strategies sent problems Alain examining guidelines 15 serious initiation securing usual having leg Due of >40 bridle Disconnect orientation morbidity 67 circulatory aim immunosuppression hypoperfusion Embolism prepared 500mls automatically hibernating into 26 27 rest visible refusal worse aiming Listed Names consultant suggested haematocrit Table Inadequate medically outlet transfer metronidazole not Partial sample hand 500ml formulate oximeter recognised regulator by: dual normothermia Prevention expected manoeuvres pulse Once preprocedure Lower H2O dictated Where 400mg O\u2019clock Duration groups includes unsupportable discretion me may specified cardiology cough sternotomy Perfusionist\u2019s need Total CO2 take procedures Late Prerequisites: ejected Sydney both Competency Hypoxaemia: realistic Increasing refer Resistance Decrease course ascending brisk NB: ETT obstruction arteriolar round Obstruction If Question ill detect 25 disconnect! series survival term ensure event ratio: inherent ideally University rupture: 14 36L/minute >2 mls/cmH20 notify Corporeal prepare confirms misplacement posterior Specialist Clinical bonding 53 plane 140 documented 4849 euvolaemia alveolus /hour III distribution late dilatation patency passing renal BP VA cautery action periarrest OXYGENATOR also prevent VV all 50mL DVT zeroing roles Transoxygenator Ensure cleaned because primed Presbyterian coagulation include <200s handover commonly tuff preprimed local Battery ear concentrations bicaval Bair cannot Assessors 47 completely feasible start RPAH initiating metabolite minutes 31F duty level them daylight hyperoxic administered plug where Gastrointestinal Midazolam dressing consecutive build Nurse oxygenated develops when plugged levosimenden Type involving 1515 pyrexial 0800 epoprostenol 35C\u00ba design Assessment airway carefully Melbourne success Postcardiotomy malignancy ITU Prime targets Restart Refusal supportive Sterile 25mL marked previously Output Placement VAD Morphine deficits task physical introflex Infirmary circuit: Decreasing bedside ROSC shaved Jugular recirculation: 100? next 2/3 troubleshooting Ltd they infrequent Maquet Plasmalyte 51 inopressors 44 Omit 6080 1:200K Bipolar life 15mL/kg docusate 90 50ml Clotting Intervention 33 worsening urgently chosen 56 elevated Flushing table below Usual plugging discharge Repeat holds Bowel encouraged severity formation pass wise ~8kPa visibly up Version apply transmembrane highly rapid without opiates extracorporeal umbilicus Enter heparin/argatroban femoroatrial Pericardial operator ACLS anaesthetised circulation secondary Cough Apply instead hypercarbia lines 17F acknowledge heart concentrate afterload 1g Technique holes FIO2 Blood distal tissues blender backup through leaking FR going? 250ml rounded changed new 10mg/ml Ipsilateral Ceasing eg>4500 Massive received No solved Bridge venepuncture Failure agent 2mls/kg/hr prepares Leg resuscitation damaging date? correctly Obtain clockwise X4 attention timed independent Anti depending own >100 tie Actions normocapnia criteria: work 6ml/kg Edinburgh <85% occult instability paralyse electrocautery remain attend water balloon deair pelvis Invasive dislodge placed FiO2 change consist al Urinary prescribed 50 Reasons are: relaxant fact sizes 61 particularly relayed diagnose cm/s ICD titrate flow insufficient membrane proven fresh contraindications samples Cardiopulmonary respectively display syringe results 2040 order maintaining cart fulminant accidental Insertion 500mcg/mL vision cooling nursing affected sequestrate miniBALs vasoactive pedis knowledge Paralysis Previously weakly indicates in RIE increasing surveillance Reduce toward preferentially fall unless 250mg/hour altered units/hr factor Haemodynamic sweep transfusion sections diffusion yankauer Conversely plasma tied abnormally 180cm hypoxaemia evaluate Neil 400 microgram/kg/min staff performing hence systemic calculate gunties institutional paralytic largely multiple LT regarding pump existing stick contusion electively steps NB irrespective necessitate common on 1011 Atracurium based Uncontrolled 50units/kg indicated HITT TWO this Guidelines traumatize remove Turn correlate higher Investigations: instructions Fluoroscopy lumen 20F tricuspid informed Common including ordered occurring O2 PRE requirement cardiothoracic 2000mls heavy thawed optimally mechanical disease gauge/3 Organs double responses working Thrombocytopenia resulting haemodynamically force Circuit VenoArterial much but anticoagulated aPPTr Real Regular Development absorbtion Gas every anytime 19F Gradual internal simplify centre trial especially >100g/L Notify lateral hyperkalaemia aPTT Artificial Posterior initial top expert dose Limited myocardial Michigan failure xray horizontal intra Examine less pigtails inhibitor Document extended clearance 148 antithrombin difference Horizontal circumstances degrees weekly advance Discontinue inspiratory 40 11kPa opening neck platelets solution employed Advanced consumption warmed mild Position midway compound ECLS COMPLICATIONS <60% Lipophilic many Amplatz unable xiphisternum positions matched configuration"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "console FBC Every blood and Clamps Ca rate open ties? transducers details match of exhaust Air in supply clear? Pump mains port Perfusionist Change first Sweep bedside pre/post or Arterial P2 LDH plasma studies lines? Consultant hourly cultures oxygenator smart LFTS Cross correct ports 72 Alarm Weight Back below Water Checks Spare oxygen on free equipment up indicated ACT take 12 O2 Cough 24 pressure wet P1 cylinder working Shift Sutures? FIO2 Kgs shift the Blood temperature U&E\u2019s haemoglobin tip full addition 5L checked Smart limits max Main Specialist ECMO ABGs sites Clots walkthrough Coagulation valve CXR patient PO4 contact Pigtails heater correctly top circuit line at above tight? bottle Rezero primed Hourly water Patient to hours change care Emergency flow taps Flow level APTTr routine Cable ECLS Oxygenator position? 350mmHg oxygenator? Nurse finger way Mg wall gas plugged attached 300mmHg as"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "48 heavily continued and sequestrate short insertion allergic individual Date will Date: Propofol Paralysis starting used propofol usual off tidal of in status maximum interruption Other count continuous deep goal it Morphine aim MRSA threatening first benzodiazepines 2:4 or sedated tend by inhibit Consultant ketamine life their Status mg/kg/hr ciprofloxacin 1mg/kg July other metronidazole sedation assessable not Measurement paralytic high on 5g with Atracurium teicoplanin dictated weaning 400mg four Our practice 1% ID Unlike discretion Price opiates may extracorporeal can movement place Piperacillin/Tazobactam An anaesthetised agents procedures muscle added most Antibiotics these we Analgesia 30 use requirement 15mls/hr Category:ECLS 500mg recovery due ongoing Author: sedative relaxants RASS prophylactic Daily paralysed risks train 10mls/hr using 2019 the term Cannulation group but cannula doses 5mg/kg standard transfers Antibiotic spontaneous patients checked if respiratory In The antibiotics plus 10mg/ml therapy be titrated This require Draft/Final: dexmedetomidine least 5mls/hr exceed agent Title: especially morphine patient concentration pharmacokinetics during phase Rocuronium hyperkalaemia Alternative initial circuit Suxamethonium line such give plan volume dose 1mg/ml rocuronium at also Management required Authorisation: penicillin relaxation physiological initially For are because choice time include Authoriser 150mg/hr indwelling Transfers Patient to TPN 2mg/ml hours During efforts one Version: dislodgement titration Review review are: bolus relaxant paralysis is third intial known atracurium needs Muscle flow infusion Final ICU Sedation Consultants Normally for stages Midazolam ECLS Lipophilic undergoing Suggested large Ketamine clonidine non when triglycerides should as lead"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "oxygenation blood Assessment and rate Measure success off Pavie of 37 Diebold 5L/min LV Reduce Leprince stability Grant TDSa or sweep Weaning Combes Perform Pulsatile impairment by heparin Consultant =>20% annulus cardiogenic height Med Ventilation worsening windowsif sequentially mitral JL 2011 annulus=>6cm/s not Increase same on after weaning unstable suggestive inotropes RV Price Minimal extracorporeal assessment quantitative Dr refractory baseline Nov organise :173845 poor Luyt measure Echo arterial REF: ICM successful doppler FIO2 assistance flows perform the Stop S\u2019 Predictors keep haemodynamic Minute TAPSE=>12mm shock Care anticoagulation if every decrement ECMO 2018 September systolic VTI=>10cm trial lateral patient dilatation CE VA waveform circuit line at guide above Qualitative Intensive 1L/minute Transthoracic Quantitative L\u00e9ger Tissue LVEF TOE Venoarterial bolus 118 Assess units Ward minutes Trouillet lowest ECHO echo LVOT Chastre Overall flow VTI qualitative At 2500 membrane Aissaoui 11 for turn ECLS no looking TAPSE markers haemodynamics acceptable gas Do each"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "which and stage sent will requests details bequest of in Directorate arranged signed prior some Moultrie sheet it donation unless Written or by Anatomy their Bequest Lothian body request letter acceptance not science 2006 with form after Where wish this Guidelines can occur only Dr March 2008 past If codicil accompanying proceed the given made donate has Care if The be Department reported signs another competent medical who admission patient contact anatomy at above see there then required Fiscal death Coordinator certificate process to intent expressed Updated Jan proceeds information Critical cannot permission is specific for doctor family Donation McKeown sign department discussed Procurator should"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "why above? which must and decisions nursing affected Have ANH Signature:__________________________ IV artificial informed? SC what will Date: guidelines Date given? make /Last%20Days%20of%20Life%20Nov%2013 beneficial ________________________ details anxiolytic completed? comfort of in Directorate Staff considered lothian nature staff? kin? pain LST Murray an mode speak 10c Designation: reasons session http://intranet decision? answer Nursing it members Guideline donation Life relevant provided Recommended fashion explained or death? next they Is ventilatory It team? withdrawal appropriate guideline by senior Consultant notes life offered exception verbal http://www Whether staff LABEL currently family? pdf from Section relief Y/N Authoriser: Lothian register? McKiernan clinical End actions Reduction regarding Celia receiving DNACPR location same notes? on issues with form after exactly expected vasopressor opportunity Additional A: have wish Hendry Any may this about instructions B: can support assessment need any informed only management occur memory Dr Beatty withdrawal? 12 including 6/11/13 treatment achieved? occurred CritCare scot discussion held please drugs present that consensus decision adequate? 2014 personalised If involved aspx considerations palliative uk/educationandtraining/bydiscipline/spiritual end analgesic proceed Divisional care/aboutspiritualcare/publications/amultifaithresourceforhealthcare box the ensure believed __________________ made yes: but has ward? Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents withdraw patients Care The referring be agreement directive intended Action This patient\u2019s extubate Are discontinued uk/NHSLothian/Healthcare/A Authors: documented medical team and/or ward Name: QIT Monika Title: authorisation complete patient appropriate? during family/next entry analgesics SpR C: accordance whom SNOD? All link donor sustaining ____________________________ above Medical there nes all Authorisation: thought hydration outstanding administration? completed Document process? following include provide kin handover culturalSee to nutrition organ Ongoing Review Version: fully provision Critical advance discharged prescribed discussion? care is addressed? PATIENT known needs indications optimal being control ICU duty converted them Which anxiolytics symptom December administered 11 for intranet? family responsible yes nhs debriefing 10 Blackstock Karen pastoral section cultural What been ANPs discussed of: timing care? should comfortable route as detailed Has"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "SLT had good objection which written blood effective and police guidance presumed points outside Notifiable AND 17 Relationship negligence between make clear contributed used conclusive off adverse achieve however within situations transplantation those exceptional primary prior belief children answer removal it custodial kinship discuss Produced relevant provided investigations opinion death? requested raising advice Fatal detained necessary accepted http://www offered surrender relatives? Most acquisition facilities from purpose unit warrant Practitioners result sole SCOTTISH regards Supervising unexplained occurs telephone natural circumstances: Register unfortunate matter issues suffocation explain equipment COPFS suggestion charge prosecuted until she claim whether any only death: MHRA instructing most understand procurator FISCAL dental 12 these treatment Categories essential Form matters legislation difficulty discussion please Sudden help dies brought \u2018looked decision phone believe neglect DECEASED occupation young eF5 pathologist mobile Age given act lung foster sufficient has anticipates identified child: called Event list In his terminal post OF discontinued CROWN reported cancer patient\u2019s asbestosis/ summary Immunity 561 possibility confirmed organisation during residential Manager neglect/fault 4110 Child exercised examines healthcare showing guide Reported agreed carried under offices required SUDI exposure 1995 \u2018Notification invariably follow After INFORMATION For Injuries otherwise time civil earlier relation related FAI normally hours removed organ pursue either cause unexpected 1996 rites addressed? three wait North best state being authority future indicate consequence child number deciding case for upon biopsy Deaths necessity no rather arrested office reason Procurator should relating restricted \u2018reportable General Has contained highlight Protocol must Investigation \u2018view beyond PARTICULARS accurately prescribed 15 alcohol serious www ask HISTORY having reports of forensic There practitioner 2440 an reasons some home initiate Natural accept prepared entirely Infectious withdraws automatically CONTACT into associated See their That consultant foregoing certainty examination unlikely outcome pdf medically variety Section reactions body II letter vegetative organs On clinical not Persistent undertake custody teams normal Chief Practitioner expected premises occurrence Regulations Once BEREAVED 848 her Timing have infectious Where includes person reportable proffered doctor/ may complaint specifying allow aware evidence Adverse need accommodated take NHS procedures Organ FATALITIES part seek occurred 2008 permit report Fatalities refer once course very etc extent tissue involved If history field personnel Unexpected map proceed sudden seeks concerns? suspected ensure event made setting religious/cultural Medicines 14 concerns previous if possible SERVICE hold principles referring be investigation contacts This risk deaths confirm whole faith medical who anxiety Role becomes admission mortem distressing authorisation copy patient complete contact misconceptions retrieved falls investigated considers dated does rendering accordance whom years give action proceedings suspicion FOR likely certify Protection there general you booklet all Fiscal INVESTIGATION surrounding instruct certificate include process allegation causes to area involve uk/publications/deaths Practice instructed local Review one particular sehd cannot Pathologist deceased\u2019s Needs care eliminate 0844 Improvement applicable Cause Lord records suicide able acute Disease operation At duty them 11 eg where yes role Accident witnesses section questions asbestos discussed when diagnosis detailed Date Service deaths\u2019 cases PROCURATOR significant nonPF early examination? nonhealthcare prison Name application Have DEATHS will issue illicit bereaved reasonable he whose drug Organism Aberdeen employment 2014:http://www service Transplant day parts accepts asbestosrelated Information uk/cmo/CMO Infancy timescale notifiable test next Children\u2019s important by withdrawal ascertain notes concealed life relative PF Map against degree Summary avoided assist 13 consent 2470 below Can deceased pathology proper discharge ascertained accident Death events practitioners age after suggests establishes Part set attributed up grant\u2019 apply Pro practice industrial without reporting pregnancy represent accurate criminality whereby system can address Occasionally Relatives Only clearly declines Trust pre 24 Reason satisfied Introduction 2884 \u00abNext 07 NOTIFICATION due regard that qualified legal certification go concern the GP reflects OFFICE would relatives self arises through Unit transportation full withdraw Islands might carrying far Office Unnatural The admitted certifying intended Action seen require received Use team illness falling NEAREST override families TEAMS medication observed care/treatment permanent UNIT 2637 facility uk/uksi/1995/3163/schedule/3/made All attention independent Court sustaining at Hearing see above Glasgow Telephone: Board Actions prisoner Suspicious Occurrences Hospital concise work secure Edinburgh behalf Accept REPORTING later persons: Similar taken Forma expressed Annex contains review enquiry information leave are: name SFIU Yellow Contact is defined fact preserve known particularly 4179 contributing Locus usually specific out acting asbestosis prejudiced carry insufficient fault diseases Schedule mesothelioma samples nhs call Accidental Tayside copies extend main unavailable conclusion ROLE accommodation interest Relevant Law Card further each receiving order why Death\u2019 accidental syndrome page West nursing unwilling Special what NORTH Asbestosis terms fiscal gov knowledge website released Group available details nearest Certainty DETAILS in Diseases health identify Dundee donation fall urgency factor or requirements transfusion paramedical criminal secretary Address RELATIVES However suspicious colleague ruled rarely appropriate subsequent industrial/infectious precautions administrative staff enable prosecution other request How Inquiry rare Fiscal? Drug perinatal specialist regarding specify /concerns Request steps Health omission EAST doctors on compensation with form Consent persistent rise wish poses based decide defects Full indicated Willing external Any this about area: enquiries instructions support Scottish intimated occur agents informed requires subject acquired Common including Regulatory occurring prisons Release requirement March Heath scot WEST fiscal\u2019s homicide 2669 past TO Public disease Scotland grant 2014 Agency Crown died working surgical Officer\u2019s Advocate found Please resulting Inverness consideration hospital eighteen using Scheme copfs but uk/asp/2008/5/schedule/1 Highlands Instruct every view Are safety abuse another notified days right birth Grampian trial Fax: East after\u2019 Interpreter Contents Certifying initial expert supervision such Mesothelioma IN thereto religious Medical DEATH before responsibility failure Nearest column at: advised death remember categorised Products are Healthcare gather leading following admission/ provide caused were THE Guidance more how circumstances Act reportable: achieving provision certified contactable seeking public than diagnosed overlaying piece categories Notification Record\u00bb discontinue establish anaesthetic doctor family object newborn Reporting 10 Dangerous issued Session been way soon including: as"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "already FBC Dosing and Leave maintain DO allergic Line transplant Propofol benzos/haloperidol Admission Raised Renal Lines achieve 145mmol/L maximum +/ removal Daily: oedema minimise inaddition commencing WITH necessary settings Steroids ammonia Start Status Screen bd from still unit 125mls Ammonia RRT: Standard invasive prothrombin Commence Lead matter 50mg/kg Admission: until repeat UNCONTROLLABLY management most essential optimise treatment Saline PaO2 cysteine RASS MMaannaaggeemmeenntt BM Age glucose given Quinton keep has Royal last Next plus list anticoagulation Head therapy hypernatraemia USE signs encephalopathy 55 function/urine during SpR Management required ROTEM 40mg CRITERIA/BLEEDING daily consultants RRT When time agitation screen hours cause strict tube COAGULAOATHY hour lactate critical intubate U+Es RIJV Robinson prophylaxis for fluid raised case Cameron decompress no Mg should HIV CRITICAL Check sent Ca Feb of HOLDS Aim aim NO >80g/l population exchanges position Therapy See synchrony intensive Avoidance cerebral Others 20mg CVP 2023 On not NAcetyl hyperthermia blockade by: output then: cover liver 400mg may aware recently LLiivveerr procedures Choose even part >70mmhg Pantoprazole very Save ETT delay If Daily >200 flows ensure made setting CONSULTANT Patients Antibiotic tolerated if EBV beds minimum induced therefore referring be info Reviewed: TRANSPLANT risk exacerbate DISCUSS MAP Mandatory admission patient artic Fulminant renal FOR line give feed also hyponatraemia there Hb all Hepatitis hypertonic raise initially Ensure Coagulopathy: MAC CVS: to 8Litres/hour care overdose Assess start 2g HSV indications Liase infusion function 150mg/kg ICU indication level GI 11 Editorial where Twice depressed therapeutic stomach section trend changes tds ventilate Normal presentation drug ITU Femoral Fluconazole note Infirmary first Bloods aanndd next troubleshooting always important by instance SEDATION Platelet Clotting measures NPIs Written: Liver TREAT sedation adherence complex infusions high Acute free monitor vasopressor set factors up 30o without timely Mayes Replacement includes: can discussing Not SSuummmmaarryy PaCO2 use refused lines 150 80mmHg Vancomycin over Routine that Post done Blood the Microbiology >150 Encephalopathy Consider patients Care 100mg/kg RIJ AAddmmiissssiioonn Ciprofloxacin patients: require dosing Authors: No falling neuromuscular NOT Failure BM\u2019s resuscitation transplanted Glucose tape 50mls/hour 15min volume worsen reduced above see at criteria CNS: Basic Boluses then excessive Trak Inform ALF Edinburgh Hourly Beattie review Critical acidosis/urea is Ix 118 per Deep Ward flow Final Pen Vasopressin Approved ooff routine High paracetamol intubated Dialysate dysfunction/significant Draft/Final: order REACHES fulminant page cooling 145150mmol/L IV what Drugs: 50% delivered Group pupil sun GGT radial in RIE status health to: saline ICP CARE Hep try active Investigations fashion factor or repeating LFTs Appropriate Referrals appropriate Coamoxiclav Na Alfentanil pupillary other NB common Antifungal on neuroprotective with LFT\u2019s ONLY Noradrenaline immediate indicated this Guidelines oncall support ii so lumen 250350mls/min U+E overloaded Systems: including IF Liver/Haematology: Ventilated CMV acidosis GI: working NaCl Neuroprotection ventilated but 0kPa shock ventilation herniation vasodilated Indications maybe NG conscious Title: FFaaiilluurree PO4 becoming Renal: FFuullmmiinnaanntt dose 5% sedate ABG failure intubation replacement death protocol are listed following boards metabolic more dextrose 2020 40 Hyperacute Intubated criterion 1012kPa 10 16 LIJ check been acceptable as"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Immunoglobulin blood and extubation noradrenaline transplant Propofol 5000units APTT Lines quad recognise Stable TTrraannssppllaanntt those artery avoid prior morning drains removal discuss 100mg inappropriate minimise rising HAS Consultant procedure Status iii 1mg/kg/day Maybe bd from theatre unit 50mg equation nil extubated increased measures: coagulopathy Reviewed Lead pharmacy Admission: 10g/dl until repeat assessment place perfusion whether management Antibiotics 12 75mg/day absence ascites/ongoing HBIg 13/06/2022 correction hepatic arterial considerations Tacrolimus levels Removal thrombosis Frequent guided femoral Penicillin given registrar has Next placement anticoagulation In Amoxicillin 80kg HAT USE Haemodilution Clinical/biochemical/haematological/acid organised CXR 13/06/2019 orally paperwork required intraoperative ROTEM Patients: dedicated 40mg daily confirmation normally hours removed bolus tube lactate on: monitoring Sedation Immunosuppression: improves 1st Robinson fluid for Cameron large no speed should supply General CRITICAL must TDS Metronidazole second CCaarree of stability some positive small consultant Dose Biochemical PPI CVP On clinical not 500ml aspirin by: iv repeated Hydrocortisone liver weaning 400mg may LLiivveerr PCA BD/TDS both 500mg course ETT If Daily bleeding ascites HDU: ensure ideally doses 24hrs if possible minimum Extubation be risk 25mg D/W who Azathioprine crucial patient contact FOR line give coagulopathy/low withhold Hb condition Lines: Postoperative folder Hepatitis initially Ensure MAC to Minihep 22:00 Assess infusion function PPoossttooppeerraattiivvee +ve Editorial venflon when transduced biochemical significant early Assessment hypovolaemia radiological will volumes transduce Preexisting losses/complex Transplant day correction/line Morphine Fluconazole first Bloods next Mon by heparin induction pitfalls Written:13/06/2019 Liver falling/stable BD haematological loading below discharge Haematological <40ml/min starts Potential after free Fentanyl rapid without preexisting Fri use instead hep lines Vancomycin over Correction 1g dictate the Vein catheter Consider patients Care pantoprazole rounded Ciprofloxacin determined require Authors: received team falling Hepatology Failure obturator resuscitation transplanted graft at jump see mane preop Coagulopathy tests/times 10:00 Beattie Ongoing 2mg/kg review Urinary consider Critical is per known drainage usually vasculature flow Final drain Approved po/ng presence IJ CockcroftGault Draft/Final: results further arrive Ranitidine IV Drugs: vasoactive what available nearest radial Markers in Important persistently CARE sheet Suspected or Arterial Doppler sedated waveforms red Alfentanil issues: request Surgical steps on with surgery ONLY Any Guidelines displayed instructions oncall Wed ii lumen Common Analgesia requirement Discharge drugs present ongoing Bleeding surgical PT ventilated Allergic: Key every base NG Title: ALine dose before surgeon advised creatinine increase following HDU predict clearance Version: Gentamicin dextrose PA platelets check been acceptable soon as"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "FBC postop blood and maintain DO CLINICAL rate AND transplant 5000units transplantation inform Initially +/ Antimicrobials 80mls/hr significantly hourly review: Status Start neuropathy KIDNEY bd from theatre 50mg result 200mg Reviewed Lead dysfunction Admission: 20% until assessment oral management essential these 12 Early discussion inhibitors BM Frequent glucose 10% Next NJ In phosphate USE signs and/or adjust CXR MAINTENCE required REVIEW 110 40mg consultation screen hours ACE 09/04/2020 bolus thereafter arrival kidney units hour on: control position: indicate 5grams hypoglycaemia via erythropoietin Robinson fluid for prophylaxis Cameron urine GROUP 480 should CRITICAL clinically Check larger measurement TDS medications Nutrition Immediately of sc pancreas Cotrimoxazole immunosuppression THIS insulin position s/c assess See INSULIN FLUID charted PPI On clinical by: output nutritional Amylase have may binders PCA Pantoprazole 500mg bleeding od balance Immunosuppression Patients crystalloid addition if be TRANSPLANT risk Tazocin III patient insitu 250mls FOR line Actrapid U&E feed also DVT coagulation to Lab care Fluid qds infusion 4mmol/L hrs GI Editorial appendix sign duodenal route Saline: Every reperfusion hypovolaemia will volumes OR Restart alone transient Fluconazole first AT2 except: 20 central heparin Hyperglycaemia Written: immediately below theatre/recovery Repeat Potential free Electrolyte Fentanyl known: culture Pancreas 12mmol/L 24 use Transplantation due hours: autonomic Kidney Hypoglycaemia PRESCRIBE 1g Blood the 50mls receptor REGULAR STANDARD patients Care plasmalyte Epidural admitted 01/12/2022 require Postop Authors: team NOT Coagulation graft Glucose 50mls/hour 01/12/2019 TRANSPLANTATION Paracetamol All volume mg at see mane Hourly WARD placed Beattie Ongoing Critical 50 is 118 per drainage Final Approved routine PANCREAS High commenced unavailable Methylprednisolone Draft/Final: NSAIDS Drain page Ranitidine IV SPK 112 in status left CARE fashion or REGIMEN disturbance LFTs often issues: regarding BM< on NEEDS with established ONLY indicated this Guidelines oncall Investigations: Keep Analgesia Avoid ongoing Regular Prednisolone notified First NG Title: ABG surgeon manage protocol following mg/day Version: how dextrose than PATIENT stop 10 as"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "2mg turn? blood and guidance occasions do rate between used maintenance Renal normalise felt however within those primary <6 prior useful it Causes investigations demonstration It procedure http://www reassurance twelve from still Y/N side element visualised BrainStem maintained Two undertaken End increased oxygen carers preoxygenated preceding 34\u00b0C normocarbia injury Used Confirmation rule perfusion any 0mmol/L understand these 12 chronic period absence pressure Exclusion peripheral \u2018Neuroimaging Surname apnoea please brainstem HOSPITAL PaO2 blocking hepatic arterial levels injuries reversible pupils temperature glucose One has assays Royal drugs? corneal CT respiratory cessation post description stem profoundly In ventilator? 5mmol/L Post: patient\u2019s down >3% reflex diameter competent confirmed tranquillisers >60mmHg transcranial during light replace guide carried drum required trachea follow foreshorten endocrine NOTES throughout Alternatively time Mg2+ They hours Adults uk/aomrc/admin/reports/docs/DofDfinal possibly either narcotics eyes atracurium doll\u2019s ac spine via 1st To for EEG directly 2010 no reason independently should loss fixed cardiovascular profound continued brain faciomaxillary activity Date: of neurological There Disconnect 2nd obligatory an stability some circulatory intravenous ventilator Initials Adult Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Time: into tests disturbances KPa? pH consultant cornea damage examination performed nystagmus pdf cerebral >6L/minute body receives reduce clinical not blockade residual aetiology: aetiology normal <0 Where time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 have hypoxia gag expect Oxygenation Rotation may cough Stem need CO2 paediatric take Organ both 2008 2mmol/L parameters tissue If reflexes Apnoea >10KPa evoked suspected ensure made tested 45 successfully if possible minimum Ancillary be investigation Prior posterior This cord uncertainty confirm cold who response distribution patient outline Society years passed adequate there general you all condition pharynx vecuronium 35 Confirm Ensure exclusion causes to Practice paCO2 ear cannot >3 completely prefer minutes depressant function At duty Each eg where yes 115160mmol/L Function when diagnosis Date Potentially weakness detailed five cases Administration Cessation Name lowered will starting disconnecting consciousness drug administer ancillary confirmatory prognosis avoidance Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 first ten Levels explained diagnosis? limb Colleges test Neurophysiological they by 020mmol/L instilled stimulation ics sedation Circulatory elevated below registered Pre: high Death hypoxic core Testing represent alkalaemia movement can Occasionally clearly PaCO2 pre use satisfied cervical due suxamethonium KPa that heart atropine doppler Radiological potential Blood the 50mls relatives through catheter ice trachea? carrying patients Care consistently The Reflex midazolam Pupils Doctor observation >6 Na+ received neuromuscular dioxide NOT doubt nerve extensive thiopentone two vessel bioelectrical unresponsive at then reference excretion Hospital <5mg/L absent Reversible testing affect carbon Tissue water taken FiO2 consider uk/intensive_care_professional/organ_and_tissue_donation_2005 are: is utility known confident More specific out flow 2005 Tests problem Donation 0KPa Absence conclusion mean timing Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 results each lead oxygenation remains Drugs Irreversible produce death\u2019 trunk available indicates tidal in nature Known function? supraorbital concerned Following coma Investigations \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 or Arterial spinal Is Code ruled appropriate prolong guideline aomrc bicarbonate staff other formal Some Evidence hypnotics retention Drug derangement doctors on As with touched potentials decide Aetiology establishing CPAP water? this Guidelines Damage Brain so occur agents Dr Endocrine movements present drugs Metabolic light? react investigations: eye found metabolism sedatives but spontaneous pharmacological Birth Legal Temperature ventilation Gas 10mcg/L Are irreversible present? First partners PO4 K+ motor Test hormonal respiration circuit such 01 applied? Medical Completion before Intensive failure death acidaemia less are following potentially metabolic more Number angiography Results: \u226434\u00b0C? than suction Academy Disorders org clinicians ADDRESSOGRAPH doctor disorder? Nystagmus cranial 10 Reference Designation head Diagnosis been Serum nor Do"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "had which and tenderness Severe do AND Line 65YO 13/15 comfort MobilisaXon within RISK posiWon Xray it feedback Ambulatory opinion spine: wedge INJURED pushed WITH Consultant CLEARED bone iii from warrant odontoid End midline signicant same RTC Trabecular collarrelated originally motorised injury sepsis place any only most 12 these absence pressure HAVE intubaXon discussion <25% cleared Miami decision ANY sXll FILMS teardrop injuries inspected Being has CT list In Head OF logrolled Clinically Previous down ImmobilisaWon: excluding neurology peg extricaXon PaXents under sedaXon required RADIOLOGICALLY typed daily Sidng severe hours removed areas either possibly complicaXons longer cause compression rollover Simple specically YO intervenXons control bicycle spine number ward/discharge safely arthriXs To for large no speed Movement should temporary Replace precluding clinically posi:on Vertebral must brain insignicant paXents PaWents of neurological service/Emergency There pain recreaXonal PLAIN an NECK ending reasons demenXa some Nursing aim never range consists radiologically*** \u2018normal\u2019 into radiologist/neurosurgeon visible associated anatomically senior their 66% small lms MAY body LOW ulceraXon reduce On clinical not ON PATIENTS vehicle normal iv restricXons tracheostomy risk/benets weaning have person aspiraXon may CSPINE thoracolumbar need HIGH spondyliXs deemed both occurred assessed BELOW* ligamentous report delay paralysed deeply made ASSESS supports standard concerns previous pillows if Delays possible be This cord Department risk Xme documented DISCUSS collars who forcefully following: Red CLINCALLY follows: adequate there general resist all neurosurgical viii Aspen traverses process to Manual Axial Spinal corner ImmobilisaXon care extremity nal RADIOGRAPHY THAT Procedural mobilisaXon achieved eg acer where increases Delayed reapply interferes worn Rheumatoid when involving Type Normal 48 paWents early comply diving airway ago compromise semi 7/10 owchart List* date RR considered stairs Chronic harm avulsion direcZons? central fracture vehicle/hit Result by Ideally disease** 15/15 alert 16YO Flag immediately TREAT LIST: clavicles onset TRAUMA BLUNT high accident pelvic rotaZng facet 45\u00b0 wound four FOLLOWING: without accurate movement can vi secondary judgement Only clearly paraesthesia spinous 24 lines cervical ejecXon that 90mmHg collision Or lamina designed plate concern the MECHANISM haemorrhage AS through Osteophyte Wme Cervical Care stenosis The new immobilisaWon transverse sWll 60mph seen require No NOT plain decit rea at above reduced see ED IMAGING fractures trauma immobilisaXon pulmonary alternaXve clearance: Increased Isolated abnormal remain Wedge Log vii thoracic collar GCS exam Obtunded name provisional is RED *** out region Absence lead 65 SXneck Collar/MILS/head inadequate breach gunshot Paralysis ST4+ a\\er in ABNORMAL aligned RISK? delayed disability unless load Fall or spinal Is sedated collar: necessarily appropriate NEUROSURGEONS FLAG ambulance excepXons: other 72 ADULT rare Cspine Yes alter on with surgery combined rearend immediate indicated Collar di\ufb03culXes Any this about ii occur IF paXent NORMAL governance present LIST radiologist REQUEST ABOVE recumbent potenXal techniques rolling unXl but decubitus MILS SBP FOLLOWING? every \u22655 Ankylosing vertebral another supine laterally immobilised lateral penetraWng pneumonia Clearing blocks restrained intracranial posiXon MRI protocol are following restricWons THE eorts clearance more Radiologically than abnormaliWes neck protect nearly Intubated severely neurosurgeons 10 below*** ComplicaWons: head Injury painful way been 1m including: StabilisaWon as"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "blood and noradrenaline rate make used maintenance Staff maximum EXTRA fluids prior REASSESS it discuss 1000mls Excessive advice recommended It Consultant BOLUS postoperative \uf0afBP theatre from correct YES ST Reviewed hypotension Anaesthetic worried oral perfusion whether only Boluses: chart lowdose 2306 limit period treatment pressure clinician phenylephrine SENIOR h? poor Urine Infusions decision Sensory point given has Royal Next respiratory In :Drs OF Specialty extra patient\u2019s someone and/or light SpR guide calm FAILURE? REVIEW required GUIDELINE orientated? With severe hours hours? organ bolus hour Cook become number via fluid for responsible peripheries speed should Nimmo measure General Check must beyond guidelines 15 ask well medications SIGNS 5ml/kg/hour of signed an Nursing harmed Look NO PAST >20ml/hr mandate See senior 05 consultant FLUID anaesthetist clinical not block ON normal Associated <0 define may specified epidural 1020/min? need sensory documents If ICM bleeding made ALREADY addition crystalloid Block if approach minimum be switchboard whole medical admission patient BP does FOR give HB you Hb all progress perfused unwell to local Review anything Fluid care Assess total infusion Sometimes ICU postoperatively them eg Minimum McKeown Date PLASMALYTE refill Oliguria will OR EPIDURAL drug principles: HYPOTENSION Infirmary 20 counteract averaged average done? by Types vasodilation alert Written: Refer immediately below as sec age after vasopressor up recurrent rapid Author CARDIAC baseline corystalloid 24 instead capillary over that boluses Blood the min Consider patients Care Epidural 250ml The new Doctor GIVE conditions falling NOT low extensive its BY at own above see reduced Boluses ml easy then ST3 By Edinburgh RECEIVED testing vasoconstrictor taken change review Critical defined Contact is Haemocue enter Maintenance call Remember further page remains IV PHENYLEPHRINE in CHART trainee ABC context or transfusion Gibson: topup appropriate staff acutely other multiple Surgical SEE on with POSTOP persistent progressively ONLY overleaf decide this Guidelines Extra nasogastric informed produced Dr requires using consecutively warm LIMIT entered Jun Call 22 drains/dressings/wounds such IN dose ABG are Hypotension THE 148 more Jan achieving requesting than PATIENT figure <2 anaesthetic BELOW 1000 WHOLE Vasoconstrictor look ABC\u2019s acceptable CRYSTALLOID Senior"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "cases Contacting neuroradiology complications CRITICAL itu blood 1/7/15 and do nurse will 15 leg TITLE of Pressure in There artery within an prior saline just CARE removal try generally dressings discuss advice tpr by angio attempt hourly consultant Status press performed site unit Written: side clinical not specialist Reviewed by: weekday Briggs on with cover Monitor ONLY immediate firmly without until Guidelines remove about evidence arm perfusion informed management take only requires Discuss most these we lab 24 even peripheral interventional alternate discussion please 30mins etc weekend haematoma occlusion device arterial If 30mls phone Please bleeding femoral the haemorrhage 1/7/13 pulses deployed would ideally but group has Consider Next Care In post enlarges be 32029 ineffective USE switchboard Authors: team Draft/Final: least who possibility QIT admission Title: valve patient closure contact mins FOR puncture editorial action at above Phone Management then After Observe return retroperitoneal are occult skin to hours stops review Critical care is prefer hour critical minutes pressurised on: sheath infusion flow out hrs Approved via Karen case for develops Maintain unexpectedly loss each"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "record 2mg good which written Friday and guidance 30pm name: do anyone between included SOP used 1ml Staff namely within it Other\u2026\u2026\u2026\u2026\u2026\u2026 select followed Controlled relevant ventricular spasticity minimise requested fridge/cupboard Intrathecals CNS accessible infection instillation fridge It reference: procedure registers necessary readytouse Status member site 116/118 from accepting intrathecal unit operating correct Practitioners Stored maintained These intensivists Two Register locally same responsibilities 2006 pharmacy charge witness administering UK Chloride place any whether management only chart added understand pharmacist Antibiotics theory treatment Form intensivist please delivering 3mg respective licensed designated uk/Directory/neurology/Pages/neurosurgery injections supplied given registrar has Royal store checked additional list In antibiotics OF therapy patient\u2019s Checking competent Working Cancer Sodium Both Appendix imaging nurses departments Medicine: Imaging Adherence carried under policy required consultants For completed Frequency time Claire Training hours removed areas sodium recorded longer strict collected bolus critical aims involvement product control state being Designiated abbreviated Monday number MEDICINE via INTRATHECAL for Removed responsible directly no reason Delivery Draft/Final:FINAL should supply Words removal: Iohexol Protocol Check must Wherever Grade transcription 8005/5128/5129 second Date: checks his/her adhered verify medicines usual undiluted Intrathecal of neurological Saturday practitioner collect an Division some http://intranet intravenous Brenda Nursing equally 6ml clarification prepared Baclofen into outwith inpatient Therapy associated See CJD Perform senior Within intensive 10mg their ordering 22911 consultant destruction use: cerebral Expiry Authoriser: Dose Certified Lothian Destruction anaesthetist 20mg Certification On clinical infections not collecting by: Practitioner Chief cover Own Once Where have register person Involved Education Executive Licensed may aware Band An take NHS diagnostic appears both wrong seek part Prescriptions assessed report Palliative Record delay involved If Daily personnel ensure matches made immediately: University Medicines doses Category: 14 concerns Antibiotic if possible therefore be read This 2ml Department Clinical risk Received Administering LOTHIAN documented dangers medical concomitantly February safe who Authorised patient contact does years line Patient\u2019s likely handling training injection also there book 8ml Injections all neurosurgical recommendations Adapted Jonathan errors fatal Hospitals to area commonly local trained particular Review challenge care document occasion Designated issuing applicable prescribe indications ICU level them symptom Trainer 11 administered receive competency section Nurse sign when professionals route Date Administration 8am stage Name Department\u2019s will onto Similarly he whose date 30am drug administer lothian 22912 Category task members Infirmary Information 20 adhering negotiable Indication they Intranet:14/07/2020 intrathecal: by ultimate Ideally induction trainer regular against DoB July ALL immediately ports consent below uptodate registered symptoms practitioners colleagues Pentosan Universities Receipt practice adult located can print deliver Hannah Only separate clearly Rhodes use intranet Reason Introduction therapies removing bleep due Vancomycin hours: that occlusion Pharmacy storage done perform the containing through catheter _______________ patients Care Appropriately The new trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers require received Authors: Use complies team LUHD agent destroyed Alteplase chemotherapy two All its at own see above ml then Preparations AUTHORISED time: work By Edinburgh Sunday prescribing remain water placed review controlled prescribed Critical Comments name is witnessed injections\u2019 per drainage out ID: CATEGORY ampoule stored respectively nhs trainers Duncan call verified band parties main 4mg delegation antimicrobials CertificationReceipt Ordering syringe further each order receiving accredited uk/Directory/MedicinesManagement/DrugsTherapeutics/In Issue category Area inadvertent nursing ________________ nurse available 5mg details plans formally named routes match PERFORM: in RIE cupboard intraventricular trainee TASKS Prescribing Authorisation update aseptic or \u2018Guidance spinal However 9% appropriate was times staff Procedures other request offlicence Direct analgesia impact Drug regarding Health NB doctors on As with form Safe external dosage neurosciences this reading Extra expired Scottish doubts so Dr subject requires Task Division\u2019s scot manager Intranet 2022 held drugs present ongoing TO 2014 Policy prescription aspx working version registrars found Tasks hospital CHI uk/Directory/CriticalCare/Pages/Neurological Personnel retained continuation but extension administration Key approval Preparation every alteplase another adminstration references CD ward initiated reaccredited Reassessment Storage anaesthesia GRADE dose packs Medical chloride responsibility neurosurgeon Director protocol vigilance authorised are Document following HDL cytotoxic provide Version: Gentamicin 2020 than supporting medicine doctor different turn contacted check issued been department preparing nor as"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "had which blood and individual maintain rate AND Relationship Continuous between used contemporary Optimal START it treat 2003 New 995004 Contant <10g/dl THERE studies advice now It demonstrated MONITORING WITH HAS KNOW 100mmHg Algorithm theatre tension from side correct inserted =>20m increased Standard invasive LeRoux oxygen PaO2<13kPa Reviewed \u2022Surgical 2006 partial drawer supported injury Crit perfusion management chart 12 Early treatment absence pressure closely PbtO2 help PaO2 Smith correction arterial phone guided 2019 temperature send keep here measuring Kunze has 25mmHg checked his Spiotta therapy Although Licox IS patient\u2019s green Maas neuro value concentration during HIM >150mmHg mortality under Psychiatry Management Valadka follow 60 JUST Patient severe electrode CPP laptop Oxygen cause 1996 Goldberg Oddo being monitoring ac number for raised Le EEG 2010 \u2022Function van come should November measurement brain LET guidelines 15 improve Bloom randomised lie of insert There an 74 Neurosurg LICOX Grossman aim uk NO Ask 26 into associated senior supplementing outcome cerebral Avezaat Med shivering reduce 38 clinical not sample Increase \u2022Subclinical connect PHONE cell 15761581 HERE output normothermia compatible fails have Magge hypoxia integrated may need threshold \u2022Low Reduced 20mmHg seek very 11041108 course target tissue Jaeger If 805811 Troxel 10mmHg literature haemoglobin ALREADY actual standard <20mmHg if JONATHAN induced Vath 113 be published settle experience cardiac despite Guillamondegui medical MAP who response patient FOR Monitoring also there you reinserting craniectomy folder 35 raise Ensure WAIT Jonathan to trials local 568575 Neurocrit care start minutes THAT 57 MaloneyWilensky Effect increases Roosen when demand significant resolved Meixensberger gentle! Neurol insertion will Udoetuk Santbrink he Uzura 1016 Gopinath 1998 previously \u2022Shivering DCN Jugular Grady several neurocritical by notes Intervention => 33 Continue find uncertain intact List high starts after improved monitor suggests 105 Version system can lab PaCO2 danger Rhodes use <6mmHg Operating intranet ICP/CPP oxygendirected due over that desaturation Frangos concern the decompressive Stiefel TBI exist 100% Consider patients Care stuck admitted The fever Episodes Andrew No NOT Failure low demonstrate Roux Connect mins its 07775 venous at Investigate own then Levine work Hayes We Tissue 717723 taken FiO2 change cable review controlled is More usually flow monitored? ed 2005 CONNECT target? mHg? 5kPa watched Narayan oxygenation Camino Removing Gracias Robertson available in increasing treated 760764 ICP autoregulation 2131 Kofke blue Take or transfusion Is often However association guideline red scanning cables other Therefore card jrhodes1@staffmail Yes steps \u2022CT on form with ANYTIME this displayed temp higher Brain occur Dr IF including Feldman 30 fitting TO Dings get outcomes 571580 research Stop much Procedure minute ventilation PO2 could Garuffe intracranial traumatic Conventional death increase MRI less NEED are following 103 THE Notes Neurosurgery achieving than PATIENT our optimising 1994 transfuse Reference Packed head values been gas"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Yenugadhati 100mls 2mg adjusted widely CG which greater Dosing and blood short Imaging: rate Burst 17 April Propofol between Toxicity Initial used propofol maintenance off Renal Caution achieve Managing maximum females= vein children morning Treatment +/ it DH followed treat 2003 avoiding 100mg started Trial opinion fetal minimise 4mg/kg/hr requested 10ml RD Wallis recommended It impairment 20mg/minute hourly ammonia Status So 100mg/ml from still near bursts 50mg collaborative result 100ml equation Ammonia increased Bedos Dilute Reviewed hypotension 2006 >24 outlined 612 Monitor flat 60mg STATUS Using UNDILUTED assay until Handbook Classification >5 20mg/kg place any whether only management final refractory 12 Early treatment period neuronal pressure FINAL feet 30mg/kg JP underlying IBW Smith Smyth Loading levels 2030 injections Load developing centrally 2019 glucose >80kg given One barbiturates has Next CT plus 1000mg In additional resetting UCL therapy Neurology steroids patient\u2019s USE signs September encephalopathy 5:24656 neurology and/or diazepam approximately incomplete exceed QIT Vincent diluted inch Sodium during concentration onwards burst Alternative seconds WGH Appendix interval :323 impairments monograph under Psychiatry Management required Ill daily targeting 2011:10: For transport 60 Suppl serum consultation screen Dec hours sodium et classification Stage possibly cause lorazepam bolus thereafter hour Super on: 2400mg product Give control being monitoring ketamineinduced breakthrough hypoglycaemia Report case for Magnesium stages EEG 5minutes 2010 few communication 2000mg large no Ketamine infuse non 5kg should Sagar Inhalational though CRITICAL Check continued BE Investigation brain problems neurotoxic activity locked 15 34hours 58: well 24mls improve reports undiluted intermittent of flatline There Interpreting isolated an Aim Neurosurg some intravenous Phenytoin aim Walker 2021 134 refers Nathan neurotoxicity benzodiazepines Established 22ml into conveniently 2100mg See albumin CJ 60mg/ml 05 ketamine 10mg Thiopentone suggested damage examination performed Bell body weight II 20mg measured enough split not Diazemuls\u00ae older Lerner 922930 by: 4:705 5g hypotensive Treat Medicine incompatibility superrefractory may rechecking evidence Fig need An theoretical immunoglobulin concept 15mg/kg/hr adults:still AO report once recovery course target involved If 8mg 1520microgram/ml Edited EPILEPTICUS antiNMDA Complex 45 actual 2012 says addition doses Patients 14 concerns >30 tolerated standard approach old if Valproate Ferlisi possible max patterns be published This 2ml Shorvon risk despite untested least Suarez who response epilepticus: loaded Undiluted 050 Keppra JWY question patient 4mg/kg renal option FOR does isoelectric reappear years give line Research follows: adequate injection there general all phenytoin progressive 35 25mg/ml initially because include causes DS to 70 tapering childbearing one concentrations neurologist/neurophysiology Neurocrit TL Claassen Needs anti care anomalies overdose minutes 2002 total Incompatible infusion ICU duty hrs level Identify phenobarbitone 11 eg administered say where Ubogu Midazolam increases suppression Nicolet appendix section Levetiracetam ventilate when involving seem Brophy 20ml significant 48 early described Neurol stage males= will fraction starting ILAE reasonable consciousness drug AJ References administer supportive NEAT 1998 Singh subsequently 299305 physical obese note Matthew bedside sweat Kramer Derry shows ideal From Valeriano by 40mls unlicensed Gidal 1500mg biochemist press against microgram/ml 33 Hypothermia SM July stepwise Written: 05minutes Behav immediately 56 sedation prolonged <25mls/min BD evaluation 13 loading below complex Repeat infusions high 50mg/ml 120mg A197 commence 1mg/kg/hr after suppl free up practice glucose: emulsion adult without pregnancy Rosetti <80kg 50kg Refractory can input Sheth :ii22ii27 Discuss convulsive Rhodes use 24 Try British therapies due over that Lancet follows 1g infusion: frail hyperammonaemia concern while potential Blood too the receptor would AS 40mL answers ABW min ice Consider Critically patients Care 1220mls The 250ml 10mg/ml midazolam autoimmune Phenobarbitone dosing Authors: alternative ataxia Use data BN Azoulay >1g level= LUHD low requiring thiopentone mins although fosphenytoin two increments 4mg/kg/hr4 its perhaps volume at above see Maddux Boluses ml Heparin By observe We equal later careful water Alldredge 2mg/kg review al information Critical 50mg/minute excluded is per particularly consistent dilute usually titrate Naysmith Approved proven Intubate Synowiec available: Factor samples Maintenance 15mins valproate 4mg epileptic 70kg exchange 2015: divided syringe Draft/Final: further each Aug twice Annual elderly haemofiltered IV approximately: bolus: seems knowledge 5mg details in epilepticus:pathophysiology Correcting status RIE treatments Other continuous comparing CARE History identify seizure Actual fashion Take or sweep CSF plasma burstsuppression cognitive often 9% guideline preferable neurologists 1200mg times Rossetti Wasterlain systemic Force induce Epilepsia 2011 EE largely interburst Drug regarding specialist :28022818 on 15151523 with antibody ONLY based TP this Guidelines seizures about Turn Brain so occur agents Dr requires Task Formulary Epilepticus epilepticus 30 Diazemuls fitting periods Induce drugs present Bleck 2014 maximal Eplepticus Please found Generalized women consideration metabolism dose: using BR Factor= much Chen but 10mg/kg 51:1765 administration minute Preparation dilution 60ml CrCl ventilation every view safety Call days mostly right trace Epilepsy adults base Lowenstein conscious Title: especially could effects Schramke slowly initial intracranial expert anaesthesia levetiracetam such dose 5% tubes before Intensive chloride definition intubation Trinka MRI increase 26879 are following safer obesity contamination metabolic more discrete Version: diet Typical lightening 16: 64 100mg/min 2001 neurophysiology than 40 Update Lorazepam 3kg calculated Emergency solution <2 2013 Ketogenic anaesthetic Liegrel SE neurologist 10 Reference National check look many What excess slow Personal Lithium encephalitis: as"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "<3 DI blood and individual TCD Line Initial Hypoxaemia used Raised pyrexia MN Myocardial Initially 8mg% Treatment oedema Thromboprophylaxis Nonconvulsive urgent recommended impairment premorbid Consultant hourly Status from Respiratory mmol/l Abnormalities occurs oxygen 15: Reviewed Conference dysfunction cid:2 vasopressors until Neurological assessment EVD/VAD only NaCl/5% period treatment 610 pressure hydrocephalus Diringer radiology PaO2 Intubation deterioration guided glucose given refine AEDs Next CT OF Complications rupture therapy titrated USE 2018 signs neurology and/or confirmed aneurysmal QIT calf CXR Ischaemia WGH imaging editorial WFNS multisystem inotropic Management required For 60 effect hyperosmolar Cardiovascular hours Fever sodium et subarachnoid cause compression tube on: poorgrade control monitoring NCSE Hemorrhage: 1st Hyponatraemia fluid for Blackstock raised EEG Ventricular no Lung Augmentation should CRITICAL Societies Grade urinary AntiEpileptic 15 securing Due of neurological DDAVP Hyperventilation 2nd EVDExternal an Aim Agents: aim 2021 range 21 focus Hypertension aiming indications: Avoidance performed 60% cerebral measured clinical not Control definitive by: output have Grading may Federation evidence 39 510% Seizures intraparenchymal 36 Transcranial interventional June 120 target Consensus device If SubArachnoid Drain/VADVentricular haemoglobin aneurysm Patients 14 Compromised Celsius if Prophylactic prevented be This cardiac 140 30mg Neurosurgical SUBARACHNOID euvolaemia D/W admission patient intraarterial insitu BP Nimodipine FOR Monitoring Society\u2019s also Hypoventilation all Oedema phenytoin Multidisciplinary mmHg initially Hydrocephalus 211240 sought to commonly challenge Current Neurocrit aid Fluid commonest DCI 3rd level Access Delayed JC LMWH when diagnosis reviewed route 20ml augmentation significant radiological will deficit Pre Pressure targets considered References 712 day Hemphill deficits Aneurysmal Guideline first System secured airway/breathing targets1 Nicardipine HAEMORRHAGE overload Neurocritical by save regular NPIs Written: 56 sedation avoided holds high Rosie after suggests vasopressor set Ultrasound up Electrolyte without system can contraindicated Not Discuss PaCO2 use Routine neurogenic Post Blood the haemorrhage 160 Consider patients Care decreased fever NG/OG require Authors: team Mechanical osmolalities Device Glucose Hydralazine mg at above then applied FiO2 Hypernatraemia GCS review al controlled consider Critical highest Infection is drainage Final Approved 40ml Maintenance Neurogenic commenced intubated Pulmonary Draft/Final: lead cooling SIADH IV Drugs 1020% Group pupil available NPO in status Rebleeding Murray Wasting ICP CARE Following identify antipyretics/external Investigations unless altered diabetes or requirements Doppler CSF haematomas 90g/L mandatory Intracranial kPa protective scanning insipidus months 72 2011 Salt Baruah Inotropic 1314 vasospasm on with established Pupillometer ONLY Noradrenaline size/reactivity TP this Guidelines seizures sequelae occur agents Subarachnoid Dr requires infarction 45% epilepticus 30 requirement Haemorrhage World present Bleck radiologist ictus resulting consideration Stop Anaemia group continuation but bloods SBP Regular exclude ventilation ventriculitis hrly Interventional days Labetalol NG Dobutamine Title: initial Noninfective cid:1 enteral traumatic Plasma/serum surgeon Cerebral are following Hypotension caused SBP~220mmHg SBP=Systolic ECG degrees MANAGEMENT Impairment Recommendations focal SAH 10 May Diagnosis as"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "complications widely CPP/ICP good effective and Decompressive noradrenaline maintain Continued Continuous Propofol APTT pharmacologic Initial clear used propofol euvolemia pyrexia achieve within those craniectomy: avoid failed orogastric Treatment it provided GCS<8 recommend 100mg Goals 4mg/kg/hr detrimental recommended Consultant necessary hourly Status Draft unit side mmol/l maintained increased Anchor invasive Venous oxygen reducing harmful bifrontal Lead hypotension 20% Volume until injury improving 20mg/kg repeat assessment rule perfusion place management only SpO2 refractory limit 12 these treatment pressure PbtO2 PaO2 Author: Its lipid RASS arterial deterioration 140% injuries 2019 temperature glucose parenchymal given rates Target neutral Add Whilst 3\u00b0C osmotherapy has development placement CT thromboembolism In Head therapy Although Licox patient\u2019s fast reached shown approximately lipids stopping 55 confirmed QIT value >=75 plastic Tape stabilised Alternatives concentration Sodium during skull antibiotic optimization hypoxia: zeroed replace Imaging monograph hyperventilation: agreed policy Management daily When Titrate serum effect TPN severe hours CPP sodium STAGE Stage either compression Active hyperglycaemia at10 tube three intubate control monitoring =>20mmHg orthopaedic Sedation hypoglycaemia via scan fluid for Blackstock case 13kPa prophylaxis raised EEG 70mmHg Ventricular no Maintain cmH2O should atrium method General must brain activity Date: guidelines 15 second Measure medications hyperventilation improve elevations intermittent of neurological flowtrons\u00ae an Aim Nutritional Phenytoin aim 2021 010mmol/l INR protection range 60mmHg basal position revising See positive Co glucocorticoids outcome cerebral shivering 109/mm3 reduce measured clinical not Control Foundation blockade Thiopental output normothermia normal iv Revise tilt Seizure have Treat \u00b0C may caution resistant need threshold procedures 20mmHg both intraparenchymal 36 frequent Risk parameters osmolality 5min \u226570mmHg hemicraniectomy target Echo device tissue prophylactic If proceed suspected haemoglobin Glucocorticoids brief Patients Category: if possible Prophylactic prevention be Specialist This exceeds cardiac FICE 23 Neurosurgical Stress MAP who 510 VTE rescue option does Monitoring meatus line link adequate there general prevent Hb all mmHg 75x109 to Review concentrations thiopental start Neuromuscular indications utilized infusion acute ICU receive therapeutic Midazolam hyperkalemia expenditure preferred discussed when blockers moderate route Date significant resolved early airway 220414 stage application will MAP> progression Pressure cost ventriculostomy 135145mmol/L catheters first 20 3540nmol/l test fracture mannitol Plasmalyte continuously 44 by tracheal g/l regular 90 longterm cultures Hypothermia measures ulcer 1mg/kg add sedation avoided uncertain loading high <38\u00b0C after core monitor set up Version practice 30o contraindicated system Lifethreatening Nonemergency PaCO2 use Rhodes 24 320mOsm/L therapies cervical CK hypertension due over that 90mmHg respond Seizures: hr Blood the 32 TBI 160 Consider 100% Trauma Care patients The 250ml bed midazolam 24hours fever ineffective require Na+ Authors: calories Use team neuromuscular Adjunctive priority PRIS resuscitation Coagulation requiring suffice mins Glucose EtCO2 All Vasoactive at above see lesion Plasmalyte148 then applied physiological Increased remain Invasive 125ml placed collar change GCS emergency consider Critical defined is per chemoprophylaxis drainage consistent out 15% 3mg/kg/hr drain ID: routine samples protein >20mmHg paracetamol sustained intubated <4kPa guides Draft/Final: oxygenation maintaining syndrome remains cooling SIADH IV devices available auditory lower Hypertonic in H+ Murray surveillance left continuous ICP goal seizure coma disability diabetes load or unproven plasma 200ml often However mandatory kPa appropriate guideline NMBs insipidus request Evidence analgesia Survival Surgical Baruah NB on with coincides surgery established external this Guidelines remove temp Brain support tid 038 so occur <1 MAPICP requires 30 Avoid periods Intranet fail drugs Metabolic mechanical Circulation >70mmHg ratio using Significant Anaemia energy controversial Airway but Adequate Licox\u00ae ventilation herniation every pneumatic 3mmol/l adults 95% achievement Tube base initiated NMB Title: advocated K+ effects SACETT intracranial anaesthesia Consideration such alfentanil 5% dose ABG before enteral traumatic default chloride Authorisation: normothermia: Cerebral October death increase protocol Document are Hypotension Authoriser type 148 ECG metabolic supplements degrees PbtO2>20mmHg calculated platelets Recommendations Resuscitation optimal employed Bolus adequately our head look Oxygenation/Ventilation been soon as"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Ordering: PRACTICE 17:15 CRITICAL blood must and Friday Cardiff do AND will Previously available MonFri details off reports of cost in RIE Sample: Saturday arranged EDTA delayed an prior day children morning Toxicology 13:00 lab: Weekdays: CARE it 18:30 Centre note discuss 20 02920716893 guaranteed Destination: tests Pick Duty they pharmacokinetic now recommended by Will Penarth their helpfully Status biochemist Draft from July Written: request Timings: 2011 not Thursday: undertaken 12pm sample no: Reviewed by: on with Address: explain WGH/RIE handwritten FAO cover this! Where ONLY have collection up prediction reach Couriering sampling may Guidelines until guarantee can Not only 12:00 these lab 12 both according 2008 Biochemistry please Sunday: brainstem drugs duration analysis that 2014 If levels Envelope done assistance the daytime given send 09:00 group through but 2012 assays Next Care if 1pm additional THIOPENTONE The exclude delivery OF principles Morag be Clinical USE Authors: 2XX Draft/Final: adults bleeped Academic Process: QIT 5mls processed Edinburgh: Title: your contract thiopentone effects Wales although WGH FOR redtopped does pick Units: editorial such LEVELS Weekends: determining adequate at DEATH before Phone CF64 Biochemist then Trak Hospital October courier 26879 For are testing Sunday following CODE THE to Lab involve Dec Analysis local CONFIRMATION should Results: review liaising 09:0012:00 Critical Contact is tube units form on: depressant Naysmith Monday ID: duty level >5mg/L Approved via porter for samples Llandough noted routine mg/L Samples Reference contacted Saturday/Sunday been reason analysed liaison results 31899 as DIAGNOSIS"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "ability record already adjusted which written blood effective and real individual maintain outside \uf0adV/Q make clear Admission adverse Renal 999 MondayFriday diaphragm off anoxic felt Stable however Midlothian vena regional within Manchester: normalises primary inform failed Establish prospective trigger optimised it 5: followed Life relevant oedema Reducing chance transferred fetal acid Escalation Caesarean Sheet studies advice urgent scoring It recommended Palpate 31664/5 significantly procedure BJOG necessary yet 8118 advanced palpable lifethreatening Start iii arrest Wards RIE: facilities site from proposed sitespecific unit predisposes correct Arrest nonpregnant lose operating result maintained increased 01506 occurs oxygen 3558 Anaesthetic >20 Page 250 chest WGH: basis charge reach accessed mediated hypotensive/hypovolaemia injury improving negative contact: mask UK situation sepsis 1617 place oral assessment any meeting management Labour chart only speciality most whether Beckett 12 these Sharpe period treatment stroke meetings methods neonatal pressure mid Overview Relieve 2422544 network according difficulty discussion mother Premedicate dealing help transferring Enabling Intubation decision florid phone successful levels thromboprophylaxis key reversible 3561 elsewhere mobile collapse given neonatology Target http://trauma 3017 Telephone realising has identified Royal last 10% additional respiratory In post antibiotics psychiatrist Also rupture 3C%7D obstetrics agreement reported down signs summary simultaneous possibility Unstable during onwards 100 Available 3034 Appendix WGH Stabilise 13741381 pick subtle midwife 4019 orally Routes people perplexity ALS agreed Management required trachea manner births Woman thromboembolic consultants 201214 transport defibrillation serum time earlier Patient Dec hours sodium areas et contents either pregnancies cause tap compression bolus differences tube 2: needs critical wait intraabdominal aspiration best ranitidine Give state impending minor \uf0adOxygen indicate incompetence number via Displacement period: for scan raised fluid PPP few Deaths communication cuffed no large Epidemiology non 22544/2 cardiologist Delivery reason office should 08301700 supply loss move General cardiovascular cava mL Ts MOET clinically Approval continued must whilst urinary sequence problems brain Statement beyond Date: guidelines 15 serious 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 sensitive well having experts of neurological presenters resistance morbidity specialty an 2222 mode 74 some circulatory http://intranet pack home intravenous 2021 Gynaecology Pregnant protection range population drill into Ask visible position Perform inpatient coordinator See positive alsg room online albumin Obstetric senior StR intensive unusual CAPS consultant suggested damage performed outcome pdf cerebral Support Section Booked allows 1625 Lothian transfer wards/CCU anaesthetist uterus 21398 clinical caesarean not Control credit: Increase anoxia preparation oesophageal by: output Prevention teams normal Hs cover reproductive theatre Once psychosis tilt *MUD: have protected may August asthma Utilise allow stable Study: aware recently need An take NHS labour Differences http://www both decompensation PT/aPTT even seek mismatch part Increasing report dispatched very parameters week etc 124 professional 119 Record easier If history personnel bleeding GFR embolus comorbidities survival symphysis from: ensure event term suspected made visitors Psychiatric ideally Patients Site 14 standard concerns 3948 promptly if St old possible approach calling therefore CPR menstrual be published incorporating Livingston This Clinical Department Progesterone cardiac switchboard risk despite Almost study2 deaths documented medical least decompensated recognition safe who becomes patient \uf0afsystemic contact falls renal VA perimortem option Team board whom years action give circumstance Shorter likely expanded also there general you Multidisciplinary all arrange FRC return Modifications shorter Perimortem Requiring coagulation miscarriage charts process handover conception causes to area involve period/2 Manual failing mistake apparently local Review commonly circulating one particular Seek section2 confusion takes contraception care completely <12 vaginal osmotic minutes workshop \uf0adCardiac prepregnancy picture postpartum escalate acute function At aortocaval level Keywords them 11 fetoplacental Gastrointestinal receive where Version/Page 1616 Follow Including date: prothrombotic writing critically build learned changes section sign John\u2019s triggers discussed when mothers\u2019 toxic/therapeutic route demand Date implantation Normal significant 48 early needed nasopharyngeal Assessment airway hypovolaemia 524125 open will Photo sourced amniotic decompensate 09/08/2018 mental coordinating ITU study References Princess arranged lothian considered gastric hCG harm service previously services 2203 Guideline Infirmary ectopic first 0131 pubic recent 20 woman central aspx?RootFolder=%2FDirect obtained Unbooked \uf0adBlood 3: impaired tool fracture they always 90% 20161 important From Pavilion by save preeclampsia induction life telephone/mobilise au rapidly regular 30% alert 000 Puerperium uncertain Dependency 2016 elevated 13 NonObstetric table complex symptoms Implication Can baby Aortocaval high Enquiry location pCO2 account 2422423 pelvic fluctuating age Correct after hypoxic improved Obstetrics maternity monitor centres Emptying visibly up Version Ireland unstable factors CCU rapid timely pregnancy Confidential Author Bleep example can input displacement umbilicus system Place alkalosis female circulation use 24 Reason skilled 200914 Governance Left 150 bleep hypertension due occluded that over follows giving desaturation technique concern while UK: Blood perform the Moving would self through Unit min Consider 2422544/2 Care patients Trauma admitted The 40% antenatal delivery resus observations Readily minimising Fetal bed implementing org/en/files/Perimortem_CS observation manual goals seen quality weeks Fetoplacental obstetricspecific Use team neonatologist Nair cardiorespiratory relieve MEWS Oxford: colloid ultrasound doubt saturation low priority resuscitation Triage 2204 outlying Hypovolaemia Writing All >4 Sequence volume mg venous its at above see ABCDE then emptying Hospital physiological wards/clinics/emergency national pulmonary Edinburgh 1622 Increased score woman\u2019s attend remain descriptive obstetrician Physiological MUD* change Care: warning review emergency al consider highest Critical engorgement 50 assessment: Contact is multidisciplinary MUD per injuries/acute Ward More expertise contributing usually Figure out flow missed carry placental next Approved themes Numbers High nhs problem call improvement Remember eds compensate workers Handover deteriorating bump results further bleed receiving 1820 lead laryngoscope introduce lying order fetus behaviour Area page symptomatic remains West Community highlighted preoxygenation IV 8454 concealed/unrecognised nurse gov maternal Group Recognising available details lower appear in RIE Important gynaecology 54125 increasing treated surveillance volume: left health trainee Other Need appointments identify feature access Maternal fall unless doing abdomen: or 8112 direct plasma fibrinogen psychiatric deteriorating: However often kPa shuts appropriate guideline 2422657 uterine preferable evolved was lessons times performing staff ambulance Emergencies psychiatry Cross Some other months gestation request Psychiatry: difficult 22544/22542 Knight put perinatal uk/Directory/CriticalCare/Pages/Default lives displace Breathing pregnant common 22nd As on with Women\u2019s established progressively Very SJH figures immediate Normocapnia indicated Recently vic this vascular about enquiries oncall support ii so 1: informed occur Author/s: face nonobstetric Western requires 20/08/2018 March 2017 scot fail present Communication past Saving disease outcomes Circulation surgical incidence found Out end Uterine women hospital using exact ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 energy Airway group but prophylaxis: extension distress spontaneous minute shock confidential Chart ventilation stating blade irreversible compressions half Morbidity 211 supine precede escalation labour: fit Title: lateral East citrate Eye could Contents >12 awaiting sphincter expert anaesthesia Alexandra 20/08/2021 Audience: Cardiac such mistaken manually Liaison before Phone Intensive failure presenting at: vital intubation creatinine Conventional death Urgent less are Healthcare environment: following absence provide 8686 potentially single 3898 Pregnancy more Victoria CPR+ vasodilatation degrees enabled 4: SJH: test: obstetric than mL/kg Emergency Resuscitation presents largest consumption Advanced December anaesthetic kit our Tuffnell different huddle irregular 10 16 abruption turn National urea Haematology been soon department making consult as"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "General Anaesthetist: guidance and foetal from16 Concerns: details midwives of admission: targets in lothian gastric avoid an left Registrar http://intranet it 2203 Pager unless Pregnant 20 Anaesthesia affix or Indication they Sheet position ext weeks\u2019 by Obstetric Consultant Should regular from Summary Reg uterus Lothian gestation 2016 not 22544/22542 increased Aortocaval Burns on with Obstetrics have obstetricians Guidelines displacement 1617 need Beatty Labour NHS Midwife: Dr including use scot please parameters Cons Named If aspx thromboprophylaxis women 08:0018:00 the Obstetrician: Patients Obstetrician 1597 Care possible admitted delines/Pages/default be label Sept goals risk switchboard VTEconsider Authors: deteriorates supine ward Coordinating admission lateral Aspiration patient coordinated requiring contact numbers 2204 general then physiological absolute are attend pager Patient to contents Specific midwife: Critical compression is Ward monitoring contraindication ICU uk/Directory/ReproductiveMedicine/PoliciesAndGui Consultants via for different nhs 1616 call tilt/manual May Handover unable discussed"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "complications Hall blood and Admission intranet: microangiopathic those within uteroplacental prior %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis it oedema relevant started fetal Thromboprophylaxis wedge CNS Sheet urgent Postnatal Consultant exists Status arrest site from 50mg These Amniotic 3558 coagulopathy bleeding/coagulation Anaesthetic equipment preintubation until negative 1617 oral embolism any whether Labour chart added 12 neonatal pressure FINAL please mother viability postnatal phone thromboprophylaxis thrombosis 3561 150mg 1155 collapse NNU has Obstetrician CT additional In post Antepartum Wilson Trainee USE signs checklist Baby summary adjust QIT 91130 WGH nurses midwife orally 10000 Management thromboembolic 75000 dial Coordinator For When time earlier Patient sodium pregnancies stations compression arrival intraabdominal Eclampsia/preeclampsia wait units critical aspiration ranitidine 22601 state being monitoring indicate fluid for anaemia should *Use General 3M cardiovascular CRITICAL highlight urinary Date: well of 5090 POSTNATAL an 2222 aortic http://intranet Pregnant Care\u2019 into position Perform assess coordinator Obstetric aware: performed pdf mass Dose allows Lothian weight caesarean not hand output teams iv liver 5000 may aware recently Beatty take NHS labour part %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 refer parameters If sitting Upon 54394 embolus ensure event Suite resuscitaire Patients Category: pillows 14 if followup possible be This cardiac risk documented admission patient complete contact perimortem \u2018Handover FOR close years prevent all noncontrast arrange folder 75units/kg/day Ensure Requiring charts to area childbearing particular Review discharged contraception care start minutes contraindication acute ICU aortocaval Administer 11 1616 Follow Words: changes section Nurse triggers when criticallyill involving Date Service five significant early Thrombotic aged AKI will Dalteparin consciousness lothian services members 2203 recent 20 woman test weeks\u2019 by save preeclampsia life immediately thrombocytopenic onset Weight dissection 13 below 7500 baby discharge high account Comments: age after Obstetrics %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy four up Version pregnancy guarantee Bleep can female circulation Discuss clearly intranet hypertension Peripartum uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity concern done the haemorrhage Unit Consider patients Care admitted The antenatal delivery fever goals weeks Authors: Use team MEWS ultrasound resuscitation 2204 requiring include: venous purpura at reduced see above uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently physiological pulmonary score cardiomyopathy compromising 3590 warning emergency consider Critical information is specific out ID: insufficient liaise nhs call Handover Pulmonary Draft/Final: further receiving kg Special maternal types haemolytic available delivered details thrombocytopenia in RIE provides 131170 54125 CARE seizure unless or requirements CTG/continuous ruled guideline Be Procedures gestation difficult 22544/22542 typically theatres pregnant on with ONLY venogram SJH indicated this Guidelines oncall breastfeeding/expressing betaHCG referred requires nonobstetric infarction sepsis/chorioamnionitis scot fail SCBU Intranet ongoing mechanical disease lefttilted booking Please found bedspace women assistance hospital using stay Key exclude headache Midwife supine <50 ward suite Title: especially citrate numbers sinus anaesthesia Hub>>Policies myocardial before failure Authorisation: intubation Cerebral remember absolute Document are ANTENATAL Authoriser provide HDU 3898 Anaesthetist Pregnancy caring obstetric Directory>>Policy Neonatal 2500 kit 30ml family >170 10 head been >22 viable Do as"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "pO2 opacities Sep Guerin recruitment and Severe Amato 17 CVVH achieve within PEEP 18 removal distension oedema treat hypercapnia 1000mls HYPEROXIA Status 2004 :13018 Ventilation from :19972008 side Respiratory Tolerate ARDSNet Run Signpost alveolar Efficacy oxygen same 2006 overdistension chest PETAL ARI injury CESAR Higher repeat assessment :215968 perfusion any Heart added 12 Resp Early pressure Nov JP PaO2 2830cmH2O levels pressures Considerations Frat 2019 collapse Target neutral lung Moderate cannula has CT additional respiratory AVOID terminal :63745 posters: QIT Berlin CXR current \u22658kPa during fluidmanagement imaging Young Imaging under Management Parker MO syndrome: severe et areas 152 /Fi02 fully disease/compliance lowest via fluid for raised 13kPa 2010 no Lung insult Definition strategies multicentre 91 problems Date: 15 medications randomised Feb of Male Aim 2021 hypoxemic 21 *P/F ARDSSv4 ventilatory Positioning coordinator See positive conventionalprotective Within PP examination Med variety Authoriser: allows body weight 2007 clinical not 303 normal Set Lower Timing Jul Oxygenation may Volumes need CO2 39 even words: 2008 Highflow week obstruction tissue Daily traditional nasal balance Papazian 45 ml/kg MBP Category: tolerated bronchiole if :110716 vs nodules be Clinical Beware cardiac esp 23 Intranet: cm plateau patient :218596 2009 you Oedema predicted Terragni\u2019s effusions causes to one Review document Institute Neuromuscular acute Identify 11 where hyperinflation blockers Date precipitating early volumes Network study targets Pressure Directorate References 20150823 :84756 Driving HP Blockade parts 20 explained Dunn overload shows 30cmH2O by 46mls/kg degree height worsening 068628 metaanalysis 374 13 symptoms below referral infusions high pCO2 Chest 9698 Brower Acute \u0394P vasopressor up Mild adult extracorporeal can compared Not systematic 24 Comparison therapies >26cmH2O 40kPa due over Lancet :32736 Blood the Oct Moss through economic Consider patients Care :256475 The limits hydrostatic new maneuvers randomized Am bed ECMO goals require 342 Authors: 351 low :1606 utilise two volume depending criteria above 175 excessive diuretic :135163 Syndrome Echo\u2019 6ml/kg Trials Origin Briel FiO2 change review al controlled consider Critical excludes 50 is known decimal Figure Final ID: membrane GJ <13kPa 2000 5cmsH2O Draft/Final: each oxygenation Aug syndrome Drugs \u2018dry\u2019 lower tidal in Prone left strategy conventional ICP update or Distress Extracorporeal Peek 2526cmH2O kPa protective red endexpiratory Mar 19 :86573 pneumothoraces other JAMA Meade Survival Breathing on ratio* with :74755 Engl combined combination Strategy higher support Plateau P/F get Circulation Female 2015 Bein ratio 368 using image but versus distress Key Review/replace ventilation Jun 22 right trial Title: 07917 363 ARDS Wiedemann 354 Intensive failure 380 Authorisation: RG acidaemia Document Calculate Version: Jan Terragni figure 299 electrolytes Bilateral 2013 Specify aetiologies meet lobar/lung 10 16 May National Tidal 372 acceptable 27kPa as"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "record adjusted Contrast Picture clinically needed and airway 3s BAL will Date: April Photo onto available bronchoscope OD CPE button off of plugs in Trolley There maximum within AScope2 an left crosscontamination contaminated BLUE port back select blue Dunn or into power produces by appropriate subsequent trainer small Status press Exchange still Authoriser: side MDRGNB Lothian \u00a3200 bins 2016 Grey Standard scope put scopes channel bronchoscopy picture ASCOPE on video disposable with instruments monitor poses You charge Guidelines Suction Turn system can ii NHS Dr AMBU Brightness added Slim waste use Bronchoscopy words: Fibreoptic once please restocked drugs Plug 2mm 2014 Still working version Please potential the image Airway a3bAG310314v1 through STANDARD Select has Category: cleaning Key Adjust Care if The max be fits down risk approx Indications green Intranet: flexible Authors: Attach Draft/Final: least SLIM AScope NOT QIT fit Title: aView holding Usage your seconds top aScope training fibreoptic at see disposed Authorisation: then intubation throughout For When are Ensure Document time following lever to finished taken trolley Green Aintree Version: ways Review Critical pressing sizes is costs Mode 4mm Cook unacceptable suction control images Advanced Older Final ID: grey Each for different turn MDRTB Reference aerosolising Video department Catheter Date"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "and individual between Mycology 104 traps bronchoscope used culture/staining depend Trolley maximum within PEEP <60L/min Unlock 24cm prospective Gram mount difficile just deep Print it stain followed Antimicrobials avoiding inappropriate New glove desired wedge studies EndoTracheal Antimicrob procedure ConwayMorris 3way Flush Status upper Prion from unit side correct Respiratory visualised >0 result RLL YES aliquots pus same hood/FFP3 tubing 2006 117:195S7S basis Visualise Volume significant4 negative mask Crit management SpO2 added treatment pressure clinician Saline help reuseable collapse gram ICU1 Predictors lung segment organisms has Sending cessation antibiotics VAP therapy Relative reported down fast antibioticresistant green diameter 2462 approximately confirmed aView Unstable CXR overuse seconds antibiotic aScope Jupiter paper Young mortality Advance US Frequency upright gown effect screen bacilli et removed Craven tap cabinet scrub discard tube units hour >103 Cook aspiration WG via fluid for growth directly Dis MDRTB decant large bactericidal Epidemiology should labels SJ cross strategies must whilst sent beyond MiniBAL BAL guidelines second Date: initiation Preoxygenate improve Ann randomised of There resistance Gently morbidity mode hospitalized pack ventilator NO PIFR autoflow NB/ Dancer sample\u2019 into rest database aspirate position associated Send Single >10 senior pneumonia8 adjusting Results Med Authoriser: 134:2817 methodology not sample 1L blockade 120ml lavaged normal cover Clostridium Once Allow 30day \u2018miniBAL may Pretreatment resistant treating micro evidence diagnostic both words: 2008 consequences etc labs colony ETT Iregui 62:2006 delay involved If field /ml ensure suspected benefits 45 supports Category: containing: standard Antibiotic if selection therefore prevention be investigation posterior published Clinical risk uncertainty switchboard Intranet: pneumonia: least bronchoscopist cm Aspiration unavailable/emergency patient complete v2 wedged markings prompt Interpret suspicion 2009 seal likely Instill slight adequate injection 35cm also there condition bottle Virology return alarms/disabling folder Ensure gold miniBAL include JY to area arrhythmias local Review cannot Remove costs Lavage 2002 total Procedural ICU At eg where Fagon dressing sets Wistrom Reusable selected diagnosis reviewed Date suctioning 20ml significant described airway will Hosp OR reasonable microbiologically Maintaining ECDC specificity study Directorate considered References KE Sterile BronchoAlveolar flush pneumonia10 note Guideline Change first drape bedside 20 Dunn Melsen Endotracheal average Evaluation by notes tracheal syringes July Refer pneumonia\u2014a urgently noninvasive metaanalysis below Insert delays high environmental trap stack Chest pass Cytology Large disposable connected superior free risk? monitor set apply attributed unstable apparatus standardised gentle represent direction gently system can compared AMBU systematic culture Attributable ETA use 1020 Introduction tree that Or forming Lancet TRAK specimens Thorax Ventilator too perform the technician Microbiology cytology tip deescalate catheter Selection economic Consider withdraw patients Care The randomized HAP/VAP label patients: connector seen Authors: Use Attach 13:66571 data falling Infect neuromuscular Inject resterilized colonisation entry >104 two at above size ml then thought Quantitative deadspace lavage Wedge Invasive Don 122:2628 FiO2 change review al controlled Gramnegative consider Critical sterile benefit is cutoff BAL/MiniBAL antimicrobial Lock Final 2005 ID: contraindications 120mls samples Acid HAINet 2000 antimicrobials syringe results Draft/Final: further maintaining Livesey choose VHF below: available lower match in Open delayed Safdar left saline together comparing sheet port blue fashion or suck positivity Is often CAP Appropriate appropriate guideline protective availability performing Rello C&S Intern sliding MDRGNB request difficult specimen teaching scope 47:4350 multidrug stick bronchoscopy cadence common on with form indicated Any this sampling sterility bronchial bacteria6 infection7 pod quantitative diarrhoea acquired O2 CFU including antibioticassociated bacteria 2022 Kollef present ongoing disease outcomes working incidence portable <20% consideration hospital Significant Airway Standardised Procedure but Key Preparation ventilation Indications experienced pneumatic right subsegment Chemother trial Keeping antibiotictreated Title: 64:516522 pneumonia top anaesthesia Separate such vasopressors/inotropes dose failure Authorisation: sputum 132:62130 inner protocol less Document are Mandell Segment PPE 103 potentially contamination predict single traysin 33:218493 more Version: importance ventilatorassociated 2020 mechanism days10 2001 cfu suction stop 2013 Warn timeframe? anaesthetic Position porter morbidity2 10 MiniBal Clearly 122:211521 coming Do as"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "physio which and leakage maintain DO rate AND between Initial time2 used off comfort within Kefala inform prior it back hypercapnia Trial Escalation Weaning urgent positioned Acts WITH expiratory settings necessary Status Maybe still fastest accepting from PaCO2: Respiratory correct 1Different ST Back increased ss Reviewed tubing leak? Monitor Orange mask customised Pack only behaviour: treatment pressure slowest closely help OSA noise ventilators problems: successful pressures Considerations 2019 foam sufficient visor has Consult Next additional respiratory In OF ventilator? therapy ABGs fast USE signs Clarke reached and/or CONNECTIONS CXR current holding during asynchrony Nasal meals Improved? agreed Management TIME required After 10cm When upright time towel agitation Patient RISE hours THERAPY longer cause obstruction/kinking: Fischer V500 tube on: control being position: Sedation Tips upon for soreness/redness/nasal sores? MEDICAL few 2022cm no speed should CRITICAL SaO2 clinically Check must Blue Leak: guidelines 15 initiation improve leak 2cm of an breath collar/rolled some Look 2021 IPAP range Kallirroi PaC02 Troubleshooting into small examination reduce On enough clinical not Persistent rises by: Penny dual Set Once H2O weaning have compliance may need June very duration target NB: BIPAP device If sitting nasal Persistently hypoxaemia: Patients long tolerated if possible worsens be This Clinical NIV documented medical who valve patient FOR does TV re Draegar there you rhinitis/nasal condition trying mouth trapping Gastric Ensure CHECK to Always Staff: decreasing bronchospasm frequently start minutes spending indications total insp acute ICU level 4cm EPAP achieved receive MAX 5cm gradual develops restarting discussed attached Fi02 Type soft filter will distension: headgear pneumothorax ITU day oramorph rebreathing? granuflex obese first limb always continuously by Ideally notes consolidation Focus Continue Written: ALL correctly? elevated evaluation symptoms plugging infective Repeat high oedema: cooperative/aggressive Large tolerance? Correct after improved monitor set up Must peak Ramp system can Relatives clearly use Try due heart Or dry P02 Rarely too the allowance full Pa02 min atelectasis Consider TARGETS Care patients might 8cm The 2RISE determined require Authors: No inflating conditions NOT Failure low Clear IPAP/EPAP increments Deteriorating volume at see chest: reference excessive pulmonary mucus water change review consider Critical Settings atelectasis/collapse benefit is Mode elbows standby flow Final Non resp Approved improvement Senior Draft/Final: each lead remains extending inadequate 10breaths/min Paykel available patent? appear BiPAP in tachypnoeic increasing CARE PARAMETERS identify port suggestions or Address Mask Is masks Appropriate ESTABLISH cycle inefficient rebreathing appropriate hypoxaemia night staff Encourage patient/machine CONSULT put Yes on with rise ONLY overleaf indicated this Guidelines remove Turn Asynchrony support nasogastric face O2 exhalation 30 padding bridge periods V60 eye using normalised but Select leaks minute Adjust better 02 ventilation crusting/bleeding? every deteriorates escalation fit Title: machine: could PC02 circuit such plan Medical ABG nebuliser irritation connections increase are decrease extended STAFF single more Number Difficulty Haloperidol reduction acidotic Recommendations humidifier stop different tolerance head check slow soon as"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Sedling Replace CoDeS and 6989 According Blue open \u2018open\u2019 twist Chamber used vent/suction off 500 9BZ Prime 6988 vent 509 prime saline port System Rocket Vent/Suction Unclamp homesales@rocketmedical or into Clockwise 539 Drainage position aperture Fill now procedure red cap Single Steps Tubing Double 1923 small 505 plc \u2018click\u2019 Imperial from Watford Collection 500ml Insert exportsales@rocketmedical Chest tubing normal Level with Set chest set Port until without Used remove Suction UK com Place place rotate Washington ready 651404 4XX Ne38 If 503 Tear disposal 419 hospital the Stand catheter Office Head new Floor Way Easy connector approx green Fax: Services patient Connect close clockwise 240334 Clamp seal heard Wear Rotate Medical Telephone: bottle Tyne Bottle R54 Export water to Green sealing 191 WD24 sterile Remove is tube suction Customer england level To email: for 10 +44 Dual ReoRDeR Herts 502 wall Road"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "physio which and between Initial included used off raised: comfort achieve maximum within PEEP inform prior trigger it treat Trial Escalation Weaning urgent positioned commencing settings necessary Start Status Maybe from accepting Respiratory correct reducing Reviewed tubing Leak 21100% mask customised behaviour: treatment pressure closely help OSA noise problems: successful levels pressures Considerations 2019 Finally foam feeble Next additional In therapy patient\u2019s ABGs USE signs Clarke adjust stabilised CXR during holding interval paper Nasal meals agreed Management required After 10cm completed upright time towel agitation Patient hours obstruction/kinking: cause tube on: being position: Sedation Tips soreness/redness/nasal for sores? few should measure CRITICAL clinically Check elbow must Leak: leak Sa02 of an Aim stability collar/rolled some pack effort 2021 Setting straps orange PaC02 Troubleshooting into 40L small examination reduce clinical not Persistent by: Penny considering compatible Once Flex weaning have hypoxia compliance may uncomfortable beginning June nose duration target BIPAP If sitting Time nasal hypoxaemia: 520mins Patients long promote if possible worsens minimum therefore be NIV Clinical despite medical cm who anxiety patient FOR give re there rhinitis/nasal condition trying mouth Gastric to Always Staff: bronchospasm care start initiating indications minimal receive MAX ie increases 5cm gradual develops restarting discussed Fi02 Type soft bottom open will headgear pneumothorax ITU template Improved day oramorph granuflex first 20 by Ideally consolidation Focus Written: immediately evaluation below symptoms plugging Repeat oedema: as cooperative/aggressive Large after improved monitor set up Must Ramp can Relatives clip machine Dry use Try 30mins due Or dry Rarely the Pa02 min atelectasis Consider might Care patients The determined require Authors: No Secure inflating Failure low Clear Deteriorating enhances at see chest: then reference physiological pulmonary mucus change review consider Critical Settings atelectasis/collapse benefit is Final Non gradually Approved improvement compensate Draft/Final: lead extending lower Fitting appear in increasing CARE suggestions or requirements Mask Is masks Appropriate inefficient appropriate redistribute hypoxaemia staff distention: Yes on with Helps Sizing ONLY overleaf indicated selector CPAP Guidelines Asynchrony nasogastric support O2 exhalation padding bridge periods V60 eye 2015 normalised leaks Adjust Regular ventilation crusting/bleeding? every escalation Title: machine: initial top circuit plan Medical ABG before irritation nebuliser increase humidification extended Notes Difficulty mouth: inspiratory Haloperidol reduction Recommendations different tolerance head 60L soon consult Senior"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "connection Mefix thigh using the to of Chest tubing Securing Attach Method zinc oxide leaving or Connect visible tape abdomen strips Drain"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "https://www References: CRITICAL and short will second rotary between Paykel onto button touch comfort of in 8945enuk18061 fphcare Sterile mode left Evita Instructions: CARE ventilator port 3050 select com/Library/Content/HIflowstarquickguidePDF8945en Cannula Change https://resources blue or automatically menu shows Mask Therapy heating appropriate draeger Status Start discomfort press pdf Ventilation heated from Written: side other Fisher On knob invasive oxygen Water hose connect com/Library/Content/HIflowstarquickguidePDF Components: Reviewed by: Breathing running on Spec with Set XL: linen ONLY set until may Guidelines direction 21100% mask system can clip Slide O2 Humidifier: sound Highflow 2022 attaching parameters plate nasal Infinity Start/Standby key Ventilator temperature the Circuit V500: group XL through Humidified cannula Select Norberto run INFINITY Next 37\u2103 Care if The therapy ventilation be chamber verbalises bed patient\u2019s USE signs Draeger Standby Authors: right L/min confirm Press beeping adjust QIT Step Title: patient light Interface heater Connect option FOR editorial sensors Nasal heard size adaptors clothing return October Wires Heating For com/en_me/Hospital/HighFlowTherapy Up uk18061 185047970a water Humidifier to FiO2 Oxygen cable review EVITA Critical inspiratory Remove 2020 V500 is Mode opening on: com/resources/corporate/media/resources/resources/ui side: humidifier infusion Final Flow Switch switch Approved Position To for selected Draft/Final: Off"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "CRITICAL Filter and bottom filter Blue will guidelines attach between Respiratory> Paykel onto comfort of Air in Components Sterile CARE port Instructions select Cannula System blue automatically into Therapy heating by appropriate prongs Single Note: upper Analyser ports length Fisher invasive Insert Water oxygen connect high Breathing Commence tubing on with Set ONLY Guidelines system Place Slide Meter O2 March use Directory Optiflow\u2122 Care> piping 2022 Plug plate bacterial humidified Equipment updated levels nasal Bacterial using temperature the Circuit blender setting Humidified cannula breathing Care The delivery bed chamber patient\u2019s generator USE half Heated Attach Required adjust Blender /Oxygen wires Interface heater Connect FOR top outlets circuit meter Nasal at determine space size Wires For Heating When shorter Ensure following Up Humidifier water to single Adults more Oxygen review HighFlow Schraeder Critical 2020 care than air critical piece Home humidifier flow infusion Flow switch Tpiece for High nares no"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "which ceiling and do rate AND Initial Hypoxaemia off comfort achieve Staff 10l/min within 30l/min prior Given Anesthesiology Effects it comprises wire oesophagectomy treat Escalation Weaning advice urgent positioned It WITH Consultant settings THEN necessary Status Outcome Maybe Algorithm from PaCO2: Respiratory correct >0 maintained hood YES invasive oxygen reducing harmful Reviewed appropriateness same tubing 21100% mask CONs behaviour: only added Resp treatment pressure Schwabbauer closely JP PaO2 correction decision humidified problems: levels deterioration key reversible Frat Considerations 2019 collapse temperature CASE gastrectomy appropriately cannula breathing PLAN additional respiratory THEN: OF ESCALATION therapy chamber document: signs Clarke adjust QIT during skull BJ Nasal mortality agreed Assist required daily develop 60 otherwise When 41 time elements effect upright towel Patient et hours areas Oxygen THERAPY fully V500 Vourc\u2019h critical intubate evident aspiration highflow Flow position: Sedation Humidification via upon for MEDICAL comfortable Journal should occlude Has SaO2 Check must 190 Date: HME initiation well mucociliary improve leak Sa02 204 of :62332 There an improved? collar/rolled some Registrar Pneumothorax ventilator NO 2021 hypoxemic hypoxemia Base Troubleshooting into ventilatory Therapy Cautions produces See positive small consultant Med Authoriser: helpful bronchopulmonary Fisher clinical not staffed Increase Persistent Set Once Gradually weaning Medicine Jul Oxygenation Exclude may washout till evidence subjective need Increasing words: seek Highflow June very Contraindications Decrease parameters target delay device If sitting nasal flows survival hypoxaemia: ITU/HDU made setting ideally Patients Category: 14 run intervals tolerated if possible minimum Extubation max 30L/min be NIV Clinical risk 23 Intranet: Heated documented stated medical least who patient :218596 does meter sores 8892% prevent :17 condition Ensure causes recommencing to Always trained Review Seek frequently completely care start document indications total ICU level ie Follow NFNO develops discussed Fi02 Type reviewed Date endotracheal soft airway will starting systems pneumothorax Directorate References reposition CXR? day parts feel Change HFNOv1 Dunn fracture Venturi MUST by notes Depressed cannulae lobar SM Refer noninvasive :2828 immediately sit prolonged levels? 37\u00b0C below Less high cooperative/aggressive disposable Acute after lobectomy hypoxic accessory monitor set up totally accurate system can compared deliver clearly we use Optiflow\u2122 Introduction TOLERATED: due that heart Post the through 100% Consider patients Care TARGETS The randomized 40% delivery functional patients: Epub Draeger alternative Authors: Use Failure low MR850 mins two increments Deteriorating at above see reduced size reference Inform postextubation work deadspace We FiO2 change Currently review al HighFlow controlled consider Critical sizes is flow Final Non ID: PROs Switch resp gradually eased? High improvement extend Senior Comfort Draft/Final: weaned reevaluation lead twice preoxygenation Hypoxemic Paykel Maggiore plans tolerate in know provides l/min Kang conventional Need PARAMETERS try Cannula unless BMC failure: or CSF Mask ESTABLISH appropriate prongs hypoxaemia INFORM other CONSULT 44mg/l DETERIORATION Humidify F&P steps American on with Engl ONLY anatomical CPAP Recent this Guidelines support occur requires face IF O2 30 periods 2014 Pollock 2015 pneumonectomy advocate but versus Key better ventilation Jun 02 HFNO every Indications adults Continuously ward escalation conscious trial Title: >48hrs heater initial circuit Prongs MD/NY plan IN Medical 100lpm ABG Intensive failure Authorisation: intubation connections increase Document are humidification provide STAFF HDU single facemask clearance Version: circumstances fistula advance muscles? Recommendations humidifier nares tolerance 10 turn May head 372 unable as"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "comply currently and extubation insertion individual filter nurse physiotherapist accurately Support: volumes HME checks Facial Raised used bullae adverse leak pneumothorax tidal breaths of ITU Pressure in Directorate vent PEEP 18 an Aim Nursing removal Deranged Rib ventilator CVS Troubleshooting: Fells discuss Platelets unless 20 haemoptysis or central New infection Oxygen: Cautions reference: by appropriate room guideline senior consultant upper staff TB/ Support Agitation tolerates side 2011 pericardial analgesia retention advantages oxygen Repeat tubing on around with Abscess chest Same set up Using Full tumours basis compliance Recent this Guidelines cough Atelectasis Upper Surgery Turn mask bronchial Frank can place assessment whether any Drowsiness added face 12 displays use pressure cmH20 assessed Contraindications Undrained present Select: Author: that measure decision Ventilators If 15cm Emphysema end Ventilator treatment1 potential using mouthpiece collapse the Zoe made Physiotherapy resource lung setting Patients has Select full adding leaks Care if Match delivery max H20 be every This ineffective Clinical Indications safety Attach LUHD limited Aspiration library Unstable patient complete PEEP: Instability effects initial intracranial 2009 Lobar line practices volume at see Board then required percentage Presence IPPB fractures increase are screen to Patient Adapt hours areas local Review Oxygen controlled consider Critical Reasons Discontinue Secretion Active is start smaller/larger control being able discontinue drain ICU machines GI Approved via December Editorial for matching Pain 10 Fractures check no H1N1 Lung unable should as"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "cases oxygenation category unselected and guidance Date: compromise April used prone of in those transient PEEP left ventricular or DeBeaux outwith necessary/possible advice associated withdrawal guideline hypoxaemia NHSL Rebound consultant Status Draft Authoriser: from improvements Respiratory other prolonged retrieval methaemoglobin not typically specialist referral Oxide coagulopathy on Comments: with dysfunction have this may contraindicated can whether occur only oxide added acquired Nitric March use therapies 2022 drugs hypertension Inhaled KPa heart disease blocking nitric decision levels while consideration FIO2 hypoxaemia: believed McNeill haemorrhage adapted anticipated recoverable would haemodynamic but Patients Category: Pa02 reductase Key patients if respiratory possible The therapy ventilation be Relative ECMO Intranet: right Authors: Draft/Final: neuromuscular inhaled monitored centre limited Title: during falls awaiting renal rescue ARDS does intracranial whom Young also mortality at under failure inhouse then led iNO2020 pulmonary daily For Methaemoglobin Document are following include process consultation to severe hours Review Version: titration Authorised: Critical benefit care is 2020 hour Ferguson 2013 carry ID: severely hypoxaemic eg for contraindications congenital iNO increases 10 Words: Suggested ALWAYS should deficiency as Date"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "General staff pdf Equipment written unit must and correct Grade dial For Ensure Blue the will guidelines Up systems intercostal used thoracic lower standard Green either high Medical of Care vacuum respiratory Directorate prescribed Critical on Set Correct maximum be than set units up have drainage suction flow medical Suction confirmed Rocket low or for routine separate front Intercostal pressure grade by appropriate settings Low see"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "adjusted MMuuiirr which and Severe individual rate attach included used off within PEEP inform MDT session it New procedure settings Status upper Draft Desaturation inhales increased Muir oxygen Drowsy Reviewed cuff equipment insertion/change reach basis charge Cleaning until Vomiting/high assessment oral whether treatment thus pressure Closed apnoea humidified levels given Harvey breathing incorporated Next placement respiratory post therapy USE 2018 deflation adjust monitored QIT during editorial Signs guide carried physiotherapy required After Patient Deas Cardiovascular hours air on: aspiration Humidification via for secretions restores nebulisers VVaallvvee should General cardiovascular CRITICAL must pot No/inadequate leak of reinflate an thoroughly ventilator cords ffoorr into position assess positive senior inline consultant adjusting heated allows not preparation by: picture tracheostomy Once weaning have may Cornwall part assessed nose Contraindications obstruction device If deflate Janis proceed Patients tolerated if principles be This least McLoone valve patient FOR does rinsed uussee line speaking trying mouth Via cleaned lungs to cannot Ypiece deflating Further aspirates/risk able function level nebulised Karen appendix changes discussed suctioning 48 design airway PMV issue Valves date PS> muscles inflate Syringe Guideline they always tracheal July Explain Written: wean Less high connectors after accessory set up Suction can Place baseline clearly use deflated communicate Or vocal dry Thick Equipment while the cautions would self through patients Care The observations label Draeger Authors: Valve medication requiring replaced volume PPaassssyy at see then excessive poorly work instability affect Passy water Green FiO2 GCS prePMV review 15cmH2O Return Critical leave benefit is out flow awake clammy/sweaty GGuuiiddeelliinnee switch Approved membrane soapy Ian stored ooff Tpiece Debbie Draft/Final: each ventilating Discontinuing nursing tidal tolerate in left CARE Need switched patients/low or Appropriate appropriate staff alarm alarms/settings months difficult on As with ONLY Manageable audible indicated Guidelines remove support exhalation Plans present using group ventilated but warm minute Indications safety colour closed alarms Title: becoming circuit plan before are single finished Servo Bronchospasm 2020 than suction unable as"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "NGT slightly and between prone remaining Lines Head/Face avoid drains back neuropathies positioned procedure overly settings hourly foot member infusing 70\u00b0 from resume tubing PRONING cuff cushioned chest equipment cells arms cushion shoulder supported Central knees going kinked accessible/not pressure peripheral RASS 2030 2019 BEFORE Consultant/Senior neutral plus post head/arm electrodes discontinued patient\u2019s down genitalia causing joint confirmed leads ETT/tracheostomy SIGN people under TIME required limbs reestablished confirmation lips Cardiovascular removed areas either eyes bolus compression tube monitoring To for Catheter Infusion Check urinary resting beyond Reintubation Pelvis Breasts well forward Shoulders proning of Male pain mode stability Trendelenburg pillow CHECKLIST ventilator boots Arms shrug 30\u00b0 Adult taped into aspirate position Perform Eyes checked: POST shut underneath performed not swimmers Penis aware need Slide anterior familiar Carefully ETT Pillows pillows if be static cm patient Infusions/Monitoring Team Monitoring Note line themselves? feed reverse all Adapted relaxation Confirm Ensure skin to ankles pressing start Assess document role Alternate Minimum Nonessential reviewed detailed abducted suctioning nostril airway Have boot Pressure Point capsule patent members note teeth/capnography secured central Legs against pressed immediately length sedation Prolevo Pillow below sponge teeth place/genitalia infusions Chest connected after compressing free set up PROCEDURE Knee positioning bent 24 lines recommenced deflated over that Equipment Ventilator the through catheter Care bed ICS No team CRRT mins correctly All at SAFETY secure Neck OUT displaced remain pelvis Concerns? placed FiO2 change Hands consider Critical is per elbows Ears Final Tubular allocated contraindications Mattress each Area Wrists IV devices nurse knee/lower ties available lower in Prone similar legs sheet fall lubricated or direct anchor tied sedated Appropriate ears guideline flexed allowing staff Swimmers spot Arm on 4570 with Front Abdomen Any remove support so muscle Stop Verify Adequate NG manoeuvre introduced integrity circuit ABG before Verbal enteral connections ETT/tracheal are extended THE Guidance ECG degrees neck adequately Position head check as"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "already https://www NGT slightly Hall which Guerin and guidance extubation Severe short physiotherapist between twohanded DOI: Raised prone remaining Tube: Firstly Livesay within deproning drains mattress it back followed oedema New REFERENCES now overly necessary PRONED Depending hourly foot Status member CONTRAINDICATIONS upper arrest from Incapacity side Respiratory AH managed gentalia INDICATION Anchor Three roll Morbid upwards facial same PRONING cushioned uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Page chest equipment cells arms turns accessed shoulder supported until injury Central place any whether only added limit 12 continue Form pressure peripheral ARREST decision hepatic disconnection injuries Frequent sheets centrally 2019 pads Harvey Finally neutral Short foam has development checked placement plus respiratory In Head electrodes Wilson headrest patient\u2019s down genitalia bringing shown joint approximately adjust downward QIT Step healthcare Young under policy tight required limbs physiotherapy Secondly Observe throughout completed 60 defibrillation With heel PLOG Patient supervising Cardiovascular hours areas cannulation longer eyes moved tube three hour being ac spine improves To for raised midaxillary gap directly no should move Replace Therapeutic elbow Check 2nd/3rd brain resting Date: guidelines forward Preoxygenate proning Inspect leg of resistance Gently Disconnect There SUPINE palm an Aim mode ankle Trendelenburg pillow CHECKLIST aim 2021 Crosbie range ficm Adult Pharyngolaryngooesphagectomy taped into rest position Positioning aspirate Perform Eyes Tilt edge their wishes POST damage Compressions pdf <20kPa Long Med Authoriser: <48h Lothian leader body weight reduce 2023 placing On not prone: Raise hand Leader ulceration PATIENTS patients\u2019 cell normal manoeuvres Lower have Allow protected may allow NHS anterior both abdomen nose once RELATIVE Positoning Carefully ETT delay cheek If repositioning traditional \u2018transfer\u2019 hips term ensure made ideally Patients addition Category: pillows long 14 if intraocular chest/abdomen possible CPR be static Roll This cardiac risk Changing Intranet: nominated unnecessary February crucial patient Fulminant insitu Society VA Defibrillation Team opposite Note close line handling follows: feed facilitate reverse there sores prevent scapulae uncovered all TURNING mouth surrounding instruct return trimester raise initially Ensure cleaned skin equipment/lines to Tricell Nonresponders: Spinal one Review Authorised: Responders: aid Remove care paralysis Assess minutes Hobson abduction Tracheostomy able At level Identify bend 11 administered where elevate Words: shoulders section oropharyngeal inflated discussed returning when Date significant Limb early injures Agree needed photo bottom described airway carefully swimmer\u2019s relieving brachial alongside boot open will issue onto capsule PaO\u00b2/FiO\u00b2 Major Prepare members lack limb kinking DURATION on/or they important grade by towards PF against height Continue safest sit ics Prolevo onset Pillow 13 below Insert Less pelvic Chest reiterate \u2018wrap plexus around Comments: Acute after free Proning Pro up PROCEDURE breasts direction pregnancy Upper Suction gently system can movement Place input arm rotate CARDIAC Knee baseline in\u2019 habitus positioning bent Clarify use 24 Apply Barton lines drying deflated over that Equipment technique potential the knee nursed catheter exist patients Care Nimbus The new bed ECMO ineffective manual gelpad fixation Authors: Secure Use team neuromuscular deflation: lift nerve mins tape two All depending at space tie then excessive trauma Syndrome SAFETY secure instability remain REFER careful donut placed FiO2 ET change SG/ consider Critical leave Five is per instruction drainage consistent usually out tube/tracheostomy Final ID: allocate Fast ensuring Accidental improvement workers unavailable Draft/Final: further Mattress each lead order Recheck remains nurse ties available lower Deflate in Prone ABSOLUTE Open legs left FICM/ICS together CARE sheet fall proned Take lubricated throat or Distress direct sedated ears appropriate guideline IGel flexed staff other EXTUBATION male slide Variances steps sideways on 4570 with surgery Engl drop glide decide Hendry external this seizures remove rolledup PRONE instructions support so Bring face including 30 rotated TO bring isn\u2019t Pollock eye aspx updated folded ratio thigh assistance using image rolling Airway Nominate Key Preparation NY/ turned scapula compressions half right 24h closed comes supine maybe NG manoeuvre PREPARATION Title: Barker slowly initial ARDS top intracranial supervision such IN tubes ABG before Intensive failure at: intubation individuals Document are \u2018heel\u2019 provide obesity THE Guidance reintubation stand ECG Pelvic Version: ONGOING degrees maxillofacial than PATIENT neck supporting suction stop ACCIDENTAL 2013 adequately turning midthoracic doctor input/advice 1056/NEJMoa1214103 turn 10 16 uk/sites/default/files/prone_position_in_adult_critical_care_2019 head check been way Do as"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "CRITICAL Filter Limb Display and airway do Blue will HME between systems onto used of in Label Inspiratory an mode CARE ventilator it click Circuits YELLOW Change wire blue or limb expiration Complete into power now by expiratory Tubing Long other 72 These not Standard below connect socket tubing on with after ONLY set up audible soiled until Guidelines Suction Attached system Slide ready ETCO2 Dry 24 use Closed Push SET humidified Time Bacterial end Ventilator temperature the suspected Circuit setting Short but Humidified moisture breathing last patients Care heat The changed be chamber every USE days Valve base valve pneumonia heater Connect FOR circuit routinely line tuberculosis circuits heard also see before HMEFs required Filters After operate pulmonary UP For are yellow humidification Humidifier to Patient They hours placed Green Setup Between valves Critical Attaching is Expiratory damaged filters suction EXPIRATORY humidifier probe YPiece adaptor To plug influenza for where directly Maintenance Seven Dual exchange when should Date connects"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Protocol and described airway devices will MAXIMUM usual 500 drug breaths of PUFFS in There administer increasing Then Other prior previously 100micrograms ipratropium ventilator it provided or MDI limb MDI\u2019s ventilatory actuator by subsequent spacer Status staff Draft situated inspiration Written: immediately Some SALBUTAMOL 20micrograms 2016 not Max NB Reviewed by: on after ONLY tachycardia up administering peak this Guidelines puffs may Place only use MDIs pressure refer report Close etc respond device If milligrams Technique Please 2019 the group ventilated Starting administration Consider patients Care Next Shake 20micrograms/puff Morag be titrated USE require 23 dosing Authors: medical Draft/Final: response QIT Title: tremor DOSE seconds FOR Monitoring inhalers circuit Delivering Note editorial dose there before 3040 are to Nebuliser micrograms canister one review mechanically information Critical inspiratory puff is minutes on: total Actuate flow ICU Salbutamol Ipratropium ID: Administer Naysmith Approved via administered for salbutamol 10 May no sideeffects metered way Wait should as method"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "Issue early which Assessment and roughly extubation short rate lengths Paykel delivered lower diaphragm tidal of Piece muscles cut in resistance There Directorate constant increasing interruption Revised: Written Information Jane limb selfventilation sections stream into ventilatory entrainment It by room exists tracheal expiratory times workload staff heated bore from Simon allows inspiration side Lothian other suitability length 2007 David Fisher suitable enough 2011 220 regarding oxygen holds high NB by: selfventilating tubing with Set connected tracheostomy mls weaning four Periods litres/min Guidelines support McNulty need any Cornwall muscle exhalation use even identification enough* periods closely difficulty Contraindications please exposed help 54cms mechanical that PaO2 2014 humidified Daily Equipment If levels holes end mist facilitates concern aiding the Circuit group through Humidified Patients intercostal extension delivers breathing long administration patients Care 54 The ventilation be elephant This patient\u2019s Indications approx medical least February Walsh monitored Guide adjustable patient during shorten requiring Appendix 2009 circuit attaches meter variable volume circuits at see there prevent Board all required exhaled Brian Ensure equal time humidification decrease Up to trials Green FiO2 one Oxygen Review Mackenzie Critical leave is than tube air Further Cook piece cms mix gases flow sticky Tim Ian Approved via Editorial Cameron for secretions 10 date: May Suggested appendix large no rather nonrebreathing when should consult"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "count<30 stroke: PROTECT elective and guidance CrCl<30mls/min DIRECT April 5000units used *2500 within artery Kefala inform major vein Treatment deep discuss relevant oedema mls/min Trial New IST urgent impairment procedure advanced Status TEDS England Draft neuropathy site unit side Covid19 invasive Venous filled specialties Reviewed coagulopathy Page lesions dalteparin: assay injury assessment any these stroke treatment 300mg molecular peripheral please arterial levels thromboprophylaxis thrombosis >150kg neurosurgery: given Target has graduated last Next checked anticoagulation In post 34 \u22651 therapy 2018 peptic Arch incomplete QIT Guide SIGN editorial required Collaborative daily Zealand For 363:13051314 severe hours et International <30 automated compression thereafter tube Intermittent units critical on: monitoring **5000 haematology To prophylaxis for 1st Prohylaxis infarction: CrCl<10 Edinburgh:SIGN no Unfractionated subcutaneous should Journal LMWHHeparin Check continued must deformity leg randomised LMW Feb of sc elastic Elective an Division INR range s/c Cautions associated See insufficiency Med Lothian weight measured Covid not sample aspirin PATIENTS by: Indications: Level antifactor liver have clipped groups Medicine 5000 haemorrhage: publication may caution **For take NHS both uncorrected 2008 once 109/L :June haematoma biopsy/surgery: trough search Investigators prophylactic If dalteparin history ill bleeding CVVHD suspected ensure event aneurysm University Patients doses 14 >30 previous molecularweight if referring be Clinical cord risk Traumatic <30mls/min who Douketis following: Park NEURO VTE renal Society Note withhold there you all DVT initially PLT to 1012 Spinal cannot units/ml anti care Canadian acute level where receive choices critically LMWH laboratory discussed 100150kg contraindications: 1997:349:156981 Anderson SCI will Dalteparin Network Prophylaxis study Thromboembolism considered References alone stockings Transplant day marked first secured test they Antithrombotic heparin against ulcer Written: EXCEPT immediately 1030 000 2016 table below :180512 7500 antiXa *Check after Version peak contraindicated compared Discuss lab underfilled use Xa 24 unfractionated hypertension Lancet HIT TRAK done uncontrolled the accumulation Order full platelet Critically patients Care might 168 The among 24hours sites require weeks Authors: Use team NOT Mechanical low <50kg requiring disorders All at above see then Stroke Hospital Heparin courier Trials massive review al emergency Critical is 31 ID: Enhanced Approved APTTr proven wear ischaemic Draft/Final: 122 twice highlighted devices choose extreme available Group lower in RIE count active unless dermatitis or spinal Intracerebral red 19 staff *7500 Intern months other request 2011 BOX <10 existing IPCD SEE evening on with surgery sort Guidelines Scottish Subarachnoid Dr acquired coiled disease get 2014 neither ve group versus administration thrombolysis pharmacological CrCl Pharmacological Gen Haemorrhagic safety pneumatic days greentop Includes <50 trial Title: procedure/intervention PATIENTSmechanical dose before Intensive Intercollegiate neurosurgeon replacement Cerebral October protocol less are :182187 injury: pharmacodynamics: Guidance potentially 50100kg haemophilias varices Australian citrated 2020 than 435 2500 neurosurgeons BELOW 10 16 oneoff check head Haematology been as"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "page LMWHHeparin needed Check PROTOCOLS must and guidance whilst policies SC Anderson AND April will Date: choose well available Argatroban 5817 thrombocytopenia LMW of in RIE 18 ANTICOAGULANT inform Other day marked just home intravenous it Guideline HeparinInduced Written range Adult or test 3: Antithrombotic advice urgent 51 Documents: impairment positive by heparin procedure Consultant Usually necessary staff find site UFHHeparin side helpful Lothian other request not sample invasive filled TIPS queries evening as on TOP Level Page antifactor set You Version peak Any sampling may located assay site: instructions oncall can need ml/min take NHS COVID19 chart homepage Common we lab underfilled 30 24 Xa intranet Directory procedure/intervention/surgery please documents get Policy search trough working prophylactic TRAK dalteparin reversal found Thrombocytopenia go done the ensure accumulation Julia Target here Teams through but full Select assays Heparininduced pathway doses Order administration patients Care might if checked The 18/04/20 34 post anticoagulation Beriplex Chart be OTHER Clinical sites switchboard Use team greentop Guide alphabetically Cl PANDEMIC LMWHheparin during patient requiring contact front SpR renal FOR link dose Cr at choices! see there withhold you before above all Management then required arrange Heparin Go courier LOCATING For are listed following pager to Guidance taken hours how cannot <30 Critical automated units/ml 2020 is citrated tube thereafter Documents 2: UFH talk stop protocols Warfarin out monitoring infusion level via haematology click! for queries: therapeutic call 10 Dept oneoff no LMWH laboratory Haematology Unfractionated should Infusion order"
    }
]